
<html lang="en"     class="pb-page"  data-request-id="c45c520a-43f4-4179-9d92-5676518306f7"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/jm201118h;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2012.55.issue-5"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery and Synthesis of Hydronaphthoquinones as Novel Proteasome Inhibitors" /></meta><meta name="dc.Creator" content="Yiyu  Ge" /></meta><meta name="dc.Creator" content="Aslamuzzaman  Kazi" /></meta><meta name="dc.Creator" content="Frank  Marsilio" /></meta><meta name="dc.Creator" content="Yunting  Luo" /></meta><meta name="dc.Creator" content="Sanjula  Jain" /></meta><meta name="dc.Creator" content="Wesley  Brooks" /></meta><meta name="dc.Creator" content="Kenyon G.  Daniel" /></meta><meta name="dc.Creator" content="Wayne C.  Guida" /></meta><meta name="dc.Creator" content="Saïd M.  Sebti" /></meta><meta name="dc.Creator" content="Harshani R.  Lawrence" /></meta><meta name="dc.Description" content="Screening efforts led to the identification of PI-8182 (1), an inhibitor of the chymotrypsin-like (CT-L) activity of the proteasome. Compound 1 contains a hydronaphthoquinone pharmacophore with a t..." /></meta><meta name="Description" content="Screening efforts led to the identification of PI-8182 (1), an inhibitor of the chymotrypsin-like (CT-L) activity of the proteasome. Compound 1 contains a hydronaphthoquinone pharmacophore with a t..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 14, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm201118h" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm201118h" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm201118h" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm201118h" /></link>
        
    
    

<title>Discovery and Synthesis of Hydronaphthoquinones as Novel Proteasome Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm201118h" /></meta><meta property="og:title" content="Discovery and Synthesis of Hydronaphthoquinones as Novel Proteasome Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/large/jm-2011-01118h_0009.jpeg" /></meta><meta property="og:description" content="Screening efforts led to the identification of PI-8182 (1), an inhibitor of the chymotrypsin-like (CT-L) activity of the proteasome. Compound 1 contains a hydronaphthoquinone pharmacophore with a thioglycolic acid side chain at position 2 and thiophene sulfonamide at position 4. An efficient synthetic route to the hydronaphthoquinone sulfonamide scaffold was developed, and compound 1 was synthesized in-house to confirm the structure and activity (IC50 = 3.0 ± 1.6 μM [n = 25]). Novel hydronaphthoquinone derivatives of 1 were designed, synthesized, and evaluated as proteasome inhibitors. The structure–activity relationship (SAR) guided synthesis of more than 170 derivatives revealed that the thioglycolic acid side chain is required and the carboxylic acid group of this side chain is critical to the CT-L inhibitory activity of compound 1. Furthermore, replacement of the carboxylic acid with carboxylic acid isosteres such as tetrazole or triazole greatly improves potency. Compounds with a thio-tetrazole or thio-triazole side chain in position 2, where the thiophene was replaced by hydrophobic aryl moieties, were the most active compounds with up to 20-fold greater CT-L inhibition than compound 1 (compounds 15e, 15f, 15h, 15j, IC50 values around 200 nM, and compound 29, IC50 = 150 nM). The synthetic iterations described here not only led to improving potency in vitro but also resulted in the identification of compounds that are more active such as 39 (IC50 = 0.44 to 1.01 μM) than 1 (IC50 = 3.54 to 7.22 μM) at inhibiting the proteasome CT-L activity in intact breast cancer cells. Treatment with 39 also resulted in the accumulation of ubiquitinated cellular proteins and inhibition of tumor cell proliferation of breast cancer cells. The hit 1 and its analogue 39 inhibited proteasome CT-L activity irreversibly." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm201118h"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm201118h">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm201118h&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm201118h&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm201118h&amp;href=/doi/10.1021/jm201118h" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 5</span><span class="cit-fg-pageRange">, 1978-1998</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/5" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm201489a" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm201121b" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery and Synthesis of Hydronaphthoquinones as Novel Proteasome Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yiyu++Ge">Yiyu Ge</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Aslamuzzaman++Kazi">Aslamuzzaman Kazi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Frank++Marsilio">Frank Marsilio</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yunting++Luo">Yunting Luo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sanjula++Jain">Sanjula Jain</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wesley++Brooks">Wesley Brooks</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kenyon+G.++Daniel">Kenyon G. Daniel</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wayne+C.++Guida">Wayne C. Guida</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sa%C3%AFd+M.++Sebti">Saïd M. Sebti</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Harshani+R.++Lawrence">Harshani R. Lawrence</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Drug Discovery Department, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, Florida 33612, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Chemical Biology Core, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, Florida 33612, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Department of Oncologic Sciences, University of South Florida, Tampa, Florida 33620, United States</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Department of Chemistry, University of South Florida, Tampa, Florida 33620, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: (813)-745-6076. Fax: (813)-745-6748. E-mail: <a href="/cdn-cgi/l/email-protection#3c745d4e4f545d525512705d4b4e59525f597c51535a5a55484812534e5b"><span class="__cf_email__" data-cfemail="0c446d7e7f646d626522406d7b7e69626f694c61636a6a65787822637e6b">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm201118h&amp;href=/doi/10.1021%2Fjm201118h" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 5</span><span class="cit-pageRange">, 1978–1998</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 5, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>19 August 2011</li><li><span class="item_label"><b>Published</b> online</span>14 February 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 March 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm201118h" title="DOI URL">https://doi.org/10.1021/jm201118h</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1978%26pageCount%3D21%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DYiyu%2BGe%252C%2BAslamuzzaman%2BKazi%252C%2BFrank%2BMarsilio%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D5%26contentID%3Djm201118h%26title%3DDiscovery%2Band%2BSynthesis%2Bof%2BHydronaphthoquinones%2Bas%2BNovel%2BProteasome%2BInhibitors%26numPages%3D21%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1998%26publicationDate%3DMarch%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm201118h"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2413</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">38</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm201118h" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery and Synthesis of Hydronaphthoquinones as Novel Proteasome Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Yiyu&quot;,&quot;last_name&quot;:&quot;Ge&quot;},{&quot;first_name&quot;:&quot;Aslamuzzaman&quot;,&quot;last_name&quot;:&quot;Kazi&quot;},{&quot;first_name&quot;:&quot;Frank&quot;,&quot;last_name&quot;:&quot;Marsilio&quot;},{&quot;first_name&quot;:&quot;Yunting&quot;,&quot;last_name&quot;:&quot;Luo&quot;},{&quot;first_name&quot;:&quot;Sanjula&quot;,&quot;last_name&quot;:&quot;Jain&quot;},{&quot;first_name&quot;:&quot;Wesley&quot;,&quot;last_name&quot;:&quot;Brooks&quot;},{&quot;first_name&quot;:&quot;Kenyon&quot;,&quot;last_name&quot;:&quot;G. Daniel&quot;},{&quot;first_name&quot;:&quot;Wayne&quot;,&quot;last_name&quot;:&quot;C. Guida&quot;},{&quot;first_name&quot;:&quot;Saïd&quot;,&quot;last_name&quot;:&quot;M. Sebti&quot;},{&quot;first_name&quot;:&quot;Harshani&quot;,&quot;last_name&quot;:&quot;R. Lawrence&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;14&quot;,&quot;issue&quot;:&quot;5&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;1978-1998&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm201118h&quot;},&quot;abstract&quot;:&quot;Screening efforts led to the identification of PI-8182 (1), an inhibitor of the chymotrypsin-like (CT-L) activity of the proteasome. Compound 1 contains a hydronaphthoquinone pharmacophore with a thioglycolic acid side chain at position 2 and thiophene sulfonamide at position 4. An efficient synthetic route to the hydronaphthoquinone sulfonamide scaffold was developed, and compound 1 was synthesized in-house to confirm the structure and activity (IC50 = 3.0 ± 1.6 μM [n = 25]). Novel hydronaphthoquinone derivatives of 1 were designed, synthesized, and evaluated as proteasome inhibitors. The structure–activity relationship (SAR) guided synthesis of more than 170 derivatives revealed that the thioglycolic acid side chain is required and the carboxylic acid group of this side chain is critical to the CT-L inhibitory activity of compound 1. Furthermore, replacement of the carboxylic acid with carboxylic acid isosteres such as tetrazole or triazole greatly improves potency. Compounds with a thio-tetrazole or thio-t&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm201118h&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201118h" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm201118h&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201118h" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm201118h&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201118h" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm201118h&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201118h&amp;href=/doi/10.1021/jm201118h" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm201118h" /></input><a href="/doi/pdf/10.1021/jm201118h" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm201118h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm201118h%26sid%3Dliteratum%253Aachs%26pmid%3D22220566%26genre%3Darticle%26aulast%3DGe%26date%3D2012%26atitle%3DDiscovery%2Band%2BSynthesis%2Bof%2BHydronaphthoquinones%2Bas%2BNovel%2BProteasome%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D5%26spage%3D1978%26epage%3D1998%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291012" title="Organic acids">Organic acids</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=290716" title="Sulfones">Sulfones</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/5" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jmcmar.2012.55.issue-5/production/jmcmar.2012.55.issue-5.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/medium/jm-2011-01118h_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/large/jm-2011-01118h_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201118h&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Screening efforts led to the identification of PI-8182 (<b>1</b>), an inhibitor of the chymotrypsin-like (CT-L) activity of the proteasome. Compound <b>1</b> contains a hydronaphthoquinone pharmacophore with a thioglycolic acid side chain at position 2 and thiophene sulfonamide at position 4. An efficient synthetic route to the hydronaphthoquinone sulfonamide scaffold was developed, and compound <b>1</b> was synthesized in-house to confirm the structure and activity (IC<sub>50</sub> = 3.0 ± 1.6 μM [<i>n </i>= 25]). Novel hydronaphthoquinone derivatives of <b>1</b> were designed, synthesized, and evaluated as proteasome inhibitors. The structure–activity relationship (SAR) guided synthesis of more than 170 derivatives revealed that the thioglycolic acid side chain is required and the carboxylic acid group of this side chain is critical to the CT-L inhibitory activity of compound <b>1</b>. Furthermore, replacement of the carboxylic acid with carboxylic acid isosteres such as tetrazole or triazole greatly improves potency. Compounds with a thio-tetrazole or thio-triazole side chain in position 2, where the thiophene was replaced by hydrophobic aryl moieties, were the most active compounds with up to 20-fold greater CT-L inhibition than compound <b>1</b> (compounds <b>15e</b>, <b>15f</b>, <b>15h</b>, <b>15j</b>, IC<sub>50</sub> values around 200 nM, and compound <b>29</b>, IC<sub>50</sub> = 150 nM). The synthetic iterations described here not only led to improving potency in vitro but also resulted in the identification of compounds that are more active such as <b>39</b> (IC<sub>50</sub> = 0.44 to 1.01 μM) than <b>1</b> (IC<sub>50</sub> = 3.54 to 7.22 μM) at inhibiting the proteasome CT-L activity in intact breast cancer cells. Treatment with <b>39</b> also resulted in the accumulation of ubiquitinated cellular proteins and inhibition of tumor cell proliferation of breast cancer cells. The hit <b>1</b> and its analogue <b>39</b> inhibited proteasome CT-L activity irreversibly.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec articleNote"><h4><span>⊥</span> Author Contributions</h4><p class="last">These authors contributed equally</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15673" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15673" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Regulated protein degradation is an essential aspect of cell signaling.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> In 2004, Ciechanover,<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Hershko,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> and Rose<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> were awarded the Nobel Prize for chemistry in elucidating the importance of proteolytic degradation inside cells and the role of ubiquitin in proteolytic pathways. Proteasomes are highly conserved compartmentalized protease complexes belonging to the family of N-terminal nucleophilic hydrolases.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> The proteasome degrades ubiquitinated proteins into small peptides,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> and the ubiquitin proteasome system (UPS) is responsible for the degradation of cellular proteins (e.g., potentially toxic, oxidized, misfolded proteins, and cell cycle regulatory proteins). In cancer cells, the UPS is essential to the mechanisms underlying tumorigenesis, metastasis, angiogenesis, and apoptosis.<a onclick="showRef(event, 'ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9">(7-9)</a> Therefore, targeting the regulation of protein production and degradation that mediates proliferation and other hallmarks characteristics of malignancy has been a major focus of cancer research. Since the approval of Bortezomib (Velcade) for multiple myeloma in 2003 by the FDA (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), the proteasome has been validated as an important target for cancer therapy.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> In addition, several studies have shown that proteasome inhibition is also important for inflammatory and autoimmune diseases.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11, 12)</a> Most natural and synthetic proteasome inhibitors reported to date including Bortezomib contain a reactive moiety in the pharmacophore that forms an irreversible and/or slowly reversible covalent bond with the nucleophilic N-terminal Thr in the β5 subunit of the proteasome.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a> Proteasome inhibitors reported to date fall into five classes:<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> peptide boronates, peptide aldehydes, peptide vinyl sulfones, peptide epoxyketones, and β-lactones. Peptide aldehydes and vinyl sulfones also inhibit other proteases (cathepsin A, tripeptidyl peptidase II) in addition to the proteasome.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> The β-lactone salinosporamide A<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17, 18)</a> and tetrapeptide epoxyketone Carfilzomib<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) represent two classes of irreversible and/or slowly reversible proteasome inhibitors that are in clinical trials.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> The proteolytic activity of the chymotrypsin-like (CT-L) active site (β5 subunit) of the proteasome cleaves peptides that contain amino acid residues with large hydrophobic side chains.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> The trypsin-like (T-L, β2 subunit) and postglutamylpeptidase hydrolysis (PGPH, β1 subunit) proteolytic sites of the proteasome cleave peptides after acidic and basic amino acid residues, respectively.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Therefore, the selectivity of proteasome inhibition using peptide based compounds would be hard to achieve just by simply manipulating the peptide backbone. Examples of nonpeptidic, small drug-like synthetic molecules which act as proteasome inhibitors are rare, and these molecules would have potential advantages over the existing inhibitors for therapeutic interventions. Recently, we disclosed identification of PI-083 (NSC-45382), a small synthetic molecule with a naphthoquinone pharmacophore as a reversible proteasome inhibitor that selectively targets cancer cells over nontransformed cells in vitro as well as in vivo.<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21, 22)</a> In the course of our search for new classes of inhibitors of the 20S proteasome, compound <b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) was recently identified and characterized as a “hit” for proteasome inhibition with CT-L inhibitory activity from our in-house ChemDiv library. The synthesis of compound <b>1</b> is not reported in the literature. Herein we describe an efficient synthetic route to <b>1</b> and detailed in vitro structure–activity relationship (SAR) studies of <b>1</b> via focused library synthesis as a part of our ongoing efforts in the development of proteasome inhibitors.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/medium/jm-2011-01118h_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/large/jm-2011-01118h_0012.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of representative proteasome inhibitors: Bortezomib (clinically approved), Carfilzomib (in clinical trials), and the proteasome activity profile of the “hit” <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/large/jm-2011-01118h_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201118h&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82626" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82626" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Compound <b>1</b> was recently identified in our program as a “hit” from our in-house ChemDiv 20000 compound library that showed CT-L proteasome inhibitory activity with an IC<sub>50</sub> value of 3.0 ± 1.6 (<i>n</i> = 25, >95% pure by HPLC). This result prompted us to further investigate <b>1</b> as a proteasome inhibitor and establish structure and activity relationship studies (SAR) via synthetic modifications around the hydronaphthoquinone pharmacophore. The hydronaphthoquinone pharmacophore in compound <b>1</b> exhibits desirable structural diversity that was exploited for focused library synthesis and medicinal chemistry. Synthetic modifications were primarily focused on the side chain at the 2-position of the hydronaphthoquinone pharmacophore (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), and the sulfonamide moiety of <b>1</b> to understand the structural moieties responsible for proteasome inhibition. Proposed synthetic modifications to probe binding interactions in the β5 subunit of the proteasome are described in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/medium/jm-2011-01118h_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/large/jm-2011-01118h_0013.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. A. Proposed synthetic modifications around compound <b>1</b> (hit); B. side chain at 1-position to probe interactions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/large/jm-2011-01118h_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201118h&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A synthetic route to compound <b>1</b> is not reported to the best of our knowledge. Initially, halogenated hydronaphthoquinones <b>4a</b>–<b>c</b> were synthesized starting from commercially available 4-aminonaphthol hydrochloride salt (<b>2</b>) and thiophene-2-sulfonyl chloride in good yields (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). The intermediate <b>3</b> was easily obtained with high yields (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>, <i>condition a</i>, this reaction is reported with NaHCO<sub>3</sub> as a base with moderate yields<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a>) and reacted with hydrogen peroxide and 4 M HCl in dioxane solution, similar to a literature reported protocol<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> to obtain the compound <b>4a</b>. Compounds <b>4b</b> and <b>4c</b> were also synthesized in a similar manner in the presence of bromine and iodine respectively with triethylamine in DMF (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>) according to a reported method<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> (see <sup>1</sup>H NMR and HRMS of <b>4a</b>, <b>4b</b>, and <b>4c</b> in the <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>). Our strategy was to oxidize the hydronaphthoquinone <b>4a</b> to obtain the oxidized 2-chloronaphthoquinone (structure shown for oxidized <b>4a</b> in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>) that would facilitate the synthesis of the final compound <b>1</b>. Our attempts to oxidize compound <b>4a</b> (using H<sub>2</sub>O<sub>2</sub>, Pb(OAc)<sub>4</sub>) were not successful. Furthermore, attempts to directly introduce the thioether carboxylic ester side chain in compound <b>1</b> via the intermediate <b>5</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>), similar to a reported protocol with hydrazides<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> and thiols,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> were not successful. Syntheses of derivatives of intermediate <b>5</b> are reported from derivatives of compound <b>3</b> using lead (IV) tetraacetate<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> in acetic acid, hydrogen peroxide,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> or MnO<sub>2</sub><a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> in methanol. In spite of repeated attempts, we were unable to obtain the required oxidized intermediate <b>5</b> from the hydroxynaphthalene sulfonamide intermediate <b>3</b> using these reported protocols. Our reactions produced unidentified impurities by <sup>1</sup>H NMR and TLC. Hence, this route to obtain compound <b>1</b> was abandoned.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/medium/jm-2011-01118h_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/large/jm-2011-01118h_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Hydronaphthoquinone Sulfonamide Scaffold<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/large/jm-2011-01118h_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201118h&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) thiophene-2-sulfonyl chloride, Et<sub>3</sub>N, dichloromethane, rt, 14 h, 90%; (b) for <b>4a</b>, (i) H<sub>2</sub>O<sub>2</sub> (35%), CH<sub>3</sub>OH, rt, 2 h, (ii) 4 M HCl/dioxane, rt, 2 h, 22%; for <b>4b</b>, Br<sub>2</sub>, Et<sub>3</sub>N, DMF, 0 °C to rt, 12–14 h, 36%, and for <b>4c</b>, I<sub>2</sub>, Et<sub>3</sub>N, DMF, 0 °C to rt, 12 h, 100%.</p></p></figure><div class="NLM_p">To combine the hydronaphthoquinone ring and the thioether side chain in structure <b>1</b> as required, we then validated the synthetic protocols shown in Schemes <a class="ref internalNav" href="#sch2" aria-label="2">2</a> and <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. Commercially available 1,4-naphthoquinone (<b>6</b>) (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>), 2-hydroxy-1,4-naphthoquinone (<b>7</b>) (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>), or 2-chloro-1,4-naphthoquinone (<b>12</b>) (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>) were used as starting materials. First, naphthoquinone intermediates <b>8a</b> and <b>8b</b> were obtained in good yield using ethyl 2-mercaptoacetate (one carbon side chain) or methyl 3-mercaptopropionate (2-carbon side chain), respectively, with 2 equiv of 1,4-naphthoquinone (<b>6</b>) using EtOH as the solvent. (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>, <i>condition a</i>). The intermediate <b>8c</b> was obtained via alkylation of 2-hydroxy-1,4-naphthoquinone (<b>7</b>) with <i>tert</i>-butyl bromoacetate using silver(I) oxide as a base using a reported protocol (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>, <i>condition b</i>).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> The sulfonamide building blocks that were not commercially available were synthesized according to a reported protocol.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The sulfonamide building blocks either commercially available or in-house synthesized were then regioselectively coupled to naphthoquinone intermediates <b>8a</b>–<b>c</b> according to a procedure that has been widely used in the formation of sulfonimide building blocks<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> using titanium(IV) chloride and triethylamine with conventional heating. We modified the conditions of this reaction (i.e., synthesis of intermediate <b>9</b> in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>, <i>condition c</i>) using microwave assisted heating (60 °C, 5–20 min, 26–62% yield) to accommodate parallel synthesis. This reaction was a key reaction in building the sulfonimide naphthoquinone scaffold <b>9</b> in our synthetic route to final compounds and microwave assisted heating was convenient for library synthesis. Coupling intermediates <b>8</b> with various sulfonamides proceeded regioselectively at the 4-carbonyl of the naphthoquinone ring. We observed the change of the chemical shift of hydrogen at 3-position of <b>8a</b> from 6.7 to 7.9 ppm in <b>9a</b> (see NMR spectra in <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>). However, the coupling reactions of 3-methyl substituted naphthoquinone (i.e., <b>8</b> with a methyl group at 3-position, Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>) with arylsulfonamides were not successful using this protocol, possibly due to the steric hindrance of the adjacent methyl group.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/medium/jm-2011-01118h_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/large/jm-2011-01118h_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Route to Compound 1 (Hit) and Derivatives of the Hit<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/large/jm-2011-01118h_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201118h&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) HS(CH<sub>2</sub>)<i><sub>n</sub></i>COOR<sup>1</sup> (R<sup>1</sup> = ethyl, <i>n</i> = 1 for <b>8a</b>, 89% and R<sup>1</sup> = methyl, <i>n</i> = 2 for <b>8b</b>, 94%), ethanol (2.5 mL/mmol), rt 0.5 h; (b) BrCH<sub>2</sub>COO<sup><i>t</i></sup>Bu, Ag<sub>2</sub>O, CHCl<sub>3</sub>, cat. KI, reflux under Ar, 36 h, 33%; (c) R<sup>2</sup>SO<sub>2</sub>NH<sub>2</sub>, TiCl<sub>4</sub>·2THF, Et<sub>3</sub>N, DCM, microwave, 60 °C, 5–20 min, 26–62%; (d) Na<sub>2</sub>S<sub>2</sub>O<sub>4</sub>, THF, 1 h, rt or EtOAc, H<sub>2</sub>O, rt 10 min, 59–93%; (e) oxone, H<sub>2</sub>O, acetone, rt, 12–14 h, 100%; (f) conc HCl/dioxane (1:1, 16 mL/mol), rt 3–36 h or microwave, 100 °C, 10 min, 54–97%.</p></p></figure><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/medium/jm-2011-01118h_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/large/jm-2011-01118h_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Optimized Synthetic Route to Hit and Final Compounds<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/large/jm-2011-01118h_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201118h&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) R<sup>1</sup>SO<sub>2</sub>NH<sub>2</sub>, TiCl<sub>4</sub>·2THF, or 1 M TiCL<sub>4</sub> in DCM, Et<sub>3</sub>N, THF, microwave, 60 °C, 15–30 min, 30–86%; (b) EtOH:DCM (1:1) for tetrazole-5-thiol, rt, 2 h, THF for 1-methyl-tetrazole-5-thiol or 3-mercapto-1,2,4-triazole, rt, 2 h, THF, 1 equiv pyridine for thioglycolic acid, rt, 10–30 min; (c) Na<sub>2</sub>S<sub>2</sub>O<sub>4</sub>, EtOAc, and H<sub>2</sub>O (mixing in a separating funnel), 54–100%; (d) NaN<sub>3</sub>, water, reflux 2 h, 67%; (e) TFA/anisole (5:1, 2 mL/mmol), microwave 100 °C, 2 h, 93%.</p></p></figure><div class="NLM_p">In the coupling reactions with intermediate <b>8</b>, formation of several impurities were observed by TLC, and one of the major byproduct formed was shown to be the reduced structure hydronaphthoquinone (i.e., compound <b>10</b>). We were able to isolate this impurity using SiO<sub>2</sub> chromatography and confirmed it to be, by NMR and LCMS, the hydronaphthoquinone derivative <b>10</b>. The key intermediates <b>9</b> were reduced in situ using sodium hydrosulfite<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> to hydronaphthoquinone carboxylic esters <b>10</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>, <i>condition d</i>). Hydrolysis of <b>10</b> in a 1:1 mixture of concentrated HCl and dioxane gave the final hydronaphthoquinone acid library <b>11</b> in moderate yield (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>, <i>condition f</i>). Compound <b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) was synthesized via this route to confirm the structure and CT-L proteasome inhibitory activity. The sulfone moiety in compound <b>11e</b> was formed by oxidation of compound <b>10a</b> with oxone,<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> followed by acid hydrolysis (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>, <i>conditions e and f</i>). The byproduct formation in the sulfonamide coupling reaction (i.e., step <b>c</b> in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>) made the isolation of intermediates <b>9</b> laborious and inconvenient for library synthesis. Therefore, further optimization of the synthetic route was carried out with commercially available 2-chloro-1,4-naphthoquinone (<b>12</b>) as shown in the Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>.</div><div class="NLM_p">The hydronaphthoquinone focused library <b>15</b> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>) was synthesized via coupling various sulfonamides to commercially available 2-chloro-1,4-naphthoquinone (<b>12</b>) using the same synthetic protocol validated for naphthoquinone intermediate <b>9</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>, <i>condition c</i>). The yield of this reaction was significantly improved from 56% to 83% by replacing DCM with THF (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>, <i>condition a</i>). The key intermediates <b>13</b> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>) were then easily purified by either recrystallization or triturating from appropriate solvents (see <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>), which was more convenient for library synthesis. Substitution of the 2-chlorine intermediates <b>13</b> with various nucleophiles was carried out in the presence of pyridine when thioglycolic acid was used and without a base when tetrazole-5-thiol (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>, <i>condition b</i>), 1-methyl-tetrazole-5-thiol or 3-mercapto-1,2,4-triazole (commercially available building blocks) was used to generate the library <b>14</b> with the appropriate thioether moieties.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Synthesis of the tetrazole-5-thiol building block (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>, <i>condition d</i>) was carried out from <i>para</i>-methoxybenzylisothiocyanate and sodium azide. Deprotection of the <i>para</i>-methylbenzyltetrazole intermediate was achieved with trifluoroacetic acid to synthesize the final tetrazole-5-thiol building block (<i>Caution!!! This reaction can be explosive, isolation and drying large quantities of the thiotetrazole building block should be avoided. Once prepared, the thio-tetrazole building block should be stored in a solvent until further use</i>). The final step in the Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a> involved in situ reduction of the library <b>14</b> with thioether side chains (XR<sup>2</sup> = thioglycolic acid, thiolactic acid, thiotetrazoles, thiotriazoles, thiomethyltetrazoles, thioaromatic groups, thioalkyl and thioamide side chains [not reported here]) with high yields to afford the required final library <b>15</b> with >95% purity by NMR and LCMS. The purity of the most potent biologically active thioether analogues was >95% as determined by HPLC (see <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>). Few of the intermediates of the library <b>14</b> leading to library <b>15</b> were characterized and confirmed by NMR, LCMS, and formula guided mass spectroscopy. The library members <b>15</b> with thioether side chains appeared more stable at room temperature compared to the compound bearing ether moiety (i.e., <b>11b</b>). The synthesis of the final library <b>15</b> with thioether side chains via <b>14</b> using the key naphthoquinone intermediate <b>13</b> proved to be more convenient (3 steps), and we used this optimized synthetic route to generate >170 compounds (varying the sulfonamide moiety and the side chain) including the original hit <b>1</b>.</div><div class="NLM_p">Moving the carboxylic acid side chain from the 2-position to 1-position of the naphthalene ring in compound <b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) is outlined in the Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>. Our aim was to synthesize a small number of derivatives of the hit with <i>O</i>-substituted and <i>S</i>-substituted carboxylic acid side chains at 1-position of the naphthoquinone ring to probe interactions in the CT-L subunit of the proteasome. First, compounds <b>16a</b> and <b>16b</b> were obtained by directly alkylating the compound <b>3</b> (synthesis of <b>3</b> is shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>) with 2-bromoacetate or 4-bromobutyrate using DBU (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>, <i>condition a</i>). Compound <b>3</b> was less reactive, and 15 equiv of 2-bromoacetate or 4-bromobutyrate were required to push the reactions. Acidic hydrolysis of the intermediate esters <b>16a</b> and <b>16b</b> gave <b>17a</b> and <b>17b</b>, respectively, in good yields. The synthesis of the intermediates <b>16a</b> and <b>16b</b> and the final compounds <b>17a</b> (one carbon side chain) and <b>17b</b> (3-carbon side chain) were confirmed by NMR, LCMS, and formula guided mass spectroscopy.</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/medium/jm-2011-01118h_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/large/jm-2011-01118h_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of the Thioglycolic Acid Side Chain at 1-Position<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/large/jm-2011-01118h_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201118h&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 15 equiv Br(CH<sub>2</sub>)<i><sub>n</sub></i>COOR, 2 equiv DBU, DMF, microwave, 90 °C, 50–60 min, 51%; (b) conc HCl/dioxane (1:1, 20 mL/mmol), rt, 1–12 h, 50–80%; (c) Me<sub>2</sub>NCSCl, K<sub>2</sub>CO<sub>3</sub>, NMP, 50 °C, 2 h, 90%; (d) NMP, microwave, 180 °C, 20 min, 72%; (e) (i) 4 equiv KOH, CH<sub>3</sub>OH, inert conditions, rt, 12 h, (ii) BrCH<sub>2</sub>COOC(CH<sub>3</sub>)<sub>3,</sub> rt, 12 h, 86%; (f) H-Cube, H<sub>2</sub> (40 bar, 25 °C), Pd/C (10%), CH<sub>3</sub>OH, flow rate 1 mL/min, 100%; (g) (i) pyridine, THF/H<sub>2</sub>O (4:1), 0 °C, (ii) thiophene-2-sulfonyl chloride, 0 °C → rt, 4 h, 58%.</p></p></figure><div class="NLM_p last">Reaction of commercially available 4-nitronaphthol with <i>N</i>,<i>N</i>-dimethylthiocarbamoyl chloride (Me<sub>2</sub>NCSCl) produced thiocarbamate <b>19</b> in good yield. A Newman–Kwart rearrangement was employed to build the thioether scaffold (intermediate <b>20</b> in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>, <i>condition d</i>) in the 1-position of the naphthalene ring. Hydrolysis of <i>N</i>,<i>N</i>-dimethylthioamide <b>20</b> in KOH solution (1 M, 4 equiv) under inert conditions, followed by alkylation with <i>tert</i>-butyl 2-bromoacetate, directly gave the acid intermediate <b>21</b>. Hydrogenation of the 4-nitro group using an H-cube reactor (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>, <i>condition f</i>) gave intermediate <b>22</b> in quantitative yield. The intermediate <b>22</b> was used in the final step that involved sulfonamide formation with thiophene-2-sulfonyl chloride and pyridine in an aqueous solution to afford the desired compound thioether carboxylic acid <b>23</b> in good yield. Formation of compound <b>23</b> was confirmed by NMR, LCMS, and formula guided mass spectroscopy and the purity of <b>23</b> was shown to be >95% as determined by HPLC.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37008" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37008" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The in-house synthesis (via both Schemes <a class="ref internalNav" href="#sch2" aria-label="2">2</a> and <a class="ref internalNav" href="#sch3" aria-label="3">3</a>) of compound <b>1</b> confirmed the structure and CT-L proteasome inhibitory activity (IC<sub>50</sub> = 3.0 ± 1.6 μM [<i>n</i> = 25]), which in turn allowed us to develop novel compounds with improved activity and selectivity. In an effort to determine the important moieties of the pharmacophore that are critical to its CT-L inhibitory activity and to improve its in vitro and whole cell activities, we have synthesized over 170 derivatives and performed SAR studies using a fluorogenic assay as previously described.<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21, 22)</a> In the initial screen, the % of CT-L inhibitory activity was determined, and on the basis of these results a dose–response (IC<sub>50</sub> values) was obtained for compounds that displayed >70% inhibition at 10 μM. The compounds that displayed potent CT-L inhibitory activity were also tested for in vitro trypsin-like (T-L) inhibitory activity (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21, 22)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SAR around the Side Chain S-R<sup>2</sup>, Sulfonamide Moiety R<sup>1</sup> of Compound <b>1</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/medium/jm-2011-01118h_0017.gif" alt="" id="GRAPHIC-d7e1230-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/medium/jm-2011-01118h_0006.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/medium/jm-2011-01118h_0007.gif" alt="" id="GRAPHIC-d7e1232-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/medium/jm-2011-01118h_0008.gif" alt="" id="GRAPHIC-d7e1233-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Each IC<sub>50</sub> is at least the mean of 3 determinations. ND: IC<sub>50</sub> not determined, these compounds showed less than 70% T-L inhibition at 10 μM.</p></div></div><div></div></div><div class="NLM_p">In the hit-to-lead optimization chemistry, we first investigated in detail the importance of the thioglycolic acid side chain while maintaining the thiophene sulfonamide moiety in structure <b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A). Removal of the side chain from <b>1</b> as in the 2-unsubstituted counterpart <b>3</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>, IC<sub>50</sub> > 30 μM) was not tolerated, indicating that the thioglycolic acid side chain is required for CT-L inhibitory activity. Hydronaphthoquinone analogues bearing halogens Cl, Br, and I at the 2-position <b>4a</b>, <b>4b</b>, and <b>4c</b>, respectively (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>), resulted in loss of CT-L inhibitory activity (IC<sub>50</sub> > 30 μM), further confirming the importance of the thioglycolic acid side chain. Furthermore, direct replacement of “sulfur” by “oxygen” (ether side chain, <b>11b</b> in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>) or “sulfone” (<b>11e</b> in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>) was also detrimental to CT-L inhibitory activity (IC<sub>50</sub> > 100 μM), indicating that the thio-ether moiety in compound <b>1</b> is important. The replacement of the thioglycolic acid with groups, such as <i>S</i>-ethyl, <i>O</i>-ethyl, <i>S</i>-ethanol, thio-<i>N</i>,<i>N</i>-dimethylpropionamide (S(CH<sub>2</sub>)<sub>2</sub>CO-N-Me<sub>2</sub>), and thio-<i>N</i>-methylpropionamide (S(CH<sub>2</sub>)<sub>2</sub>CO-NH-CH<sub>3</sub>), showed weaker CT-L proteasome activity (IC<sub>50</sub> > 5 μM, compounds not reported here), suggesting that the carboxylic acid moiety was essential for proteasome activity. The compound <b>10a</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>) with ethyl ester was shown to be less potent (IC<sub>50</sub> > 10 μM) than the corresponding acid, further confirming the importance of the H-bond donor/acceptor features of the carboxylic group for CT-L activity. The length of the side chain is also important, as demonstrated by the 2-fold decreased potency in the extended thioether carboxylic acid side chain as in <b>11d</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>, IC<sub>50</sub> = 5.7 μM). The position of the thioglycolic acid side chain is critical, as demonstrated by the loss of CT-L inhibitory activity (IC<sub>50</sub> >100 uM) in compound <b>23</b> (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>), where the thioglycolic acid side chain was moved from the 2 to the 1-position. Our attempts to substitute the thioglycolic acid chain of <b>1</b> with amines (not reported here) were not successful due to oxidized impurities formed in the final products. Finally, the naphthoquinone analogues of librar<b>y 14</b> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>) showed 2–3-fold weaker activity compared to the corresponding active analogues of hydronaphthoquinone library <b>15</b>, indicating that the H-bond donor properties of the hydronaphthoquinone may be important for binding interactions with the β5 subunit of the protein. The SAR studies described above demonstrate that the thioglycolic acid side chain is required for the CT-L inhibitory activity of compound <b>1</b> and that the carboxylic acid moiety in this side chain is critical. Subsequently, our chemistry efforts for side chain modifications were focused on substituting the carboxylic acid moiety with carboxylic acid isosteres such as tetrazoles or triazoles with a thioether moiety. By incorporating the tetrazole or triazole moieties, we were aiming to improve the potency, solubility, and cell permeability of this class of compounds. Replacement of the carboxylic acid moiety with tetrazole is well-known and has increasingly been used with success in drug discovery.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Comparison of carboxylic acid and tetrazole groups at physiological pH reveals that tetrazole group is almost 10 times more lipophilic while having similar acidity, p<i>K</i><sub>a</sub> = 4.9, to that observed for carboxylic acids (p<i>K</i><sub>a</sub> = 4.2–4.4).<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></div><div class="NLM_p">The replacement of the thioglycoloic acid side chain in structure <b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) with thio-tetrazole (compound <b>15d</b> in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>) showed improved CT-L inhibitory activity (IC<sub>50</sub> = 0.51 ± 0.12 μM, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Furthermore, replacement of the thioglycoloic acid side chain with thio-methyltetrazole (<b>15b</b>, Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>), thio-triazole (<b>15c</b>, Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>), and thiobenzoic acid (<b>24</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) resulted in retention of the CT-L proteasome activity (IC<sub>50</sub> = 4.2, 4.2, and 4, respectively, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). We were encouraged by these results, and our next generation of compounds (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>) were synthesized with thio-tetrazole, <i>-</i>triazole, or <i>-</i>methyl tetrazole to mimic the H-bond donor/acceptor features of the carboxylic acid moiety in our original hit. The compound <b>24</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) with thiobenzoic acid side chain was not further pursued for library synthesis due to poor solubility. In the next generation of analogues, we varied the sulfonamide moiety while keeping the thio-tetrazole, -triazole, or -methyltetrazole moieties as side chains at the 2-position of the hydronaphthoquinone pharmacophore. Compounds with thio-tetrazole and thio-triazole side chains containing biaryl sulfonamide moieties (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) displayed the best CT-L activities. For example, compounds <b>15e</b>, <b>15f</b>, <b>15h</b>, <b>15j</b>, <b>15k</b>, <b>27</b>, and <b>29</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) displayed up to 20-fold (IC<sub>50</sub> values around 150–250 nM) improved CT-L inhibitory activity. These results indicate that aromatic hydrophobic sulfonamide groups are tolerated in the binding region. Interestingly, compounds bearing 5-methyl-thio-tetrazole side chain with biaryl sulfonamide moieties (analogues of <b>15b</b> in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, not reported here) failed to improve the CT-L activity indicating that the tetrazole anion is contributing to potency (tetrazole is deprotonated at pH 7 similar to a carboxylic acid group). Overall, compounds with methyl-thiotetrazole side chain did not improve the CT-L proteasome activity.</div><div class="NLM_p">The stability of some of the potent hydronaphthoquinone analogues (<b>15f</b> and <b>25</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) with thioether side chain (thioglycolic acid, thio-tetrazole, thio-triazole) including the “hit” were examined by <sup>1</sup>H NMR in deuterated DMSO up to 3 weeks at room temperature. The HPLC and LCMS were also determined under the assay conditions (in tris buffer at room temperature). Our data concluded the hydronaphthoquinone class of compounds showed >95% purity by LCMS, HPLC, and <sup>1</sup>H NMR and were stable at room temperature for up to two weeks. Approximately 3–5% impurities (oxidized material) were shown after 2 weeks. Further analysis of stability of the compounds <b>1</b>, <b>15k</b>, and <b>39</b> was carried out using the two biological media we used for our in vivo studies (Dulbecco’s Modified Eagle Medium [DMEM] and Roswell Park Memorial Institute-1640 [RPMI1640]) without serum. Stock solutions of compounds <b>1</b>, <b>15k</b>, and <b>39</b> (1 mM solutions) were prepared using DMSO, and 10 μL aliquot of the each of the stock solution was diluted to 1 mL using the biological medium. The final concentration of each of the samples was 10 μM with 1% DMSO. These samples were left in an incubator at 37 °C and analyzed by HPLC to determine the amount of respective compound present in each sample vial at 1, 3, 5, and 7 day time intervals. The HPLC results, peak area against time were plotted as shown in the Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>, which shows the peak area of each of the compounds in either DMEM or RPMI, did not significantly change or deviate with the time. From these data we concluded compounds <b>1</b>, <b>15k</b>, and <b>39</b> were stable up to 7 days at 37 °C in the biological media we used.</div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/medium/jm-2011-01118h_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/large/jm-2011-01118h_0014.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Stability assessment of compounds <b>1</b>, <b>15k</b>, and <b>39</b> in biological medium (DMEM and RPMI-1640) up to 7 days.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/large/jm-2011-01118h_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201118h&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">One of the important aims in this study was to obtain a compound highly selective for CT-L activity. Therefore, we next determined if those compounds that are potent proteasome inhibitors are selective for CT-L over the T-L activity of the proteasome. Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> shows that most compounds were more selective for CT-L over T-L activity of the proteasome. The most potent and selective CT-L activity (28-fold, in vitro) was displayed by compound <b>29</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Interestingly, compounds <b>35</b> and <b>36</b> were equipotent against CT-L and T-L activities while compound <b>15d</b> was more selective for T-L over CT-L.</div><div class="NLM_p">Our initial goal was to identify compounds that were more potent in the primary in vitro assay as well as the cell culture assay. Our in vitro study showed several tetrazole containing analogues to be more potent than the initial hit (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). We, therefore, determined whether some of these compounds were cell permeable and could inhibit the CT-L activity of the proteasome in intact cells. Treatment of the human breast cancer cell lines MDA-MB-468 and MDA-MB-231 with various doses of <b>1</b> for 48 h resulted in inhibition of the CT-L activity in these cells with an IC<sub>50</sub> value of 7.22 and 3.54 μM, respectively. Out of several compounds tested for intact cell CT-L inhibitory activity in MDA-MB-468 and MDA-MB-231 cells, we identified <b>39</b> that potently inhibited CT-L activity with IC<sub>50</sub> values of 1.01 and 0.44 μM, respectively. To determine if the most potent compound <b>39</b> could inhibit CT-L activity at earlier time points, and if this results in the accumulation of ubiquitinated cellular proteins, we treated MDA-MB-468 cells with various concentrations of <b>39</b> for 11 h and processed the cells for CT-L assays and Western blotting as described in <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>. After 11 h of treatment, <b>39</b> inhibited CT-L activity in MDA-MB-468 cells with an IC<sub>50</sub> value of 15.6 μM (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A). Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B shows that treatment of MDA-MB-468 cells with <b>39</b> resulted in a concentration-dependent increase in ubiquitination. Finally, to determine the effects of <b>39</b> on MDA-MB-468 tumor cell proliferation, we treated the cells as described above and analyzed cell proliferation by MTT assay after 11 h. Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>C shows that <b>39</b> inhibited tumor cell proliferation with an IC<sub>50</sub> value of 17.0 μM.</div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/medium/jm-2011-01118h_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/large/jm-2011-01118h_0015.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effects of compound <b>39</b> on proteasomal CT-L activity, ubiquitination, and tumor cell viability in human breast cancer MDA-MB-468 cells. Exponentially growing human breast cancer cells were treated with different concentrations of compound <b>39</b> for 11 h, followed by measurement of CT-L activity in whole cell extracts (A), determination of ubiquitination by Western blot analysis (B), and cell viability as measured by MTT assay (C).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/large/jm-2011-01118h_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201118h&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To investigate whether compound <b>1</b>- and <b>39</b>-mediated proteasome inhibition is reversible or irreversible; we performed a dialysis experiment with compounds <b>1</b>, <b>39</b>, and Bortezomib, a covalent slowly reversible proteasome inhibitor that was used as an internal control. Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a> shows that in the absence of dialysis, <b>1</b>, <b>39</b>, and Bortezomib were able to inhibit the CT-L activity of the 20S proteasome by 68%, 73%, and 87%, respectively. During dialysis, the CT-L activity did not show any recovery in the compounds <b>1</b> and <b>39</b> treated samples. By contrast, in the Bortezomib treated samples, CT-L activity recovery started within 4 h. These results suggest that both compounds <b>1</b> and <b>39</b> behave differently than Bortezomib. It is likely that both <b>1</b> and <b>39</b> behave as irreversible CT-L proteasome inhibitors.</div><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/medium/jm-2011-01118h_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/large/jm-2011-01118h_0001.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Recovery of CT-L activity upon dialysis of the 20S proteasome–compound complexes after preincubation with Bortezomib (▲), compound <b>39</b> (■), and compound <b>1</b> (●).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/large/jm-2011-01118h_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201118h&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47443" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47443" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In this report, we describe the design and synthesis of novel class of compounds as proteasome inhibitors. The hit <b>1</b> was identified from screening of an in-house ChemDiv 20000 compound library. The synthetic route to 1-hydroxy-4-thiophenesulfonamido naphthalene-2-thioacetic acid (<b>1</b>) class of compounds was established, and analogues of <b>1</b> were shown to be potent inhibitors of CT-L activity of protesome both in vitro and in vivo. The SAR-guided lead optimization showed that incorporation of the tetrazole moiety, a carboxylic acid isostere and triazole at the 2-position of the hydronaphthoquinone moieties was crucial to achieving improved potency. The most potent compounds <b>25</b>, <b>27</b>, <b>29</b>, <b>15e</b>, <b>15f</b>, <b>15h</b>, <b>15j</b>, and <b>15k</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) with IC<sub>50</sub> values 150–300 nM were obtained with hydrophobic sulfonamide moieties. Compounds <b>1</b> and <b>39</b> (that showed improved whole cell activity) were further tested to understand the binding mode with the proteasome. It was concluded that compounds that contain 1-hydroxy-4-thiophenesulfonamidonaphthalene scaffold with 2-thoacetic acid or thio-tetrazole moieties as side chains are irreversible proteasome inhibitors. Furthermore, compound <b>39</b> was much more potent than <b>1</b> at inhibiting CT-L activity in intact human breast cancer cells. Compound <b>39</b> also induced the accumulation of ubiquitinated cellular proteins and inhibited breast tumor cell proliferation.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25470" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25470" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All reagents were purchased from commercial suppliers and used without further purification. Melting points were determined using a Barnstead international melting point apparatus and remain uncorrected. <sup>1</sup>H NMR spectra were recorded on a Varian Mercury 400 MHz spectrometer with CD<sub>2</sub>Cl<sub>2</sub>, CDCl<sub>3</sub>, CD<sub>3</sub>CN, or DMSO-<i>d</i><sub>6</sub> as the solvent. <sup>13</sup>C NMR spectra are recorded at 100 MHz. All coupling constants are measured in hertz (Hz), and the chemical shifts (δ<sub>H</sub> and δ<sub>C</sub>) are quoted in parts per million (ppm) relative to TMS (δ 0), which was used as the internal standard. The definition apparent is used as app to describe <sup>1</sup>H NMR signals. Liquid chromatography mass spectroscopy (LCMS) and high resolution mass spectroscopy (HRMS) were carried out on an Agilent 6210 LC/MS (ESI-TOF). For LCMS and HRMS, the compounds were eluted between 2 and 5 min using Rapid Resolution Cartridge (2.1 mm × 30 mm, particle size 3.5 μm) from Agilent Technologies. LCMS was used to detect ions of mass 100–1000 Da, and single peak was observed in the chromatogram after purification. HPLC was carried out using Jasco UV-2075 plus UV–vis detector (column: ultra C18, 5 μm, 150 mm × 4.6 mm). H-Cube (ThalesNano) continuous-flow hydrogenation reactor was used for hydrogenation reactions. Microwave reactions were performed in CEM Discover 908005 model and Biotage initiator 8 machines. Thin layer chromatography was performed using silica gel 60 F254 plates (Fisher), with observation under UV when necessary. Anhydrous solvents were used as purchased: dichloromethane (DCM) (anhydrous, 99.8% contains 50–150 ppm hydrocarbon as stabilizer from Aldrich), dimethyl formamide (DMF) (anhydrous, 99.9% from Aldrich), tetrahydrofuran (THF) (anhydrous, 99.9%, inhibitor free, Aldrich), acetonitrile (anhydrous, 99.8%, Aldrich), toluene (anhydrous, 99.8%, Aldrich), methanol (MeOH) (anhydrous, 99.8%, Aldrich), and ethanol (EtOH) (absolute, 99.5%, Aldrich). <i>N</i>-Methyl-2-pyrolidinone was purchased from Acros (99%) and used as a solvent. All biologically characterized compounds were >95% pure as determined by HPLC and LCMS except <b>4b</b>, <b>10a</b>, <b>10c</b>, <b>11b</b>, <b>11c</b>, <b>15b</b>, <b>15c</b>, <b>15e</b>, <b>15i</b>, <b>24</b>, and <b>37</b> that showed purity between 89 and 94% by HPLC. All biologically characterized compounds were analyzed by <sup>1</sup>H NMR, <sup>13</sup>C NMR, and HRMS (formula guided mass spectroscopy). Most of the intermediates of the library <b>14</b> were not isolated because the reaction produced a mixture of naphthoquinone sulfonimides (<b>14</b>) and hydronathoquinone sulfonamides (<b>15</b>). This mixture was treated with Na<sub>2</sub>S<sub>2</sub>O<sub>4</sub> to get the final library <b>15</b> with high purity. However, the <b>14a</b>, <b>14b</b>, and <b>14c</b> were isolated and reported here.</div><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Analysis of Stability of Compounds <b>1</b>, <b>15</b>, and <b>39</b> Using HPLC</h3><div class="NLM_p last">Using fresh powder, 1 mM stock solutions were made (in DMSO) for each compound <b>1</b>, <b>15k</b>, and <b>39</b>. Then a 10 μL aliquot from each stock solution was taken and diluted to 1 mL with biological media (DMEM and RMPI). We prepared five replicates per sample per media, and the final concentration of each solution was 10 μM with 1% DMSO. These sample solutions were incubated at 37 °C for 1, 3, 5, and 7 days, respectively. The vials containing the sample solution were taken out from the incubator at day-1, day-3, day-5, and day-7 and cooled to 0 °C in an ice bath. The sample solutions were analyzed immediately with HPLC. Peak areas were plotted against time (day). HPLC conditions: Agilent Eclipse XDB-C18, 5 μm, 4.6 mm × 150 mm, 35% CH<sub>3</sub>CN, 65% H<sub>2</sub>O (with 0.1% TFA), 1 mL/min, 30 min for compound <b>1</b>; 50% CH<sub>3</sub>CN, 50% H<sub>2</sub>O (with 0.1% TFA), 1 mL/min, 30 min for compounds <b>15k</b> and <b>39</b>.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Cell Culture and Cell Lysate Preparation and Determination of Proteolytic Activity in Cell Lysates</h3><div class="NLM_p last">Human MDA-MB-468 breast cancer cells were cultured in DMEM medium containing 10% fetal calf serum (FCS) and 100 units/mL of penicillin and 100 μg/mL of streptomycin. Cells were maintained at 37 °C in a humidified incubator in an atmosphere of 5% CO<sub>2</sub>. Cells were treated with different concentrations of compounds <b>1</b>, <b>39</b>, or vehicle control (DMSO) for 48 or 11 h. Cells were then harvested, washed with PBS twice, and homogenized in lysis buffer (50 mM Tris-HCl, pH = 8.0, 5 mM EDTA, 150 mM NaCl, 0.5% NP-40) for 30 min at 4 °C. Cell lysates were centrifuged at 12000<i>g</i> for 15 min, and the supernatants were collected as cell lysates. To determine the proteasome CT-L activity in whole cell extracts from cultured cells, we used the same method<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21, 22)</a> described for in vitro CT-L activity assay, except instead of using 20S rabbit proteasome, we used 5 μg of cell lysates.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Western Blot Analysis</h3><div class="NLM_p last">Cell lysates (30 μg) were separated by SDS-PAGE and transferred to a nitrocellulose membrane, probed with ubiquitin antibody (Santa Cruz Biotechnnology Inc. (Santa Cruz, CA), and signals were visualized by enhanced chemoluminescence (ECL, Amersham, Piscataway, NJ) according to the manufacturer’s protocol.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> MTT (3-(4,5-Dimethythiazol-2-yl)-2,5-diphenyltetrazolium bromide) Metabolism Assay</h3><div class="NLM_p last">Cells were plated in 96-well plates in 100 μL medium and allowed to attach overnight. Cells were then incubated for 11 h with varying concentrations of compound <b>39</b> and appropriate control. Media was aspirated and replaced with 100 μL of complete media containing 1 mg/mL MTT and incubated for 3 h at 37 °C in 5% CO<sub>2</sub> humidified incubator. Media was then aspirated, and DMSO was added. Cells were incubated for 10 min at room temperature while shaking, and the absorbance was determined at 540 nm using a μQuant spectrophotometric plate reader (Bio-TEK, Winooski, VT).</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Dialysis Using Purified Rabbit 20S Proteasome</h3><div class="NLM_p">To measure the effect of dialysis on CT-L activity, compounds <b>1</b>, <b>39</b>, Bortezomib (10 μM), or vehicle (0.1% DMSO) were added to rabbit 20S proteasome at a final concentration of 1.5 nM in proteasome assay buffer (50 mM Tris-HCl, pH = 7.6) and incubated at room temperature for 30 min. After 30 min of incubation, proteasome–compound mixtures were added to 3500 MWCO Thermo Scientific Slide-A-Lyzer MINI Dialysis Unit (Rockford, IL) and dialyzed against proteasome assay buffer. Immediately (<i>t</i> = 0) and 0.5 h, 1 h, 4 h, 8 h, and 18 h of dialysis at 4 °C, samples were removed from the dialysis unit and the CT-L 20S proteasome activity was determined as described previously.<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21, 22)</a> Proteasome activity was normalized against proteasome activity of DMSO control.</div><div id="sec5_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> <i>N</i>-(4-Hydroxynaphthalen-1-yl)thiophene-2-sulfonamide (<b>3</b>)</h4><div class="NLM_p last">The 4-aminonaphthol hydrochloride salt (<b>2</b>) (1.957 g, 0.01 mol) was suspended in DCM (80 mL) and added triethylamine (3.0 mL, 22 mmol) at 0 °C (the suspension became a dark brown solution). Thiophene-2-sulfonyl chloride (1.827 g, 0.01 mol) was added, and the reaction mixture was stirred at rt overnight (14 h). The reaction mixture was diluted with DCM (200 mL) washed with aqueous HCl (1 N, 30 mL × 3), water (30 mL × 3), and brine (30 mL). The organic layer was separated, dried (MgSO<sub>4</sub>), and concentrated to obtain a dark-brown solid. The crude solid was suspended in methanol/water (1:1, ∼50 mL), filtered, and washed with methanol/H<sub>2</sub>O (1:1, ∼15 mL × 2) to obtain pure compound <b>3</b> (2.7 g, 90%) as a brown solid; <i>R</i><sub>f</sub> = 0.23 (TLC, EtOAc/hexane [1:2]); mp 146–148 °C. HPLC 96% (<i>R</i><sub><i>t</i></sub> = 3.51 min, 60% CH<sub>3</sub>CN in 0.1% TFA water, 20 min). <sup>1</sup>H NMR (400 MHz, CD<sub>2</sub>Cl<sub>2</sub>) δ 7.83–1.78 (m, 2H), 7.70 (dd, <i>J</i> = 5.8, 1.2 Hz, 1H), 7.60 (dd, <i>J</i> = 3.6, 1.2 Hz, 1H), 7.49–7.42 (m, 2H), 7.07 (d, <i>J</i> = 8.0 Hz, 1H), 7.06 (dd, <i>J</i> = 5.2, 4.0 Hz 1H), 6.66 (d, <i>J</i> = 8.4 Hz, 1H), 4.30 (br s, 2H, disappeared on D<sub>2</sub>O shake). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 141.83, 138.30, 135.52, 135.19, 134.61, 128.06, 127.69, 126.93, 125.81, 124.11, 122.19, 121.18, 119.63, 108.26. LC-MS (ESI+) 306.03 (M + H)<sup>+</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>14</sub>H<sub>12</sub>NO<sub>3</sub>S<sub>2</sub> (M + H)<sup>+</sup> 306.0253, found 306.0266.</div></div><div id="sec5_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> <i>N</i>-(3-Chloro-4-hydroxynaphthalen-1-yl)thiophene-2-sulfonamide (<b>4a</b>)</h4><div class="NLM_p last">The compound <b>3</b> (987 mg, 3.2 mmol) was suspended in MeOH (10 mL), hydrogen peroxide added (35% in water, 3 mL), and stirred at rt for 2 h. Additional hydrogen peroxide (3 mL) was added, followed by HCl (4 M in dioxane, 1 mL) and continued stirring at rt for another 2 h. The organic phase was evaporated, and the residue was dissolved in ethyl acetate (100 mL) and washed with water (20 mL × 3) and brine (20 mL × 2). The organic phase was dried (Mg<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated to obtain a crude solid. The crude solid was purified using SiO<sub>2</sub> chromatography (hexane/EtOAc gradient elution) to obtain pure compound <b>4a</b> (244 mg, 22.2%) as a brown solid. <i>R</i><sub>f</sub> = 0.46 (TLC, EtOAc/hexane [1:2]); mp 113–115 °C. HPLC 98% (<i>R</i><sub>t</sub> = 6.79 min, 60% CH<sub>3</sub>CN in 0.1% TFA water, 20 min). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.79 (d, <i>J</i> = 8.4 Hz, 1H), 7.69 (d, <i>J</i> = 8.4 Hz, 1H), 7.64 (dd, <i>J</i> = 4.8, 1.1 Hz, 1H), 7.60 (dd, <i>J</i> = 4.0, 1.2 Hz, 1H), 7.44–7.35 (m, 2H), 7.19 (s, 1H), 7.02 (dd, <i>J</i> = 5.2, 4.0, Hz, 1H), 4.46 (br s, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 138.07, 137.40, 135.81, 134.98, 134.78, 127.84, 126.96, 126.92, 126.82, 123.74, 122.44, 121.08, 120.54, 111.99. LC-MS (ESI+) 339.98 (M + H)<sup>+</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>14</sub>H<sub>11</sub>ClO<sub>3</sub>S<sub>2</sub> (M + H)<sup>+</sup> 339.9863, found 339.9856.</div></div><div id="sec5_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> <i>N</i>-(3-Bromo-4-hydroxynaphthalen-1-yl)thiophene-2-sulfonamide (<b>4b</b>)</h4><div class="NLM_p last">The compound <b>3</b> (306 mg, 1 mmol) was dissolved in DMF (1 mL) at 0 °C, and Br<sub>2</sub> (320 mg in 1 mL of DCM solution, 2 mmol) was added and stirred at rt for 1 h. Triethylamine (0.558 mL, 4 mmol) was added at 0 °C and continued stirring at rt overnight (12–14 h). The reaction mixture was diluted with ethyl acetate (50 mL), washed with water (10 mL) and brine (10 mL), dried (Na<sub>2</sub>SO4), and concentrated to obtain a brown crude solid. The crude product was purified using SiO<sub>2</sub> chromatography (hexane/EtOAc gradient elution) to obtain <b>4b</b> (140 mg, 36.4%) as an orange–red solid. <i>R</i><sub>f</sub> = 0.38 (TLC, EtOAc/hexane [1:2]); mp 128–130 °C. HPLC 88% (<i>R</i><sub>t</sub> = 7.33 min, 60% CH<sub>3</sub>CN in 0.1% TFA water 20 min). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.80 (d, <i>J</i> = 7.6 Hz, 1H), 7.70 (d, <i>J</i> = 7.6 Hz, 1H), 7.66 (appdd, <i>J</i> = 4.8, 1.2 Hz, 1H), 7.61 (appdd, <i>J</i> = 4.0, 1.2 Hz, 1H), 7.47–7.39 (m, 2H), 7.32 (s, 1H), 7.04 (dd, <i>J</i> = 4.8, 3.6 Hz, 1H), 4.75 (br s, 2H). LC-MS (ESI+) 383.93 (M + H)<sup>+</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>14</sub>H<sub>11</sub>BrO<sub>3</sub>S<sub>2</sub> (M + H)<sup>+</sup> 383.9358, found 383.9348.</div></div><div id="sec5_5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> <i>N</i>-(3-Iodo-4-hydroxynaphthalen-1-yl)thiophene-2-sulfonamide (<b>4c</b>)</h4><div class="NLM_p last">This compound was prepared using the procedure described for compound <b>4b</b>, except using I<sub>2</sub> (152 mg, 0.6 mmol). The pure product <b>4c</b> (129.4 mg, 100%) was obtained as a brown solid. <i>R</i><sub>f</sub> = 0.45 (TLC, EtOAc/hexane [1:2]); mp 134–136 °C. HPLC 97% (<i>R</i><sub><i>t</i></sub> = 8.19 min, 60% CH<sub>3</sub>CN in 0.1% TFA water 20 min). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.83–7.81 (m, 1H), 7.75–7.72 (m, 1H), 7.68 (dd, <i>J</i> = 4.8, 1.2 Hz, 1H), 7.62 (dd, <i>J</i> = 4.0, 1.2 Hz, 1H), 7.46–7.41 (m, 3H), 7.06 (dd, <i>J</i> = 5.0, 3.8 Hz, 1H), 4.7 (br s, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 142.59, 137.62, 135.83, 134.95, 134.82, 128.37, 127.89, 127.83, 127.28, 126.82, 122.64, 122.62, 121.56, 75.24. LC-MS (ESI+) 431.92 (M + H)<sup>+</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>14</sub>H<sub>11</sub>IO<sub>3</sub>S<sub>2</sub> (M + H)<sup>+</sup> 431.9220, found 431.9216.</div></div><div id="sec5_5_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> Ethyl 2-(1,4-Dioxo-1,4-dihydronaphthalen-2-ylthio)acetate (<b>8a</b>)</h4><div class="NLM_p last">The 1,4-naphthoquinone (791 mg, 5 mmol) was added portionwise to EtOH (10 mL) containing ethyl mercaptoacetate (0.27 mL, 25 mmol) at room temperature. The reaction mixture was stirred at room temperature for 30 min. The yellow solid obtained was filtered, washed with ethanol, and dried under vacuum to obtain naphthoquinone intermediate <b>8a</b> (491 mg, 88.9%) as a yellow solid. <i>R</i><sub>f</sub> = 0.60 (TLC, EtOAc/hexane = 1:2); mp 150–152 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.11–8.07 (m, <i>J</i> = 7.4 Hz, 2H), 7.78–7.69 (m, 2H), 6.70 (s, 1H), 4.24 (q, <i>J</i> = 7.1 Hz, 2H), 3.66 (s, 2H), 1.31 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 182.15, 181.73, 167.68, 153.42, 134.69, 133.67, 132.27, 131.88, 128.12, 127.08, 126.84, 62.60, 33.14, 14.33. LC-MS (ESI+) 299.01 (M + Na)<sup>+</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>14</sub>H<sub>13</sub>O<sub>4</sub>S (M + H)<sup>+</sup> 277.0529, found 277.0529.</div></div><div id="sec5_5_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> Methyl 3-(1,4-Dioxo-1,4-dihydronaphthalen-2-ylthio)propanoate (<b>8b</b>)</h4><div class="NLM_p last">This compound was prepared using the procedure described for compound <b>8a</b> except using methyl 3-mercaptopropionate (1.582 g, 0.01 mol). The pure product <b>8b</b> (1.298 g, 93.9%) was obtained as a yellow solid. <i>R</i><sub>f</sub> = 0.40 (TLC, EtOAc/hexane [1:2]); mp 108–110 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.09 (t, <i>J</i> = 7.6 Hz, 2H), 7.76 (td, <i>J</i> = 7.6, 1.6 Hz, 1H), 7.71 (td, <i>J</i> = 7.6, 1.2 Hz, 1H), 6.64 (s, 1H), 3.74 (s, 3H), 3.13 (t, <i>J</i> = 7.4 Hz, 2H), 2.78 (t, <i>J</i> = 7.3 Hz, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 182.16, 181.66, 171.43, 154.29, 134.63, 133.59, 132.31, 132.02, 127.36, 127.10, 126.81, 52.42, 32.29, 25.46. LC-MS (ESI+) 299.04 (M + Na)<sup>+</sup>, 277.05 (M + H)<sup>+</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>14</sub>H<sub>13</sub>O<sub>4</sub>S (M + H)<sup>+</sup> 277.0529, found 277.0539.</div></div><div id="sec5_5_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> <i>tert</i>-Butyl 2-(1,4-Dioxo-1,4-dihydronaphthalen-2-yloxy)acetate (<b>8c</b>)</h4><div class="NLM_p last">A mixture of 2-hydroxynaphthalene-1,4-dione <b>6</b> (174.2 mg, 1.0 mmol), <i>tert</i>-butyl 2-bromoacetate (0.2 mL, 1.33 mmol), silver oxide (308 mg, 1.33 mmol), and potassium iodide (16.6 mg, 0.1 mmol) in chloroform (5 mL) was refluxed under argon atmosphere for 12 h. Additional <i>tert</i>-butyl 2-bromoacetate (1.5 mL, 10 mmol) was added, and the reaction was continued under reflux for further 24 h. The reaction mixture was filtered through a pad of Celite, washed with DCM (3 × 10 mL), and the filtrate was concentrated to obtain a gray–yellow solid. The crude product was purified using SiO<sub>2</sub> chromatography (5 g silica gel, EtOAc/hexane gradient elution) to give pure compound <b>8c</b> (93.2 mg, 32%) as a light-yellow solid. <i>R</i><sub>f</sub> = 0.50 (TLC, EtOAc/hexane [1:2]); mp 120–122 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.15 (m, 1H), 8.08 (m, 1H), 7.77–7.71 (m, 2H), 6.04 (s, 1H), 4,61 (s, 2H), 1.41 (s, 9H). LC-MS (ESI+) 233.03 (M + H-<sup><i>t</i></sup>Bu)<sup>+</sup>, 289.10 (M + H)<sup>+</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>16</sub>H<sub>17</sub>O<sub>5</sub> (M + H)<sup>+</sup> 289.1071, found 289.1090.</div></div><div id="sec5_5_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> Ethyl 2-(1-Oxo-4-(thiophen-2-ylsulfonylimino)-1,4-dihydronaphthalen-2-ylthio)acetate (<b>9a</b>)</h4><div class="NLM_p last">To a mixture of <b>8a</b> (63 mg, 0.228 mmol) and thiophene-2-sulfonamide (37 mg, 0.228 mmol) in DCM (2.5 mL) at 0 °C was added TiCl<sub>4</sub>·2THF complex (76 mg, 0.228 mmol) followed by triethylamine (70 μL, 0.5 mmol). The mixture was heated at 60 °C using the microwave reactor for 20 min. The reaction mixture was diluted with DCM (60 mL) and washed with water (∼15 mL) and brine (∼15 mL). The organic phase was separated, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated to obtain a brown crude semisolid. The crude mixture was purified using SiO<sub>2</sub> chromatography (EtOAc/hexane gradient elution) to obtain the required pure compound <b>9a</b> (58 mg, 60%) as an orange oil which solidified on standing at room temperature. <i>R</i><sub>f</sub> = 0.30 (TLC, EtOAc/hexane [1:2]); mp 110–112 °C. HPLC 95% (<i>R</i><sub>t</sub> = 4.63 min, 70% CH<sub>3</sub>CN in 0.1% TFA water, 20 min). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.22 (dd, <i>J</i> = 6.0, 3.2 Hz, 1H), 8.15 (dd, <i>J</i> = 5.6, 3.2 Hz, 1H), 7.96 (s, 1H), 7.83 (dd, <i>J</i> = 4.0, 1.6 Hz, 1H), 7.71–7.68 (m, 3H), 7.15 (dd, <i>J</i> = 5.0, 4.0 Hz, 1H), 4.31 (q, <i>J</i> = 7.2 Hz, 2H), 3.80 (s, 2H), 1.35 (t, <i>J</i> = 7.2 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 180.80, 167.34, 160.01, 153.40, 142.08, 134.42, 133.61, 133.59, 133.27, 133.00, 131.81, 127.56, 127.23, 120.91, 62.95, 33.56, 14.29. LC-MS (ESI+) 422.03 (M + H)<sup>+</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>18</sub>H<sub>16</sub>NO<sub>5</sub>S<sub>3</sub> (M + H)<sup>+</sup> 422.0185, found 422.0192.</div></div><div id="sec5_5_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> <i>tert</i>-Butyl-2-(1-oxo-4-(thiophen-2-ylsulfonylimino)-1,4-dihydronaphthalen-2-yloxy)acetate (<b>9b</b>)</h4><div class="NLM_p last">Triethylamine (0.12 mL, 0.88 mmol) was added to a mixture of <i>tert</i>-butyl 2-(1,4-dioxo-1,4-dihydronaphthalen-2-yloxy)acetate <b>8c</b> (115 mg, 0.4 mmol) and thiophene-2-sulfonamide (78 mg, 0.48 mmol) in anhydrous DCM (4 mL). TiCl<sub>4</sub>·2THF (134 mg, 0.4 mmol) was added to the reaction mixture and heated at 60 °C using the microwave reactor for 20 min. The crude mixture was poured into EtOAC (20 mL), filtered using a Celite pad, and the filtrate was concentrated and purified (SiO<sub>2</sub> chromatography, EtOAc/hexane gradient elution) to give pure compound <b>9b</b> (0.068 g, 39%) as a yellow solid; mp 153–155 °C. HPLC 94% (<i>R</i><sub>t</sub> = 4.86 min, 70% CH<sub>3</sub>CN in 0.1% TFA water 20 min). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.08–8.06 (m, 1H), 8.02–8.00 (m, 1H), 7.64 (appdd, <i>J</i> = 3.7, 1.2 Hz, 1H), 7.55–7.53 (m, 3H), 7.10 (s, 1H), 6.98 (t, <i>J</i> = 4.0 Hz, 1H), 4.58 (s, 2H), 1.39 (s, 9H). LC-MS (ESI+) 334.02 (M + H)<sup>+</sup>.</div></div><div id="sec5_5_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> Ethyl 2-(1-Oxo-4-(phenylsulfonylimino)-1,4-dihydronaphthalen-2-ylthio)acetate (<b>9c</b>)</h4><div class="NLM_p last">This compound was prepared using the procedure described for compound <b>9a</b> except using phenylsulfonamide (157 mg, 1 mmol) to give pure product <b>9c</b> (132 mg, 31.7%) as a yellow solid. <i>R</i><sub>f</sub> = 0.50 (TLC, EtOAc/hexane [1:2]); mp 93–95 °C. HPLC 95% (<i>R</i><sub><i>t</i></sub> = 5.11 min, 70% CH<sub>3</sub>CN in 0.1% TFA water 20 min). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.11 (appdd, <i>J</i> = 7.2, 2.4 Hz, 2H), 8.07 (appd, <i>J</i> = 7.2 Hz, 2H), 7.99 (s, 1H), 7.65–7.62 (m, 3H), 7.58 (appt, <i>J</i> = 8.0 Hz, 2H), 4.32 (q, <i>J</i> = 7.2 Hz, 2H), 3.81 (s, 2H), 1.34 (t, <i>J</i> = 7.2 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 180.89, 167.41, 160.31, 152.98, 141.25, 134.32, 133.74, 133.45, 133.37, 131.78, 129.26, 127.49, 127.46, 127.09, 121.29, 62.94, 33.56, 14.30. LC-MS (ESI+) 416.06 (M + H)<sup>+</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>20</sub>H<sub>18</sub>NO<sub>5</sub>S<sub>2</sub> (M + H)<sup>+</sup> 416.0621, found 416.0621.</div></div><div id="sec5_5_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> Methyl 3-(1-Oxo-4-(thiophen-2-ylsulfonylimino)-1,4-dihydronaphthalen-2-ylthio) propanoate (<b>9d</b>)</h4><div class="NLM_p last">This compound was prepared according to the procedure described for compound <b>9a</b> except using <b>8b</b> (276 mg, 1 mmol). The title compound <b>9d</b> (110 mg, 26.1%) was obtained as an orange color solid. <i>R</i><sub>f</sub> = 0.50 (TLC, EtOAc/hexane [1:2]); mp 140–142 °C. HPLC 99% (<i>R</i><sub>t</sub> = 4.47 min, 70% CH<sub>3</sub>CN in 0.1% TFA water 20 min). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.24–8.22 (m, 1H), 8.15–8.13 (m, 1H), 7.91 (s, 1H), 7.83–7.82 (m, 1H), 7.71–7.68 (m, 3H), 7.16–7.14 (m, 1H), 3.75 (s, 3H), 3.26 (t, <i>J</i> = 6.9 Hz, 2H), 2.85 (t, <i>J</i> = 6.9 Hz, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 180.79, 171.35, 160.09, 154.37, 142.10, 134.39, 133.63, 133.53, 133.23, 132.95, 131.99, 127.59, 127.57, 127.23, 120.19, 52.46, 32.07, 25.88. LC-MS (ESI+) 422.03 (M + H)<sup>+</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>18</sub>H<sub>16</sub>NO<sub>5</sub>S<sub>3</sub> (M + H)<sup>+</sup> 422.0185, found 422.0181.</div></div><div id="sec5_5_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Ethyl 2-(1-Hydroxy-4-(thiophene-2-sulfonamido)naphthalen-2-ylthio)acetate (<b>10a</b>)</h4><div class="NLM_p last">The (<i>E</i>)-ethyl 2-(1-oxo-4-(thiophen-2-ylsulfonylimino)-1,4-dihydronaphthalen-2-ylthio)acetate (<b>9a)</b> (52 mg, 0.123 mmol) was dissolved in THF (2 mL), and  Na<sub>2</sub>S<sub>2</sub>O<sub>4</sub> (107 mg, 0.62 mmol in 2 mL of water) was added. The biphasic mixture obtained was stirred at rt for 1 h until it turned pale yellow. The mixture was diluted with ethyl acetate (∼30 mL) and washed with water (∼10 mL) and brine (∼10 mL). The organic phase was dried (Na<sub>2</sub>SO<sub>4</sub>) and filtered, and the filtrate was concentrated. The crude product obtained was purified (SiO<sub>2</sub> chromatography, EtOAc/hexane gradient elution) to obtain pure <b>10a</b> (0.025 g, 58.7%) as an off-white solid. <i>R</i><sub>f</sub> = 0.25 (TLC, EtOAc/hexane [1:2]); mp 116–118 °C. HPLC 93% (<i>R</i><sub>t</sub> = 4.72 min, 60% CH<sub>3</sub>CN in 0.1% TFA water 20 min). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.42 (s, 1H), 8.29 (dd, <i>J</i> = 6.3, 3.2 Hz, 1H), 7.80 (dd, <i>J</i> = 6.3, 3.1 Hz, 1H), 7.52 (d, <i>J</i> = 4.0 Hz, 1H), 7.48 (dd, <i>J</i> = 6.4, 3.2 Hz, 2H), 7.38 (d, <i>J</i> = 2.4 Hz, 1H), 7.34 (s, 1H), 6.95 (t, <i>J</i> = 4.8 Hz, 1H), 6.7 (br s, 1H), 4.18 (q, <i>J</i> = 7.1 Hz, 2H), 3.48 (s, 2H), 1.21 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 171.46, 155.83, 139.71, 133.32, 132.69, 131.87, 128.70, 127.59, 126.46, 124.78, 124.05, 123.41, 122.18, 110.19, 62.75, 39.73, 14.24. LC-MS (ESI+) 441.05 (M + NH<sub>4</sub>)<sup>+</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>18</sub>H<sub>18</sub>NO<sub>5</sub>S<sub>3</sub> (M + H)<sup>+</sup> 424.0342, found 424.0335.</div></div><div id="sec5_5_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> <i>tert</i>-Butyl-2-(1-hydroxy-4-(thiophene-2-sulfonamido)naphthalen-2-yloxy)acetate (<b>10b</b>)</h4><div class="NLM_p last">The <i>tert</i>-butyl-2-(1-oxo-4-(thiophen-2-ylsulfonylimino)-1,4-dihydronaphthalen-2-yloxy)acetate <b>9b</b> (70 mg, 0.16 mmol) was dissolved in THF (3 mL) and stirred at rt for 5 min. The Na<sub>2</sub>S<sub>2</sub>O<sub>4</sub> (139 mg, 0.8 mmol) and water (1 mL) was added to the mixture and stirred vigorously until Na<sub>2</sub>S<sub>2</sub>O<sub>4</sub> was completely dissolved. The reaction mixture was further stirred at rt for 10 min. The color changed from orange to light yellow. EtOAc (40 mL) was added into the mixture and washed with water (40 mL) followed by brine. The organic phase was dried (MgSO<sub>4</sub>) and filtered, and the filtrate was concentrated. The required product <b>10b</b> was obtained by crystallization with EtOAc/hexane as a light-yellow solid (50 mg, 71%); mp = 155–157 °C. HPLC 96% (<i>R</i><sub>t</sub> = 3.39 min, 70% CH<sub>3</sub>CN in 0.1% TFA water 20 min). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.52 (br s, 1H, disappeared on D<sub>2</sub>O shake), 8.24 (d, <i>J</i> = 8.4 Hz, 1H), 7.54 (d, <i>J</i> = 8.0 Hz, 1H), 7.46 (dd, <i>J</i> = 4.8, 1.3 Hz, 1H), 7.44–7.40 (m, 1H), 7.35–7.29 (m, 2H), 7.23 (s, 1H), 6.90 (dd, <i>J</i> = 5.2, 4.0 Hz, 1H), 6.68 (s, 1H, disappeared on D<sub>2</sub>O shake), 4.53 (s, 2H), 1.50 (s, 9H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 171.34, 143.83, 140.29, 139.79, 133.09, 132.62, 127.98, 127.54, 126.44, 125.97, 125.64, 123.13, 122.78, 121.04, 119.32, 84.20, 71.12, 28.29. LC-MS (ESI−) 434.07 (M – H)<sup>−</sup>. HRMS (ESI−) <i>m</i>/<i>z</i> calculated for C<sub>20</sub>H<sub>20</sub>NO<sub>6</sub>S<sub>2</sub> (M – H)<sup>−</sup> 434.0738, found 434.0755.</div></div><div id="sec5_5_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> Ethyl 2-(1-Hydroxy-4-(phenylsulfonamido)naphthalen-2-ylthio)acetate (<b>10c</b>)</h4><div class="NLM_p last">This compound was prepared using the procedure described for <b>10a</b> except using the starting material <b>9c</b> (83 mg, 0.2 mmol). The title compound <b>10c</b> was obtained as a pale-yellow solid (68 mg, 81.5%). <i>R</i><sub>f</sub> = 0.22 (TLC, EtOAc/hexane [1:2]); mp 118–120 °C. HPLC 92% (<i>R</i><sub>t</sub> = 5.04 min, 60% CH<sub>3</sub>CN in 0.1% TFA water 20 min). <sup>1</sup>H NMR (400 MHz, CD<sub>2</sub>Cl<sub>2</sub>) δ 8.51 (s, 1H), 8.27–8.24 (m, 1H), 7.87–7.85 (m, 1H), 7.69 (d, <i>J</i> = 7.4 Hz, 2H), 7.56 (t, <i>J</i> = 7.2 Hz, 1H), 7.51–7.47 (m, 2H), 7.43 (t, <i>J</i> = 7.9 Hz, 2H), 7.17 (s, 1H), 6.59 (br s, 1H), 4.17 (q, <i>J</i> = 7.1 Hz, 2H), 3.43 (s, 2H), 1.21 (t, <i>J</i> = 7.2 Hz, 3H). LC-MS (ESI+) 440.07 (M + Na)<sup>+</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>20</sub>H<sub>19</sub>NNaO<sub>5</sub>S<sub>2</sub> (M + Na)<sup>+</sup> 440.0597, found 440.0596.</div></div><div id="sec5_5_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> Methyl 3-(1-Hydroxy-4-(thiophene-2-sulfonamido)naphthalen-2-ylthio)propanoate (<b>10d</b>)</h4><div class="NLM_p last">This compound was prepared using the procedure described for <b>10a</b> except using starting material <b>9d</b> (30 mg, 0.071 mmol). The title compound <b>10d</b> was obtained without any purification as a pale-yellow solid (28 mg, 93%). <i>R</i><sub>f</sub> = 0.20 (TLC, EtOAc/hexane [1:2]); mp 117–119 °C. HPLC 97% (<i>R</i><sub><i>t</i></sub> = 4.09 min, 60% CH<sub>3</sub>CN in 0.1% TFA water 20 min). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.25 (dd, <i>J</i> = 6.4, 3.2 Hz, 1H), 7.87 (dd, <i>J</i> = 6.4, 3.2 Hz, 1H), 7.60 (br s, 1H), 7.52–7.48 (m, 3H), 7.41 (dd, <i>J</i> = 3.6 1.2 Hz, 1H), 7.32 (s, 1H), 6.95 (dd, <i>J</i> = 4.8, 3.6 Hz, 1H), 6.91 (br s, 1H), 3.70 (s, 3H), 2.93 (t, <i>J</i> = 7.1 Hz, 2H), 2.51 (t, <i>J</i> = 7.0 Hz, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 172.41, 154.89, 139.74, 133.29, 132.77, 132.48, 131.35, 128.54, 127.60, 126.54, 124.24, 123.76, 123.51, 122.35, 109.96, 52.31, 34.09, 31.79. LC-MS (ESI+) 446.01 (M + Na)<sup>+</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>18</sub>H<sub>17</sub>NNaO<sub>5</sub>S<sub>3</sub> (M + Na)<sup>+</sup> 446.0161, found 446.0157.</div></div><div id="sec5_5_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> Ethyl 2-(1-Hydroxy-4-(thiophene-2-sulfonamido)naphthalen-2-ylsulfonyl)acetate (<b>10e</b>)</h4><div class="NLM_p last">Ethyl 2-(1-hydroxy-4-(thiophene-2-sulfonamido)naphthalen-2-ylthio)acetate (<b>10a</b>) (42.4 mg, 0.1 mmol) was dissolved in acetone (2 mL), to which was added oxone (307.4 mg in 2 mL of aqueous solution). The resulting mixture was stirred at rt overnight (12–14 h). The organic solvent was evaporated, and the aqueous phase was extracted with ethyl acetate. The combined organic extracts were washed with water and brine and dried over Na<sub>2</sub>SO<sub>4</sub>. The organic phase was filtered, and the filtrate was concentrated to obtain <b>10e</b> (47 mg, 100%) as a pale-yellow solid; mp 154–156 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>), δ 10.02 (s, 1H), 8.43 (d, <i>J</i> = 8.4 Hz, 1H), 7.98 (d, <i>J</i> = 8.4 Hz, 1H), 7.70 (t, <i>J</i> = 8.0 Hz, 1H), 7.62 (td, <i>J</i> = 8.0, 0.8 Hz, 1H), 7.58 (appdd, <i>J</i> = 5.0, 1.2 Hz, 1H), 7.43 (appdd, <i>J</i> = 4.0, 1.6 Hz, 1H), 7.29 (s, 1H), 7.00 (dd, <i>J</i> = 4.8, 3.6 Hz, 1H), 6.58 (s, 1H), 4.16 (q, <i>J</i> = 7.2 Hz, 2H), 4.12 (s, 2H), 1.15 (t, <i>J</i> = 7.2 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>2</sub>Cl<sub>2</sub>) δ 162.16, 155.75, 139.23, 134.91, 133.62, 133.21, 131.25, 127.86, 127.66, 125.75, 124.53, 124.26, 122.85, 122.26, 112.67, 63.05, 61.22, 13.77. LC-MS (ESI−) 454.01 (M – H)<sup>−</sup>. HRMS (ESI−) <i>m</i>/<i>z</i> calculated for C<sub>18</sub>H<sub>17</sub>NO<sub>7</sub>S<sub>3</sub> (M – H)<sup>−</sup> 454.0094, found 454.0112.</div></div><div id="sec5_5_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 2-(1-Hydroxy-4-(thiophene-2-sulfonamido)naphthalen-2-ylthio)acetic Acid <b>11a</b> (Compound <b>1</b>)</h4><div class="NLM_p last">The ethyl 2-(1-hydroxy-4-(thiophene-2-sulfonamido)naphthalen-2-ylthio)acetate (<b>10a)</b> (8 mg, 0.019 mmol) was dissolved in dioxane, (0.5 mL) and HCl (0.5 mL, 4 N) added. The reaction mixture was heated at 100 °C using the microwave reactor for 10 min and diluted with ethyl acetate (20 mL) and washed with water and brine. The organic phase was dried (Na<sub>2</sub>SO<sub>4</sub>) and filtered, and the filtrate was concentrated to afford the title compound as a pale-yellow solid (6 mg, 80%). <i>R</i><sub>f</sub> = 0.25 (TLC, CH<sub>3</sub>OH/DCM [1:10]); mp 175–177 °C. HPLC 97% (<i>R</i><sub>t</sub> = 15.6 min, 35% CH<sub>3</sub>CN in 0.1% TFA water, 30 min). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.08 (s, 1H, disappeared on D<sub>2</sub>O shake), 9.87 (br s, 1H, disappeared on D<sub>2</sub>O shake), 8.13 (d, <i>J</i> = 8.0 Hz, 1H), 7.85–7.83 (m, 1H, 2H), 7.48–7.39 (m, 2H), 7.33 (dd, <i>J</i> = 4.0, 1.6 Hz, 1H), 7.06–7.03 (m, 2H), 3.52 (s, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 171.11, 152.44, 140.21, 133.13, 132.38, 131.31, 129.38, 127.61, 126.78, 125.82, 125.05, 123.95, 123.21, 122.41, 112.95, 36.83. LC-MS (ESI−) 393.99 (M – H)<sup>−</sup>. HRMS (ESI−) <i>m</i>/<i>z</i> calculated for C<sub>16</sub>H<sub>12</sub>NO<sub>5</sub>S<sub>3</sub> (M – H)<sup>−</sup> 393.9883, found 393.9885.</div></div><div id="sec5_5_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 2-(1-Hydroxy-4-(thiophene-2-sulfonamido)naphthalen-2-yloxy)acetic Acid (<b>11b</b>)</h4><div class="NLM_p last">The <i>tert</i>-butyl-2-(1-hydroxy-4-(thiophene-2-sulfonamido)naphthalen-2-yloxy)acetate (<b>10b</b>) (0.025 g, 0.057 mmol) was dissolved in dioxane and concentrated hydrochloric acid (dioxane/ HCl, 1:1, 4 mL) and stirred at rt for 3 h (the solution changed from clear to white cloudy). The solvent was evaporated, and the solid obtained was washed with DCM and hexane separately to get pure product as a gray solid (0.021 g, 97%); mp = 155–157 °C. HPLC 90% (<i>R</i><sub>t</sub> = 6.48 min, 40% CH<sub>3</sub>CN in 0.1% TFA water 20 min). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.08 (s, 1H, disappeared on D<sub>2</sub>O shake), 9.68 (br s, 1H, disappeared on D<sub>2</sub>O shake), 8.04 (d, <i>J</i> = 8.8 Hz, 1H), 7.82 (d, <i>J</i> = 4.0 Hz, 1H), 7.67 (d, <i>J</i> = 8.0 Hz, 1H), 7.38 (t, <i>J</i> = 7.2 Hz, 1H), 7.33 (appd, <i>J</i> = 2.4 Hz, 1H), 7.27 (t, <i>J</i> = 7.2 Hz, 1H), 7.03 (appt, <i>J</i> = 4.0 Hz, 1H), 6.89 (s, 1H), 4.55 (s, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 171.66, 141.36, 140.97, 140.60, 133.76, 132.95, 128.26, 127.96, 125.98, 125.94, 125.26, 123.74, 123.56, 122.26, 117.23, 68.16. LC-MS (ESI−) 378.01 (M – H)<sup>−</sup>. HRMS (ESI−) <i>m</i>/<i>z</i> calculated for C<sub>16</sub>H<sub>12</sub>NO<sub>6</sub>S<sub>2</sub> (M – H)<sup>−</sup> 378.0112, found 378.0117.</div></div><div id="sec5_5_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 2-(1-Hydroxy-4-(phenylsulfonamido)naphthalen-2-ylthio)acetic Acid (<b>11c</b>)</h4><div class="NLM_p last">This compound was prepared using the procedure described for <b>11a</b> except using <b>10c</b> (40 mg, 0.096 mmol) at rt overnight (12–14 h). The title compound was obtained as an off-white solid (20 mg, 53.6%); mp 100–102 °C. HPLC 94% (<i>R</i><sub>t</sub> = 9.3 min, 40% CH<sub>3</sub>CN in 0.1% TFA water, 40 min). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.75 (br s, 1H), 9.91 (s, 1H), 9.80 (br s, 1H), 8.10 (d, <i>J</i> = 8.1 Hz, 1H), 7.83 (d, <i>J</i> = 8.3 Hz, 1H), 7.60 (d, <i>J</i> = 7.7 Hz, 2H), 7.56 (d, <i>J</i> = 7.3 Hz, 1H), 7.46 (t, <i>J</i> = 7.6 Hz, 2H), 7.39–7.36 (m, 2H), 6.96 (s, 1H), 3.47 (s, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 171.74, 152.82, 140.39, 133.31, 131.82, 129.79, 129.72, 127.51, 127.33, 126.45, 125.71, 124.82, 124.02, 123.02, 113.60, 37.40. LC-MS (ESI−) 388.03 (M – H)<sup>−</sup>. HRMS (ESI−) <i>m</i>/<i>z</i> calculated for C<sub>18</sub>H<sub>14</sub>NO<sub>5</sub>S<sub>2</sub> (M – H)<sup>−</sup> 388.0319, found 388.0330.</div></div><div id="sec5_5_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 3-(1-Hydroxy-4-(thiophene-2-sulfonamido)naphthalen-2-ylthio)propanoic Acid (<b>11d</b>)</h4><div class="NLM_p last">This compound was prepared using the procedure described for <b>11a</b> except using <b>10d</b> (43 mg, 0.1 mmol) at rt overnight (12–14 h). The title compound was obtained as a white solid (38 mg, 90.4%); mp 185 °C (dec.). HPLC 96% (<i>R</i><sub>t</sub> = 8.8 min, 40% CH<sub>3</sub>CN in 0.1% TFA water, 40 min). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.35 (s, 1H), 10.07 (s, 1H), 9.70 (br s, 1H), 8.13 (d, <i>J</i> = 7.6 Hz, 1H), 7.91 (d, <i>J</i> = 7.8 Hz, 1H), 7.85 (td, <i>J</i> = 4.8, 0.5 Hz, 1H), 7.49–7.42 (m, 2H), 7.34 (td, <i>J</i> = 4.0, 1.6 Hz, 1H), 7.07–7.05 (m, 1H), 6.96 (s, 1H), 2.84 (t, <i>J</i> = 7.6 Hz, 2H), 2.37 (t, <i>J</i> = 6.8 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 173.40, 153.02, 140.76, 133.87, 133.07, 131.86, 129.69, 128.30, 127.31, 126.49, 125.77, 124.67, 124.06, 123.05, 113.58, 34.61, 29.92. LC-MS (ESI−) 408.00 (M – H)<sup>−</sup>. HRMS (ESI−) <i>m</i>/<i>z</i> calculated for C<sub>17</sub>H<sub>14</sub>NO<sub>5</sub>S<sub>3</sub> (M – H)<sup>−</sup> 408.0040, found 408.0054.</div></div><div id="sec5_5_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 2-(1-Hydroxy-4-(thiophene-2-sulfonamido)naphthalen-2-ylsulfonyl)acetic Acid (<b>11e</b>)</h4><div class="NLM_p last">Ethyl 2-(1-hydroxy-4-(thiophene-2-sulfonamido)naphthalen-2-ylsulfonyl)-acetate (<b>10e</b>) (20 mg, 0.044 mmol) was dissolved in dioxane (2 mL) and conc HCl (2 mL) added. The mixture was stirred at rt for 36 h. The solvent was removed using the rotary evaporator, and the solid obtained was washed with dichloromethane affording title compound <b>11e</b> (18.3 mg, 97.3%) as an off-white solid, mp 210–212 °C. HPLC 97% (<i>R</i><sub>t</sub> = 7.45 min, 35% CH<sub>3</sub>CN in 0.1% TFA water, 20 min). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.62 (br s, 1H), 10.24 (s, 1H), 8.37 (d, <i>J</i> = 7.6 Hz, 1H), 7.97 (d, <i>J</i> = 7.6 Hz, 1H), 7.86 (dd, <i>J</i> = 5.2, 0.8 Hz, 1H), 7.64–7.58 (m, 2H), 7.35 (s, 1H), 7.33 (dd, <i>J</i> = 4.0, 0.8 Hz, 1H), 7.05 (dd, <i>J</i> = 4.9, 3.9 Hz, 1H), 4.52 (s, 2H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ 164.35, 154.42, 139.92, 135.05, 132.84, 132.62, 129.98, 127.39, 126.83, 125.81, 124.99, 123.52, 123.48, 122.58, 115.59, 59.78. LC-MS (ESI−) 426.00 (M – H)<sup>−</sup>. HRMS (ESI−) <i>m</i>/<i>z</i> calculated for C<sub>16</sub>H<sub>13</sub>NO<sub>7</sub>S<sub>3</sub> (M – H)<sup>−</sup> 425.9781, found 425.9788.</div></div><div id="sec5_5_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> <i>N</i>-(3-Chloro-4-oxonaphthalen-1(4<i>H</i>)-ylidene)thiophene-2-sulfonamide (<b>13a</b>)</h4><div class="NLM_p last">The 2-chloro-1,4-naphthoquinone <b>12</b> (385 mg, 2 mmol) was added to thiophene-2-sulfonamide (326 mg, 2 mmol) in DCM (15 mL) at 0 °C, followed by TiCl<sub>4</sub> (2 mL, 1 M solution in DCM) and TEA (0.613 mL, 4.4 mmol). The mixture was heated at 60 °C using the microwave reactor for 15 min, and the black mixture obtained was poured into ethyl acetate (100 mL). The insoluble particles were removed by filtering through a pad of Celite. The filtrate was concentrated, and the residue obtained was suspended in DCM (100 mL). The brown insoluble particles were removed by filtration, and the filtrate was again concentrated to dryness. The residue was suspended in ethyl acetate/hexane (1:1–20 mL), and the yellow solid obtained was filtered. The solid was washed with ethyl acetate/hexane (1:1, 5 mL × 2) and dried under vacuum to afford the title compound as a yellow solid (378 mg, 55.9%). When TiCl<sub>4</sub>·2THF (668 mg, 2 mol), TEA (0.615 mL, 4.4 mmol), and THF (15 mL) were used instead of TiCl<sub>4</sub> in DCM, the reaction afforded the title compound with better yields also as a yellow solid (522 mg 77.3%). <i>R</i><sub>f</sub> = 0.53 (TLC, EtOAc/hexane [1:2]); mp 167–169 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.62 (s, 1H), 8.24–8.20 (m, 2H), 7.86 (dd, <i>J</i> = 3.6, 1.2 Hz, 1H), 7.78–7.70 (m, 3H), 7.18 (dd, <i>J</i> = 4.8, 3.6 Hz, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 177.11, 160.88, 145.59, 141.08, 134.45, 134.28, 134.04, 133.81, 132.98, 131.61, 129.60, 128.16, 127.73, 127.24. LC-MS (ESI+) 355.00 (M + NH<sub>4</sub>)<sup>+</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>14</sub>H<sub>9</sub>ClNO<sub>3</sub>S<sub>2</sub> (M + H)<sup>+</sup> 337.9707, found 337.9708.</div></div><div id="sec5_5_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> <i>N</i>-(3-Chloro-4-oxonaphthalen-1(4<i>H</i>)-ylidene)biphenyl-4-sulfonamide (<b>13b</b>)</h4><div class="NLM_p last">This compound was prepared using the procedure described for <b>13a</b> except using 4-biphenylsulfonamide (233 mg, 1 mmol). The title compound <b>13b</b> was obtained as a yellow solid (154 mg, 37.8%). When TiCl<sub>4</sub>·2THF (668 mg, 2 mmol), TEA (0.615 mL, 4.4 mmol), and THF (15 mL) were used in the reaction, the title compound <b>13b</b> was obtained also as a yellow solid with improved yield (586.7 mg, 71.9%). <i>R</i><sub>f</sub> = 0.60 (TLC, EtOAc/hexane [1:2]); mp 190–192 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.71 (s, 1H), 8.24 (appt, <i>J</i> = 8.8 Hz, 2H), 8.14 (d, <i>J</i> = 8.6 Hz, 2H), 7.81 (d, <i>J</i> = 8.6 Hz, 2H), 7.74 (td, <i>J</i> = 7.2, 1.6 Hz, 1H), 7.69 (td, <i>J</i> = 8.0, 2.0 Hz, 1H), 7.64 (d, <i>J</i> = 8.0 Hz, 2H), 7.51 (t, <i>J</i> = 6.8 Hz, 2H), 7.46–7.43 (m, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 177.21, 161.14, 146.82, 145.33, 139.40, 138.95, 134.37, 134.14, 133.12, 131.59, 129.91, 129.35, 128.93, 128.26, 128.11, 128.04, 127.64, 127.14. LC-MS (ESI+) 425.06 (M + NH<sub>4</sub>)<sup>+</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>22</sub>H<sub>15</sub>ClNO<sub>3</sub>S (M + H)<sup>+</sup> 408.0456, found 408.0460.</div></div><div id="sec5_5_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> <i>N</i>-(3-Chloro-4-oxonaphthalen-1(4<i>H</i>)-ylidene)-5-phenylthiophene-2-sulfonamide (<b>13c</b>)</h4><div class="NLM_p last">This compound was prepared using the procedure described for <b>13a</b> except using 5-phenylthiophene-2-sulfonamide (477 mg, 2 mmol), TiCl<sub>4</sub> (2 mL, 1 M solution in DCM), TEA (0.615 mL, 4.4 mol), and THF (15 mL) as the solvent. The title compound was obtained as an orange solid (520 mg, 63.0%); mp 112.4 °C (dec.). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.65 (s, 1H), 8.27–8.25 (m, 1H), 8.22–8.19 (m, 1H), 7.81 (d, <i>J</i> = 4.0 Hz, 1H), 7.77–7.70 (m, 2H), 7.65 (dd, <i>J</i> = 8.4, 1.6 Hz, 2H), 7.47–7.41 (m, 3H), 7.32 (d, <i>J</i> = 3.6 Hz, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 177.14, 160.72, 153.69, 145.55, 138.88, 134.73, 134.45, 134.25, 133.03, 132.73, 131.62, 129.73, 129.54, 129.52, 128.15, 127.28, 126.65, 123.29. LC-MS (ESI+) 414.00 (M + H)<sup>+</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>20</sub>H<sub>13</sub>ClNO<sub>3</sub>S<sub>2</sub> (M + H)<sup>+</sup> 414.0020, found 414.0018.</div></div><div id="sec5_5_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> <i>N</i>-(3-Chloro-4-oxonaphthalen-1(4<i>H</i>)-ylidene)-4-phenoxybenzenesulfonamide (<b>13d</b>)</h4><div class="NLM_p last">This compound was prepared using the procedure described for <b>13a</b> except using 4-phenoxyphenylesulfonamide (434 mg, 2 mmol), TiCl<sub>4</sub> (2 mL, 1 M solution in DCM), TEA (0.615 mL, 4.4 mmol), and THF (15 mL) as the solvent. The title compound was obtained as a yellow solid, (526 mg, 67.2%) mp 124.8 °C (dec.). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.67 (s, 1H), 8.19 (appdd, <i>J</i> = 7.6, 1.6 Hz, 1H), 8.16 (appdd, <i>J</i> = 7.6, 1.6 Hz, 1H), 8.00 (d, <i>J</i> = 9.2 Hz, 2H), 7.73 (td, <i>J</i> = 7.6, 1.6 Hz, 1H), 7.67 (td, <i>J</i> = 7.6, 1.6 Hz, 1H), 7.44–7.40 (m, 2H), 7.26–7.22 (m, 1H), 7.15–7.08 (m, 4H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 177.22, 162.67, 160.78, 155.11, 145.21, 134.33, 134.08, 133.81, 133.15, 131.58, 130.48, 130.09, 129.78, 128.08, 127.07, 125.42, 120.69, 117.76. LC-MS (ESI+) 424.03 (M + H)<sup>+</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>22</sub>H<sub>15</sub>ClNO<sub>4</sub>S (M + H)<sup>+</sup> 424.0405, found 424.0403.</div></div><div id="sec5_5_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> <i>N</i>-(3-Chloro-4-oxonaphthalen-1(4<i>H</i>)-ylidene)naphthalene-2-sulfonamide (<b>13e</b>)</h4><div class="NLM_p last">This compound was prepared using the procedure described for <b>13a</b> except using naphthalene-2-sulfonamide (415 mg, 2 mmol), TiCl<sub>4</sub>·2THF (668 mg, 2 mmol), TEA (0.615 mL, 4.4 mmol), and THF (15 mL) as the solvent. The title compound was obtained as a yellow solid (0. 595 g, 77.9%). <i>R</i><sub>f</sub> = 0.55 (TLC, EtOAc/hexane [1:2]); mp 200–202 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.73 (s, 1H), 8.64 (s, 1H), 8.20 (appd, 7.6 Hz, 1H), 8.14 (appd, <i>J</i> = 8.0 Hz, 1H), 8.05–8.03 (m, 3H), 7.96 (d, 8.4 Hz, 1H), 7.72 (appq, <i>J</i> = 7.4 Hz, 2H), 7.66 (appt, <i>J</i> = 7.1 Hz, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 177.05, 160.98, 145.15, 137.09, 135.34, 134.38, 134.14, 132.92, 132.11, 131.42, 129.77, 129.64, 129.57, 129.00, 128.15, 127.95, 127.04, 122.61. LC-MS (ESI+) 382.03 (M + H)<sup>+</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>20</sub>H<sub>13</sub>ClNO<sub>3</sub>S (M + H)<sup>+</sup> 382.0299, found 382.0301.</div></div><div id="sec5_5_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> <i>N</i>-(3-Chloro-4-oxonaphthalen-1(4<i>H</i>)-ylidene)-4′-fluorobiphenyl-4-sulfonamide (<b>13f</b>)</h4><div class="NLM_p last">This compound was prepared using the procedure described for <b>13a</b> except using 4′-fluorobiphenyl-4-sulfonamide (251 mg, 1 mmol), TiCl<sub>4</sub> (1 mL,1 M solution in DCM), TEA (308 mL, 2.2 mmol), and THF (10 mL) as the solvent. The title compound was obtained as a yellow solid (348 mg, 81.6%); mp 172.1–172.8 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.68 (s, 1H), 8.20 (dd, <i>J</i> = 7.6, 1.2 Hz, 1H), 8.17 (dd, <i>J</i> = 8.0, 1.2 Hz, 1H), 8.13 (d, <i>J</i> = 8.4 Hz, 2H), 7.77–7.75 (m, 2H), 7.72–7.66 (m, 2H), 7.60 (dd, <i>J</i> = 8.8, 5.2 Hz, 2H), 7.19 (t, <i>J</i> = 8.8 Hz, 2H). <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>) δ −113.53 (m). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 177.17, 163.46, (d, <i>J</i> = 245 Hz), 161.20, 145.74, 145.38, 139.04, 135.53 (d, <i>J</i> = 3.5 Hz), 134.36, 134.16, 133.09, 131.59, 129.35 (d, <i>J</i> = 8 Hz), 129.31, 128.33, 128.12, 127.87, 127.10, 116.36 (d, <i>J</i> = 21.5 Hz). LC-MS (ESI+) 426 (M + H)<sup>+</sup>, 443.05 (M + NH<sub>4</sub>)<sup>+</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>22</sub>H<sub>14</sub>ClFNO<sub>3</sub>S (M + H)<sup>+</sup> 426.0362, found 426.0356.</div></div><div id="sec5_5_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> <i>N</i>-(3-Chloro-4-oxonaphthalen-1(4<i>H</i>)-ylidene)-5-(pyridin-2-yl)thiophene-2-sulfonamide (<b>13g</b>)</h4><div class="NLM_p last">This compound was prepared using the procedure described for <b>13a</b> except using 5-(pyridin-2-yl)thiophene-2-sulfonamide (481 mg, 2 mmol), TiCl<sub>4</sub> (2 mL, 1 M solution in DCM), TEA (0.615 mL, 4.4 mmol), and THF (15 mL) as the solvent. The title compound was obtained as an orange solid (511 mg, 61.5%); mp 155.3 °C (dec.). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.66 (d, <i>J</i> = 5.2 Hz, 1H), 8.60 (s, 1H), 8.28–8.26 (m, 1H), 8.21–8.18 (m, 1H), 7.87 (td, <i>J</i> = 7.8, 1.5 Hz, 1H), 7.84 (d, <i>J</i> = 4.0 Hz, 1H), 7.79 (s, 1H), 7.77 (s, 1H), 7.75–7.71 (m, 2H), 7.37 (dd, <i>J</i> = 6.7, 5.1 Hz, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 176.99, 162.05, 153.71, 150.64, 150.45, 145.71, 138.40, 135.74, 135.18, 135.13, 132.96, 132.22, 128.59, 128.00, 127.09, 125.94, 125.01, 120.42, 104.99. LC-MS (ESI+) 414.99 (M + H)<sup>+</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>19</sub>H<sub>12</sub>ClN<sub>2</sub>O<sub>3</sub>S<sub>2</sub> (M + H)<sup>+</sup> 414.9972, found 414.9969.</div></div><div id="sec5_5_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> <i>N</i>-(3-Chloro-4-oxonaphthalen-1(4<i>H</i>)-ylidene)-4-cyclohexylbenzenesulfonamide (<b>13h</b>)</h4><div class="NLM_p last">This compound was prepared using the procedure described for <b>13a</b> except using 4-cyclohexylphenylsulfonamide (290 mg, 1.2 mmol), TiCl<sub>4</sub> (1.2 mL, 1 M solution in DCM), TEA (0.372 mL, 2.7 mmol), and THF (10 mL) as the solvent. The title compound was obtained as a yellow solid (213 mg, 42.4%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.68 (s, 1H), 8.19–8.15 (m, 2H), 7.97 (d, <i>J</i> = 8.4 Hz, 2H), 7.72 (td, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.67 (td, <i>J</i> = 7.6, 1.6 Hz, 1H), 7.42 (d, <i>J</i> = 8.4 Hz, 2H), 2.64–2.58 (m, 1H), 1.91–1.85 (m, 4H), 1.79–1.75 (m, 1H), 1.50–1.34 (m, 4H), 1.31–1.23 (m, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 177.24, 160.85, 154.67, 145.12, 137.66, 134.32, 134.03, 133.18, 131.56, 129.85, 128.03, 127.90, 127.83, 127.12, 44.93, 34.32, 26.87, 26.17. LC-MS (ESI+) 414.09 (M + H)<sup>+</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>22</sub>H<sub>21</sub>ClNO<sub>3</sub>S (M + H)<sup>+</sup> 414.0925, found 414.0924.</div></div><div id="sec5_5_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> <i>N</i>-(3-Chloro-4-oxonaphthalen-1(4<i>H</i>)-ylidene)-4′-methoxybiphenyl-4-sulfonamide (<b>13i</b>)</h4><div class="NLM_p last">This compound was prepared using the procedure described for <b>13a</b> except using 4′-methoxybiphenyl-4-sulfonamide (527 mg, 2 mmol), TiCl<sub>4</sub> (2 mL, 1 M solution in DCM), TEA (0.615 mL, 4.4 mmol), and THF (15 mL) as solvent. The title compound was obtained as a yellow solid (650 mg, 74.2%); mp 168.1 °C (dec.). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.70 (s, 1H), 8.19 (apptd, <i>J</i> = 8.8, 1.6 Hz, 2H), 8.10 (d, <i>J</i> = 8.6 Hz, 2H), 7.76 (d, <i>J</i> = 8.6 Hz, 2H, partially overlapped with the adjacent multiplet), 7.76–7.71 (m, 1H, partially overlapped with the adjacent doublet), 7.68 (td, <i>J</i> = 7.6, 1.6 Hz, 1H), 7.59 (d, <i>J</i> = 8.8 Hz, 2H), 7.02 (d, <i>J</i> = 8.8 Hz, 2H), 3.88 (s, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 177.21, 160.99, 160.48, 146.39, 145.26, 138.18, 134.34, 134.08, 133.15, 131.70, 131.58, 129.87, 128.77, 128.27, 128.07, 127.38, 127.12, 114.79, 55.65. LC-MS (ESI+) 438.04 (M + H)<sup>+</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>23</sub>H<sub>17</sub>ClNO<sub>4</sub>S (M + H)<sup>+</sup> 438.0561, found 438.0562.</div></div><div id="sec5_5_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> <i>N</i>-(3-Chloro-4-oxonaphthalen-1(4<i>H</i>)-ylidene)-4-pentylbenzenesulfonamide (<b>13j</b>)</h4><div class="NLM_p last">This compound was prepared using the procedure described for <b>13a</b> except using 4-pentylphenylsulfonamide (455 mg, 2 mmoL), TiCl<sub>4</sub> (2 mL, 1 M solution in DCM), TEA (0.615 mL, 4.4 mmol), and THF (15 mL) as solvent, and the product was purified using SiO<sub>2</sub> chromatography (hexane/EtOAc gradient elution) to afford the title compound as a yellow solid (452 mg, 56.2%); mp 111.7–112.8 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.69 (s, 1H), 8.20 (dd, <i>J</i> = 7.6, 1.2 Hz, 1H), 8.16 (dd, <i>J</i> = 7.2, 1.6 Hz, 1H), 7.97 (d, <i>J</i> = 8.4 Hz, 2H), 7.73 (td, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.68 (td, <i>J</i> = 7.6, 1.6 Hz, 1H), 7.40 (d, <i>J</i> = 8.4 Hz, 2H), 2.72 (t, <i>J</i> = 7.7 Hz, 2H), 1.66 (q, <i>J</i> = 7.5 Hz, 2H), 1.42–1.30 (m, 4H), 0.90 (t, <i>J</i> = 7.0 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 177.24, 160.86, 149.79, 145.15, 137.64, 134.30, 134.02, 133.19, 131.57, 129.86, 129.39, 128.04, 127.77, 127.10, 36.19, 31.62, 30.99, 22.70, 14.22. LC-MS (ESI+) 402 (M + H)<sup>+</sup>, 419.11 (M + NH<sub>4</sub>)<sup>+</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>21</sub>H<sub>21</sub>ClNO<sub>3</sub>S (M + H)<sup>+</sup> 402.0925, found 402.0926.</div></div><div id="sec5_5_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 5-Chloro-<i>N</i>-(3-chloro-4-oxonaphthalen-1(4<i>H</i>)-ylidene)thiophene-2-sulfonamide (<b>13k</b>)</h4><div class="NLM_p last">This compound was prepared using the procedure described for <b>13a</b> except using 5-chlorothiophene-2-sulfonamide (395 mg, 2 mmol), TiCl<sub>4</sub> (2 mL, 1 M solution in DCM), TEA (0.615 mL, 4.4 mol), and DCM (15 mL) as solvent. The title compound was obtained as a yellow solid (320 mg, 43.0%). <i>R</i><sub>f</sub> = 0.50 (TLC, EtOAc/hexane [1:2]); mp 149–151 °C. <sup>1</sup>H NMR, (400 MHz, CDCl<sub>3</sub>) δ 8.55 (s, 1H), 8.23–8.20 (m, 2H), 7.79–7.72 (m, 2H), 7.64 (d, <i>J</i> = 4.1 Hz, 1H), 7.01 (d, <i>J</i> = 4.1 Hz, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 176.99, 161.21, 145.85, 139.77, 134.53, 134.47, 133.10, 132.78, 131.60, 129.58, 128.25, 127.24, 127.00, 104.99. LC-MS (ESI+) 761.89 (2M + NH<sub>4</sub>)<sup>+</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>14</sub>H<sub>8</sub>Cl<sub>2</sub>NO<sub>3</sub>S<sub>2</sub> (M + H)<sup>+</sup> 371.9317, found 371.9324.</div></div><div id="sec5_5_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> <i>N</i>-(3-Chloro-4-oxonaphthalen-1(4<i>H</i>)-ylidene)-4′-trifluoromethylbiphenyl-4-sulfonamide (<b>13l</b>)</h4><div class="NLM_p last">This compound was prepared using the procedure described for <b>13a</b> except using 4′-trifluoromethylbiphenyl-4-sulfonamide (603 mg, 2 mmol), TiCl<sub>4</sub> (2 mL, 1 M solution in DCM), TEA (0.615 mL, 4.4 mmol), and THF (15 mL) as the solvent. The title compound was obtained as a yellow solid (794 mg, 83.4%); mp 190.4–191.3 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.67 (s, 1H), 8.21 (dd, <i>J</i> = 7.6, 1.2 Hz, 1H), 8.18–8.16 (m, 2H), 8.17 (d, <i>J</i> = 8.6 Hz, 1H), 7.81 (d, <i>J</i> = 8.6 Hz, 2H), 7.78–7.72 (m, 5H), 7.68 (td, <i>J</i> = 7.6, 1.2 Hz, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 177.12, 161.41, 145.50, 145.20, 142.93, 140.04, 134.36, 134.22, 133.05, 131.61, 130.95 (q, <i>J</i> = 32.5 Hz), 129.92, 128.42, 128.26, 128.16, 128.01, 127.09, 126.30 (q, <i>J</i> = 3.7 Hz), 124.23 (d, <i>J</i> = 270.7 Hz). <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>) δ −63.01 (s). LC-MS (ESI+) 493.05 (M + NH<sub>4</sub>)<sup>+</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>23</sub>H<sub>14</sub>ClF<sub>3</sub>NO<sub>3</sub>S (M + H)<sup>+</sup> 476.0330, found 476.0325.</div></div><div id="sec5_5_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> <i>N</i>-(3-Chloro-4-oxonaphthalen-1(4<i>H</i>)-ylidene)-5-(phenylsulfonyl)thiophene-2-sulfonamide (<b>13m</b>)</h4><div class="NLM_p last">This compound was prepared using the procedure described for <b>13a</b> except using 5-(phenylsulfonyl)thiophene-2-sulfonamide (341 mg, 1.2 mmol), TiCl<sub>4</sub> (1.1 mL, 1 M solution in DCM), TEA (0.345 mL, 2.5 mmol), and THF (10 mL) as the solvent. The title compound was obtained as a yellow solid (272 mg, 50.7%); mp 165.3 °C (dec.). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.43 (s, 1H), 8.22–8.19 (m, 2H), 8.06–8.01(m, 2H), 7.79–7.76 (m, 2H), 7.73 (d, <i>J</i> = 4.0 Hz, 1H), 7.68–7.64 (m, 2H), 7.60–7.56 (m, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 162.41, 150.49, 148.23, 146.44, 140.75, 134.85, 134.73, 134.52, 132.52, 132.46, 132.34, 131.59, 129.98, 129.70, 128.40, 128.00, 127.40, 104.99. Elemental analysis for <b>13m</b>: Calculated: C, 50.26; H, 2.53; N, 2.93. Found: C, 50.53; H, 2.85; N, 2.68.</div></div><div id="sec5_5_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> <i>N</i>-(3-Chloro-4-oxonaphthalen-1(4<i>H</i>)-ylidene)-1-(phenylsulfonyl)-1<i>H</i>-pyrrole-3-sulfonamide (<b>13n</b>)</h4><div class="NLM_p last">This compound was prepared using the procedure described for <b>13a</b> except using 1-(phenylsulfonyl)-1H<i>-</i>pyrrole-3-sulfonamide (390 mg, 1.4 mmol), TiCl<sub>4</sub> (1.4 mL, 1 M solution in DCM), TEA (0.42 mL, 3 mmol), and THF (10 mL) as the solvent. The title compound was obtained as a yellow solid (444 mg, 70.7%); mp 127.5–131.3 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.55 (s, 1H), 8.20–8.16 (m, 2H), 7.97–7.95 (m, 2H), 7.85 (dd, <i>J</i> = 2.4, 1.6 Hz, 1H), 7.76–7.68 (m, 3H), 7.60 (t, <i>J</i> = 7.6 Hz, 2H), 7.27 (dd, <i>J</i> = 3.4, 2.4 Hz, 1H), 6.74 (dd, <i>J</i> = 3.4, 1.7 Hz, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 177.11, 161.01, 145.34, 137.75, 135.29, 134.41, 134.21, 132.97, 131.58, 130.18, 129.76, 128.88, 128.13, 127.71, 127.11, 124.19, 122.43, 111.92. LC-MS (ESI+) 461.00 (M + H)<sup>+</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>20</sub>H<sub>14</sub>ClN<sub>2</sub>O<sub>5</sub>S<sub>2</sub> (M + H)<sup>+</sup> 461.0027, found 461.0024.</div></div><div id="sec5_5_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> <i>N</i>-(3-Chloro-4-oxonaphthalen-1(4<i>H</i>)-ylidene)naphthalene-1-sulfonamide (<b>13o</b>, intermediate for compound compound <b>34</b>)</h4><div class="NLM_p last">This compound was prepared using the procedure described for <b>13a</b> except using naphthalene-1-sulfonamide (415 mg, 2 mmol), TiCl<sub>4</sub> (2 mL, 1 M solution in DCM), TEA (0.615 mL, 4.4 mmol), and THF (15 mL) as the solvent. The title compound was obtained as an orange–red solid (0.653 mg, 85.5%) <i>R</i><sub>f</sub> = 0.67 (TLC, EtOAc/hexane [1:2]); mp 185.6 °C (dec.). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.75 (s, 1H), 8.67 (dd, <i>J</i> = 8.8, 0.8 Hz, 1H), 8.44 (dd, <i>J</i> = 7.4, 1.6 Hz, 1H), 8.21–8.17 (m, 2H), 8.00 (appdt, <i>J</i> = 7.9, 1.9 Hz, 2H), 7.72–7.62 (m, 4H), 7.59 (td, <i>J</i> = 8.0, 1.6 Hz, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 177.20, 161.53, 145.34, 135.61, 135.51, 134.47, 134.41, 134.08, 133.21, 131.61, 130.28, 129.32, 129.22, 128.78, 128.64, 128.08, 127.29, 127.14, 125.41, 124.44. LC-MS (ESI+) 382 (M + H)<sup>+</sup>, 399.06 (M + NH<sub>4</sub>)<sup>+</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>20</sub>H<sub>13</sub>ClNO<sub>3</sub>S (M + H)<sup>+</sup> 382.0299, found 382.0300.</div></div><div id="sec5_5_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 4-Chloro-<i>N</i>-(3-chloro-4-oxonaphthalen-1(4<i>H</i>)-ylidene)benzenesulfonamide (<b>13p</b>)</h4><div class="NLM_p last">This compound was prepared using the procedure described for <b>13a</b> except using 4-chlorobenzenesulfonamide (383 mg, 2 mmol), TiCl<sub>4</sub> (2 mL, 1 M solution in DCM), TEA (0.615 mL, 4.4 mmol), and THF (15 mL) as the solvent. The title compound was obtained as a yellow solid (399 mg, 54.5%). <i>R</i><sub>f</sub> = 0.60 (TLC, EtOAc/hexane [1:2]); mp 138–140 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.62 (s, 1H), 8.21 (dd, <i>J</i> = 7.6, 1.6 Hz, 1H), 8.12 (dd, <i>J</i> = 7.6, 1.2 Hz, 1H), 8.01 (d, <i>J =</i> 8.7 Hz, 2H), 7.75 (td, <i>J</i> = 8.8,1.2, Hz, 1H), 7.68 (td, <i>J</i> = 7.6, 1.6 Hz, 1H), 7.58 (d, <i>J</i> = 8.4 Hz, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 177.07, 161.51, 145.59, 140.47, 138.99, 134.41, 134.30, 132.93, 131.58, 129.88, 129.72, 129.17, 128.18, 127.07. LC-MS (ESI+) 383.00 (M + NH<sub>4</sub>)<sup>+</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>16</sub>H<sub>10</sub>Cl<sub>2</sub>NO<sub>3</sub>S (M + H)<sup>+</sup> 365.9753, found 365.9763.</div></div><div id="sec5_5_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 3,4-Dichloro-<i>N</i>-(3-chloro-4-oxonaphthalen-1(4<i>H</i>)-ylidene)benzenesulfonamide (<b>13q</b>)</h4><div class="NLM_p last">This compound was prepared using the procedure described for <b>13a</b> except using 3,4-dichlorobenzenesulfonamide (452 mg, 2 mmol), TiCl<sub>4</sub> (2 mL, 1 M solution in DCM), TEA (0.615 mL, 4.4 mmol), and THF (15 mL) as the solvent. The title compound was obtained as a yellow solid (622 mg, 77.6%). <i>R</i><sub>f</sub> = 0.41 (TLC, EtOAc/hexane [1:2]); mp 140.2–141.7 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.57 (s, 1H), 8.22 (dd, <i>J</i> = 7.7, 1.4 Hz, 1H), 8.16 (d, <i>J</i> = 2.2 Hz, 1H), 8.12 (dd, <i>J</i> = 8.0, 1.6 Hz, 1H), 7.90 (dd, <i>J</i> = 8.4, 2.2 Hz, 1H), 7.77 (td, <i>J</i> = 7.2, 1.2 Hz, 1H), 7.72–7.68 (m, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 176.97, 162.00, 145.89, 140.15, 138.81, 134.49, 134.10, 132.75, 131.57, 131.47, 129.90, 129.68, 128.27, 127.14, 126.73. LC-MS (ESI+) 817.90 (2M + NH<sub>4</sub>)<sup>+</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>16</sub>H<sub>9</sub>Cl<sub>3</sub>NO<sub>3</sub>S (M + H)<sup>+</sup> 399.9363, found 399.9375.</div></div><div id="sec5_5_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> <i>N</i>-(3-Chloro-4-oxonaphthalen-1(4<i>H</i>)-ylidene)benzenesulfonamide (<b>13r</b>)</h4><div class="NLM_p last">This compound was prepared using the procedure described for <b>13a</b> except using phenylsulfonamide (314 mg, 2 mmol), TiCl<sub>4</sub> (2 mL, 1 M solution in DCM), TEA (0.615 mL, 4.4 mmol), and THF (15 mL) as the solvent. The title compound was obtained as a yellow solid (508 mg, 76.6%). <i>R</i><sub>f</sub> = 0.31 (TLC, EtOAc/hexane [1:4]); mp 184.8–186.4 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.67 (s, 1H), 8.20 (dd, <i>J</i> = 7.6, 1.2 Hz, 1H), 8.15 (d, <i>J</i> = 7.6 Hz, 1H), 8.09 (d, <i>J</i> = 7.2 Hz, 2H), 7.74 (td, <i>J</i> = 7.2, 1.2 Hz, 1H), 7.71–7.66 (m, 2H), 7.62 (t, <i>J</i> = 8.0 Hz, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 177.18, 161.22, 145.33, 140.49, 134.36, 134.14, 133.81, 133.08, 131.57, 129.93, 129.40, 128.09, 127.68, 127.09. LC-MS (ESI+) 349.03 (M + NH<sub>4</sub>)<sup>+</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>16</sub>H<sub>11</sub>ClNO<sub>3</sub>S (M + H)<sup>+</sup> 332.0143, found 332.0145.</div></div><div id="sec5_5_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 2-(1-Oxo-4-(thiophen-2-ylsulfonylimino)-1,4-dihydronaphthalen-2-ylthio)acetic Acid (<b>14a</b>)</h4><div class="NLM_p last">The <b>13a</b> (188 mg, 0.56 mmol) was dissolved in THF (5 mL), and THF solution containing pyridine (0.56 mL, 0.5 M)was added, followed by THF solution containing 2-mercaptoglycolic acid (0.56 mL, 0.5 M). Additional pyridine (0.56 mL, 0.5 M in THF) and 2-mercaptoglycolic acid (0.56 mL, 0.5 M in THF) were added to the mixture. The mixture was stirred at room temperature for 30 min, and 2,3-dichloro-5,6-dicyanobenzoquinone (114 mg, 0.5 mmol) was added and stirred at room temperature overnight (12 h). The insoluble solid obtained was filtered, and the filtrate was concentrated. The crude residue was first purified via preparative TLC (2.5% CH<sub>3</sub>OH in DCM) and then using SiO<sub>2</sub> column chromatography (CH<sub>3</sub>OH/CH<sub>3</sub>COOH/DCM [1.5:0.5:100]) to afford a yellow solid as the desired pure product <b>14a</b> (20 mg, 9.2%) and a mixture of desired product and reduced product (80.9 mg, 36.9%). <i>R</i><sub>f</sub> = 0.33 (TLC, CH<sub>3</sub>OH/DCM [1:20]); mp 131.7 °C (dec.). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>CN) δ 8.21–8.19 (m, 1H), 8.12–8.10 (m, 1H), 7.92–7.90 (m, 2H), 7.87 (dd, <i>J</i> = 3.8, 1.3 Hz, 1H), 7.80–7.78 (m, 2H), 7.24 (dd, <i>J</i> = 4.8, 3.6 Hz, 1H), 3.88 (s, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 180.77, 168.99, 160.11, 153.94, 141.97, 134.37, 133.54, 133.34, 133.22 132.94, 131.78, 127.59, 127.43, 127.17, 120.53, 33.90. LC-MS (ESI−) 391.97 (M – H)<sup>−</sup>. HRMS (ESI−) <i>m</i>/<i>z</i> calculated for C<sub>16</sub>H<sub>10</sub>NO<sub>5</sub>S<sub>3</sub> (M – H)<sup>−</sup> 391.9727, found 391.9729.</div></div><div id="sec5_5_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> <i>N</i>-(3-(1-Methyl-1<i>H</i>-tetrazol-5-ylthio)-4-oxonaphthalen-1(4<i>H</i>)-ylidene)thiophene-2-sulfonamide (<b>14b</b>)</h4><div class="NLM_p last">The <b>13a</b> (36 mg, 0.1 mmol) was dissolved in THF (3 mL), and 1-methyl-tetrazole-5-thiol (11.7 mg, 0.1 mol) was added. The reaction mixture was stirred at rt for 2 h and concentrated. The residue was dissolved in DCM and triturated with hexane. The precipitate obtained was filtered and washed with DCM/hexane (1:1, 2 mL × 3) to afford the title compound as an orange–red solid (29 mg, 68.9%). <i>R</i><sub>f</sub> = 0.80 (TLC, EtOAc/hexane [7:3]); mp 172 °C (dec.). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.26–8.24 (m, 1H), 8.17–8.15 (m, 1H), 8.01 (s, 1H), 7.78 (d, <i>J</i> = 3.8 Hz, 1H), 7.76–7.72 (m, 3H), 7.15 (dd, <i>J</i> = 5.2, 4.4 Hz, 1H), 4.21 (s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub><i>6</i></sub>) δ 180.28, 160.98, 149.29, 147.61, 140.87, 136.15, 135.46, 134.90, 134.26, 133.33, 132.00, 128.82, 127.64, 127.15, 122.73, 35.38. LC-MS (ESI+) 418.01 (M + H)<sup>+</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>16</sub>H<sub>12</sub>N<sub>5</sub>O<sub>3</sub>S<sub>3</sub> (M + H)<sup>+</sup> 418.0097, found 418.0099.</div></div><div id="sec5_5_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> <i>N</i>-(3-(1<i>H</i>-1,2,4-Triazol-5-ylthio)-4-oxonaphthalen-1(4<i>H</i>)-ylidene)thiophene-2-sulfonamide (<b>14c</b>)</h4><div class="NLM_p last">This compound was prepared using the procedure described for <b>14b</b> except using 3-mercapto-1,2,4-triazole (10 mg, 0.1 mmol). The title compound <b>14c</b> was obtained as an orange–red solid (39 mg, 96.5%). <i>R</i><sub>f</sub> = 0.33 (TLC, EtOAc/hexane [1:1]); mp 197 °C (dec.). HPLC 95% (<i>R</i><sub>t</sub> = 4.08 min, 55% CH<sub>3</sub>CN in 0.1% TFA water 20 min). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>CN), δ 8.63 (s, 1H), 8.19–8.17 (m, 1H), 8.15–8.14 (m, 1H), 7.90–7.88 (m, 1H), 7.81–7.79 (m, 3H), 7.75–7.74 (m, 1H), 7.22–7.19 (m,1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 179.55, 160.03, 152.17, 150.60, 146.29, 134.58, 134.15, 133.49, 132.73, 132.23, 130.92, 127.58, 126.46, 125.92, 120.99, 117.56. LC-MS (ESI+) 402.99 (M + H)<sup>+</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>16</sub>H<sub>11</sub>N<sub>4</sub>O<sub>3</sub>S<sub>3</sub> (M + H)<sup>+</sup> 402.9988, found 402.9989.</div></div><div id="sec5_5_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 2-(1-Hydroxy-4-(thiophene-2-sulfonamido)naphthalen-2-ylthio)acetic Acid (<b>15a</b>)</h4><div class="NLM_p last">The (<i>E</i>)-<i>N</i>-(3-chloro-4-oxonaphthalen-1(4<i>H</i>)-ylidene)thiophene-2-sulfonamide (<b>13 a</b>) (34 mg, 0.1 mmol) was dissolved in THF (2 mL) and a THF solution was added containing thioglycolic acid (0.1 mL, 1 M in THF) followed by pyridine (1 equiv, 0.2 mL, 0.5 M in THF). The mixture was stirred at rt for 10 min, and the solvent was removed using a rotary evaporator. The orange–red residue obtained was redissolved in ethyl acetate (50 mL). The mixture was transferred to a separation funnel and washed with NaHSO<sub>4</sub> (0.5 M solution, 10 mL × 2) to remove pyridine. The sodium hydrosulfite solid (5 equiv, 87 mg, 0.5 mmol) was added followed by water (10 mL). The mixture was shaken until the organic phase turned colorless. The organic phase was separated and washed with water (10 mL × 2) and brine (10 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and filtered. The filtrate was concentrated. The solid obtained was suspended in DCM/hexane (1:1, ∼5 mL), filtered, and the product was washed with DCM (1 mL × 3) to afford title compound as an off-white solid (25 mg, 63.6%). The analytical data obtained for compound <b>15a</b> are identical to that obtained for <b>11a</b>.</div></div><div id="sec5_5_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> <i>N</i>-(4-Hydroxy-3-(1-methyl-1<i>H</i>-tetrazol-5-ylthio)naphthalen-1-yl)thiophene-2-sulfonamide (<b>15b</b>)</h4><div class="NLM_p last"><b>14b</b> (13 mg, 0.031 mmol) was dissolved in ethyl acetate (50 mL), and sodium hydrosulfite (27 mg, 0.156 mmol) was added followed by water (10 mL). The mixture was shaken in a separating funnel until the yellow organic phase turned colorless. The organic phase was washed with water (10 mL × 3) and brine (10 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated. The residue obtained was dissolved in DCM (3 mL) and triturated with hexane (3 mL). The precipitate was washed with DCM/hexane (1:1, 1 mL × 3) and dried under vacuum to afford the title compound <b>15b</b> as a white solid (13 mg, 99%). <i>R</i><sub>f</sub> = 0.44 (TLC, EtOAc/hexane [1:1]); mp 130 °C (dec.). HPLC 93% (<i>R</i><sub>t</sub> = 8.1 min, 40% CH<sub>3</sub>CN in 0.1% TFA water 40 min). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>CN) δ 8.28 (dd, <i>J</i> = 6.4, 2.8 Hz, 1H), 8.14 (br s, 1H, disappeared on D<sub>2</sub>O shake), 7.98 (dd, <i>J</i> = 6.8, 3.5 Hz, 1H), 7.94 (br s, 1H, disappeared on D<sub>2</sub>O shake), 7.65 (dd, <i>J</i> = 4.8, 1.2 Hz, 1H), 7.61 (dd, <i>J</i> = 6.5, 3.4 Hz, 2H), 7.38 (dd, <i>J</i> = 4.0, 1.2 Hz, 1H), 7.16 (s, 1H), 6.99 (dd, <i>J</i> = 4.8, 3.6 Hz, 1H), 4.00 (s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 154.04, 152.73, 140.64, 133.86, 133.07, 132.82, 129.49, 128.42, 128.23, 127.00, 126.30, 125.42, 124.16, 123.42, 107.44, 34.73. LC-MS (ESI+) 420.02 (M + H)<sup>+</sup>, 442.00 (M + Na)<sup>+</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>16</sub>H<sub>14</sub>N<sub>5</sub>O<sub>3</sub>S<sub>3</sub> (M + H)<sup>+</sup> 420.0253, found 420.0240.</div></div><div id="sec5_5_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> <i>N</i>-(3-(1<i>H</i>-1,2,4-Triazol-5-ylthio)-4-hydroxynaphthalen-1-yl)thiophene-2-sulfonamide (<b>15c</b>)</h4><div class="NLM_p last">This compound was prepared using the procedure described for <b>15b</b> using <b>14c</b> (20 mg, 0.05 mmol) and sodium hydrosulfite (43 mg, 0.25 mmol) to afford the title compound as a white solid (20 mg, 100%). <i>R</i><sub>f</sub> = 0.40 (TLC, EtOAc/hexane [1:1]); mp 180 °C (dec.). HPLC 92% (<i>R</i><sub>t</sub> = 5.4 min, 40% CH<sub>3</sub>CN in 0.1% TFA water 40 min). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.19 (br s, 1H), 10.05 (s, 1H), 8.61 (br s, 1H), 8.16 (d, <i>J</i> = 7.6 Hz, 1H), 7.89 (d, <i>J</i> = 7.4 Hz, 1H), 7.81 (d, <i>J</i> = 4.2 Hz, 1H), 7.48 (brt, <i>J</i> = 7.2 Hz, 2H), 7.28 (d, <i>J</i> = 2.5 Hz, 1H), 6.99 (brt, <i>J</i> = 4.2 Hz, 1H), 6.90 (br s, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 140.86, 133.68, 133.00, 132.93, 129.47, 128.16, 126.66, 126.60, 126.28, 124.90, 124.04, 123.14, 104.99. LC-MS (ESI−) 403.00 (M – H)<sup>−</sup>. HRMS (ESI−) <i>m</i>/<i>z</i> calculated for C<sub>16</sub>H<sub>11</sub>N<sub>4</sub>O<sub>3</sub>S<sub>3</sub> (M – H)<sup>−</sup> 402.9999, found 402.9989.</div></div><div id="sec5_5_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> <i>N</i>-(3-(1<i>H</i>-Tetrazol-5-ylthio)-4-hydroxynaphthalen-1-yl)thiophene-2-sulfonamide (<b>15d</b>)</h4><div class="NLM_p last"><b>13a</b> (34 mg, 0.1 mmol) and 1<i>H</i>-tetrazole-5-thiol (10 mg, 0.1 mmol) were dissolved in EtOH/DCM (2 mL, 1:1) and stirred at rt for 2 h. The reaction mixture was diluted with EtOAc (20 mL), and Na<sub>2</sub>S<sub>2</sub>O<sub>4</sub> (0.5 mmol in 5 mL of water) was added. The mixture was shaken in a separation funnel until the color of the organic phase turned colorless (from bright yellow). The organic phase was separated and washed with water (5 mL) and brine (5 mL) and dried (Na<sub>2</sub>SO<sub>4</sub>). The organic phase was filtered and concentrated, and the residue was slurred in DCM (5 mL). The solid obtained was washed with DCM (1 mL × 2) and dried to afford the title compound <b>15d</b> (28 mg, 69.9%, via 2 steps) as an off-white solid; mp 186.6 °C (dec.). HPLC 99% (<i>R</i><sub>t</sub> = 9.5 min, 35% CH<sub>3</sub>CN in 0.1% TFA water 30 min). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.63 (br s, 1H), 10.14 (s, 1H), 8.25–8.23 (m, 1H), 7.96–7.94 (m, 1H), 7.82 (d, <i>J</i> = 4.8 Hz, 1H), 7.56–7.54 (m, 2H), 7.32 (d, <i>J</i> = 3.6 Hz, 1H), 6.97 (t, <i>J</i> = 4.0 Hz, 1H), 6.92 (s, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 154.80, 140.56, 133.81, 133.17, 133.13, 130.21, 128.41, 128.13, 126.87, 126.47, 125.29, 124.16, 123.57. LC-MS (ESI+) 406.01 (M + H)<sup>+</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>15</sub>H<sub>12</sub>N<sub>5</sub>O<sub>3</sub>S<sub>3</sub> (M + H)<sup>+</sup> 406.0097, found 406.0075.</div></div><div id="sec5_5_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> <i>N</i>-(3-(1<i>H</i>-Tetrazol-5-ylthio)-4-hydroxynaphthalen-1-yl)biphenyl-4-sulfonamide (<b>15e</b>)</h4><div class="NLM_p last">This compound was prepared using the procedure described for <b>15d</b> except using <b>13b</b> (41 mg, 0.1 mmol) to afford the title compound <b>15e</b> (32 mg, 67.4%, via 2 steps) as a white solid; mp 158.8 °C (dec.). HPLC 94% (<i>R</i><sub>t</sub> = 7.8 min, 50% CH<sub>3</sub>CN in 0.1% TFA water 30 min). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.00 (s, 1H), 8.24–8.22 (m, 1H), 8.02–8.00 (m, 1H), 7.72–7.63 (m, 6H), 7.55–7.53 (m, 2H), 7.51–7.47 (m, 2H), 7.45–7.40 (m, 1H), 6.87 (s, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 154.63, 144.81, 139.08, 138.97, 133.08, 129.95, 129.77, 129.20, 128.34, 128.20, 127.78, 127.70, 126.86, 126.51, 125.58, 124.39, 123.55. LC-MS (ESI+) 476.09 (M + H)<sup>+</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>23</sub>H<sub>18</sub>N<sub>5</sub>O<sub>3</sub>S<sub>2</sub> (M + H)<sup>+</sup> 476.0846, found 476.0842.</div></div><div id="sec5_5_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> <i>N</i>-(3-(1<i>H</i>-Tetrazol-5-ylthio)-4-hydroxynaphthalen-1-yl)-5-phenylthiophene-2-sulfonamide (<b>15f</b>)</h4><div class="NLM_p last">This compound was prepared using the procedure described for <b>15d</b> except using <b>13c</b> (41 mg, 0.1 mmol), to afford the title compound <b>15f</b> (34 mg, 70.1%, via 2 steps) as an off-white solid; mp 167.9 °C (dec.). HPLC 98% (<i>R</i><sub>t</sub> = 7.7 min, 50% CH<sub>3</sub>CN in 0.1% TFA water, 30 min). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.65 (br s, 1H), 10.23 (s, 1H), 8.26–8.24 (m, 1H), 8.02–7.90 (m, 1H), 7.60 (dd, <i>J</i> = 8.1, 2.4 Hz, 2H), 7.56–7.54 (m, 2H), 7.46–7.39 (m, 3H), 7.33 (d, <i>J</i> = 3.9 Hz, 1H), 7.29 (d, <i>J</i> = 3.9 Hz, 1H), 7.04 (s, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 154.95, 150.37, 139.01, 134.22, 133.17, 132.73, 130.38, 130.01, 129.84, 128.47, 126.90, 126.59, 126.49, 125.21, 124.41, 124.17, 123.61. LC-MS (ESI+) 482.04 (M + H)<sup>+</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>21</sub>H<sub>16</sub>N<sub>5</sub>O<sub>3</sub>S<sub>3</sub> (M + H)<sup>+</sup> 482.0410, found 482.0415</div></div><div id="sec5_5_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> <i>N</i>-(3-(1<i>H</i>-Tetrazol-5-ylthio)-4-hydroxynaphthalen-1-yl)-5-(pyridin-2-yl)thiophene-2-sulfonamide (<b>15g</b>)</h4><div class="NLM_p last">This compound was prepared using the procedure described for <b>15d</b> except using <b>13g</b> (42 mg, 0.1 mmol), to afford the title compound <b>15g</b> (40 mg, 84.8%, via 2 steps) as an off-white solid; mp 163.2 °C (dec.). HPLC 96% (<i>R</i><sub>t</sub> = 7.9 min, 40% CH<sub>3</sub>CN in 0.1% TFA water, 30 min). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.63 (br s, 1H), 10.29 (s, 1H), 8.53 (app. d, <i>J</i> = 4.6 Hz, 1H), 8.23 (dd, <i>J</i> = 6.8, 3.6 Hz, 1H), 7.98 (dd, <i>J</i> = 6.5, 3.2 Hz, 1H), 7.94 (d, <i>J</i> = 8.0 Hz, 1H), 7.87 (td, <i>J</i> = 7.8, 1.6 Hz, 1H), 7.60 (d, <i>J</i> = 4.0 Hz, 1H), 7.54–7.50 (m, 2H), 7.37–7.34 (m, 1H), 7.28 (d, <i>J</i> = 4.0 Hz, 1H), 7.05 (s, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 154.87, 151.23, 150.88, 150.31, 141.44, 138.20, 134.06, 133.03, 130.29, 128.48, 126.90, 126.47, 125.26, 125.17, 124.51, 124.09, 123.62, 120.02, 106.90. LC-MS (ESI+) 483.04 (M + H)<sup>+</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>20</sub>H<sub>15</sub>N<sub>6</sub>O<sub>3</sub>S<sub>3</sub> (M + H)<sup>+</sup> 483.0362, found 483.0348.</div></div><div id="sec5_5_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> <i>N</i>-(3-(1<i>H</i>-Tetrazol-5-ylthio)-4-hydroxynaphthalen-1-yl)-4-cyclohexylbenzenesulfonamide (<b>15h</b>)</h4><div class="NLM_p last">This compound was prepared using the procedure described for <b>15d</b> except using <b>13h</b> (41 mg, 0.1 mmol) to afford the title compound <b>15h</b> (22 mg, 46.3%, via 2 steps) as an off-white solid; mp 169.2 °C (dec.). HPLC 99% (<i>R</i><sub>t</sub> = 14.5 min, 50% CH<sub>3</sub>CN in 0.1% TFA water, 40 min). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.64 (br s, 1H), 9.79 (s, 1H), 8.20 (d, <i>J</i> = 8.4 Hz, 1H), 7.93 (d, <i>J</i> = 8.4 Hz, 1H), 7.54–7.49 (m, 2H), 7.46 (d, <i>J</i> = 8.3 Hz, 2H), 7.20 (d, <i>J</i> = 8.0 Hz, 2H), 6.71 (s, 1H), 1.76–1.64 (m, 5H), 1.34–1.17 (m, 5H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 154.83, 153.32, 137.35, 133.29, 130.33, 128.27, 127.80, 127.72, 126.77, 126.46, 125.63, 124.42, 123.53, 44.19, 34.12, 26.82, 26.11. LC-MS (ESI−) 480.11 (M −H)<sup>−</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>23</sub>H<sub>24</sub>N<sub>5</sub>O<sub>3</sub>S<sub>2</sub> (M + H)<sup>+</sup> 482.1315, found 482.1318</div></div><div id="sec5_5_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> <i>N</i>-(3-(1<i>H</i>-Tetrazol-5-ylthio)-4-hydroxynaphthalen-1-yl)-4′-methoxybiphenyl-4-sulfonamide (<b>15i</b>)</h4><div class="NLM_p last">This compound was prepared using the procedure described for <b>15d</b> except using <b>13i</b> (44 mg, 0.1 mmol) to afford the title compound <b>15i</b> (42 mg, 82.0%, via 2 steps) as a white solid; mp 156.8 °C (dec.). HPLC 93% (<i>R</i><sub>t</sub> = 12.0 min, 45% CH<sub>3</sub>CN in 0.1% TFA water, 40 min). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.61 (br s, 1H), 9.95 (s, 1H), 8.24–8.21 (m, 1H), 8.02–7.99 (m, 1H), 7.68–7.59 (m, 4H), 7.55–7.52 (m, 2H), 7.03 (d, <i>J</i> = 9.2 Hz, 2H), 6.87 (s, 1H), 3.79 (s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 160.39, 154.61, 144.43, 138.15, 133.08, 131.26, 129.91, 128.90, 128.34, 128.18, 127.04, 126.86, 126.50, 125.64, 124.40, 123.55, 115.20, 106.77, 55.95. LC-MS (ESI+) 506.10 (M + H)<sup>+</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>24</sub>H<sub>20</sub>N<sub>5</sub>O<sub>4</sub>S<sub>2</sub> (M + H)<sup>+</sup> 506.0951, found 506.0936.</div></div><div id="sec5_5_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> <i>N</i>-(3-(1<i>H</i>-Tetrazol-5-ylthio)-4-hydroxynaphthalen-1-yl)-4′-fluorobiphenyl-4-sulfonamide (<b>15j</b>)</h4><div class="NLM_p last">This compound was prepared using the procedure described for <b>15d</b> except using <b>13f</b> (43 mg, 0.1 mmol) to afford the title compound <b>15j</b> (40 mg, 81.8%, via 2 steps) as a white solid; mp 168.1 °C (dec.). HPLC 95% (<i>R</i><sub>t</sub> = 13.7 min, 45% CH<sub>3</sub>CN in 0.1% TFA water 30 min). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.56 (br s, 1H), 9.99 (s, 1H), 8.24–8.22 (m, 1H), 8.02–8.00 (m, 1H), 7.71–7.64 (m, 6H), 7.55–7.52 (m, 2H), 7.32 (t, <i>J</i> = 8.9 Hz, 2H), 6.85(s, 1H). <sup>19</sup>F NMR (376 MHz, DMSO-<i>d</i><sub>6</sub>) δ −114.25 (m). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 163.13 (d, <i>J</i> = 245 Hz), 154.57, 143.72, 138.96, 135.57, 133.05, 129.85, 129.84 (d, <i>J</i> = 8 Hz), 128.35, 128.21, 127.74, 126.88, 126.51, 125.57, 124.39, 123.54, 116.63 (d, <i>J</i> = 21 Hz), 106.90. LC-MS (ESI+) 494.07 (M + H)<sup>+</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>23</sub>H<sub>17</sub>FN<sub>5</sub>O<sub>3</sub>S<sub>2</sub> (M + H)<sup>+</sup> 494.0751, found 494.0739.</div></div><div id="sec5_5_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> <i>N</i>-(3-(1<i>H</i>-Tetrazol-5-ylthio)-4-hydroxynaphthalen-1-yl)-4-phenoxybenzenesulfonamide (<b>15k</b>)</h4><div class="NLM_p last">This compound was prepared using the procedure described for <b>15d</b> except using <b>13d</b> (42 mg, 0.1 mmol) to afford the title compound <b>15k</b> (22 mg, 45.1%, via 2 steps) as a white solid; mp 172.5 °C (dec.). HPLC 99% (<i>R</i><sub>t</sub> = 8.2 min, 50% CH<sub>3</sub>CN in 0.1% TFA water 30 min). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.58 (br s, 1H, disappeared on D<sub>2</sub>O shake), 9.88 (s, 1H, disappeared on D<sub>2</sub>O shake), 8.22–8.20 (m, 1H), 7.94–7.92 (m, 1H), 7.53 (d, <i>J</i> = 8.8 Hz, 4H), 7.41 (t, <i>J</i> = 7.6 Hz, 2H), 7.21 (t, <i>J</i> = 7.2 Hz, 1H), 6.98 (d, <i>J</i> = 7.6 Hz, 2H), 6.92 (d, <i>J</i> = 8.8 Hz, 2H), 6.83 (s, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 161.03, 155.79, 154.58, 134.15, 133.06, 130.99, 130.21, 130.09, 128.30, 126.81, 126.48, 125.57, 125.36, 124.35, 123.54, 120.31, 118.45, 106.87. LC-MS (ESI+) 492.07 (M + H)<sup>+</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>23</sub>H<sub>18</sub>N<sub>5</sub>O<sub>4</sub>S<sub>2</sub> (M + H)<sup>+</sup> 492.0795, found 492.0805</div></div><div id="sec5_5_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> <i>N</i>-(3-(1<i>H</i>-Tetrazol-5-ylthio)-4-hydroxynaphthalen-1-yl)naphthalene-2-sulfonamide (<b>15l</b>)</h4><div class="NLM_p last">This compound was prepared using the procedure described for <b>15d</b> except <b>13e</b> (38 mg, 0.1 mmol) to afford the title compound <b>15l</b> (29 mg, 64.9%, via 2 steps) as a gray solid; mp 173.6 °C (dec.). HPLC 98% (<i>R</i><sub>t</sub> = 5.4 min, 50% CH<sub>3</sub>CN in 0.1% TFA water 30 min). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.54 (br s, 1H), 10.06 (s, 1H), 8.19–8.16 (m, 2H), 7.99–7.93 (m, 4H), 7.70 (dd, <i>J</i> = 8.6, 1.5 Hz, 1H), 7.63 (t, <i>J</i> = 7.2 Hz, 1H), 7.55 (t, <i>J</i> = 7.5 Hz, 1H), 7.49–7.43 (m, 2H), 6.88 (s, 1H). LC-MS (ESI+) 450.07 (M + H)<sup>+</sup>. <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 154.69, 137.30, 134.78, 133.03, 132.10, 130.08, 129.79, 129.77, 129.46, 128.54, 128.43, 128.32, 128.16, 126.82, 126.44, 125.49, 124.29, 123.55, 123.10, 104.99. LC-MS (ESI+) 450.07 (M + H)<sup>+</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>21</sub>H<sub>16</sub>N<sub>5</sub>O<sub>3</sub>S<sub>2</sub> (M + H)<sup>+</sup> 450.0689, found 450.0702.</div></div><div id="sec5_5_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> <i>N</i>-(3-(1<i>H</i>-Tetrazol-5-ylthio)-4-hydroxynaphthalen-1-yl)-4-pentylbenzenesulfonamide (<b>15m</b>)</h4><div class="NLM_p last">This compound was prepared using the procedure described for <b>15d</b> except using <b>13j</b> (40 mg, 0.1 mmol) to afford the title compound <b>15m</b> (39 mg, 83.6%, via 2 steps) as a gray solid; mp 155.6 °C (dec.). HPLC 99% (<i>R</i><sub>t</sub> = 15.3 min, 50% CH<sub>3</sub>CN in 0.1% TFA water 40 min). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.53 (br s, 1H), 9.80 (s, 1H), 8.21–8.19 (m, 1H), 7.96–7.94 (m, 1H), 7.56–7.49 (m, 2H), 7.48 (d, <i>J</i> = 8.3 Hz, 2H), 7.16 (d, <i>J</i> = 8.3 Hz, 2H), 6.76 (s, 1H), 2.54 (t, <i>J</i> = 7.5 Hz, 2H), 1.50 (p, <i>J</i> = 7.5 Hz, 2H), 1.30–1.23 (m, 2H), 1.18–1.11 (m, 2H), 0.83 (t, <i>J</i> = 7.2 Hz, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 154.75, 148.33, 137.34, 133.23, 130.26, 129.40, 128.27, 127.62, 126.76, 126.47, 125.63, 124.42, 123.53, 106.51, 35.43, 31.24, 30.77, 22.55, 14.56. LC-MS (ESI+) 470.13 (M + H)<sup>+</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>22</sub>H<sub>24</sub>N<sub>5</sub>O<sub>3</sub>S<sub>2</sub> (M + H)<sup>+</sup> 470.1315, found 470.1310.</div></div><div id="sec5_5_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> 2-(4-(5-Chlorothiophene-2-sulfonamido)-1-hydroxynaphthalen-2-ylthio)acetic Acid (<b>15n</b>)</h4><div class="NLM_p last">This compound was prepared using the procedure described for <b>15a</b> using <b>13k</b> (52 mg, 0.14 mmol) and a solution of thioglycolic acid (0.14 mL, 1 M solution in THF). The title compound <b>15n</b> (32 mg, 54%) was obtained as a white solid; mp 143–145 °C. HPLC 95% (<i>R</i><sub>t</sub> = 17.1 min, 40% CH<sub>3</sub>CN in 0.1% TFA water, 40 min). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.77 (br s, 1H), 10.30 (s, 1H), 9.96 (br s, 1H), 8.14 (d, <i>J</i> = 7.7 Hz, 1H), 7.85 (d, <i>J</i> = 8.8 Hz, 1H), 7.50–7.43 (m, 2H), 7.22 (d, <i>J</i> = 4.1 Hz, 1H), 7.12–7.11 (m, 2H), 3.55 (s, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 171.78, 153.29, 139.27, 135.68, 132.92, 131.87, 130.16, 128.59, 127.59, 126.59, 125.76, 124.15, 123.69, 123.18, 113.74, 37.42. LC-MS (ESI−) 427.94 (M – H)<sup>−</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>16</sub>H<sub>12</sub>ClNO<sub>5</sub>S<sub>3</sub>Na (M + Na)<sup>+</sup> 451.9458, found 451.9468.</div></div><div id="sec5_5_57" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> 2-(4-(Biphenyl-4-ylsulfonamido)-1-hydroxynaphthalen-2-ylthio)acetic Acid (<b>15o</b>)</h4><div class="NLM_p last">This compound was prepared using the procedure described for <b>15a</b> using <b>13b</b> (50 mg, 0.12 mmol) and a solution of thioglycolic acid (0.12 mL, 1 M solution in THF). The title compound <b>15o</b> (19 mg, 40%) was obtained as a gray solid; mp 170 °C (dec.). HPLC 97% (<i>R</i><sub>t</sub> = 10.44 min, 50% CH<sub>3</sub>CN in 0.1% TFA water 20 min). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.78 (br s, 1H), 9.95 (s, 1H), 8.11 (d, <i>J</i> = 8.0 Hz, 1H), 7.85 (d, <i>J</i> = 7.6 Hz, 1H), 7.76 (d, <i>J</i> = 8.4 Hz, 2H), 7.68–7.65 (m, 4H), 7.548–7.39 (m, 5H), 7.00 (s, 1H), 5.73 (br s, 1H), 3.46 (s, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 171.73, 152.91, 144.78, 139.23, 139.14, 131.89, 129.77, 129.17, 128.25, 127.87, 127.71, 127.28, 126.41, 125.79, 124.79, 124.13, 123.09, 113.72, 37.44. LC-MS (ESI+) 464.07 (M + H)<sup>+</sup>. HRMS (ESI−) <i>m</i>/<i>z</i> calculated for C<sub>24</sub>H<sub>18</sub>NO<sub>5</sub>S<sub>2</sub> (M – H)<sup>−</sup> 464.0632, found 464.0638.</div></div><div id="sec5_5_58" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> <i>tert</i>-Butyl 2-(4-(thiophene-2-sulfonamido)naphthalen-1-yloxy)acetate (<b>16a</b>)</h4><div class="NLM_p last">The compound <b>3</b> (61 mg, 0.2 mmol) was dissolved in DMF (1 mL) and added <i>tert</i>-butyl bromoacetate (0.060 mL, 0.4 mmol), followed by DBU (0.4 mL, 1 M solution in NMP) and catalytic amount of KI. The reaction mixture was heated using a microwave reactor at 90 °C for 20 min. The TLC analysis (EtOAc/hexane [1:2]) showed the presence of starting material. To drive the reaction to completion, additional <i>tert</i>-butyl bromoacetate (13.5 equiv, 0.4 mL, 2.7 mmol) was added, and the reaction was continued at 90 °C for further 30 min. The resulting mixture was diluted with ethyl acetate (40 mL) and washed with NaHSO<sub>4</sub> (10 mL × 2, 0.5 M), water (10 mL × 6) and brine (10 mL). The organic phase was dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated. The solid obtained was purified via SiO<sub>2</sub> chromatography (hexane/EtOAc, gradient elution) to afford <b>16a</b> (43 mg, 51.3%) as a gray solid. <i>R</i><sub>f</sub> = 0.27 (TLC, EtOAc/hexane [1:2]); mp 128.6 °C (dec.). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.85 (d, <i>J</i> = 7.6 Hz, 1H), 7.80 (dd, <i>J</i> = 7.6, 1.2 Hz, 1H), 7.61 (dd, <i>J</i> = 4.8, 1.2 Hz, 1H), 7.56 (dd, <i>J</i> = 3.6, 1.2 Hz, 1H), 7.46–7.36 (m, 2H), 7.16 (d, <i>J</i> = 8.4 Hz, 1H), 6.99 (dd, <i>J</i> = 5.0, 3.8 Hz, 1H), 6.31 (d, <i>J</i> = 8.4 Hz, 1H), 3.92 (s, 2H), 1.52 (s, 9H). LC-MS (ESI+) 420.09 (M + H)<sup>+</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>20</sub>H<sub>22</sub>NO<sub>5</sub>S<sub>2</sub> (M + H)<sup>+</sup> 420.0934, found 420.0932.</div></div><div id="sec5_5_59" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> Methyl 4-(4-(Thiophene-2-sulfonamido)naphthalen-1-yloxy)butanoate (<b>16b</b>)</h4><div class="NLM_p last">This compound was synthesized according to the procedure described for <b>16a</b> except using 15 equiv of ethyl bromobutanoate (0.44 mL, 3 mmol), and the reaction mixture was heated using a microwave reactor at 90 °C for 30 min. The TLC analysis indicated presence of starting material, and additional 30 min at 90 °C was required to complete the reaction. The crude solid <b>16b</b> was purified (SiO<sub>2</sub> chromatography, hexane/EtOAc gradient elution) to afford <b>16b</b> (43 mg, 51.3%) as a brown oil. The baseline impurities were still observed after SiO<sub>2</sub> purification. This product was used in the next step without further purification. <i>R</i><sub>f</sub> = 0.36 (TLC, EtOAc/hexane = 1:2). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.82–7.80 (m, 1H), 7.78–7.75 (m, 1H), 7.62 (dd, <i>J</i> = 5.2, 1.6 Hz, 1H), 7.58 (dd, <i>J</i> = 4.0, 1.2 Hz, 1H), 7.42–7.36 (m, 2H), 7.13 (d, <i>J</i> = 8.4 Hz, 1H), 7.00 (dd, <i>J</i> = 4.8, 4.0 Hz, 1H), 6.44 (d, <i>J</i> = 8.4 Hz, 1H), 4.15 (q, <i>J</i> = 7.1 Hz, 2H), 3.31 (t, <i>J</i> = 6.7 Hz, 2H), 2.52 (t, <i>J</i> = 6.8 Hz, 2H), 2.11 (p, <i>J</i> = 6.7 Hz, 2H), 1.25 (t, <i>J</i> = 7.1 Hz, 3H).</div></div><div id="sec5_5_60" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> 2-(4-(Thiophene-2-sulfonamido)naphthalen-1-yloxy)acetic Acid (<b>17a</b>)</h4><div class="NLM_p last">The <b>16a</b> was dissolved in dioxane (1 mL) and added conc HCl (1 mL, 32%). The mixture was stirred at room temperature for 1 h (TLC analysis EtOAc/hexane [1:2] indicated completion of the reaction) and concentrated. The residue was suspended in DCM/hexane (1:1, 2 mL) and left in a refrigerator (overnight). The precipitate was collected by filtration and washed with DCM/hexane (1:1, 3 mL), affording <b>17a</b> (21.4 mg, 82.3%) as a gray solid. <i>R</i><sub>f</sub> = 0.33 (TLC, CH<sub>3</sub>OH/DCM [1:20]); mp 148.9 °C (dec.). HPLC 98% (<i>R</i><sub>t</sub> = 6.19 min, 50% CH<sub>3</sub>CN in 0.1% TFA water 20 min). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.64 (br s, 1H), 8.14–8.13 (m, 1H), 8.11 (dd, <i>J</i> = 5.2, 1.4 Hz, 1H), 7.78 (dd, <i>J</i> = 3.8, 1.4 Hz, 1H), 7.66–7.63 (m, 1H), 7.46–7.43 (m, 2H), 7.19 (dd, <i>J</i> = 4.8, 3.6 Hz, 1H), 7.01 (d, <i>J</i> = 8.5 Hz, 1H), 6.80 (br s, 1H), 6.23 (d, <i>J</i> = 8.4 Hz, 1H), 3.96 (s, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 172.94, 143.97, 137.63, 136.87, 135.95, 134.32, 129.07, 127.88, 127.43, 125.75, 123.72, 122.55, 121.54, 120.25, 101.97, 45.39. LC-MS (ESI−) 362.01 (M – H)<sup>−</sup>.; HRMS (ESI– ) <i>m</i>/<i>z</i> calculated for C<sub>16</sub>H<sub>12</sub>NO<sub>5</sub>S<sub>2</sub> (M – H)<sup>−</sup> 362.0162, found 362.0174.</div></div><div id="sec5_5_61" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> 4-(4-(Thiophene-2-sulfonamido)naphthalen-1-yloxy)butanoic Acid (<b>17b</b>)</h4><div class="NLM_p last">This compound was synthesized using the procedure described for <b>17a</b> except using <b>16b</b> (43 mg, 0.1 mmol), dioxane (2 mL), and conc HCl (4 mL, 32%). The required product <b>17b</b> (23 mg, 56.6%) was obtained as a brown greasy solid. <i>R</i><sub>f</sub> = 0.09 (TLC, CH<sub>3</sub>OH/DCM [1:20]). HPLC 97% (<i>R</i><sub>t</sub> = 7.43 min, 50% CH<sub>3</sub>CN in 0.1% TFA water 20 min). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.11 (br s, 1H), 8.18–8.15 (m, 1H), 8.10 (dd, <i>J</i> = 4.8, 1.2 Hz, 1H), 7.77 (dd, <i>J</i> = 2.8, 0.8 Hz, 1H), 7.64–7.62 (m, 1H), 7.42–7.40 (m, 2H), 7.18 (t, <i>J</i> = 4.0 Hz, 1H), 6.99 (d, <i>J</i> = 8.4 Hz, 1H), 6.42–6.39 (m, 2H), 3.20–3.17 (m, 2H), 2.36 (t, <i>J</i> = 7.2 Hz, 2H), 1.92–1.85 (m, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 175.19, 144.40, 137.55, 136.84, 135.46, 134.32, 129.02, 127.94, 127.30, 125.42, 123.75, 122.75, 121.45, 120.37, 101.52, 43.20, 32.04, 24.05. LC-MS (ESI−) 390.05 (M – H)<sup>−</sup>. HRMS (ESI−) <i>m</i>/<i>z</i> calculated for C<sub>18</sub>H<sub>16</sub>NO<sub>5</sub>S<sub>2</sub> (M – H)<sup>−</sup> 390.0475, found 390.0476.</div></div><div id="sec5_5_62" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> <i>O</i>-4-Nitronaphthalen-1-yl Dimethylcarbamothioate (<b>19</b>)</h4><div class="NLM_p last">The 4-nitro-1-naphthol (378 mg, 2 mmol) was dissolved in NMP (2 mL) and added K<sub>2</sub>CO<sub>3</sub> (276 mg, 2 mmol). The mixture was heated to 50 °C and a solution of <i>N</i>,<i>N</i>-dimethylthiocarbamoyl chloride (260 mg, 2.1 mmol) was added in NMP (1 mL) dropwise over 5 min. The resulting solution was stirred at 50 °C for 2 h and quenched with water (30 mL) at 50 °C. The brown precipitate obtained was filtered and washed with water and dried to obtain intermediate <b>19</b> (496 mg, 89.8%) as a dark-brown solid. <i>R</i><sub>f</sub> = 0.40 (TLC, EtOAc/hexane [1:2]); mp 110.4 °C (dec.). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.67 (d, <i>J</i> = 8.8 Hz, 1H), 8.33 (d, <i>J</i> = 8.4 Hz, 1H), 7.96 (d, <i>J</i> = 8.0 Hz, 1H), 7.77–7.72 (m, 1H), 7.66–7.62 (m, 1H), 7.30 (d, <i>J</i> = 8.4 Hz, 1H), 3.53 (s, 6H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 186.71, 154.44, 144.13, 130.11, 128.49, 127.95, 126.84, 124.77, 123.93, 122.62, 118.66, 43.77, 39.35. LC-MS (ESI+) 277.07 (M + H)<sup>+</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>13</sub>H<sub>13</sub>N<sub>2</sub>O<sub>3</sub>S (M + H)<sup>+</sup> 277.0641, found 277.0637.</div></div><div id="sec5_5_63" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> <i>S</i>-4-Nitronaphthalen-1-yl Dimethylcarbamothioate (<b>20</b>)</h4><div class="NLM_p last">The intermediate <b>19</b> (276 mg, 1 mmol) was dissolved in NMP (2 mL), and the solution was heated to 180 °C in a microwave reactor for 20 min. The reaction mixture was diluted with ethyl acetate (50 mL) and washed with water and brine. The organic phase was dried (Na<sub>2</sub>SO<sub>4</sub>), concentrated, and the crude product obtained was purified using chromatography (10 g silica gel, hexane/EtOAc gradient elution) to afford compound <b>20</b> as a brown solid (198 mg, 71.5%). <i>R</i><sub>f</sub> = 0.38 (TLC, EtOAc/hexane [1:2]); mp 91.2 °C (dec.). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.50–8.46 (m, 2H), 8.13 (d, <i>J</i> = 7.9 Hz, 1H), 7.87 (d, <i>J</i> = 7.9 Hz, 2H), 7.77–7.64 (m, 1H), 3.24 (s, 3H), 3.03 (s, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 165.00, 148.27, 136.12, 134.33, 134.22, 129.61, 128.46, 126.75, 125.69, 123.66, 122.83, 37.41. LC-MS (ESI+) 277.07 (M + H)<sup>+</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>13</sub>H<sub>13</sub>N<sub>2</sub>O<sub>3</sub>S (M + H)<sup>+</sup> 277.0641, found 277.0642.</div></div><div id="sec5_5_64" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> 2-(4-Nitronaphthalen-1-ylthio)acetic Acid (<b>21</b>)</h4><div class="NLM_p last">The intermediate <b>20</b> (97 mg, 0.35 mmol) was suspended in methanol (1 mL) under argon atmosphere and added KOH (1.4 mL, 1 M solution in CH<sub>3</sub>OH). The reaction mixture was stirred at room temperature for 12 h, affording a homogeneous solution. The <i>tert</i>-butyl bromoacetate (0.103 mL, 0.7 mmol) was added, and stirring was continued for 12 h. The reaction mixture was concentrated, and the residue was dissolved in water and acidified (pH = 1–2) using solid NaHSO<sub>4</sub>. The yellow precipitate obtained was filtered, washed with water, and air-dried to obtain a yellow solid, (79 mg, 85.6%, via 2 steps). <i>R</i><sub>f</sub> = 0.18 (TLC, CH<sub>3</sub>OH/DCM/HOAc [1:20:0.1]); mp 144.9 °C (dec.). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.57 (d, <i>J</i> = 8.8 Hz, 1H), 8.40 (d, <i>J</i> = 8.8 Hz, 1H), 8.18 (d, <i>J</i> = 8.1 Hz, 1H), 7.77–7.73 (m, 1H), 7.69–7.65 (m, 1H), 7.52 (d, <i>J</i> = 8.4 Hz, 1H), 3.91 (s, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 170.63, 144.42, 143.51, 131.71, 129.92, 127.67, 125.31, 124.74, 124.16, 124.00, 121.35, 35.19. LC-MS (ESI−) 218.03 (M – H–CO<sub>2</sub>)<sup>−</sup>. HRMS (ESI−) <i>m</i>/<i>z</i> calculated for C<sub>12</sub>H<sub>8</sub>NO<sub>4</sub>S (M – H)<sup>−</sup> 262.0179, found 262.0179.</div></div><div id="sec5_5_65" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> 2-(4-Aminonaphthalen-1-ylthio)acetic Acid (<b>22</b>)</h4><div class="NLM_p last">The intermediate <b>21</b> (70 mg, 0.27 mmol) was dissolved in methanol (50 mL) and the solution was passed through the H-cube hydrogenator (10% Pd–C cat. cartridge, 1.0 mL/min., 25 °C, 40 bar) to obtain a slightly brown color solution. The solution was concentrated to dryness to afford the required product <b>22</b> (70 mg, 100%) as a gray solid. <i>R</i><sub>f</sub> = 0.40 (TLC, CH<sub>3</sub>OH/DCM [1:10]); mp 138.9 °C (dec.). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.48 (d, <i>J</i> = 8.4 Hz, 1H), 8.01 (d, <i>J</i> = 8.5 Hz, 1H), 7.59 (d, <i>J</i> = 8.0, 1H), 7.55–7.51 (m, 1H), 7.46–7.42 (m, 1H), 6.71 (d, <i>J</i> = 7.6 Hz, 1H), 3.42 (s, 2H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ 172.73, 146.04, 135.53, 135.20, 126.58, 125.77, 124.47, 124.40, 122.33, 117.42, 108.43, 38.58. LC-MS (ESI−) 188.05 (M – H–CO<sub>2</sub>)<sup>−</sup>. HRMS (ESI−) <i>m</i>/<i>z</i> calculated for C<sub>12</sub>H<sub>10</sub>NO<sub>2</sub>S (M – H)<sup>−</sup> 232.0438, found 232.0435.</div></div><div id="sec5_5_66" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> 2-(4-(Thiophene-2-sulfonamido)naphthalen-1-ylthio)acetic Acid (<b>23</b>)</h4><div class="NLM_p last">The compound <b>22</b> (33 mg, 0.14 mmol) was dissolved in THF (1 mL), and pyridine (0.28 mL, 0.5 M solution in THF) was added at 0 °C, followed by water (0.5 mL). Thiophene-2-sulfonyl chloride (26 mg in 1 mL THF) was added dropwise, followed by additional pyridine (0.28 mL 0.5 M solution in THF). The resulting solution was stirred vigorously at 0 °C and slowly warmed to room temperature. After 4 h, the organic phase was removed and the aqueous portion was diluted with water (10 mL) and acidified (pH = 2–3) at 0 °C using NaHSO<sub>4</sub> solution (0.5 M). The mixture was extracted with ethyl acetate. The organic phase was washed with water and brine, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated. The crude product obtained was purified using chromatography (SiO<sub>2</sub>, DCM/CH<sub>3</sub>OH [20:1]) to afford <b>23</b> (31 mg, 58.4%) as a gray solid. <i>R</i><sub>f</sub> = 0.17 (TLC, CH<sub>3</sub>OH/DCM/HOAc [1:20:0.1]); mp 159.8 °C (dec.). HPLC 99% (<i>R</i><sub>t</sub> = 4.43 min, 50% CH<sub>3</sub>CN in 0.1% TFA water 20 min). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>CN) δ 8.36 (d, <i>J</i> = 8.4 Hz, 1H), 7.99 (d, <i>J</i> = 8.4 Hz, 1H), 7.68 (dd, <i>J</i> = 4.8, 1.3 Hz, 1H), 7.64–7.60 (m, 1H), 7.57–7.51 (m, 2H), 7.43 (dd, <i>J</i> = 3.6, 1.2 Hz, 1H), 7.28 (d, <i>J</i> = 7.6 Hz, 1H), 7.04 (dd, <i>J</i> = 5.2, 4.0 Hz, 1H), 3.78 (s, 2H). LC-MS (ESI−) 378.00 (M – H)<sup>−</sup>. HRMS (ESI−) <i>m</i>/<i>z</i> calculated for C<sub>16</sub>H<sub>12</sub>NO<sub>4</sub>S<sub>3</sub> (M – H)<sup>−</sup> 377.9934, found 377.9937.</div></div><div id="sec5_5_67" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> 2-(1-Hydroxy-4-(thiophene-2-sulfonamido)naphthalen-2-ylthio)benzoic Acid (<b>24</b>)</h4><div class="NLM_p last">This compound was prepared using the procedure described for <b>15a</b> except using thiosalicylic acid (15 mg, 0.1 mmol). The title compound <b>24</b> (19 mg, 99%) was obtained as a white solid; mp 215 °C (dec.). HPLC 91% (<i>R</i><sub>t</sub> = 18.9 min, 40% CH<sub>3</sub>CN in 0.1% TFA water, 40 min). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.15 (br s, 1H), 10.09 (s, 1H), 8.19 (d, <i>J</i> = 8.0 Hz, 1H), 8.01 (d, <i>J</i> = 7.6 Hz, 1H), 7.92 (d, <i>J</i> = 8.0 Hz, 1H), 7.76 (d, <i>J</i> = 4.8 Hz, 1H), 7.58–7.50 (m, 2H), 7.34–7.31 (m, 2H), 7.17 (t, 7.2 Hz, 1H), 6.91 (s, 2H), 6.47 (d, <i>J</i> = 8.8 Hz, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 168.15, 156.08, 141.87, 140.39, 133.88, 133.34, 133.21, 133.17, 132.65, 131.78, 128.38, 128.17, 126.70, 126.58, 126.18, 125.15, 125.06, 124.21, 123.69, 109.66, 104.98. LC-MS (ESI+) 475.05 (M + NH<sub>4</sub>)<sup>+</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>21</sub>H<sub>15</sub>NO<sub>5</sub>S<sub>3</sub>Na (M + Na)<sup>+</sup> 480.0005, found 479.9992.</div></div><div id="sec5_5_68" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> <i>N</i>-(3-(1<i>H</i>-1,2,4-Triazol-3-ylthio)-4-hydroxynaphthalen-1-yl)-3,4-dichlorobenzenesulfonamide (<b>25</b>)</h4><div class="NLM_p last">This compound was prepared using the procedure described for <b>15d</b> except using <b>13b</b> (82 mg, 0.2 mmol) and 1<i>H</i>-1,2,4-triazole-3-thiol (24 mg, 0.24 mmol). The title compound <b>25</b> (23 mg, 91.3%, via 2 steps) was obtained as a white solid. HPLC 98% (<i>R</i><sub>t</sub> = 21.0 min, 40% CH<sub>3</sub>CN in 0.1% TFA water, 40 min); mp 154.8 °C (dec.). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.17 (br s, 1H), 9.95 (s, 1H), 8.55 (br s, 1H), 8.145 (d, <i>J</i> = 7.6 Hz, 1H), 7.91 (d, <i>J</i> = 7.6 Hz, 1H), 7.71 (d, <i>J</i> = 8.4 Hz, 2H), 7.68–7.58 (m, 4H), 7.50–7.39 (m, 5H), 6.94 (br s, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 152.68, 144.69, 139.25, 139.08, 132.05, 129.79, 129.39, 129.18, 128.11, 127.77, 127.70, 127.59, 126.58, 126.30, 125.15, 124.15, 123.19. LC-MS (ESI+) 475.09 (M + H)<sup>+</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>24</sub>H<sub>19</sub>N<sub>4</sub>O<sub>3</sub>S<sub>2</sub> (M + H)<sup>+</sup> 475.0893, found 475.0898.</div></div><div id="sec5_5_69" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> <i>N</i>-(3-(1<i>H</i>-1,2,4-Triazol-3-ylthio)-4-hydroxynaphthalen-1-yl)-5-phenylthiophene-2-sulfonamide (<b>26</b>)</h4><div class="NLM_p last">This compound was prepared using the procedure described for <b>15d</b> except using <b>13c</b> (83 mg, 0.2 mmol) and 1<i>H</i>-1,2,4-triazole-3-thiol (20 mg, 0.2 mmol). The title compound <b>26</b> (12 mg, 43.0%, via 2 steps) was obtained as a gray solid; mp 172.9 °C (dec.). HPLC 95% (<i>R</i><sub>t</sub> = 20.1 min, 40% CH<sub>3</sub>CN in 0.1% TFA water, 40 min). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.17 (br s, 2H), 8.52 (br s, 1H), 8.17 (d, <i>J</i> = 8.8 Hz, 1H), 7.94 (d, <i>J</i> = 8.8 Hz, 1H), 7.62 (appd, <i>J</i> = 7.2 Hz, 2H), 7.50–7.39 (m, 6H), 7.29 (d, <i>J</i> = 4.0 Hz, 1H), 7.04 (br s, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 152.94, 150.22, 139.29, 134.02, 132.78, 132.25, 130.04, 129.82, 129.73, 127.73, 126.66, 126.58, 126.31, 124.83, 124.48, 124.03, 123.23, 111.15. LC-MS (ESI+) 481.05 (M + H)<sup>+</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>22</sub>H<sub>17</sub>N<sub>4</sub>O<sub>3</sub>S<sub>3</sub> (M + H)<sup>+</sup> 481.0457, found 481.0456.</div></div><div id="sec5_5_70" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> <i>N</i>-(3-(1<i>H</i>-1,2,4-Triazol-3-ylthio)-4-hydroxynaphthalen-1-yl)-4′-fluorobiphenyl-4-sulfonamide (<b>27</b>)</h4><div class="NLM_p last">This compound was prepared using the procedure described for <b>15d</b> except using <b>13f</b> (85 mg, 0.2 mmol) and 1<i>H</i>-1,2,4-triazole-3-thiol (20 mg, 0.2 mmol). The title compound <b>27</b> (29 mg, 38.1%, via 2 steps) was obtained as an off-white solid; mp 194.1 °C (dec.). HPLC 97% (<i>R</i><sub>t</sub> = 24.2 min, 40% CH<sub>3</sub>CN in 0.1% TFA water, 40 min). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.92 (s, 1H), 8.51 (br s, 1H), 8.13 (d, <i>J</i> = 7.6 Hz, 1H), 7.90 (d, <i>J</i> = 8.0 Hz, 1H), 7.70–7.67 (m, 4H), 7.61 (d, <i>J</i> = 8.6 Hz, 2H), 7.45–7.42 (m, 2H), 7.30 (t, <i>J</i> = 8.8 Hz, 2H), 6.88 (br s, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 163.12 (d, <i>J</i> = 244.3 Hz), 145.75, 143.61, 139.26, 135.56, 129.84 (d, <i>J</i> = 8.3 Hz), 128.12, 127.72, 127.54, 126.56, 126.29, 125.04, 124.14, 123.18, 116.64 (d, <i>J</i> = 21.4 Hz). <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>) δ −114.28 (m). LC-MS (ESI+) 493.09 (M + H)<sup>+</sup>.</div></div><div id="sec5_5_71" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> <i>N</i>-(3-(1<i>H</i>-1,2,4-Triazol-3-ylthio)-4-hydroxynaphthalen-1-yl)-4-cyclohexylbenzenesulfonamide (<b>28</b>)</h4><div class="NLM_p last">This compound was prepared using the procedure described for <b>15d</b> except using <b>13h</b> (83 mg, 0.2 mmol) and 1<i>H</i>-1,2,4-triazole-3-thiol (20 mg, 0.2 mmol). The title compound <b>28</b> (40 mg, 68.0%, via 2 steps) was obtained as an off-white solid; mp 154.7 °C (dec.). HPLC 95% (<i>R</i><sub>t</sub> = 14.6 min, 50% CH<sub>3</sub>CN in 0.1% TFA water 40 min). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.18 (br s, 1H), 9.77 (s, 1H), 8.59 (br s, 1H), 8.14 (d, <i>J</i> = 8.4 Hz, 1H), 7.84 (d, <i>J</i> = 8.4 Hz, 1H), 7.48–7.39 (m, 4H), 7.24 (d, <i>J</i> = 8.4, 2H), 6.84 (br s, 1H), 1.76–1.67 (m, 5H), 1.35–1.30 (m, 5H), 1.25–1.20 (m, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 153.21, 137.76, 132.17, 129.70, 127.86, 127.57, 127.48, 126.48, 126.25, 125.23, 124.13, 123.16, 44.22, 34.18, 26.83, 26.12. LC-MS (ESI+) 481.15 (M + H)<sup>+</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>24</sub>H<sub>25</sub>N<sub>4</sub>O<sub>3</sub>S<sub>2</sub> (M + H)<sup>+</sup> 481.1363, found 481.1371.</div></div><div id="sec5_5_72" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> <i>N</i>-(3-(1<i>H</i>-1,2,4-Triazol-3-ylthio)-4-hydroxynaphthalen-1-yl)-4-phenoxybenzenesulfonamide (<b>29</b>)</h4><div class="NLM_p last">This compound was prepared using the procedure described for <b>15d</b> except using <b>13d</b> (78 mg, 0.2 mmol) and 1<i>H</i>-1,2,4-triazole-3-thiol (20 mg, 0.2 mmol). The title compound <b>29</b> (36 mg, 56.5%, via 2 steps) was obtained as an off-white solid; mp 176.1 °C (dec.). HPLC 99% (<i>R</i><sub>t</sub> = 23.2 min, 40% CH<sub>3</sub>CN in 0.1% TFA water, 40 min). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.12 (br s, 1H, disappeared on D<sub>2</sub>O shake), 9.78 (s, 1H, disappeared on D<sub>2</sub>O shake), 8.53 (br s, 1H), 8.10 (d, <i>J</i> = 8.0 Hz, 1H), 7.83 (d, <i>J</i> = 8.1 Hz, 1H), 7.49 (d, <i>J</i> = 8.8 Hz, 2H), 7.46–7.35 (m, 4H), 7.18–7.14 (m, 1H), 6.95 (appd, <i>J</i> = 7.7 Hz, 2H), 6.90 (d, <i>J</i> = 8.8 Hz, 2H), 6.82 (br s, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 160.92, 155.92, 152.67, 134.42, 132.11, 130.99, 130.01, 129.74, 127.56, 126.53, 126.29, 125.28, 125.13, 124.15, 123.18, 120.23, 118.60, 104.99. LC-MS (ESI+) 491.09 (M + H)<sup>+</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>24</sub>H<sub>19</sub>N<sub>4</sub>O<sub>4</sub>S<sub>2</sub> (M + H)<sup>+</sup> 491.0842, found 491.0847.</div></div><div id="sec5_5_73" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> <i>N</i>-(3-(1<i>H</i>-1,2,4-Triazol-3-ylthio)-4-hydroxynaphthalen-1-yl)-4′-(trifluoromethyl)biphenyl-4-sulfonamide (<b>30</b>)</h4><div class="NLM_p last">This compound was prepared using the procedure described for <b>15d</b> except using <b>13l</b> (95 mg, 0.2 mmol) and 1<i>H</i>-1,2,4-triazole-3-thiol (20 mg, 0.2 mmol). The title compound <b>30</b> (31 mg, 79.2%, via 2 steps) was obtained as an off-white solid; mp 193.8 °C (dec.). HPLC 95% (<i>R</i><sub>t</sub> = 13.7 min, 50% CH<sub>3</sub>CN in 0.1% TFA water, 40 min). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.18 (br s, 1H), 9.97 (s, 1H), 8.48 (br s, 1H), 8.12 (d, <i>J</i> = 7.9 Hz, 1H), 7.90–7.79 (m, 5H), 7.76 (d, <i>J</i> = 8.4 Hz, 2H), 7.64 (d, <i>J</i> = 8 Hz, 2H), 7.44–7.41 (m 2H), 6.86 (s, 1H). <sup>19</sup>F NMR (376 MHz, DMSO-<i>d</i><sub>6</sub>) δ −61.44 (s). LC-MS (ESI+) 543.08 (M + H)<sup>+</sup>. HRMS (ESI + ve) <i>m</i>/<i>z</i> calculated for C<sub>25</sub>H<sub>18</sub>F<sub>3</sub>N<sub>4</sub>O<sub>3</sub>S<sub>2</sub> (M + H)<sup>+</sup> 543.0767, found 543.0781.</div></div><div id="sec5_5_74" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> <i>N</i>-(3-(1<i>H</i>-1,2,4-Triazol-3-ylthio)-4-hydroxynaphthalen-1-yl)-5-(phenylsulfonyl)thiophene-2-sulfonamide (<b>31</b>)</h4><div class="NLM_p last">This compound was prepared using the procedure described for <b>15d</b> except using <i>N</i>-(3-chloro-4-oxonaphthalen-1(4<i>H</i>)-ylidene)-5-(phenylsulfonyl)thiophene-2-sulfonamide (<b>13m</b>) (96 mg, 0.2 mmol) and 1<i>H</i>-1,2,4-triazole-3-thiol (20 mg, 0.2 mmol). The title compound <b>31</b> (36 mg, 68.9%, via 2 steps) was obtained as an off-white solid; mp 153.3 °C (dec.). HPLC 98% (<i>R</i><sub>t</sub> = 11.5 min, 40% CH<sub>3</sub>CN in 0.1% TFA water 40 min). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.52 (s, 1H), 10.33 (br s, 1H), 8.46 (br s, 1H), 8.12 (d, <i>J</i> = 8.4 Hz, 1H), 7.89 (d, <i>J</i> = 7.6 Hz, 2H), 7.74 (d, <i>J</i> = 7.6 Hz, 1H), 7.69 (d, <i>J</i> = 4.0 Hz, 1H), 7.64 (t, <i>J</i> = 7.6 Hz, 3H), 7.40 (t, <i>J</i> = 7.2 Hz, 1H), 7.29 (d, <i>J</i> = 4.4 Hz, 1H), 7.17 (t, <i>J</i> = 7.6 Hz, 1H), 6.99 (s, 1H), approximately 5% baseline impurity was observed. <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 153.26, 148.25, 147.60, 145.27, 140.93, 140.66, 135.23, 134.43, 133.19, 131.81, 130.76, 130.38, 127.87, 127.70, 126.71, 126.21, 123.81, 123.32, 123.24. LC-MS (ESI+) 545.00 (M + H)<sup>+</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>22</sub>H<sub>17</sub>N<sub>4</sub>O<sub>5</sub>S<sub>4</sub> (M + H)<sup>+</sup> 545.0076, found 545.0096.</div></div><div id="sec5_5_75" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> <i>N</i>-(3-(1<i>H</i>-1,2,4-Triazol-3-ylthio)-4-hydroxynaphthalen-1-yl)-1-(phenylsulfonyl)-1H-pyrrole-3-sulfonamide (<b>32</b>)</h4><div class="NLM_p last">This compound was prepared using the procedure described for <b>15d</b> except using <i>N</i>-(3-chloro-4-oxonaphthalen-1(4<i>H</i>)-ylidene)-1-(phenylsulfonyl)-1<i>H</i>-pyrrole-3-sulfonamide (<b>13n</b>) (92 mg, 0.2 mmol) and 1<i>H</i>-1,2,4-triazole-3-thiol (20 mg, 0.2 mmol). The title compound <b>32</b> (34 mg, 75.2%, via 2 steps) was obtained as an off-white solid; mp 157.1 °C (dec.). HPLC 99.8% (<i>R</i><sub>t</sub> = 9.8 min, 50% CH<sub>3</sub>CN in 0.1% TFA water 40 min). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.19 (br s, 1H), 9.81 (s, 1H), 8.47 (br s, 1H), 8.11 (d, <i>J</i> = 8.3 Hz, 1H), 7.92 (d, <i>J</i> = 7.5 Hz, 2H), 7.81 (d, <i>J</i> = 8.5 Hz, 1H), 7.75 (t, <i>J</i> = 7.5 Hz, 1H), 7.59 (t, <i>J</i> = 7.9 Hz, 2H), 7.53–7.52 (m, 1H), 7.44–7.36 (m, 3H), 7.30 (t, <i>J</i> = 7.3 Hz, 1H), 6.79 (s, 1H), 6.36 (dd, <i>J</i> = 3.3, 1.6 Hz, 1H), approximately 5% baseline impurity was observed. <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 171.01, 152.65, 137.54, 136.00, 131.87, 130.77, 129.37, 128.83, 127.84, 127.80, 127.44, 126.53, 126.21, 124.98, 123.99, 123.43, 123.21, 123.17, 112.26. LC-MS (ESI+) 528.05 (M + H)<sup>+</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>22</sub>H<sub>18</sub>N<sub>5</sub>O<sub>5</sub>S<sub>3</sub> (M + H)<sup>+</sup> 528.0465, found 528.0476.</div></div><div id="sec5_5_76" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> <i>N</i>-(3-(1<i>H</i>-1,2,4-Triazol-3-ylthio)-4-hydroxynaphthalen-1-yl)-3,4-dichlorobenzenesulfonamide (<b>33</b>)</h4><div class="NLM_p last">This compound was prepared using the procedure described for <b>15d</b> except using <b>13e</b> (76 mg, 0.2 mmol) and 1<i>H</i>-1,2,4-triazole-3-thiol (20 mg, 0.2 mmol). The title compound <b>33</b> (71 mg, 78.9%, 2 steps) was obtained as a white solid; mp 183.2 °C (dec.). HPLC 99.9% (<i>R</i><sub>t</sub> = 21.9 min, 35% CH<sub>3</sub>CN in 0.1% TFA water 40 min). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.02 (br s, 1H), 8.30 (br s, 1H), 8.17 (appd, <i>J</i> = 1.3 Hz, 1H), 8.12 (d, <i>J</i> = 8.0 Hz, 1H), 8.00–7.93 (m, 5H), 7.70–7.63 (m, 2H), 7.59 (appt, <i>J</i> = 7.6 Hz, 1H), 7.45–7.37 (m, 2H), 6.87 (s, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 137.61, 134.79, 132.15, 132.03, 129.85, 129.79, 129.41, 129.23, 128.45, 128.37, 128.15, 127.50, 126.55, 126.28, 125.13, 124.18, 123.12, 123.06. LC-MS (ESI+) 449.08 (M + H)<sup>+</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>22</sub>H<sub>17</sub>N<sub>4</sub>O<sub>3</sub>S<sub>2</sub> (M + H)<sup>+</sup> 449.0737, found 449.0746.</div></div><div id="sec5_5_77" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> <i>N</i>-(3-(1<i>H</i>-1,2,4-Triazol-3-ylthio)-4-hydroxynaphthalen-1-yl)naphthalene-1-sulfonamide (<b>34</b>)</h4><div class="NLM_p last">This compound was prepared according to the procedure for <b>15d</b> using <i>N</i>-(3-chloro-4-oxonaphthalen-1(4<i>H</i>)-ylidene)naphthalene-1-sulfonamide (<b>13o</b>) (76 mg, 0.2 mmol) and 1<i>H</i>-1,2,4-triazole-3-thiol (20 mg, 0.2 mmol). The title compound <b>34</b> (29 mg, 74.5%, via 2 steps) was obtained as a white solid; mp 158.1 °C (dec.). HPLC 98% (<i>R</i><sub>t</sub> = 10.6 min, 40% CH<sub>3</sub>CN in 0.1% TFA water, 40 min). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.24 (s, 1H), 10.10 (br s, 1H), 8.73 (d, <i>J</i> = 8.4 Hz, 1H), 8.50 (br s, 1H), 8.11 (d, <i>J</i> = 8.0 Hz, 1H), 8.07 (d, <i>J</i> = 8.4 Hz, 1H), 8.03 (d, <i>J</i> = 7.6 Hz, 1H), 7.83–7.782 (m, 2H), 7.69–7.61 (m, 2H), 7.44–7.38 (m, 2H), 7.26 (t, <i>J</i> = 7.2 Hz, 1H), 6.74 (s, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 152.14, 135.53, 134.70, 134.34, 131.79, 130.06, 129.64, 128.88, 128.49, 128.24, 127.46, 127.27, 126.50, 126.16, 125.33, 124.96, 123.88, 123.04. LC-MS (ESI+) 449.08 (M + H)<sup>+</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>22</sub>H<sub>17</sub>N<sub>4</sub>O<sub>3</sub>S<sub>2</sub> (M + H)<sup>+</sup> 449.0737, found 449.0741.</div></div><div id="sec5_5_78" class="NLM_sec NLM_sec_level_3"><div id="ac_i94" class="anchor-spacer"></div><h4 class="article-section__title" id="_i94"> <i>N</i>-(3-(1<i>H</i>-Tetrazol-5-ylthio)-4-hydroxynaphthalen-1-yl)-4-chlorobenzenesulfonamide (<b>35</b>)</h4><div class="NLM_p last">This compound was prepared using the procedure described for <b>15d</b> using 4-chloro-<i>N</i>-(3-chloro-4-oxonaphthalen-1(4<i>H</i>)-ylidene)benzenesulfonamide (<b>13p</b>) (37 mg, 0.1 mmol) and 1<i>H</i>-tetrazole-5-thiol (10 mg, 0.1 mmol). The title compound <b>35</b> (35 mg, 81.6%, via 2 steps) was obtained as an off-white solid; mp 180.9 °C (dec.). HPLC 98% (<i>R</i><sub>t</sub> = 11.0 min, 40% CH<sub>3</sub>CN in 0.1% TFA water, 30 min). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.61 (br s, 1H), 10.06 (s, 1H), 8.323–8.20 (m, 1H), 7.94–7.91 (m, 1H), 7.57 (d, <i>J</i> = 8.8 Hz, 2H), 7.55–7.52 (m, 2H), 7.45 (d, <i>J</i> = 8.8 Hz, 2H), 6.83 (s, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 154.72, 138.99, 138.27, 132.96, 130.12, 129.78, 129.44, 128.41, 126.93, 126.50, 125.23, 124.24, 123.60, 106.88. LC-MS (ESI+) 434.01 (M + H)<sup>+</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>17</sub>H<sub>13</sub>ClN<sub>5</sub>O<sub>3</sub>S<sub>2</sub> (M + H)<sup>+</sup> 434.0143, found 434.0129.</div></div><div id="sec5_5_79" class="NLM_sec NLM_sec_level_3"><div id="ac_i95" class="anchor-spacer"></div><h4 class="article-section__title" id="_i95"> <i>N</i>-(3-(1<i>H</i>-Tetrazol-5-ylthio)-4-hydroxynaphthalen-1-yl)-3,4-dichlorobenzenesulfonamide (<b>36</b>)</h4><div class="NLM_p last">This compound was prepared using the procedure for <b>15d</b> using 3,4-dichloro-<i>N</i>-(3-chloro-4-oxonaphthalen-1(4<i>H</i>)-ylidene)benzenesulfonamide (<b>13q</b>) (40 mg, 0.1 mmol) and 1<i>H</i>-tetrazole-5-thiol (10 mg, 0.1 mmol). The title compound <b>36</b> (40 mg, 84.8%, via 2 steps) was obtained as a white solid; mp 174.4 °C (dec.). HPLC 97% (<i>R</i><sub>t</sub> = 10.1 min, 45% CH<sub>3</sub>CN in 0.1% TFA water, 40 min). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.64 (br s, 1H), 10.18 (s, 1H), 8.24–8.22 (m, 1H), 7.94–7.92 (m, 1H), 7.75 (appd, <i>J</i> = 2.0 Hz, 1H), 7.68 (d, <i>J</i> = 8.4 Hz, 1H), 7.56–7.54 (m, 2H), 7.51 (dd, <i>J</i> = 8.4, 1.6 Hz, 1H), 6.85 (s, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 154.80, 140.35, 136.54, 132.95, 132.65, 132.07, 130.17, 129.21, 128.46, 127.63, 127.00, 126.55, 124.86, 124.15, 123.63, 107.07.; LC-MS (ESI+) 467.98 (M + H)<sup>+</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>17</sub>H<sub>12</sub>Cl<sub>2</sub>N<sub>5</sub>O<sub>3</sub>S<sub>2</sub> (M + H)<sup>+</sup> 467.9753, found 467.9752.</div></div><div id="sec5_5_80" class="NLM_sec NLM_sec_level_3"><div id="ac_i96" class="anchor-spacer"></div><h4 class="article-section__title" id="_i96"> <i>N</i>-(3-(1<i>H</i>-Tetrazol-5-ylthio)-4-hydroxynaphthalen-1-yl)benzenesulfonamide (<b>37</b>)</h4><div class="NLM_p last">This compound was prepared using the procedure described for <b>15d</b> using <i>N</i>-(3-chloro-4-oxonaphthalen-1(4<i>H</i>)-ylidene)benzenesulfonamide (<b>13r</b>) (32 mg, 0.1 mmol) and 1<i>H</i>-tetrazole-5-thiol (10 mg, 0.1 mmol). The title compound <b>37</b> (32 mg, 78.9%, via 2 steps) was obtained as a white solid; mp 154.8 °C (dec.). HPLC 92% (<i>R</i><sub>t</sub> = 6.5 min, 40% CH<sub>3</sub>CN in 0.1% TFA water 30 min). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.57 (br s, 1H), 9.94 (s, 1H), 8.21–8.19 (m, 1H), 7.95–7.92 (m, 1H), 7.59–7.56 (m, 2H), 7.54–7.48 (m, 3H), 7.39 (t, <i>J</i> = 8.0 Hz, 2H), 6.79 (s, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 154.57, 140.16, 133.33, 133.03, 129.97, 129.60, 128.31, 127.48, 126.83, 126.47, 125.53, 124.32, 123.52, 106.87. LC-MS (ESI+) 400.06 (M + H)<sup>+</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>17</sub>H<sub>14</sub>N<sub>5</sub>O<sub>3</sub>S<sub>2</sub> (M + H)<sup>+</sup> 400.0526, found 400.0529.</div></div><div id="sec5_5_81" class="NLM_sec NLM_sec_level_3"><div id="ac_i97" class="anchor-spacer"></div><h4 class="article-section__title" id="_i97"> <i>N</i>-(3-(1<i>H</i>-Tetrazol-5-ylthio)-4-hydroxynaphthalen-1-yl)-5-chlorothiophene-2-sulfonamide (<b>38</b>)</h4><div class="NLM_p last">This compound was prepared using the procedure described for <b>15d</b> using <b>13k</b> (37 mg, 0.1 mmol) and 1<i>H</i>-tetrazole-5-thiol (10 mg, 0.1 mmol). The title compound <b>38</b> (36 mg, 81.6%, via 2 steps) was obtained as a gray solid; mp 159.4 °C (dec.). HPLC 96% (<i>R</i><sub>t</sub> = 6.9 min, 45% CH<sub>3</sub>CN in 0.1% TFA water, 40 min). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.68 (br s, 1H), 10.32 (s, 1H), 8.25–8.23 (m, 1H), 7.95–7.93 (m, 1H), 7.57–7.55 (m, 2H), 7.20 (d, <i>J</i> = 4.0 Hz, 1H), 7.04 (d, <i>J</i> = 4.0 Hz, 1H), 6.98 (s, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 154.92, 138.97, 135.76, 133.03, 133.00, 130.29, 128.54, 128.45, 126.97, 126.50, 124.88, 124.02, 123.65, 107.13. LC-MS (ESI+) 439.96 (M + H)<sup>+</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>15</sub>H<sub>11</sub>ClN<sub>5</sub>O<sub>3</sub>S<sub>3</sub> (M + H)<sup>+</sup> 439.9707, found 439.9707.</div></div><div id="sec5_5_82" class="NLM_sec NLM_sec_level_3"><div id="ac_i98" class="anchor-spacer"></div><h4 class="article-section__title" id="_i98"> <i>N</i>-(3-(1<i>H</i>-Tetrazol-5-ylthio)-4-hydroxynaphthalen-1-yl)-4′-(trifluoromethyl)biphenyl-4-sulfonamide (<b>39</b>)</h4><div class="NLM_p last">This compound was prepared using the procedure described for <b>15d</b> using <b>13l</b> (48 mg, 0.1 mmol) and 1<i>H</i>-tetrazole-5-thiol (10 mg, 0.1 mmol). The title compound <b>39</b> (41 mg, 76.1%, via 2 steps) was obtained as a white solid; mp 168 °C (dec.). HPLC 99% (<i>R</i><sub>t</sub> = 14.6 min, 50% CH<sub>3</sub>CN in 0.1% TFA water 30 min). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.59 (br s, 1H), 10.04 (s, 1H), 8.23–8.20 (m, 1H), 8.00–7.97 (m, 1H), 7.88–7.82 (m, 4H), 7.77 (d, <i>J</i> = 8.6 Hz, 2H), 7.69 (d, <i>J</i> = 8.6 Hz, 2H), 7.54–7.51 (m, 2H), 6.83 (s, 1H). LC-MS (ESI+) 544.08 (M + H)<sup>+</sup>. HRMS (ESI+) <i>m</i>/<i>z</i> calculated for C<sub>24</sub>H<sub>17</sub>F<sub>3</sub>N<sub>5</sub>O<sub>3</sub>S<sub>2</sub> (M + H)<sup>+</sup> 544.0719, found 544.0704.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i99"><a href="/doi/suppl/10.1021/jm201118h">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41846" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41846" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Supporting analytical data; <sup>1</sup>H NMR, <sup>13</sup>C NMR, LCMS, and HPLC for key compounds.  This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm201118h/suppl_file/jm201118h_si_001.pdf">jm201118h_si_001.pdf (9.26 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm201118h" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21406" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21406" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Harshani R. Lawrence</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery
Department, Moffitt Cancer Center, 12902
Magnolia Drive, Tampa,
Florida 33612, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Chemical Biology Core, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa,
Florida 33612, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#8ac2ebf8f9e2ebe4e3a4c6ebfdf8efe4e9efcae7e5ecece3fefea4e5f8ed"><span class="__cf_email__" data-cfemail="f9b1988b8a91989790d7b5988e8b9c979a9cb994969f9f908d8dd7968b9e">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yiyu Ge</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery
Department, Moffitt Cancer Center, 12902
Magnolia Drive, Tampa,
Florida 33612, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Chemical Biology Core, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa,
Florida 33612, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aslamuzzaman Kazi</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery
Department, Moffitt Cancer Center, 12902
Magnolia Drive, Tampa,
Florida 33612, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Frank Marsilio</span> - <span class="hlFld-Affiliation affiliation">Chemical Biology Core, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa,
Florida 33612, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yunting Luo</span> - <span class="hlFld-Affiliation affiliation">Chemical Biology Core, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa,
Florida 33612, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sanjula Jain</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery
Department, Moffitt Cancer Center, 12902
Magnolia Drive, Tampa,
Florida 33612, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wesley Brooks</span> - <span class="hlFld-Affiliation affiliation">Chemical Biology Core, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa,
Florida 33612, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kenyon G. Daniel</span> - <span class="hlFld-Affiliation affiliation">Chemical Biology Core, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa,
Florida 33612, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wayne C. Guida</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery
Department, Moffitt Cancer Center, 12902
Magnolia Drive, Tampa,
Florida 33612, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Chemical Biology Core, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa,
Florida 33612, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Chemistry, University of South Florida, Tampa, Florida 33620,
United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Oncologic Sciences, University of South
Florida, Tampa, Florida 33620,
United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Saïd M. Sebti</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery
Department, Moffitt Cancer Center, 12902
Magnolia Drive, Tampa,
Florida 33612, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Oncologic Sciences, University of South
Florida, Tampa, Florida 33620,
United States</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack" id="ACK-d7e8897-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i100">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37655" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37655" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We acknowledge the NIH for funding (1PO1 CA118210-03), principal investigator Dr. Saïd M. Sebti. We also acknowledge Experimental Lab, Chemical Biology Core, for high throughput screening.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i101" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i101"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i102" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i102"> Abbreviations Used</h2><tr><td class="NLM_term">CT-L</td><td class="NLM_def"><p class="first last">chymotrypsin like</p></td></tr><tr><td class="NLM_term">T-L</td><td class="NLM_def"><p class="first last">trypsin like</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">PGPH</td><td class="NLM_def"><p class="first last">postglutamylpeptidase hydrolysis</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">terahydrofuran</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term">DBU</td><td class="NLM_def"><p class="first last">diazabicycloundecene</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethylsulfoxide</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">DMEM</td><td class="NLM_def"><p class="first last">Dulbecco’s Modified Eagle Medium</p></td></tr><tr><td class="NLM_term">RPMI1640</td><td class="NLM_def"><p class="first last">Roswell Park Memorial Institute-1640</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i103">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12465" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12465" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 36 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Pickart, C. M.</span><span> </span><span class="NLM_article-title">Back to the future with ubiquitin</span> <span class="citation_source-journal">Cell (Cambridge, MA, U.S.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">190</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm201118h&amp;key=10.1016%2FS0092-8674%2803%2901074-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm201118h&amp;key=14744430" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm201118h&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtValsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2004&pages=181-190&author=C.+M.+Pickart&title=Back+to+the+future+with+ubiquitin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Back to the future with ubiquitin</span></div><div class="casAuthors">Pickart, Cecile M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">181-190</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review and discussion.  Two papers published in 1984 by A. Varshavsky and coworkers revealed that the ubiquitin/proteasome pathway is the principal system for the degrdn. of short-lived proteins in mammalian cells, setting the stage for future demonstrations of this pathway's many regulatory roles.  This perspective discusses the impact of those papers and highlights some of the subsequent insights that have led to the current appreciation of the breadth of ubiquitin-mediated signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMf20W4nwasbVg90H21EOLACvtfcHk0lgsjXmXN8-upg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtValsrg%253D&md5=ee82d114a69232e304cf3eda29b49971</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2803%2901074-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252803%252901074-2%26sid%3Dliteratum%253Aachs%26aulast%3DPickart%26aufirst%3DC.%2BM.%26atitle%3DBack%2520to%2520the%2520future%2520with%2520ubiquitin%26jtitle%3DCell%2520%2528Cambridge%252C%2520MA%252C%2520U.S.%2529%26date%3D2004%26volume%3D116%26spage%3D181%26epage%3D190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Ciechanover, A.</span><span> </span><span class="NLM_article-title">Intracellular protein degradation: from a vague idea, through the lysosome and the ubiquitin proteasome system, and onto human diseases and drug targeting (Nobel lecture)</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">5944</span><span class="NLM_x">–</span> <span class="NLM_lpage">5967</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=5944-5967&author=A.+Ciechanover&title=Intracellular+protein+degradation%3A+from+a+vague+idea%2C+through+the+lysosome+and+the+ubiquitin+proteasome+system%2C+and+onto+human+diseases+and+drug+targeting+%28Nobel+lecture%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCiechanover%26aufirst%3DA.%26atitle%3DIntracellular%2520protein%2520degradation%253A%2520from%2520a%2520vague%2520idea%252C%2520through%2520the%2520lysosome%2520and%2520the%2520ubiquitin%2520proteasome%2520system%252C%2520and%2520onto%2520human%2520diseases%2520and%2520drug%2520targeting%2520%2528Nobel%2520lecture%2529%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2005%26volume%3D44%26spage%3D5944%26epage%3D5967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Hershko, A.</span><span> </span><span class="NLM_article-title">The ubiquitin system for protein degradation and some of its roles in the control of the cell-division cycle (Nobel lecture)</span> <span class="citation_source-journal">Angew. Chem., Int. Ed. Engl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">5932</span><span class="NLM_x">–</span> <span class="NLM_lpage">5943</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=5932-5943&author=A.+Hershko&title=The+ubiquitin+system+for+protein+degradation+and+some+of+its+roles+in+the+control+of+the+cell-division+cycle+%28Nobel+lecture%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHershko%26aufirst%3DA.%26atitle%3DThe%2520ubiquitin%2520system%2520for%2520protein%2520degradation%2520and%2520some%2520of%2520its%2520roles%2520in%2520the%2520control%2520of%2520the%2520cell-division%2520cycle%2520%2528Nobel%2520lecture%2529%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%2520Engl.%26date%3D2005%26volume%3D44%26spage%3D5932%26epage%3D5943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Rose, I.</span><span> </span><span class="NLM_article-title">Ubiquitin at fox chase</span> <span class="citation_source-journal">Prix Nobel</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_fpage">218</span><span class="NLM_x">–</span> <span class="NLM_lpage">225</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm201118h&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1egur3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&pages=218-225&author=I.+Rose&title=Ubiquitin+at+fox+chase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Ubiquitin at fox chase</span></div><div class="casAuthors">Rose, Irwin</div><div class="citationInfo"><span class="NLM_cas:title">Prix Nobel</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">218-225</span>CODEN:
                <span class="NLM_cas:coden">PRIXAL</span>;
        ISSN:<span class="NLM_cas:issn">0546-8175</span>.
    
            (<span class="NLM_cas:orgname">Almqvist & Wiksell International</span>)
        </div><div class="casAbstract">A review.  A Nobel lecture by Irwin Rose, discussing primarily ubiquitin, the ubiquitin activating enzyme, the discovery and mechanism of ubiquitin-carboxy terminal hydrolase, and unresolved issues in ubiquitin, is presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVt5Oeryc5PLVg90H21EOLACvtfcHk0lgsjXmXN8-upg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1egur3I&md5=ddc72993972f9f5e5889a6bd521ca8eb</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRose%26aufirst%3DI.%26atitle%3DUbiquitin%2520at%2520fox%2520chase%26jtitle%3DPrix%2520Nobel%26date%3D2005%26spage%3D218%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Verdoes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Florea, B. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Marel, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overkleeft, H. S.</span><span> </span><span class="NLM_article-title">Chemical Tools To Study the Proteasome</span> <span class="citation_source-journal">Eur. J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_fpage">3301</span><span class="NLM_x">–</span> <span class="NLM_lpage">3313</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=3301-3313&author=M.+Verdoesauthor=B.+I.+Floreaauthor=G.+A.+van+der+Marelauthor=H.+S.+Overkleeft&title=Chemical+Tools+To+Study+the+Proteasome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVerdoes%26aufirst%3DM.%26aulast%3DFlorea%26aufirst%3DB.%2BI.%26aulast%3Dvan%2Bder%2BMarel%26aufirst%3DG.%2BA.%26aulast%3DOverkleeft%26aufirst%3DH.%2BS.%26atitle%3DChemical%2520Tools%2520To%2520Study%2520the%2520Proteasome%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2009%26spage%3D3301%26epage%3D3313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_contrib-group">Ciechanover, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, A. L.</span><span> </span><span class="NLM_article-title">The ubiquitin–proteasome pathway: the complexity and myriad functions of proteins death</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">2727</span><span class="NLM_x">–</span> <span class="NLM_lpage">2730</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=2727-2730&author=A.+Ciechanoverauthor=A.+L.+Schwartz&title=The+ubiquitin%E2%80%93proteasome+pathway%3A+the+complexity+and+myriad+functions+of+proteins+death"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCiechanover%26aufirst%3DA.%26aulast%3DSchwartz%26aufirst%3DA.%2BL.%26atitle%3DThe%2520ubiquitin%25E2%2580%2593proteasome%2520pathway%253A%2520the%2520complexity%2520and%2520myriad%2520functions%2520of%2520proteins%2520death%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1998%26volume%3D95%26spage%3D2727%26epage%3D2730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_contrib-group">Ciechanover, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz Alan, L.</span><span> </span><span class="NLM_article-title">Ubiquitin-mediated degradation of cellular proteins in health and disease</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2002&pages=3-6&author=A.+Ciechanoverauthor=L.+Schwartz+Alan&title=Ubiquitin-mediated+degradation+of+cellular+proteins+in+health+and+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCiechanover%26aufirst%3DA.%26aulast%3DSchwartz%2BAlan%26aufirst%3DL.%26atitle%3DUbiquitin-mediated%2520degradation%2520of%2520cellular%2520proteins%2520in%2520health%2520and%2520disease%26jtitle%3DHepatology%26date%3D2002%26volume%3D35%26spage%3D3%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_contrib-group">King, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshaies, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirschner, M. W.</span><span> </span><span class="NLM_article-title">How proteolysis drives the cell cycle</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">1652</span><span class="NLM_x">–</span> <span class="NLM_lpage">1658</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1996&pages=1652-1658&author=R.+W.+Kingauthor=R.+J.+Deshaiesauthor=J.-M.+Petersauthor=M.+W.+Kirschner&title=How+proteolysis+drives+the+cell+cycle"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKing%26aufirst%3DR.%2BW.%26aulast%3DDeshaies%26aufirst%3DR.%2BJ.%26aulast%3DPeters%26aufirst%3DJ.-M.%26aulast%3DKirschner%26aufirst%3DM.%2BW.%26atitle%3DHow%2520proteolysis%2520drives%2520the%2520cell%2520cycle%26jtitle%3DScience%26date%3D1996%26volume%3D274%26spage%3D1652%26epage%3D1658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_contrib-group">Adams, J.</span><span> </span><span class="NLM_article-title">The development of proteasome inhibitors as anticancer drugs</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">417</span><span class="NLM_x">–</span> <span class="NLM_lpage">421</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Fjm201118h&amp;key=10.1016%2FS1535-6108%2804%2900120-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Fjm201118h&amp;key=15144949" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Fjm201118h&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksFCmt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=417-421&author=J.+Adams&title=The+development+of+proteasome+inhibitors+as+anticancer+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The development of proteasome inhibitors as anticancer drugs</span></div><div class="casAuthors">Adams, Julian</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">417-421</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The ubiquitin-proteasome pathway plays a central role in the targeted destruction of cellular proteins, including cell cycle regulatory proteins.  Because these pathways are crit. for the proliferation and survival of all cells, and in particular cancerous cells, proteasome inhibition is a potentially attractive anticancer therapy.  Based on encouraging cytotoxic activity, bortezomib was the first proteasome inhibitor to be evaluated in clin. trials.  Efficacy and safety results from a phase 2 clin. trial contributed to approval of bortezomib for use in patients with relapsed and refractory multiple myeloma who have received at least 2 prior therapies and have demonstrated disease progression on their last therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozXYZQ-zxJdbVg90H21EOLACvtfcHk0lgpk2d7z1Ipeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksFCmt7s%253D&md5=9a070d342533a3b6108150c40852834e</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1016%2FS1535-6108%2804%2900120-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1535-6108%252804%252900120-5%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DJ.%26atitle%3DThe%2520development%2520of%2520proteasome%2520inhibitors%2520as%2520anticancer%2520drugs%26jtitle%3DCancer%2520Cell%26date%3D2004%26volume%3D5%26spage%3D417%26epage%3D421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Rajkumar, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hideshima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. C.</span><span> </span><span class="NLM_article-title">Proteasome inhibition as a novel therapeutic target in human cancer</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">630</span><span class="NLM_x">–</span> <span class="NLM_lpage">639</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm201118h&amp;key=10.1200%2FJCO.2005.11.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm201118h&amp;key=15659509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm201118h&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitVartb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=630-639&author=S.+V.+Rajkumarauthor=P.+G.+Richardsonauthor=T.+Hideshimaauthor=K.+C.+Anderson&title=Proteasome+inhibition+as+a+novel+therapeutic+target+in+human+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Proteasome inhibition as a novel therapeutic target in human cancer</span></div><div class="casAuthors">Rajkumar, S. Vincent; Richardson, Paul G.; Hideshima, Teru; Anderson, Kenneth C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">630-639</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">A review.  The 26S proteasome is a large intracellular ATP-dependent protease that identifies and degrades proteins tagged for destruction by the ubiquitin system.  The orderly degrdn. of cellular proteins is crit. for normal cell cycling and function, and inhibition of the proteasome pathway results in cell-cycle arrest and apoptosis.  Dysregulation of this enzymic system may also play a role in tumor progression, drug resistance, and altered immune surveillance, making the proteasome an appropriate and novel therapeutic target in cancer.  Bortezomib (formerly known as PS-341) is the first proteasome inhibitor to enter clin. practice.  It is a boronic aid dipeptide that binds directly with and inhibits the enzymic complex.  Bortezomib has recently shown significant preclin. and clin. activity in several cancers, confirming the therapeutic value of proteasome inhibition in human malignancy.  It was approved in 2003 for the treatment of advanced multiple myeloma (MM), with approx. one third of patients with relapsed and refractory MM showing significant clin. benefit in a large clin. trial.  Its mechanism of action is partly mediated through nuclear factor-kappa B inhibition, resulting in apoptosis, decreased angiogenic cytokine expression, and inhibition of tumor cell adhesion to stroma.  Addnl. mechanisms include c-Jun N-terminal kinase activation and effects on growth factor expression.  Several clin. trials are currently ongoing in MM as well as several other malignancies.  This article discusses proteasome inhibition as a novel therapeutic target in cancer and focuses on the development, mechanism of action, and current clin. experience with bortezomib.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRgZ_Crd9Ut7Vg90H21EOLACvtfcHk0lgpk2d7z1Ipeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitVartb0%253D&md5=5e8050b9dbbaf3192051c21f10bf8bb4</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1200%2FJCO.2005.11.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2005.11.030%26sid%3Dliteratum%253Aachs%26aulast%3DRajkumar%26aufirst%3DS.%2BV.%26aulast%3DRichardson%26aufirst%3DP.%2BG.%26aulast%3DHideshima%26aufirst%3DT.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26atitle%3DProteasome%2520inhibition%2520as%2520a%2520novel%2520therapeutic%2520target%2520in%2520human%2520cancer%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2005%26volume%3D23%26spage%3D630%26epage%3D639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Chauhan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hideshima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. C.</span><span> </span><span class="NLM_article-title">Proteasome inhibition in multiple myeloma: therapeutic implication</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">465</span><span class="NLM_x">–</span> <span class="NLM_lpage">476</span><div class="note"><p class="first last">2 plates.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2005&pages=465-476&author=D.+Chauhanauthor=T.+Hideshimaauthor=K.+C.+Anderson&title=Proteasome+inhibition+in+multiple+myeloma%3A+therapeutic+implication"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChauhan%26aufirst%3DD.%26aulast%3DHideshima%26aufirst%3DT.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26atitle%3DProteasome%2520inhibition%2520in%2520multiple%2520myeloma%253A%2520therapeutic%2520implication%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2005%26volume%3D45%26spage%3D465%26epage%3D476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Papandreou, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daliani, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nix, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madden, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pien, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Millikan, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, S.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pagliaro, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esseltine, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrusich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dieringer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logothetis, C. J.</span><span> </span><span class="NLM_article-title">Phase I trial of the proteasome inhibitor bortezomib in patients with advanced solid tumors with observations in androgen-independent prostate cancer</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2108</span><span class="NLM_x">–</span> <span class="NLM_lpage">2121</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm201118h&amp;key=10.1200%2FJCO.2004.02.106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm201118h&amp;key=15169797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm201118h&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpsVWlsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2004&pages=2108-2121&author=C.+N.+Papandreouauthor=D.+Dalianiauthor=D.+Nixauthor=H.+Yangauthor=T.+Maddenauthor=X.+Wangauthor=C.+S.+Pienauthor=R.+E.+Millikanauthor=S.-M.+Tuauthor=L.+Pagliaroauthor=J.+Kimauthor=J.+Adamsauthor=P.+Elliottauthor=D.+Esseltineauthor=A.+Petrusichauthor=P.+Dieringerauthor=C.+Perezauthor=C.+J.+Logothetis&title=Phase+I+trial+of+the+proteasome+inhibitor+bortezomib+in+patients+with+advanced+solid+tumors+with+observations+in+androgen-independent+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I trial of the proteasome inhibitor bortezomib in patients with advanced solid tumors with observations in androgen-independent prostate cancer</span></div><div class="casAuthors">Papandreou, Christos N.; Daliani, D.; Nix, Darrell; Yang, Hong; Madden, Timothy; Wang, Xuemei; Pien, Christine S.; Millikan, Randall E.; Tu, Shi-Ming; Pagliaro, Lance; Kim, Jeri; Adams, Julian; Elliott, Peter; Esseltine, Dixie; Petrusich, Alexandria; Dieringer, Pauline; Perez, Cherie; Logothetis, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2108-2121</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">The aim was to det. the dose-limiting toxicity and max.-tolerated dose of the proteasome inhibitor bortezomib administered i.v. weekly for 4 every 5 wk; to det. the bortezomib pharmacokinetics and pharmacodynamics using plasma levels and an assay for 20S proteasome inhibition (PI) in whole blood to correlate toxicity with bortezomib dose and degree of 20S PI; and to conduct a preliminary detn. of the antitumor activity of bortezomib in patients with androgen independent prostate cancer (AlPCa).  Fifty-three patients (48 with AlPCa) received 128 cycles of bortezomib in doses ranging from 0.13 to 2.0 mg/m2/dose, utilizing a careful escalation scheme with a continuous reassessment method.  Pharmacokinetic and pharmacodynamic studies were performed in 24 patients (at 1.45 to 2.0 mg/m2).  A dose-related 20S PI was seen, with dose-limiting toxicity at 2.0 mg/m2 (diarrhea, hypotension) occurring at an av. 1-h post-dose of ≥ 75% 20S PI.  Other side effects were fatigue, hypertension, constipation, nausea, and vomiting.  No relationship was seen between body-surface area and bortezomib clearance over the narrow dose range tested.  There was evidence of biol. activity (decline in serum prostate-specific antigen and interleukin-6 levels) at ≥ 50% 20S PI.  Two patients with AlPCa had prostate-specific antigen response and two patients had partial response in lymph nodes.  The max.-tolerated dose and recommended phase II dose of bortezomib in this schedule is 1.6 mg/m2.  Biol. activity (inhibition of nuclear factor-kappa B-related markers) and antitumor activity is seen in AlPCa at tolerated doses of bortezomib.  This agent should be further explored with chemotherapy agents in advanced prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaqizw4wtYNbVg90H21EOLACvtfcHk0liiV4zRW1ixUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpsVWlsLc%253D&md5=17d7f5c54be7e1fce7faa303c1a53036</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1200%2FJCO.2004.02.106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2004.02.106%26sid%3Dliteratum%253Aachs%26aulast%3DPapandreou%26aufirst%3DC.%2BN.%26aulast%3DDaliani%26aufirst%3DD.%26aulast%3DNix%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DMadden%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DPien%26aufirst%3DC.%2BS.%26aulast%3DMillikan%26aufirst%3DR.%2BE.%26aulast%3DTu%26aufirst%3DS.-M.%26aulast%3DPagliaro%26aufirst%3DL.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DElliott%26aufirst%3DP.%26aulast%3DEsseltine%26aufirst%3DD.%26aulast%3DPetrusich%26aufirst%3DA.%26aulast%3DDieringer%26aufirst%3DP.%26aulast%3DPerez%26aufirst%3DC.%26aulast%3DLogothetis%26aufirst%3DC.%2BJ.%26atitle%3DPhase%2520I%2520trial%2520of%2520the%2520proteasome%2520inhibitor%2520bortezomib%2520in%2520patients%2520with%2520advanced%2520solid%2520tumors%2520with%2520observations%2520in%2520androgen-independent%2520prostate%2520cancer%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2004%26volume%3D22%26spage%3D2108%26epage%3D2121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Palombella, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conner, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuseler, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Destree, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laroux, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brand, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazarus, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCormack, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parent, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grisham, M. B.</span><span> </span><span class="NLM_article-title">Role of the proteasome and NF-kB in streptococcal cell wall-induced polyarthritis</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">15671</span><span class="NLM_x">–</span> <span class="NLM_lpage">15676</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=15671-15676&author=V.+J.+Palombellaauthor=E.+M.+Connerauthor=J.+W.+Fuselerauthor=A.+Destreeauthor=J.+M.+Davisauthor=F.+S.+Larouxauthor=R.+E.+Wolfauthor=J.+Huangauthor=S.+Brandauthor=P.+J.+Elliottauthor=D.+Lazarusauthor=T.+McCormackauthor=L.+Parentauthor=R.+Steinauthor=J.+Adamsauthor=M.+B.+Grisham&title=Role+of+the+proteasome+and+NF-kB+in+streptococcal+cell+wall-induced+polyarthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPalombella%26aufirst%3DV.%2BJ.%26aulast%3DConner%26aufirst%3DE.%2BM.%26aulast%3DFuseler%26aufirst%3DJ.%2BW.%26aulast%3DDestree%26aufirst%3DA.%26aulast%3DDavis%26aufirst%3DJ.%2BM.%26aulast%3DLaroux%26aufirst%3DF.%2BS.%26aulast%3DWolf%26aufirst%3DR.%2BE.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DBrand%26aufirst%3DS.%26aulast%3DElliott%26aufirst%3DP.%2BJ.%26aulast%3DLazarus%26aufirst%3DD.%26aulast%3DMcCormack%26aufirst%3DT.%26aulast%3DParent%26aufirst%3DL.%26aulast%3DStein%26aufirst%3DR.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DGrisham%26aufirst%3DM.%2BB.%26atitle%3DRole%2520of%2520the%2520proteasome%2520and%2520NF-kB%2520in%2520streptococcal%2520cell%2520wall-induced%2520polyarthritis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1998%26volume%3D95%26spage%3D15671%26epage%3D15676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12a"><span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maldonado, M. A.</span><span> </span><span class="NLM_article-title">The ubiquitin–proteasome system and its role in inflammatory and autoimmune diseases</span> <span class="citation_source-journal">Cell. Mol. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">255</span><span class="NLM_x">–</span> <span class="NLM_lpage">261</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=8&amp;doi=10.1021%2Fjm201118h&amp;key=16978533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=32&amp;doi=10.1021%2Fjm201118h&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFOnurvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=255-261&author=J.+Wangauthor=M.+A.+Maldonado&title=The+ubiquitin%E2%80%93proteasome+system+and+its+role+in+inflammatory+and+autoimmune+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12aR"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The ubiquitin-proteasome system and its role in inflammatory and autoimmune diseases</span></div><div class="casAuthors">Wang, Jingsong; Maldonado, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular & Molecular Immunology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">255-261</span>CODEN:
                <span class="NLM_cas:coden">CMIEAO</span>;
        ISSN:<span class="NLM_cas:issn">1672-7681</span>.
    
            (<span class="NLM_cas:orgname">Chinese Society of Immunology</span>)
        </div><div class="casAbstract">A review.  Protein degrdn. through the ubiquitin-proteasome system is the major pathway of non-lysosomal proteolysis of intracellular proteins.  It plays important roles in a variety of fundamental cellular processes such as regulation of cell cycle progression, division, development and differentiation, apoptosis, cell trafficking, and modulation of the immune and inflammatory responses.  The central element of this system is the covalent linkage of ubiquitin to targeted proteins, which are then recognized by the 26S proteasome, an ATP-dependent, multi-catalytic protease.  Damaged, oxidized, or misfolded proteins as well as regulatory proteins that control many crit. cellular functions are among the targets of this degrdn. process.  Aberration of this system leads to the dysregulation of cellular homeostasis and the development of multiple diseases.  In this review, we described the basic biochem. and mol. biol. of the ubiquitin-proteasome system, and its complex role in the development of inflammatory and autoimmune diseases.  In addn., therapies and potential therapeutic targets related to the ubiquitin-proteasome system are discussed as well.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqDi3IlXwNXLVg90H21EOLACvtfcHk0liiV4zRW1ixUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFOnurvJ&md5=1fab2d99f7399a8909ba88aaca70b7f5</span></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DMaldonado%26aufirst%3DM.%2BA.%26atitle%3DThe%2520ubiquitin%25E2%2580%2593proteasome%2520system%2520and%2520its%2520role%2520in%2520inflammatory%2520and%2520autoimmune%2520diseases%26jtitle%3DCell.%2520Mol.%2520Immunol.%26date%3D2006%26volume%3D3%26spage%3D255%26epage%3D261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12b"><span><span class="NLM_contrib-group">Meng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwok, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crews, C. M.</span><span> </span><span class="NLM_article-title">Eponemycin exerts its antitumor effect through the inhibition of proteasome function</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">2798</span><span class="NLM_x">–</span> <span class="NLM_lpage">2801</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=8&amp;doi=10.1021%2Fjm201118h&amp;key=10383134" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=32&amp;doi=10.1021%2Fjm201118h&amp;key=1%3ACAS%3A528%3ADyaK1MXktVOkurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=2798-2801&author=L.+Mengauthor=B.+H.+Kwokauthor=N.+Sinauthor=C.+M.+Crews&title=Eponemycin+exerts+its+antitumor+effect+through+the+inhibition+of+proteasome+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12bR"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Eponemycin exerts its antitumor effect through the inhibition of proteasome function</span></div><div class="casAuthors">Meng, Lihao; Kwok, Benjamin H. B.; Sin, Ny; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2798-2801</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">AACR Subscription Office</span>)
        </div><div class="casAbstract">Cell cycle progression requires the proteasome-mediated degrdn. of key regulatory proteins such as cyclins, cyclin-dependent kinase inhibitors, and anaphase-inhibitory proteins.  Given the central role of the proteasome in the destruction of these proteins, proteasome inhibition has been proposed as a possible cancer therapy.  We report here that dihydroeponemycin, an analog of the antitumor and antiangiogenic natural; product eponemycin, selectively targets the 20S proteasome.  Dihydroeponemycin covalently modifies a subset of catalytic proteasomal subunit binding preferentially to the IFN-γ-inducible subunits LMP2 and LMP7; moreover, the three major peptidolytic activities of the proteasome are inhibited by dihydroeponemycin at different rates.  In addn., dihydroeponemycin-mediated proteasome inhibition induces a spindle-like cellular morphol. change and apoptosis.  These results validate the proteasome as a target for antitumor pharmacol. intervention and are relevant for the design of novel chemotherapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoG883WuBcePrVg90H21EOLACvtfcHk0lh5iDMUDAD1gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXktVOkurw%253D&md5=6982bd97c90a3d9d3905eaa0f274133b</span></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DL.%26aulast%3DKwok%26aufirst%3DB.%2BH.%26aulast%3DSin%26aufirst%3DN.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DEponemycin%2520exerts%2520its%2520antitumor%2520effect%2520through%2520the%2520inhibition%2520of%2520proteasome%2520function%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26spage%3D2798%26epage%3D2801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Groll, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kairies, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crews, C. M.</span><span> </span><span class="NLM_article-title">Crystal structure of epoxomicin:20S proteasome reveals a molecular basis for selectivity of a′,b′-epoxyketone proteasome inhibitors</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">1237</span><span class="NLM_x">–</span> <span class="NLM_lpage">1238</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja993588m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2000&pages=1237-1238&author=M.+Grollauthor=K.+B.+Kimauthor=N.+Kairiesauthor=R.+Huberauthor=C.+M.+Crews&title=Crystal+structure+of+epoxomicin%3A20S+proteasome+reveals+a+molecular+basis+for+selectivity+of+a%E2%80%B2%2Cb%E2%80%B2-epoxyketone+proteasome+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fja993588m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja993588m%26sid%3Dliteratum%253Aachs%26aulast%3DGroll%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DK.%2BB.%26aulast%3DKairies%26aufirst%3DN.%26aulast%3DHuber%26aufirst%3DR.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DCrystal%2520structure%2520of%2520epoxomicin%253A20S%2520proteasome%2520reveals%2520a%2520molecular%2520basis%2520for%2520selectivity%2520of%2520a%25E2%2580%25B2%252Cb%25E2%2580%25B2-epoxyketone%2520proteasome%2520inhibitors%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2000%26volume%3D122%26spage%3D1237%26epage%3D1238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Groll, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McArthur Katherine, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macherla Venkat, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manam Rama, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potts Barbara, C.</span><span> </span><span class="NLM_article-title">Snapshots of the fluorosalinosporamide/20S complex offer mechanistic insights for fine tuning proteasome inhibition</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">5420</span><span class="NLM_x">–</span> <span class="NLM_lpage">5428</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900559x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5420-5428&author=M.+Grollauthor=A.+McArthur+Katherineauthor=R.+Macherla+Venkatauthor=R.+Manam+Ramaauthor=C.+Potts+Barbara&title=Snapshots+of+the+fluorosalinosporamide%2F20S+complex+offer+mechanistic+insights+for+fine+tuning+proteasome+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm900559x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900559x%26sid%3Dliteratum%253Aachs%26aulast%3DGroll%26aufirst%3DM.%26aulast%3DMcArthur%2BKatherine%26aufirst%3DA.%26aulast%3DMacherla%2BVenkat%26aufirst%3DR.%26aulast%3DManam%2BRama%26aufirst%3DR.%26aulast%3DPotts%2BBarbara%26aufirst%3DC.%26atitle%3DSnapshots%2520of%2520the%2520fluorosalinosporamide%252F20S%2520complex%2520offer%2520mechanistic%2520insights%2520for%2520fine%2520tuning%2520proteasome%2520inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5420%26epage%3D5428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Kisselev, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, A. L.</span><span> </span><span class="NLM_article-title">Proteasome inhibitors: from research tools to drug candidates</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">739</span><span class="NLM_x">–</span> <span class="NLM_lpage">758</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm201118h&amp;key=10.1016%2FS1074-5521%2801%2900056-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm201118h&amp;key=11514224" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm201118h&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmtV2ku7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2001&pages=739-758&author=A.+F.+Kisselevauthor=A.+L.+Goldberg&title=Proteasome+inhibitors%3A+from+research+tools+to+drug+candidates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Proteasome inhibitors: from research tools to drug candidates</span></div><div class="casAuthors">Kisselev, A. F.; Goldberg, A. L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">739-758</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  The 26S proteasome is a 2.4 MDa multifunctional ATP-dependent proteolytic complex, which degrades the majority of cellular polypeptides by an unusual enzyme mechanism.  Several groups of proteasome inhibitors have been developed and are now widely used as research tools to study the role of the ubiquitin-proteasome pathway in various cellular processes, and two inhibitors are now in clin. trials for treatment of multiple cancers and stroke.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTXBSmAzp9vLVg90H21EOLACvtfcHk0lh5iDMUDAD1gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmtV2ku7g%253D&md5=b729e5f56c402172aca5b139df61c09e</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2801%2900056-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252801%252900056-4%26sid%3Dliteratum%253Aachs%26aulast%3DKisselev%26aufirst%3DA.%2BF.%26aulast%3DGoldberg%26aufirst%3DA.%2BL.%26atitle%3DProteasome%2520inhibitors%253A%2520from%2520research%2520tools%2520to%2520drug%2520candidates%26jtitle%3DChem.%2520Biol.%26date%3D2001%26volume%3D8%26spage%3D739%26epage%3D758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Meiners, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludwig, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stangl, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stangl, K.</span><span> </span><span class="NLM_article-title">Proteasome inhibitors: poisons and remedies</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">309</span><span class="NLM_x">–</span> <span class="NLM_lpage">327</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm201118h&amp;key=10.1002%2Fmed.20111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm201118h&amp;key=17880010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm201118h&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjsVerurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=309-327&author=S.+Meinersauthor=A.+Ludwigauthor=V.+Stanglauthor=K.+Stangl&title=Proteasome+inhibitors%3A+poisons+and+remedies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Proteasome inhibitors: Poisons and remedies</span></div><div class="casAuthors">Meiners, Silke; Ludwig, Antje; Stangl, Verena; Stangl, Karl</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">309-327</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  The proteasome inhibitor bortezomib has been approved as a cytostatic drug for the therapy of multiple myeloma, and is currently being tested in clin. trials for a variety of other malignancies.  At the same time, a growing no. of animal studies suggest that proteasome inhibitors may also prove to be valuable remedies for the treatment of non-tumorous diseases.  In this review, we will revisit the current applications of proteasome inhibitors in clin. research according to the cellular effects of proteasome inhibitors as poisons, which induce apoptosis, or as remedies, which modulate cellular function and protect from cell death.  We postulate that the correct distinction of a poison from a remedy depends on cell type and on the degree of proteasome inhibition.  Dose-dependent and differential inhibition of the proteasome may affect specific sets of substrates, thereby conferring substrate specificity.  According to this idea, we suggest that inhibition of the proteasome to a defined degree may offer a promising tool in achieving desired therapeutic effects in various diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozQOBlMYqIb7Vg90H21EOLACvtfcHk0ljbTILcbPtyKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjsVerurY%253D&md5=29702cf59aeec6452d5b2c91bb647814</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1002%2Fmed.20111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20111%26sid%3Dliteratum%253Aachs%26aulast%3DMeiners%26aufirst%3DS.%26aulast%3DLudwig%26aufirst%3DA.%26aulast%3DStangl%26aufirst%3DV.%26aulast%3DStangl%26aufirst%3DK.%26atitle%3DProteasome%2520inhibitors%253A%2520poisons%2520and%2520remedies%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2008%26volume%3D28%26spage%3D309%26epage%3D327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Fuchs, O.</span><span> </span><span class="NLM_article-title">Proteasome inhibition as a therapeutic strategy in patients with multiple myeloma</span> <span class="citation_source-journal">Mult. Myeloma</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">125</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm201118h&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntlOmtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=101-125&author=O.+Fuchs&title=Proteasome+inhibition+as+a+therapeutic+strategy+in+patients+with+multiple+myeloma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Proteasome inhibition as a therapeutic strategy in patients with multiple myeloma</span></div><div class="casAuthors">Fuchs, Ota</div><div class="citationInfo"><span class="NLM_cas:title">Multiple Myeloma</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">101-125</span>CODEN:
                <span class="NLM_cas:coden">69MVM2</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Nova Science Publishers, Inc.</span>)
        </div><div class="casAbstract">A review.  Multiple myeloma (MM) is the second most frequent hematol. malignancy and remains fatal despite all available therapies, because of chemotherapeutic resistance.  Novel targeted drugs for the treatment of MM are therefore needed to improve outcome of MM patients.  Bortezomib (PS-341, Velcade; Millennium Pharmaceuticals, Cambridge MA), a dipeptidyl boronic acid that reversibly inhibits the chymotrypsin-like activity in the 20S core of the 26S mammalian proteasome, is the first proteasome inhibitor that was approved by the US Food and Drug Administration (FDA) and the European Agency for the Evaluation of Medicinal Products (EMEA) for patients with relapsed and refractory MM who had received at least one prior therapy and who had already undergone or are unsuitable for the transplantation of bone marrow.  Phase I-III trials based on previous preclin. studies showed very good antimyeloma activity.  Bortezomib acts by disrupting various cell signaling pathways, thereby leading to cell cycle arrest, apoptosis, and inhibition of angiogenesis.  The main action of bortezomib is the inhibition of the key transcription factor, nuclear factor-kappaB (NF-κB) activation.  Activation of NF-κB has been noted in MM cells.  Bortezomib interferes with NF-κB-mediated cell survival, tumor growth and angiogenesis.  Several studies have shown that cancer cells are more sensitive than normal cells to the proapoptotic effects of bortezomib, perhaps due to their loss of checkpoint mechanisms for DNA repair.  The accumulation of misfolded proteins in the endoplasmic reticulum (ER) leads to the induction of the unfolded protein response, provoking apoptosis.  Proteasome inhibitors induce ER-mediated apoptosis.  The increased susceptibility of MM cells to ER stress is caused by the large amts. of Igs produced by MM cells.  The clin. success of bortezomib is encouraging.  Bortezomib is relatively well tolerated, causing manageable nonhematol. and hematol. toxicity.  However, the overall response rate was 40-50% and bortezomib resistance was also obsd.  Response rates may be improved with combination therapy (bortezomib with dexamethasone, thalidomide, lenalidomide, arsenic trioxide, cisplatin, doxorubicin, cyclophosphamide, etoposide or with melphalan and prednisone).  Clin. evaluation of addnl. proteasome inhibitors of the next generation with greater efficacy is also needed.  Three such proteasome inhibitors (carfilzomib, salinosporamide A and threonine boronic acid-derived proteasome inhibitor CEP-18770) have been recently tested in preclin. models of MM.  Carfilzomib (PR-171; Proteolix), an epoxyketone related to epoxomicin inhibits the chymotrypsin-like proteasome activity as bortezomib does.  However, carfilzomib is an irreversible inhibitor of all three proteasome proteolytic sites.  Salinosporamide A (NPI-0052), a compd. related to lactacystin binds irreversibly to the 20S proteasome and acts predominantly through caspase-8 activation.  CEP-18770 is a reversible inhibitor of the chymotrypsin-like proteasome activity as bortezomib but it inhibits also the tryptic and peptidyl glutamyl activities of the proteasome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEgVHeWnqC_rVg90H21EOLACvtfcHk0ljbTILcbPtyKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntlOmtrc%253D&md5=cb6b1732f8d4e3adc619ecb6591e1567</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFuchs%26aufirst%3DO.%26atitle%3DProteasome%2520inhibition%2520as%2520a%2520therapeutic%2520strategy%2520in%2520patients%2520with%2520multiple%2520myeloma%26jtitle%3DMult.%2520Myeloma%26date%3D2009%26spage%3D101%26epage%3D125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Lam, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lloyd, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neuteboom, S. T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palladino, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sethna, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spear, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potts, B. C.</span><span> </span><span class="NLM_article-title">From natural products to clinical trials: NPI-0052 (salinosporamide A), a marine actinomycete-derived anticancer agent</span> <span class="citation_source-journal">Nat. Prod. Chem. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">373</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm201118h&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitlCjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=355-373&author=K.+S.+Lamauthor=G.+K.+Lloydauthor=S.+T.+C.+Neuteboomauthor=M.+A.+Palladinoauthor=K.+M.+Sethnaauthor=M.+A.+Spearauthor=B.+C.+Potts&title=From+natural+products+to+clinical+trials%3A+NPI-0052+%28salinosporamide+A%29%2C+a+marine+actinomycete-derived+anticancer+agent"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">From natural products to clinical trials: NPI-0052 (salinosporamide A), a marine actinomycete-derived anticancer agent</span></div><div class="casAuthors">Lam, Kin S.; Lloyd, G. Kenneth; Neuteboom, Saskia T. C.; Palladino, Michael A.; Sethna, Kobi M.; Spear, Matthew A.; Potts, Barbara C.</div><div class="citationInfo"><span class="NLM_cas:title">Natural Product Chemistry for Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">355-373</span>CODEN:
                <span class="NLM_cas:coden">69MGLO</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The unique aspects of developing a marine actinomycete-derived therapeutic agent, NPI-0052, are highlighted.  Salinosporamide A (designated as NPI-0052) was first isolated from the fermn. broth of Salinispora tropica strain CNB392.  This highly potent 20S proteasome inhibitor is currently undergoing Phase I clin. studies for the treatment of various hematol. and solid tumor malignancies.  An account is given of events from the early mechanism of action and preclin. studies that supported its entry into clin. trials in cancer patients, to the current strategy for its continued development as an anticancer agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFzGil7yTcC7Vg90H21EOLACvtfcHk0lggTWTNIc8b3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitlCjug%253D%253D&md5=1498e5081a2ba9e7eff273ecb2124899</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLam%26aufirst%3DK.%2BS.%26aulast%3DLloyd%26aufirst%3DG.%2BK.%26aulast%3DNeuteboom%26aufirst%3DS.%2BT.%2BC.%26aulast%3DPalladino%26aufirst%3DM.%2BA.%26aulast%3DSethna%26aufirst%3DK.%2BM.%26aulast%3DSpear%26aufirst%3DM.%2BA.%26aulast%3DPotts%26aufirst%3DB.%2BC.%26atitle%3DFrom%2520natural%2520products%2520to%2520clinical%2520trials%253A%2520NPI-0052%2520%2528salinosporamide%2520A%2529%252C%2520a%2520marine%2520actinomycete-derived%2520anticancer%2520agent%26jtitle%3DNat.%2520Prod.%2520Chem.%2520Drug%2520Discovery%26date%3D2010%26spage%3D355%26epage%3D373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Zhou, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aujay Monette, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett Mark, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dajee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demo Susan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho Mark, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirk Christopher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laidig Guy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis Evan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muchamuel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parlati, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ring, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shenk Kevin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shields, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shwonek Peter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanton, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun Congcong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sylvain, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo Tina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span> </span><span class="NLM_article-title">Design and synthesis of an orally bioavailable and selective peptide epoxyketone proteasome inhibitor (PR-047)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3028</span><span class="NLM_x">–</span> <span class="NLM_lpage">3038</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801329v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm201118h&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktFemtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=3028-3038&author=H.-J.+Zhouauthor=A.+Aujay+Monetteauthor=K.+Bennett+Markauthor=M.+Dajeeauthor=D.+Demo+Susanauthor=Y.+Fangauthor=N.+Ho+Markauthor=J.+Jiangauthor=J.+Kirk+Christopherauthor=J.+Laidig+Guyauthor=R.+Lewis+Evanauthor=Y.+Luauthor=T.+Muchamuelauthor=F.+Parlatiauthor=E.+Ringauthor=D.+Shenk+Kevinauthor=J.+Shieldsauthor=J.+Shwonek+Peterauthor=T.+Stantonauthor=M.+Sun+Congcongauthor=C.+Sylvainauthor=M.+Woo+Tinaauthor=J.+Yang&title=Design+and+synthesis+of+an+orally+bioavailable+and+selective+peptide+epoxyketone+proteasome+inhibitor+%28PR-047%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of an Orally Bioavailable and Selective Peptide Epoxyketone Proteasome Inhibitor (PR-047)</span></div><div class="casAuthors">Zhou, Han-Jie; Aujay, Monette A.; Bennett, Mark K.; Dajee, Maya; Demo, Susan D.; Fang, Ying; Ho, Mark N.; Jiang, Jing; Kirk, Christopher J.; Laidig, Guy J.; Lewis, Evan R.; Lu, Yan; Muchamuel, Tony; Parlati, Francesco; Ring, Eileen; Shenk, Kevin D.; Shields, Jamie; Shwonek, Peter J.; Stanton, Timothy; Sun, Congcong M.; Sylvain, Catherine; Woo, Tina M.; Yang, Jinfu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3028-3038</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Epoxypeptides such as I are prepd. as carfilzomib analogs and proteasome inhibitors for use as antitumor agents; the inhibition of human 20S proteasomes and of the growth of multidrug-resistant and nonresistant cancer cells by selected compds. and their stabilities in simulated gastric and intestinal fluids and in liver microsomes are detd.  I selectively inhibits chymotrypsin-like activity of both the constitutive proteasome (β5) and immunoproteasome (LMP7) and demonstrated an abs. bioavailability of up to 39% in rodents and dogs.  I is well tolerated with repeated oral administration at doses resulting in >80% proteasome inhibition in most tissues and elicited an antitumor response equiv. to i.v. administered carfilzomib in multiple human tumor xenograft and mouse syngeneic models.  I is prepd. in eight steps (longest linear sequence) from Cbz-L-phenylalanine, Boc-O-methyl-L-serine, 2-methyl-5-thiazolecarboxylic acid, and isopropenylmagnesium bromide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouNBIBwb8w47Vg90H21EOLACvtfcHk0lggTWTNIc8b3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktFemtLw%253D&md5=688c8d0942539bab2e50617d083bf89a</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm801329v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801329v%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DH.-J.%26aulast%3DAujay%2BMonette%26aufirst%3DA.%26aulast%3DBennett%2BMark%26aufirst%3DK.%26aulast%3DDajee%26aufirst%3DM.%26aulast%3DDemo%2BSusan%26aufirst%3DD.%26aulast%3DFang%26aufirst%3DY.%26aulast%3DHo%2BMark%26aufirst%3DN.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DKirk%2BChristopher%26aufirst%3DJ.%26aulast%3DLaidig%2BGuy%26aufirst%3DJ.%26aulast%3DLewis%2BEvan%26aufirst%3DR.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DMuchamuel%26aufirst%3DT.%26aulast%3DParlati%26aufirst%3DF.%26aulast%3DRing%26aufirst%3DE.%26aulast%3DShenk%2BKevin%26aufirst%3DD.%26aulast%3DShields%26aufirst%3DJ.%26aulast%3DShwonek%2BPeter%26aufirst%3DJ.%26aulast%3DStanton%26aufirst%3DT.%26aulast%3DSun%2BCongcong%26aufirst%3DM.%26aulast%3DSylvain%26aufirst%3DC.%26aulast%3DWoo%2BTina%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520an%2520orally%2520bioavailable%2520and%2520selective%2520peptide%2520epoxyketone%2520proteasome%2520inhibitor%2520%2528PR-047%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D3028%26epage%3D3038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Sterz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Metzler, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahne, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamottke, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rademacher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heider, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terpos, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sezer, O.</span><span> </span><span class="NLM_article-title">The potential of proteasome inhibitors in cancer therapy</span> <span class="citation_source-journal">Expert Opin. Invest. Drug</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">879</span><span class="NLM_x">–</span> <span class="NLM_lpage">895</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm201118h&amp;key=10.1517%2F13543784.17.6.879" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm201118h&amp;key=18491989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm201118h&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmtV2ktrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2008&pages=879-895&author=J.+Sterzauthor=I.+von+Metzlerauthor=J.-C.+Hahneauthor=B.+Lamottkeauthor=J.+Rademacherauthor=U.+Heiderauthor=E.+Terposauthor=O.+Sezer&title=The+potential+of+proteasome+inhibitors+in+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">The potential of proteasome inhibitors in cancer therapy</span></div><div class="casAuthors">Sterz, Jan; von Metzler, Ivana; Hahne, Jens-Claus; Lamottke, Britta; Rademacher, Jessica; Heider, Ulrike; Terpos, Evangelos; Sezer, Orhan</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">879-895</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Background: The ubiquitin-proteasome system has become a promising novel mol. target in cancer due to its crit. role in cellular protein degrdn., its interaction with cell cycle and apoptosis regulation and its unique mechanism of action.  Objective: This review focuses both on preclin. results and on data from clin. trials with proteasome inhibitors in cancer.  Methods: Results in hematol. malignancies and solid tumors were included, and important data presented in abstr. form were considered in this review.  Results/conclusion: Bortezomib as first-in-class proteasome inhibitor has proven to be highly effective in some hematol. malignancies, overcomes conventional chemoresistance, directly induces cell cycle arrest and apoptosis, and also targets the tumor microenvironment.  It has been granted approval by the FDA for relapsed multiple myeloma, and recently for relapsed mantle cell lymphoma.  Combination chemotherapy regimens have been developed providing high remission rates and remission quality in frontline treatment or in the relapsed setting in multiple myeloma.  The combination of proteasome inhibition with novel targeted therapies is an emerging field in oncol.  Moreover, novel proteasome inhibitors, such as NPI-0052 and carfilzomib, have been developed.  This review summarizes our knowledge of the ubiquitin-proteasome system and recent data from cancer clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_Oy8M6LysgrVg90H21EOLACvtfcHk0ljugqosW0JWZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmtV2ktrc%253D&md5=d757314a7af0d16a619ebc6dcb697a65</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1517%2F13543784.17.6.879&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.17.6.879%26sid%3Dliteratum%253Aachs%26aulast%3DSterz%26aufirst%3DJ.%26aulast%3Dvon%2BMetzler%26aufirst%3DI.%26aulast%3DHahne%26aufirst%3DJ.-C.%26aulast%3DLamottke%26aufirst%3DB.%26aulast%3DRademacher%26aufirst%3DJ.%26aulast%3DHeider%26aufirst%3DU.%26aulast%3DTerpos%26aufirst%3DE.%26aulast%3DSezer%26aufirst%3DO.%26atitle%3DThe%2520potential%2520of%2520proteasome%2520inhibitors%2520in%2520cancer%2520therapy%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drug%26date%3D2008%26volume%3D17%26spage%3D879%26epage%3D895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Lawrence, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kendig, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ge, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santiago, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guida, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebti, S. M.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of naphthoquinone analogs as a novel class of proteasome inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5576</span><span class="NLM_x">–</span> <span class="NLM_lpage">5592</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=5576-5592&author=H.+R.+Lawrenceauthor=A.+Kaziauthor=Y.+Luoauthor=R.+Kendigauthor=Y.+Geauthor=S.+Jainauthor=K.+Danielauthor=D.+Santiagoauthor=W.+C.+Guidaauthor=S.+M.+Sebti&title=Synthesis+and+biological+evaluation+of+naphthoquinone+analogs+as+a+novel+class+of+proteasome+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLawrence%26aufirst%3DH.%2BR.%26aulast%3DKazi%26aufirst%3DA.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DKendig%26aufirst%3DR.%26aulast%3DGe%26aufirst%3DY.%26aulast%3DJain%26aufirst%3DS.%26aulast%3DDaniel%26aufirst%3DK.%26aulast%3DSantiago%26aufirst%3DD.%26aulast%3DGuida%26aufirst%3DW.%2BC.%26aulast%3DSebti%26aufirst%3DS.%2BM.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520naphthoquinone%2520analogs%2520as%2520a%2520novel%2520class%2520of%2520proteasome%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D5576%26epage%3D5592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Kazi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guida Wayne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLaughlin Mark, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springett Gregory, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berndt, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yip Richard, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebti Said, M.</span><span> </span><span class="NLM_article-title">Discovery of a novel proteasome inhibitor selective for cancer cells over non-transformed cells</span> <span class="citation_source-journal">Cell Cycle</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1940</span><span class="NLM_x">–</span> <span class="NLM_lpage">1951</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=1940-1951&author=A.+Kaziauthor=H.+Lawrenceauthor=C.+Guida+Wayneauthor=L.+McLaughlin+Markauthor=M.+Springett+Gregoryauthor=N.+Berndtauthor=M.+L.+Yip+Richardauthor=M.+Sebti+Said&title=Discovery+of+a+novel+proteasome+inhibitor+selective+for+cancer+cells+over+non-transformed+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKazi%26aufirst%3DA.%26aulast%3DLawrence%26aufirst%3DH.%26aulast%3DGuida%2BWayne%26aufirst%3DC.%26aulast%3DMcLaughlin%2BMark%26aufirst%3DL.%26aulast%3DSpringett%2BGregory%26aufirst%3DM.%26aulast%3DBerndt%26aufirst%3DN.%26aulast%3DYip%2BRichard%26aufirst%3DM.%2BL.%26aulast%3DSebti%2BSaid%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520proteasome%2520inhibitor%2520selective%2520for%2520cancer%2520cells%2520over%2520non-transformed%2520cells%26jtitle%3DCell%2520Cycle%26date%3D2009%26volume%3D8%26spage%3D1940%26epage%3D1951" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Avdeenko, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velichko, N. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romanenko, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirozhenko, V. V.</span><span> </span><span class="NLM_article-title">Chlorination of <i>N</i>-arylsulfonyl-1,4-aminonaphthols and <i>N</i>-arylsulfonyl-1,4-naphthoquinone-1,4-imines</span> <span class="citation_source-journal">Zh. Org. Khim.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1747</span><span class="NLM_x">–</span> <span class="NLM_lpage">1757</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm201118h&amp;key=1%3ACAS%3A528%3ADyaK38XhsFWhur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1991&pages=1747-1757&author=A.+P.+Avdeenkoauthor=N.+V.+Velichkoauthor=E.+A.+Romanenkoauthor=V.+V.+Pirozhenko&title=Chlorination+of+N-arylsulfonyl-1%2C4-aminonaphthols+and+N-arylsulfonyl-1%2C4-naphthoquinone-1%2C4-imines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Chlorination of N-arylsulfonyl-1,4-aminonaphthols and N-arylsulfonyl-1,4-naphthoquinone-1,4-imines</span></div><div class="casAuthors">Avdeenko, A. P.; Velichko, N. V.; Romanenko, E. A.; Pirozhenko, V. V.</div><div class="citationInfo"><span class="NLM_cas:title">Zhurnal Organicheskoi Khimii</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1747-57</span>CODEN:
                <span class="NLM_cas:coden">ZORKAE</span>;
        ISSN:<span class="NLM_cas:issn">0514-7492</span>.
    </div><div class="casAbstract">The final products of chlorination of the title compds. I ( R = H, Cl; Ar = substituted Ph) and II are the tetrachloro derivs. III.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox9DADKeOmvbVg90H21EOLACvtfcHk0ljugqosW0JWZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XhsFWhur8%253D&md5=39d894edc3d6184bf53870061d4fb917</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAvdeenko%26aufirst%3DA.%2BP.%26aulast%3DVelichko%26aufirst%3DN.%2BV.%26aulast%3DRomanenko%26aufirst%3DE.%2BA.%26aulast%3DPirozhenko%26aufirst%3DV.%2BV.%26atitle%3DChlorination%2520of%2520N-arylsulfonyl-1%252C4-aminonaphthols%2520and%2520N-arylsulfonyl-1%252C4-naphthoquinone-1%252C4-imines%26jtitle%3DZh.%2520Org.%2520Khim.%26date%3D1991%26volume%3D27%26spage%3D1747%26epage%3D1757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Altland, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briffa, B. F.,  Jr.</span><span> </span><span class="NLM_article-title">1,4-Addition of triazolium thiolates to quinones</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">433</span><span class="NLM_x">–</span> <span class="NLM_lpage">437</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00204a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1985&pages=433-437&author=H.+W.+Altlandauthor=B.+F.+Briffa&title=1%2C4-Addition+of+triazolium+thiolates+to+quinones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjo00204a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00204a002%26sid%3Dliteratum%253Aachs%26aulast%3DAltland%26aufirst%3DH.%2BW.%26aulast%3DBriffa%26aufirst%3DB.%2BF.%26atitle%3D1%252C4-Addition%2520of%2520triazolium%2520thiolates%2520to%2520quinones%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1985%26volume%3D50%26spage%3D433%26epage%3D437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Avdeenko, A. P.; Evgrafova, N. I.; Ryazantsev, V. P.; Luk’yanenko, L. V.; Titov, E. V.; Velichko, N. V.</span><span> </span><span class="NLM_article-title">Preparation of <i>N</i>-arylsulfonyl-2-chloro-1,4-naphthoquinone imines</span>. USSR Patent 1558901, 86–4156772, 1558901, 19861204, ,<span class="NLM_x"> </span><span class="NLM_year">1990</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1990&author=A.+P.+Avdeenko&author=N.+I.+Evgrafova&author=V.+P.+Ryazantsev&author=L.+V.+Luk%E2%80%99yanenko&author=E.+V.+Titov&author=N.+V.+Velichko&title=Preparation+of+N-arylsulfonyl-2-chloro-1%2C4-naphthoquinone+imines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAvdeenko%26aufirst%3DA.%2BP.%26atitle%3DPreparation%2520of%2520N-arylsulfonyl-2-chloro-1%252C4-naphthoquinone%2520imines%26date%3D1990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Avdeenko, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evgrafova, N. I.</span><span> </span><span class="NLM_article-title">Reaction of <i>N</i>-(arylsulfonyl)-<i>p</i>-naphthoquinonimines with acylhydrazines</span> <span class="citation_source-journal">Zh. Org. Khim.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1060</span><span class="NLM_x">–</span> <span class="NLM_lpage">1063</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm201118h&amp;key=1%3ACAS%3A528%3ADyaL1cXhtlWhsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1987&pages=1060-1063&author=A.+P.+Avdeenkoauthor=N.+I.+Evgrafova&title=Reaction+of+N-%28arylsulfonyl%29-p-naphthoquinonimines+with+acylhydrazines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Reaction of N-(arylsulfonyl)-p-naphthoquinonimines with acylhydrazines</span></div><div class="casAuthors">Avdeenko, A. P.; Evgrafova, N. I.</div><div class="citationInfo"><span class="NLM_cas:title">Zhurnal Organicheskoi Khimii</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1060-3</span>CODEN:
                <span class="NLM_cas:coden">ZORKAE</span>;
        ISSN:<span class="NLM_cas:issn">0514-7492</span>.
    </div><div class="casAbstract">Title quinonimines I (R = PhSO2, 4-MeC6H4SO2; R1 = Cl, SO2Ph) reacted with R2C6H4CONHNH2 (II; R2 = H, 3-Cl, 4-MeO) in refluxing EtOH to give ∼1-2:1 mixts. of 9 corresponding I [same R, R1 = NHNHCOC6H4R2 (III); R = R2C6H4CONH, same R1] in ≤97% combined yield.  Analogous reaction of I (same R, R1 = H) with II (R2 = H, 3-Cl, 2-HO, 4-O2N, 4-MeO) gave the corresponding III in 52.6-64.7% yield as the sole product.  Reducing III (R = PhSO2, R2 = 3-Cl) with Na2S2O4 in aq. NH3 gave the corresponding (acylhydrazino)sulfonamidonaphthol, which was reoxidized rapidly in air.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAfiTd40z8o7Vg90H21EOLACvtfcHk0ljxZuZ4mnbyTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXhtlWhsbo%253D&md5=9680737d9bbb7825f44bcc66150047ab</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAvdeenko%26aufirst%3DA.%2BP.%26aulast%3DEvgrafova%26aufirst%3DN.%2BI.%26atitle%3DReaction%2520of%2520N-%2528arylsulfonyl%2529-p-naphthoquinonimines%2520with%2520acylhydrazines%26jtitle%3DZh.%2520Org.%2520Khim.%26date%3D1987%26volume%3D23%26spage%3D1060%26epage%3D1063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Thiols</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coj, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Afanas’eva, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chupakhin, O. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sidorov, E. O.</span><span> </span><span class="NLM_article-title">Reactions of benzo analogs of <i>N</i>-phenyl-1,4-benzoquinone monoimine with thiols</span> <span class="citation_source-journal">Zh. Org. Khim.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">2409</span><span class="NLM_x">–</span> <span class="NLM_lpage">2416</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1989&pages=2409-2416&author=+Thiolsauthor=E.+Cojauthor=G.+B.+Afanas%E2%80%99evaauthor=O.+N.+Chupakhinauthor=E.+O.+Sidorov&title=Reactions+of+benzo+analogs+of+N-phenyl-1%2C4-benzoquinone+monoimine+with+thiols"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThiols%26aulast%3DCoj%26aufirst%3DE.%26aulast%3DAfanas%25E2%2580%2599eva%26aufirst%3DG.%2BB.%26aulast%3DChupakhin%26aufirst%3DO.%2BN.%26aulast%3DSidorov%26aufirst%3DE.%2BO.%26atitle%3DReactions%2520of%2520benzo%2520analogs%2520of%2520N-phenyl-1%252C4-benzoquinone%2520monoimine%2520with%2520thiols%26jtitle%3DZh.%2520Org.%2520Khim.%26date%3D1989%26volume%3D25%26spage%3D2409%26epage%3D2416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Fujita, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sano, K.</span><span> </span><span class="NLM_article-title">Reduction of quinones and quinonemonosulfonimides with <i>N</i>,<i>N</i>-diethylhydroxylamine</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">2647</span><span class="NLM_x">–</span> <span class="NLM_lpage">2651</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo01329a012" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm201118h&amp;key=1%3ACAS%3A528%3ADyaE1MXkslCgsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1979&pages=2647-2651&author=S.+Fujitaauthor=K.+Sano&title=Reduction+of+quinones+and+quinonemonosulfonimides+with+N%2CN-diethylhydroxylamine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Reduction of quinones and quinonemonosulfonimides with N,N-diethylhydroxylamine</span></div><div class="casAuthors">Fujita, Shinsaku; Sano, Kazuya</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2647-51</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">p-Quinones and quinonemonosulfonimides were reduced by Et2NOH (I) to give the corresponding hydroquinones and sulfonylaminophenols, resp.  The I redn. is a key step in an improved synthetic route to dye developers II (R = CHMe2, CH2CH2OMe, CH2CH2OEt; R1 = H or Ac).  Nitrone-hydroquinone 1:1 complexes III (R = Ph, 4-MeC6H4, 4-BrC6H4, 4-ClC6H4, R1-R3 = H; R = R2 = Me3C, R1 = R3 = H; R-R3 = Cl) were isolated as intermediates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6BLeGBRB7ULVg90H21EOLACvtfcHk0ljxZuZ4mnbyTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1MXkslCgsr4%253D&md5=f125fa6d0f6ed6dc67d12b600a8a7502</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjo01329a012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01329a012%26sid%3Dliteratum%253Aachs%26aulast%3DFujita%26aufirst%3DS.%26aulast%3DSano%26aufirst%3DK.%26atitle%3DReduction%2520of%2520quinones%2520and%2520quinonemonosulfonimides%2520with%2520N%252CN-diethylhydroxylamine%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1979%26volume%3D44%26spage%3D2647%26epage%3D2651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Lien, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, L.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teng, C.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, S.-C.</span><span> </span><span class="NLM_article-title">Synthesis of 2-alkoxy 1,4-naphthoquinone derivatives as antiplatelet, antiinflammatory, and antiallergic agents</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">672</span><span class="NLM_x">–</span> <span class="NLM_lpage">674</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2002&pages=672-674&author=J.-C.+Lienauthor=L.-J.+Huangauthor=C.-M.+Tengauthor=J.-P.+Wangauthor=S.-C.+Kuo&title=Synthesis+of+2-alkoxy+1%2C4-naphthoquinone+derivatives+as+antiplatelet%2C+antiinflammatory%2C+and+antiallergic+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLien%26aufirst%3DJ.-C.%26aulast%3DHuang%26aufirst%3DL.-J.%26aulast%3DTeng%26aufirst%3DC.-M.%26aulast%3DWang%26aufirst%3DJ.-P.%26aulast%3DKuo%26aufirst%3DS.-C.%26atitle%3DSynthesis%2520of%25202-alkoxy%25201%252C4-naphthoquinone%2520derivatives%2520as%2520antiplatelet%252C%2520antiinflammatory%252C%2520and%2520antiallergic%2520agents%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D2002%26volume%3D50%26spage%3D672%26epage%3D674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Obafemi, C. A.</span><span> </span><span class="NLM_article-title">Studies in the heterocyclic compounds. II. The mass spectra of some thiophene-sulfonyl derivatives</span> <span class="citation_source-journal">Phosphorus Sulfur</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">201</span><span class="NLM_x">–</span> <span class="NLM_lpage">204</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm201118h&amp;key=10.1080%2F03086648008078189" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm201118h&amp;key=1%3ACAS%3A528%3ADyaL3cXlvVGhtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1980&pages=201-204&author=C.+A.+Obafemi&title=Studies+in+the+heterocyclic+compounds.+II.+The+mass+spectra+of+some+thiophene-sulfonyl+derivatives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Studies in the heterocyclic compounds.  II.  The mass spectra of some thiophene-sulfonyl derivatives</span></div><div class="casAuthors">Obafemi, Craig A.</div><div class="citationInfo"><span class="NLM_cas:title">Phosphorus and Sulfur and the Related Elements</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">201-4</span>CODEN:
                <span class="NLM_cas:coden">PREEDF</span>;
        ISSN:<span class="NLM_cas:issn">0308-664X</span>.
    </div><div class="casAbstract">The mass spectra of I (R = Cl, NH2, N3, C6H11NH, PhNMe) showed that the main fragmentation in the 1st 3 compds. is S-R cleavage.  In the cyclohexylamino deriv. this cleavage occurs in 2 steps and in I (R = PhNMe) it is unimportant.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJHFLEOETV4rVg90H21EOLACvtfcHk0ljxZuZ4mnbyTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXlvVGhtLw%253D&md5=e6b2a23df96fd3f59221c2ce719d86b0</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1080%2F03086648008078189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F03086648008078189%26sid%3Dliteratum%253Aachs%26aulast%3DObafemi%26aufirst%3DC.%2BA.%26atitle%3DStudies%2520in%2520the%2520heterocyclic%2520compounds.%2520II.%2520The%2520mass%2520spectra%2520of%2520some%2520thiophene-sulfonyl%2520derivatives%26jtitle%3DPhosphorus%2520Sulfur%26date%3D1980%26volume%3D8%26spage%3D201%26epage%3D204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Matsubara, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doko, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uetake, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, S.</span><span> </span><span class="NLM_article-title">Enesulfonamides as nucleophiles in catalytic asymmetric reactions</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3047</span><span class="NLM_x">–</span> <span class="NLM_lpage">3050</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=3047-3050&author=R.+Matsubaraauthor=T.+Dokoauthor=R.+Uetakeauthor=S.+Kobayashi&title=Enesulfonamides+as+nucleophiles+in+catalytic+asymmetric+reactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMatsubara%26aufirst%3DR.%26aulast%3DDoko%26aufirst%3DT.%26aulast%3DUetake%26aufirst%3DR.%26aulast%3DKobayashi%26aufirst%3DS.%26atitle%3DEnesulfonamides%2520as%2520nucleophiles%2520in%2520catalytic%2520asymmetric%2520reactions%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2007%26volume%3D46%26spage%3D3047%26epage%3D3050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Adams, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitaker, L.</span><span> </span><span class="NLM_article-title">Quinone imides. XXXIX. Adducts of quinone monoimides and conversion of active methylene adducts to benzofurans</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1956</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">658</span><span class="NLM_x">–</span> <span class="NLM_lpage">663</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja01584a037" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm201118h&amp;key=1%3ACAS%3A528%3ADyaG28XmvFegug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=1956&pages=658-663&author=R.+Adamsauthor=L.+Whitaker&title=Quinone+imides.+XXXIX.+Adducts+of+quinone+monoimides+and+conversion+of+active+methylene+adducts+to+benzofurans"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Quinone imides. XXXIX. Adducts of quinone monoimides and conversion of active methylene adducts to benzofurans</span></div><div class="casAuthors">Adams, Roger; Whitaker, Leroy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1956</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">658-63</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">cf. C.A. 50, 8509f.  4,1-PhSO2NHC10H6OH (8.4 g.) and 12.6 g. Pb(OAc)4 in 42 cc. glacial AcOH stirred 1 h. at room temp, treated with 1 cc. (CH2OH)2, stirred 15 min., cooled, and filtered gave 5.31 g. 1,4-naphthoquinone monobenzenesulfonimide (I), yellow needles, m. 152-4° (from CHCl3-cyclohexane).  The appropriate quinone imide (0.01 mol) and 0.011 mol of a suitable active methylene compd. in 50 cc. dry dioxane kept with 40 mg. NaOMe at room temp. gave the corresponding adduct; the reaction mixt. was worked up by one of 4 different procedures: (A) the mixt. was filtered, the filtrate concd. to about 25 cc. in vacuo on the steam bath and dild. with ligroine (b.p. 80-100°), and the pptd. oil cooled; (B) the mixt. was poured into H2O; (C) the dioxane was evapd. in a stream of air, the residue dild. with ligroine, the dark oily ppt. dissolved in Me2CO, and the soln. evapd. slowly; (D) the dioxane was evapd. in a stream of air, the residue dild. with H2O, the pptd. oil dissolved in AcOH, and the soln. poured with stirring into H2O.  In this manner were prepd. a no. of adducts (reaction time in min., % crude yield, m.p. of pure adduct given, and method of isolation) from the following components: p-quinone monobenzenesulfonimide (II), Ac2CH2, 15, 94, 171-3.5° (decompn.) (from EtOAc-ligroine), (A) II, AcCH2CO2Et-0.5, 94, 171° (decompn.) (from EtOH), A; II, BzCH2CO2, Et, 5, 98, 197-8° (from EtOH), B; II, AcCH2CONHPh, 120, 87, 181.5-82° (from EtOAc), B; II, CH2(CO2Et)2, 3 days, 18, 160-2° (from EtOH), C; II, Et cyclohexanone-2-carboxylate, 60, 95, 175-7° (from EtOH), B; II, CH2(CO2Et)2, 1200, - , oil, A; p-quinone monomethanesulfonimide, Ac2CH2, 30, - , oil, A; I, Ac2CH2, 7 days, 184-6° (from EtOAc), 70, D.  The conversion of the active methylene adducts to benzofurans was accomplished by 4 methods: A, 1.00 g. adduct in 50 cc. const. boiling HCl was refluxed and cooled; B, 1.00 g. adduct in 50 cc. 70% H2SO4 was kept at room temp. and poured onto crushed ice; C, 25 cc. concd. HCl was added to 1.00 g. adduct in 40 cc. dioxane or Me2CO, and the mixt. refluxed and evapd.; D, 0.0067 mol quinonemonoimide and 0.07 mol active methylene compd. in 50 cc. dry CHCl3 was kept at room temp. with 3 drops Et3N, the CHCl3 evapd. in an air stream, the oily residue dissolved in Me2CO, and the soln. poured into HCl and ice.  In this manner were prepd. the following furans (m.p., % crude yield, reaction time in hrs., method, and adduct employed given): 3-acetyl-5-benzenesulfonamido-2-methylbenzofuran, 191.5-3.5° (from C6H6-ligroine), 77, 5.5, A, 3-(5-benzene-sulfonamido-2-hydroxyphenyl)-2,4-pentanedione; Et 5-benzenesulfonamido-2-methylbenzofuran-3-carboxylate, 143-4° (from Me2CO-ligroine), 96, 3, A (96%, 48 h., B), Et α-(5-benzenesulfonamido-2-hydroxyphenyl)acetoacetate;  Et 5-benzenesulfonamido-2-phenylbenzofuran-3-carboxylate, 134.5-5.5° (from EtOH), 92, 17, C, Et α-(5-benzenesulfonamido-2-hydroxyphenyl)benzoylacetate; 5-benzenesulfonamido-2-methylbenzofuran-3-carboxylic acid, 254.5° (decompn.) (from EtOH), 67, 18, C, α-(5-benzenesulfonamido-2-hydroxyphenyl)acetoacetanilide; 3-acetyl-5-methylsulfonamido-2-methylbenzofuran, 171-2° (from dioxane), 35, 12, C, 3-(5-methylsulfonamido-1-hydroxyphenyl)-2,4-pentanedione, 246-7° (from EtOH), 65, 14 days (75%, 24, hrs., A), D, 3-(4-benzenesulfonamido-1-hydroxynaphthalene-2)-2,4-pentanedione; 5-benzenesulfonamido-2-methylbenzofuran-3-acetic acid, 200-1.5° (decompn.) (from EtOH), 17, 24, C, di-Et 1-acetyl-1-(5-benzenesulfonamido-2-hydroxyphenyl)succinate; Et 2-benzenesulfonamido-7,8,9,9a-tetrahydrodibenzofuran-9a-carboxylate, 186-8° (from EtOH), 71, 6, A, Et 1-(5-benzenesulfonamido-2-hydroxyphenyl)-2-oxocyclohexanecarboxylate (III); 2-benzenesulfonamido-7,8,9,9a-tetrahydrodibenzofuran, 191-2.5° (from EtOH), 33, 18, C, III.  Et α-(5-benzenesulfonamido-2-hydroxyphenyl)-acetoacetate (1.89 g.) and 2.30 g. Pb(OAc)4 in 50 cc. glacial AcOH stirred 18 h. at room temp., treated with 0.50 cc. (CH2OH)2, stirred 5 min., and cooled gave 1.00 g. Et α-(3-acetoxy-5-benzenesulfonamido-2-hydroxyphenyl)acetoacetate, small white crystals, m. 193-5° (decompn.) (from EtOH).  II (2.47 g.) and 2.56 g. di-Et succinosuccinate (IV) in 25 cc. dry CHCl3 treated 1 h. with 40 mg. MeONa yielded 3.15 g. di-Et 3,6-dihydro-2,5-bis(5-benzenesulfonamido-2-hydroxyphenoxy)terephthalate, white crystals, m. 269-70° (decompn.); the original CHCl3 soln. evapd. gave 1.25 g. unchanged IV, m. 125.5-8.5°.  I (1.99 g.) and 0.60 g. piperidine in 30 cc. CHCl3 kept 21 h. at room temp. gave 0.66 g. unidentified pink solid, m. 161-6°; the CHCl3 soln. evapd. in an air stream and the oily residue treated with EtOH gave 1.77 g. 2-piperidino-1,4-naphthoquinone 4-benzenesulfonimide (V), m. 174.5-76° (from CHCl3-cyclohexane).  V (0.50 g.) in 10 cc. EtOH refluxed 10 min. with 0.75 g. Na2S2O4 in 5 cc. H2O, dild. with 10 cc. EtOH, and filtered, and the filtrate cooled gave 4-benzenesulfonamido-2-piperidino-1-naphthol, white solid which formed a black tar at 161°.  Morpholine (0.61 g.) and 1.99 g. I in 30 cc. CHCl3 kept 48 h. at room temp. and filtered gave 0.32 g. pink solid which could not be purified; the filtrate evapd. and the oily residue extd. with hot EtOH left 0.75 g. 4-benzenesulfonamido-2-morpholino-1-naphthol, white crystals, m. 201-2° (from CHCl3), which slowly turned pink in air; the EtOH ext. evapd. gave 1.40 g. 2-morpholino-1,4-naphthoquinone 4-benzenesulfonamide, red crystals, m. 193-4.5° (from EtOH).  I (1.99 g.) and 0.65 g. PhNH2 in 30 cc. CHCl3 kept 60 h. at room temp. and the cryst. deposit washed with CHCl3 gave 0.79 g. 4-benzenesulfonamido-1-naphthol, white crystals, m. 202-4° (from AcOH); the combined CHCl3 washings and original filtrate concd. and dild. with cyclohexane yielded 1.57 g. 2-anilino-1,4-naphthoquinone 4-benzenesulfonimide (VI), bright red needles, m. 175-6° (from EtOH).  VI (0.50 g.) in 50 cc. EtOH and 10 cc. H2O heated 10 min. with 1.00 g. Na2S2O4, filtered hot, and dild. with H2O yielded 0.48 g. 2-anilino-4-benzenesulfonamido-1-naphthol, white crystals, m. 184-5° (from EtOH under N); it turned slowly pink in air.  II (1.00 g.) in 30 cc. boiling glacial AcOH treated with 1.31 g. PhSO2Na, dild. with 80 cc. H2O, and cooled yielded 1.49 g. 4-benzenesulfonamido-2-phenylsulfonylphenol (VII), white flakes, m. 170-1° (from EtOH).  VII (0.50 g.) in 20 cc. glacial AcOH treated with stirring with 0.68 g. Pb(OAc)4 and after 0.5 h. with 5 drops (CH2OH)2, stirred 10 min., and cooled gave 0.41 g. 2-benzenesulfonamido-1,4-quinone 4-benzenesulfonimide (VIII), orange needles, m. 162.5-3.5° (from AcOH).  PhSO2Na (0.15 g.) in 2 cc. H2O added to 0.20 g. VIII in 10 cc. glacial AcOH, dild. with 10 cc. H2O, and cooled yielded 0.26 g. 4-benzenesulfonamido-2,6-bis(phenylsulfonyl)phenol, white crystals, m. 200° (from EtOH).  I (1.00 g.) in 30 cc. boiling glacial AcOH treated with 1.00 g. PhSO2Na and cooled gave 1.32 g. 1-naphthol analog of VII, white needles, m. 204.5° (from AcOH).  NaN3 (1.00 g.) in 4 cc. H2O added to 1.50 g. II in 30 cc. glacial AcOH, poured after 5 min. into 80 cc. H2O (protected from light) and cooled gave 1.67 g. 2-azido-4-benzenesulfonamidophenol (IX), white needles, m. 121-2.5° (decompn.) (pptd. from EtOH with H2O).  Na2S2O4 (6.0 g.) in 30 cc. H2O added to 1.00 g. IX in 30 cc. 5% aq. NaOH, boiled 10 min., dild. with H2O, and acidified slightly with dil. HCl yielded 0.76 g. 2-amino-4-benzenesulfonamidophenol (X), m. 165-8°.  Crude X (1.00 g.) in 100 cc. 5% aq. HCl treated slowly with 5% aq. NaOH until the mixt. became slightly turbid, the mixt. treated with a few cc. HCl, a few chips of ice, and then 10 cc. Ac2O, treated with shaking with 10 g. NaOAc in 100 cc. H2O, and cooled yielded 1.03 g. 2-AcNH analog of X, small white crystals, m. 242-2.5° (decompn.) (from Me2CO-CHCl3).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNhaz3x8PuU7Vg90H21EOLACvtfcHk0ljhQpRsDiknvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG28XmvFegug%253D%253D&md5=dcab3611845a85205923a388a1f17186</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fja01584a037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01584a037%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DR.%26aulast%3DWhitaker%26aufirst%3DL.%26atitle%3DQuinone%2520imides.%2520XXXIX.%2520Adducts%2520of%2520quinone%2520monoimides%2520and%2520conversion%2520of%2520active%2520methylene%2520adducts%2520to%2520benzofurans%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1956%26volume%3D78%26spage%3D658%26epage%3D663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Travis, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciaramitaro, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borhan, B.</span><span> </span><span class="NLM_article-title">Preparation of purified KHSO<sub>5</sub>·H<sub>2</sub>O and nBu<sub>4</sub>NHSO<sub>5</sub> from oxone by simple and efficient methods</span> <span class="citation_source-journal">Eur. J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_fpage">3429</span><span class="NLM_x">–</span> <span class="NLM_lpage">3434</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&pages=3429-3434&author=B.+R.+Travisauthor=B.+P.+Ciaramitaroauthor=B.+Borhan&title=Preparation+of+purified+KHSO5%C2%B7H2O+and+nBu4NHSO5+from+oxone+by+simple+and+efficient+methods"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTravis%26aufirst%3DB.%2BR.%26aulast%3DCiaramitaro%26aufirst%3DB.%2BP.%26aulast%3DBorhan%26aufirst%3DB.%26atitle%3DPreparation%2520of%2520purified%2520KHSO5%25C2%25B7H2O%2520and%2520nBu4NHSO5%2520from%2520oxone%2520by%2520simple%2520and%2520efficient%2520methods%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2002%26spage%3D3429%26epage%3D3434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Altland, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briffa, B. F.,  Jr.</span><span> </span><span class="NLM_article-title">1,4-Addition of triazolium thiolates to quinones</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">433</span><span class="NLM_x">–</span> <span class="NLM_lpage">437</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00204a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1985&pages=433-437&author=H.+W.+Altlandauthor=B.+F.+Briffa&title=1%2C4-Addition+of+triazolium+thiolates+to+quinones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjo00204a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00204a002%26sid%3Dliteratum%253Aachs%26aulast%3DAltland%26aufirst%3DH.%2BW.%26aulast%3DBriffa%26aufirst%3DB.%2BF.%26atitle%3D1%252C4-Addition%2520of%2520triazolium%2520thiolates%2520to%2520quinones%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1985%26volume%3D50%26spage%3D433%26epage%3D437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Johnston, C. I.</span><span> </span><span class="NLM_article-title">Angiotensin receptor antagonists: focus on losartan</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">346</span><span class="NLM_x">, </span> <span class="NLM_fpage">1403</span><span class="NLM_x">–</span> <span class="NLM_lpage">1407</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=346&publication_year=1995&pages=1403-1407&author=C.+I.+Johnston&title=Angiotensin+receptor+antagonists%3A+focus+on+losartan"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohnston%26aufirst%3DC.%2BI.%26atitle%3DAngiotensin%2520receptor%2520antagonists%253A%2520focus%2520on%2520losartan%26jtitle%3DLancet%26date%3D1995%26volume%3D346%26spage%3D1403%26epage%3D1407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Patani, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaVoie, E. J.</span><span> </span><span class="NLM_article-title">Bioisosterism: A rational approach in drug design</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">3147</span><span class="NLM_x">–</span> <span class="NLM_lpage">3176</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr950066q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm201118h&amp;key=1%3ACAS%3A528%3ADyaK28XntFSitLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1996&pages=3147-3176&author=G.+A.+Pataniauthor=E.+J.+LaVoie&title=Bioisosterism%3A+A+rational+approach+in+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Bioisosterism: A rational approach in drug design</span></div><div class="casAuthors">Patani, George A.; LaVoie, Edmond J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3147-3176</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review, with 191 refs., on bioisosteres that incorporates sufficient detail to enable the reader to understand the concepts being delineated.  Classical bioisosteres, such as monovalent atoms and groups, divalent isosteres, trivalent atoms and groups, tetra substituted atoms, and ring equiv., and non-classical bioisosteres, such as cyclic vs. non-cyclic non-classical bioisosteric replacements and non-classical bioisosteric replacements of functional groups, are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrADeNoRGbU9LVg90H21EOLACvtfcHk0liUTMY-ZpkYLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XntFSitLg%253D&md5=4b3ec55087feabc53e0490ebd5a3ddcd</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fcr950066q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr950066q%26sid%3Dliteratum%253Aachs%26aulast%3DPatani%26aufirst%3DG.%2BA.%26aulast%3DLaVoie%26aufirst%3DE.%2BJ.%26atitle%3DBioisosterism%253A%2520A%2520rational%2520approach%2520in%2520drug%2520design%26jtitle%3DChem.%2520Rev.%26date%3D1996%26volume%3D96%26spage%3D3147%26epage%3D3176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6a','cit6b'],'ref7':['cit7a','cit7b'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12a','cit12b'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 38 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Ziyi Guo, Yiming Zhao, Yu Wang, Meihua Xie, <span class="NLM_string-name hlFld-ContribAuthor">Jitan Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Construction of 3-Sulfonyl Naphthalenes via Tandem Reaction of 1,4-Diyn-3-yl Esters with Sodium Sulfinates. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>86 </em>
                                    (9)
                                     , 6247-6258. <a href="https://doi.org/10.1021/acs.joc.1c00038" title="DOI URL">https://doi.org/10.1021/acs.joc.1c00038</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.1c00038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.1c00038%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DConstruction%252Bof%252B3-Sulfonyl%252BNaphthalenes%252Bvia%252BTandem%252BReaction%252Bof%252B1%25252C4-Diyn-3-yl%252BEsters%252Bwith%252BSodium%252BSulfinates%26aulast%3DGuo%26aufirst%3DZiyi%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D06012021%26date%3D20042021%26volume%3D86%26issue%3D9%26spage%3D6247%26epage%3D6258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Youpeng Zuo, Xinwei He, Qiang Tang, Wangcheng Hu, Tongtong Zhou, <span class="NLM_string-name hlFld-ContribAuthor">Yongjia Shang</span>. </span><span class="cited-content_cbyCitation_article-title">Palladium-Catalyzed Cascade Decarboxylative Amination/6-endo-dig Benzannulation of o-Alkynylarylketones with N-Hydroxyamides To Access Diverse 1-Naphthylamine Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (10)
                                     , 3890-3894. <a href="https://doi.org/10.1021/acs.orglett.0c01183" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c01183</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c01183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c01183%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DPalladium-Catalyzed%252BCascade%252BDecarboxylative%252BAmination%25252F6-endo-dig%252BBenzannulation%252Bof%252Bo-Alkynylarylketones%252Bwith%252BN-Hydroxyamides%252BTo%252BAccess%252BDiverse%252B1-Naphthylamine%252BDerivatives%26aulast%3DZuo%26aufirst%3DYoupeng%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D02042020%26date%3D04052020%26volume%3D22%26issue%3D10%26spage%3D3890%26epage%3D3894" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Rizhen Huang, Xiaoteng Jing, Xiaochao Huang, Yingming Pan, Yilin Fang, Guibin Liang, Zhixin Liao, Hengshan Wang, Zhenfeng Chen, <span class="NLM_string-name hlFld-ContribAuthor">Ye Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Bifunctional Naphthoquinone Aromatic Amide-Oxime Derivatives Exert Combined Immunotherapeutic and Antitumor Effects through Simultaneous Targeting of Indoleamine-2,3-dioxygenase and Signal Transducer and Activator of Transcription 3. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (4)
                                     , 1544-1563. <a href="https://doi.org/10.1021/acs.jmedchem.9b01386" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01386</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01386&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01386%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBifunctional%252BNaphthoquinone%252BAromatic%252BAmide-Oxime%252BDerivatives%252BExert%252BCombined%252BImmunotherapeutic%252Band%252BAntitumor%252BEffects%252Bthrough%252BSimultaneous%252BTargeting%252Bof%252BIndoleamine-2%25252C3-dioxygenase%252Band%252BSignal%252BTransducer%252Band%252BActivator%252Bof%252BTranscription%252B3%26aulast%3DHuang%26aufirst%3DRizhen%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D22082019%26date%3D17022020%26date%3D30012020%26volume%3D63%26issue%3D4%26spage%3D1544%26epage%3D1563" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Shalini Verma, Manoj Kumar, <span class="NLM_string-name hlFld-ContribAuthor">Akhilesh K. Verma</span>. </span><span class="cited-content_cbyCitation_article-title">Aza-Henry Reaction: Synthesis of Nitronaphthylamines from 2-(Alkynyl)benzonitriles. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (1)
                                     , 130-134. <a href="https://doi.org/10.1021/acs.orglett.9b04045" title="DOI URL">https://doi.org/10.1021/acs.orglett.9b04045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.9b04045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.9b04045%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DAza-Henry%252BReaction%25253A%252BSynthesis%252Bof%252BNitronaphthylamines%252Bfrom%252B2-%252528Alkynyl%252529benzonitriles%26aulast%3DVerma%26aufirst%3DShalini%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D12112019%26date%3D11122019%26volume%3D22%26issue%3D1%26spage%3D130%26epage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Cheng Peng, Jingyi Zhang, Jian Xue, Siqi Li, Xiao-Na Wang, <span class="NLM_string-name hlFld-ContribAuthor">Junbiao Chang</span>. </span><span class="cited-content_cbyCitation_article-title">Lewis Acids Catalyzed Annulations of Ynamides with Acyl Chlorides for Constructing 4-Amino-2-naphthol Derivatives and 3-Aminocyclobutenones. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>83 </em>
                                    (16)
                                     , 9256-9266. <a href="https://doi.org/10.1021/acs.joc.8b01255" title="DOI URL">https://doi.org/10.1021/acs.joc.8b01255</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.8b01255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.8b01255%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DLewis%252BAcids%252BCatalyzed%252BAnnulations%252Bof%252BYnamides%252Bwith%252BAcyl%252BChlorides%252Bfor%252BConstructing%252B4-Amino-2-naphthol%252BDerivatives%252Band%252B3-Aminocyclobutenones%26aulast%3DPeng%26aufirst%3DCheng%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D16052018%26date%3D13072018%26date%3D06072018%26volume%3D83%26issue%3D16%26spage%3D9256%26epage%3D9266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Meijun Xiong, Hui Hu, Xiaoping Hu, <span class="NLM_string-name hlFld-ContribAuthor">Yuanhong Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Copper-Catalyzed Borylative Cyclization of o-(Cyano)phenyl Propargyl Carbonates: Synthesis of Functionalized 1-Naphthylamines. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2018,</strong> <em>20 </em>
                                    (12)
                                     , 3661-3665. <a href="https://doi.org/10.1021/acs.orglett.8b01457" title="DOI URL">https://doi.org/10.1021/acs.orglett.8b01457</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.8b01457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.8b01457%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DCopper-Catalyzed%252BBorylative%252BCyclization%252Bof%252Bo-%252528Cyano%252529phenyl%252BPropargyl%252BCarbonates%25253A%252BSynthesis%252Bof%252BFunctionalized%252B1-Naphthylamines%26aulast%3DXiong%26aufirst%3DMeijun%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D09052018%26date%3D04062018%26volume%3D20%26issue%3D12%26spage%3D3661%26epage%3D3665" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Meijun  Xiong</span>, <span class="hlFld-ContribAuthor ">Xin  Xie</span>, and <span class="hlFld-ContribAuthor ">Yuanhong  Liu</span>  . </span><span class="cited-content_cbyCitation_article-title">Copper-Catalyzed Borylative Cyclization of in Situ Generated o-Allenylaryl Nitriles with Bis(pinacolato)diboron. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2017,</strong> <em>19 </em>
                                    (13)
                                     , 3398-3401. <a href="https://doi.org/10.1021/acs.orglett.7b01355" title="DOI URL">https://doi.org/10.1021/acs.orglett.7b01355</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.7b01355&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.7b01355%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DCopper-Catalyzed%252BBorylative%252BCyclization%252Bof%252Bin%252BSitu%252BGenerated%252Bo-Allenylaryl%252BNitriles%252Bwith%252BBis%252528pinacolato%252529diboron%26aulast%3DXiong%26aufirst%3DMeijun%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D05052017%26date%3D27062017%26date%3D07072017%26volume%3D19%26issue%3D13%26spage%3D3398%26epage%3D3401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mnaza  Noreen</span>, <span class="hlFld-ContribAuthor ">Nasir  Rasool</span>, <span class="hlFld-ContribAuthor ">Mirna  El Khatib</span>, and <span class="hlFld-ContribAuthor ">Gary A.  Molander</span>  . </span><span class="cited-content_cbyCitation_article-title">Arylation and Heteroarylation of Thienylsulfonamides with Organotrifluoroborates. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2014,</strong> <em>79 </em>
                                    (15)
                                     , 7243-7249. <a href="https://doi.org/10.1021/jo501323z" title="DOI URL">https://doi.org/10.1021/jo501323z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo501323z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo501323z%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DArylation%252Band%252BHeteroarylation%252Bof%252BThienylsulfonamides%252Bwith%252BOrganotrifluoroborates%26aulast%3DNoreen%26aufirst%3DMnaza%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D13062014%26date%3D14072014%26date%3D01082014%26volume%3D79%26issue%3D15%26spage%3D7243%26epage%3D7249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fardokht A.  Abulwerdi</span>, <span class="hlFld-ContribAuthor ">Chenzhong  Liao</span>, <span class="hlFld-ContribAuthor ">Ahmed S.  Mady</span>, <span class="hlFld-ContribAuthor ">Jordan  Gavin</span>, <span class="hlFld-ContribAuthor ">Chenxi  Shen</span>, <span class="hlFld-ContribAuthor ">Tomasz  Cierpicki</span>, <span class="hlFld-ContribAuthor ">Jeanne A.  Stuckey</span>, <span class="hlFld-ContribAuthor ">H. D. Hollis  Showalter</span>, and <span class="hlFld-ContribAuthor ">Zaneta  Nikolovska-Coleska</span>  . </span><span class="cited-content_cbyCitation_article-title">3-Substituted-N-(4-Hydroxynaphthalen-1-yl)arylsulfonamides as a Novel Class of Selective Mcl-1 Inhibitors: Structure-Based Design, Synthesis, SAR, and Biological Evaluation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (10)
                                     , 4111-4133. <a href="https://doi.org/10.1021/jm500010b" title="DOI URL">https://doi.org/10.1021/jm500010b</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm500010b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm500010b%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D3-Substituted-N-%2525284-Hydroxynaphthalen-1-yl%252529arylsulfonamides%252Bas%252Ba%252BNovel%252BClass%252Bof%252BSelective%252BMcl-1%252BInhibitors%25253A%252BStructure-Based%252BDesign%25252C%252BSynthesis%25252C%252BSAR%25252C%252Band%252BBiological%252BEvaluation%26aulast%3DAbulwerdi%26aufirst%3DFardokht%2BA.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D03012014%26date%3D07052014%26date%3D22052014%26date%3D21042014%26volume%3D57%26issue%3D10%26spage%3D4111%26epage%3D4133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sevil  Ozcan</span>, <span class="hlFld-ContribAuthor ">Aslamuzzaman  Kazi</span>, <span class="hlFld-ContribAuthor ">Frank  Marsilio</span>, <span class="hlFld-ContribAuthor ">Bin  Fang</span>, <span class="hlFld-ContribAuthor ">Wayne C.  Guida</span>, <span class="hlFld-ContribAuthor ">John  Koomen</span>, <span class="hlFld-ContribAuthor ">Harshani R.  Lawrence</span>, and <span class="hlFld-ContribAuthor ">Saïd M.  Sebti</span>  . </span><span class="cited-content_cbyCitation_article-title">Oxadiazole-isopropylamides as Potent and Noncovalent Proteasome Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (10)
                                     , 3783-3805. <a href="https://doi.org/10.1021/jm400221d" title="DOI URL">https://doi.org/10.1021/jm400221d</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm400221d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm400221d%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOxadiazole-isopropylamides%252Bas%252BPotent%252Band%252BNoncovalent%252BProteasome%252BInhibitors%26aulast%3DOzcan%26aufirst%3DSevil%26date%3D2013%26date%3D2013%26date%3D2012%26date%3D23102012%26date%3D13052013%26date%3D23052013%26date%3D02042013%26volume%3D56%26issue%3D10%26spage%3D3783%26epage%3D3805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jia  Li</span>, <span class="hlFld-ContribAuthor ">Xuben  Hou</span>, <span class="hlFld-ContribAuthor ">Jinzhuo  Bai</span>, <span class="hlFld-ContribAuthor ">Yi  Zhou</span>, <span class="hlFld-ContribAuthor ">Chen  Chen</span>, <span class="hlFld-ContribAuthor ">Xinying  Yang</span>, <span class="hlFld-ContribAuthor ">Hao  Fang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of a UMI-77-based fluorescent probe for selective detecting Mcl-1 protein and imaging in living cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2021,</strong> <em>29 </em>, 115850. <a href="https://doi.org/10.1016/j.bmc.2020.115850" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115850</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115850&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115850%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Ba%252BUMI-77-based%252Bfluorescent%252Bprobe%252Bfor%252Bselective%252Bdetecting%252BMcl-1%252Bprotein%252Band%252Bimaging%252Bin%252Bliving%252Bcancer%252Bcells%26aulast%3DLi%26aufirst%3DJia%26date%3D2021%26volume%3D29%26spage%3D115850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">An  Wu</span>, <span class="hlFld-ContribAuthor ">Hui  Qian</span>, <span class="hlFld-ContribAuthor ">Wanxiang  Zhao</span>, <span class="hlFld-ContribAuthor ">Jianwei  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Benzannulation of isobenzopyryliums with electron-rich alkynes: a modular access to β-functionalized naphthalenes. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2020,</strong> <em>11 </em>
                                    (30)
                                     , 7957-7962. <a href="https://doi.org/10.1039/D0SC02502J" title="DOI URL">https://doi.org/10.1039/D0SC02502J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0SC02502J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0SC02502J%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DBenzannulation%252Bof%252Bisobenzopyryliums%252Bwith%252Belectron-rich%252Balkynes%25253A%252Ba%252Bmodular%252Baccess%252Bto%252B%2525CE%2525B2-functionalized%252Bnaphthalenes%26aulast%3DWu%26aufirst%3DAn%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D30%26spage%3D7957%26epage%3D7962" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hatice  Yıldırım</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, characterization, and biological evaluation of a set of new alkylthio substituted plastoquinones containing ester group. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2020,</strong> <em>1203 </em>, 127433. <a href="https://doi.org/10.1016/j.molstruc.2019.127433" title="DOI URL">https://doi.org/10.1016/j.molstruc.2019.127433</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2019.127433&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2019.127433%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DSynthesis%25252C%252Bcharacterization%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252Ba%252Bset%252Bof%252Bnew%252Balkylthio%252Bsubstituted%252Bplastoquinones%252Bcontaining%252Bester%252Bgroup%26aulast%3DY%25C4%25B1ld%25C4%25B1r%25C4%25B1m%26aufirst%3DHatice%26date%3D2020%26volume%3D1203%26spage%3D127433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chandrashekar  Mudithanapelli</span>, <span class="hlFld-ContribAuthor ">Mi-hyun  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Metal-free late-stage C(sp
              2
              )–H functionalization of
              N
              -aryl amines with various sodium salts. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2020,</strong> <em>18 </em>
                                    (3)
                                     , 450-464. <a href="https://doi.org/10.1039/C9OB02217A" title="DOI URL">https://doi.org/10.1039/C9OB02217A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9OB02217A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9OB02217A%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DMetal-free%252Blate-stage%252BC%252528sp%252B2%252B%252529%2525E2%252580%252593H%252Bfunctionalization%252Bof%252BN%252B-aryl%252Bamines%252Bwith%252Bvarious%252Bsodium%252Bsalts%26aulast%3DMudithanapelli%26aufirst%3DChandrashekar%26date%3D2020%26date%3D2020%26volume%3D18%26issue%3D3%26spage%3D450%26epage%3D464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Saurabh  Loharch</span>, <span class="hlFld-ContribAuthor ">Raman  Parkesh</span>. </span><span class="cited-content_cbyCitation_article-title">Epigenetic drug discovery: systematic assessment of chemical space. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2019,</strong> <em>11 </em>
                                    (21)
                                     , 2803-2819. <a href="https://doi.org/10.4155/fmc-2019-0096" title="DOI URL">https://doi.org/10.4155/fmc-2019-0096</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2019-0096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2019-0096%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DEpigenetic%252Bdrug%252Bdiscovery%25253A%252Bsystematic%252Bassessment%252Bof%252Bchemical%252Bspace%26aulast%3DLoharch%26aufirst%3DSaurabh%26date%3D2019%26volume%3D11%26issue%3D21%26spage%3D2803%26epage%3D2819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Svetlana V.  Vorona</span>, <span class="hlFld-ContribAuthor ">Yuri E.  Zevatskii</span>, <span class="hlFld-ContribAuthor ">Leonid V.  Myznikov</span>. </span><span class="cited-content_cbyCitation_article-title">Zinc (II) Chloride as Phase Transfer Catalyst and as Catalyst of Cycloaddition Azide Ion to Heterocumulenes and Terminal Alkynes in Organic Solvents. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2019,</strong> <em>4 </em>
                                    (36)
                                     , 10846-10850. <a href="https://doi.org/10.1002/slct.201903162" title="DOI URL">https://doi.org/10.1002/slct.201903162</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201903162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201903162%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DZinc%252B%252528II%252529%252BChloride%252Bas%252BPhase%252BTransfer%252BCatalyst%252Band%252Bas%252BCatalyst%252Bof%252BCycloaddition%252BAzide%252BIon%252Bto%252BHeterocumulenes%252Band%252BTerminal%252BAlkynes%252Bin%252BOrganic%252BSolvents%26aulast%3DVorona%26aufirst%3DSvetlana%2BV.%26date%3D2019%26date%3D2019%26volume%3D4%26issue%3D36%26spage%3D10846%26epage%3D10850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jingyu  Zhang</span>, <span class="hlFld-ContribAuthor ">Su  Wang</span>, <span class="hlFld-ContribAuthor ">Yanyan  Ba</span>, <span class="hlFld-ContribAuthor ">Zhi  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Tetrazole hybrids with potential anticancer activity. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>178 </em>, 341-351. <a href="https://doi.org/10.1016/j.ejmech.2019.05.071" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.05.071</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.05.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.05.071%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTetrazole%252Bhybrids%252Bwith%252Bpotential%252Banticancer%252Bactivity%26aulast%3DZhang%26aufirst%3DJingyu%26date%3D2019%26volume%3D178%26spage%3D341%26epage%3D351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dandan  Xi</span>, <span class="hlFld-ContribAuthor ">Yan  Niu</span>, <span class="hlFld-ContribAuthor ">Hongyue  Li</span>, <span class="hlFld-ContribAuthor ">Stefan M.  Noha</span>, <span class="hlFld-ContribAuthor ">Veronika  Temml</span>, <span class="hlFld-ContribAuthor ">Daniela  Schuster</span>, <span class="hlFld-ContribAuthor ">Chao  Wang</span>, <span class="hlFld-ContribAuthor ">Fengrong  Xu</span>, <span class="hlFld-ContribAuthor ">Ping  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of carbazole derivatives as novel allosteric MEK inhibitors by pharmacophore modeling and virtual screening. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>178 </em>, 802-817. <a href="https://doi.org/10.1016/j.ejmech.2019.06.027" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.06.027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.06.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.06.027%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bcarbazole%252Bderivatives%252Bas%252Bnovel%252Ballosteric%252BMEK%252Binhibitors%252Bby%252Bpharmacophore%252Bmodeling%252Band%252Bvirtual%252Bscreening%26aulast%3DXi%26aufirst%3DDandan%26date%3D2019%26volume%3D178%26spage%3D802%26epage%3D817" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Saurabh  Loharch</span>, <span class="hlFld-ContribAuthor ">Vikrant  Karmahapatra</span>, <span class="hlFld-ContribAuthor ">Pawan  Gupta</span>, <span class="hlFld-ContribAuthor ">Rethi  Madathil</span>, <span class="hlFld-ContribAuthor ">Raman  Parkesh</span>. </span><span class="cited-content_cbyCitation_article-title">Integrated Chemoinformatics Approaches Toward Epigenetic Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 247-269. <a href="https://doi.org/10.1007/978-3-030-05282-9_8" title="DOI URL">https://doi.org/10.1007/978-3-030-05282-9_8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-05282-9_8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-05282-9_8%26sid%3Dliteratum%253Aachs%26atitle%3DIntegrated%252BChemoinformatics%252BApproaches%252BToward%252BEpigenetic%252BDrug%252BDiscovery%26aulast%3DLoharch%26aufirst%3DSaurabh%26date%3D2019%26date%3D2019%26spage%3D247%26epage%3D269%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DStructural%252BBioinformatics%25253A%252BApplications%252Bin%252BPreclinical%252BDrug%252BDiscovery%252BProcess%26aulast%3DMohan%26aufirst%3DC.%2BGopi%26date%3D2019%26volume%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shweta  Singh</span>, <span class="hlFld-ContribAuthor ">Ramesh  Samineni</span>, <span class="hlFld-ContribAuthor ">Srihari  Pabbaraja</span>, <span class="hlFld-ContribAuthor ">Goverdhan  Mehta</span>. </span><span class="cited-content_cbyCitation_article-title">Nitromethane as a Carbanion Source for Domino Benzoannulation with Ynones: One‐Pot Synthesis of Polyfunctional Naphthalenes and a Total Synthesis of Macarpine. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2018,</strong> <em>130 </em>
                                    (51)
                                     , 17089-17093. <a href="https://doi.org/10.1002/ange.201810652" title="DOI URL">https://doi.org/10.1002/ange.201810652</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201810652&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201810652%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DNitromethane%252Bas%252Ba%252BCarbanion%252BSource%252Bfor%252BDomino%252BBenzoannulation%252Bwith%252BYnones%25253A%252BOne%2525E2%252580%252590Pot%252BSynthesis%252Bof%252BPolyfunctional%252BNaphthalenes%252Band%252Ba%252BTotal%252BSynthesis%252Bof%252BMacarpine%26aulast%3DSingh%26aufirst%3DShweta%26date%3D2018%26volume%3D130%26issue%3D51%26spage%3D17089%26epage%3D17093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shweta  Singh</span>, <span class="hlFld-ContribAuthor ">Ramesh  Samineni</span>, <span class="hlFld-ContribAuthor ">Srihari  Pabbaraja</span>, <span class="hlFld-ContribAuthor ">Goverdhan  Mehta</span>. </span><span class="cited-content_cbyCitation_article-title">Nitromethane as a Carbanion Source for Domino Benzoannulation with Ynones: One‐Pot Synthesis of Polyfunctional Naphthalenes and a Total Synthesis of Macarpine. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2018,</strong> <em>57 </em>
                                    (51)
                                     , 16847-16851. <a href="https://doi.org/10.1002/anie.201810652" title="DOI URL">https://doi.org/10.1002/anie.201810652</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201810652&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201810652%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DNitromethane%252Bas%252Ba%252BCarbanion%252BSource%252Bfor%252BDomino%252BBenzoannulation%252Bwith%252BYnones%25253A%252BOne%2525E2%252580%252590Pot%252BSynthesis%252Bof%252BPolyfunctional%252BNaphthalenes%252Band%252Ba%252BTotal%252BSynthesis%252Bof%252BMacarpine%26aulast%3DSingh%26aufirst%3DShweta%26date%3D2018%26volume%3D57%26issue%3D51%26spage%3D16847%26epage%3D16851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hongwu  Liu</span>, <span class="hlFld-ContribAuthor ">Jianwei  Wu</span>, <span class="hlFld-ContribAuthor ">Ying  Ge</span>, <span class="hlFld-ContribAuthor ">Aibo  Li</span>, <span class="hlFld-ContribAuthor ">Jia  Li</span>, <span class="hlFld-ContribAuthor ">Zhengshi  Liu</span>, <span class="hlFld-ContribAuthor ">Yungen  Xu</span>, <span class="hlFld-ContribAuthor ">Qingxiang  Xu</span>, <span class="hlFld-ContribAuthor ">Yuyan  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Novel aromatic sulfonyl naphthalene-based boronates as 20S proteasome inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (5)
                                     , 1050-1061. <a href="https://doi.org/10.1016/j.bmc.2018.01.017" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.01.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.01.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.01.017%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Baromatic%252Bsulfonyl%252Bnaphthalene-based%252Bboronates%252Bas%252B20S%252Bproteasome%252Binhibitors%26aulast%3DLiu%26aufirst%3DHongwu%26date%3D2018%26volume%3D26%26issue%3D5%26spage%3D1050%26epage%3D1061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ning  Meng</span>, <span class="hlFld-ContribAuthor ">Hua  Tang</span>, <span class="hlFld-ContribAuthor ">Hao  Zhang</span>, <span class="hlFld-ContribAuthor ">Chengshi  Jiang</span>, <span class="hlFld-ContribAuthor ">Li  Su</span>, <span class="hlFld-ContribAuthor ">Xiao  Min</span>, <span class="hlFld-ContribAuthor ">Wannian  Zhang</span>, <span class="hlFld-ContribAuthor ">Hua  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhenyuan  Miao</span>, <span class="hlFld-ContribAuthor ">Wen  Zhang</span>, <span class="hlFld-ContribAuthor ">Chunlin  Zhuang</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment-growing guided design of Keap1-Nrf2 protein-protein interaction inhibitors for targeting myocarditis. </span><span class="cited-content_cbyCitation_journal-name">Free Radical Biology and Medicine</span><span> <strong>2018,</strong> <em>117 </em>, 228-237. <a href="https://doi.org/10.1016/j.freeradbiomed.2018.02.010" title="DOI URL">https://doi.org/10.1016/j.freeradbiomed.2018.02.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.freeradbiomed.2018.02.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.freeradbiomed.2018.02.010%26sid%3Dliteratum%253Aachs%26jtitle%3DFree%2520Radical%2520Biology%2520and%2520Medicine%26atitle%3DFragment-growing%252Bguided%252Bdesign%252Bof%252BKeap1-Nrf2%252Bprotein-protein%252Binteraction%252Binhibitors%252Bfor%252Btargeting%252Bmyocarditis%26aulast%3DMeng%26aufirst%3DNing%26date%3D2018%26volume%3D117%26spage%3D228%26epage%3D237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Radek  Jorda</span>, <span class="hlFld-ContribAuthor ">Jan  Dušek</span>, <span class="hlFld-ContribAuthor ">Eva  Řezníčková</span>, <span class="hlFld-ContribAuthor ">Karel  Pauk</span>, <span class="hlFld-ContribAuthor ">Pratibha P.  Magar</span>, <span class="hlFld-ContribAuthor ">Aleš  Imramovský</span>, <span class="hlFld-ContribAuthor ">Vladimír  Kryštof</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and antiproteasomal activity of novel O -benzyl salicylamide-based inhibitors built from leucine and phenylalanine. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>135 </em>, 142-158. <a href="https://doi.org/10.1016/j.ejmech.2017.04.027" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.04.027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.04.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.04.027%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bantiproteasomal%252Bactivity%252Bof%252Bnovel%252BO%252B-benzyl%252Bsalicylamide-based%252Binhibitors%252Bbuilt%252Bfrom%252Bleucine%252Band%252Bphenylalanine%26aulast%3DJorda%26aufirst%3DRadek%26date%3D2017%26volume%3D135%26spage%3D142%26epage%3D158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ying  Ge</span>, <span class="hlFld-ContribAuthor ">Aibo  Li</span>, <span class="hlFld-ContribAuthor ">Jianwei  Wu</span>, <span class="hlFld-ContribAuthor ">Haiwei  Feng</span>, <span class="hlFld-ContribAuthor ">Letian  Wang</span>, <span class="hlFld-ContribAuthor ">Hongwu  Liu</span>, <span class="hlFld-ContribAuthor ">Yungen  Xu</span>, <span class="hlFld-ContribAuthor ">Qingxiang  Xu</span>, <span class="hlFld-ContribAuthor ">Li  Zhao</span>, <span class="hlFld-ContribAuthor ">Yuyan  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel non-peptide boronic acid derivatives as proteasome inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>128 </em>, 180-191. <a href="https://doi.org/10.1016/j.ejmech.2017.01.034" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.01.034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.01.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.01.034%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bnon-peptide%252Bboronic%252Bacid%252Bderivatives%252Bas%252Bproteasome%252Binhibitors%26aulast%3DGe%26aufirst%3DYing%26date%3D2017%26volume%3D128%26spage%3D180%26epage%3D191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mauro  Marastoni</span>, <span class="hlFld-ContribAuthor ">Claudio  Trapella</span>, <span class="hlFld-ContribAuthor ">Alessandra  Scotti</span>, <span class="hlFld-ContribAuthor ">Anna  Fantinati</span>, <span class="hlFld-ContribAuthor ">Valeria  Ferretti</span>, <span class="hlFld-ContribAuthor ">Erika  Marzola</span>, <span class="hlFld-ContribAuthor ">Gallerani  Eleonora</span>, <span class="hlFld-ContribAuthor ">Riccardo  Gavioli</span>, <span class="hlFld-ContribAuthor ">Delia  Preti</span>. </span><span class="cited-content_cbyCitation_article-title">Naphthoquinone amino acid derivatives, synthesis and biological activity as proteasome inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2017,</strong> <em>32 </em>
                                    (1)
                                     , 865-877. <a href="https://doi.org/10.1080/14756366.2017.1334649" title="DOI URL">https://doi.org/10.1080/14756366.2017.1334649</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2017.1334649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2017.1334649%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DNaphthoquinone%252Bamino%252Bacid%252Bderivatives%25252C%252Bsynthesis%252Band%252Bbiological%252Bactivity%252Bas%252Bproteasome%252Binhibitors%26aulast%3DMarastoni%26aufirst%3DMauro%26date%3D2017%26date%3D2017%26volume%3D32%26issue%3D1%26spage%3D865%26epage%3D877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lingfei  Yang</span>, <span class="hlFld-ContribAuthor ">Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Qi  Sun</span>, <span class="hlFld-ContribAuthor ">Fengrong  Xu</span>, <span class="hlFld-ContribAuthor ">Yan  Niu</span>, <span class="hlFld-ContribAuthor ">Chao  Wang</span>, <span class="hlFld-ContribAuthor ">Lei  Liang</span>, <span class="hlFld-ContribAuthor ">Ping  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Development of novel proteasome inhibitors based on phthalazinone scaffold. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (12)
                                     , 2801-2805. <a href="https://doi.org/10.1016/j.bmcl.2016.04.067" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.04.067</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.04.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.04.067%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDevelopment%252Bof%252Bnovel%252Bproteasome%252Binhibitors%252Bbased%252Bon%252Bphthalazinone%252Bscaffold%26aulast%3DYang%26aufirst%3DLingfei%26date%3D2016%26volume%3D26%26issue%3D12%26spage%3D2801%26epage%3D2805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Susan  Lee</span>, <span class="hlFld-ContribAuthor ">Thomas E  Wales</span>, <span class="hlFld-ContribAuthor ">Silvia  Escudero</span>, <span class="hlFld-ContribAuthor ">Daniel T  Cohen</span>, <span class="hlFld-ContribAuthor ">James  Luccarelli</span>, <span class="hlFld-ContribAuthor ">Catherine G  Gallagher</span>, <span class="hlFld-ContribAuthor ">Nicole A  Cohen</span>, <span class="hlFld-ContribAuthor ">Annissa J  Huhn</span>, <span class="hlFld-ContribAuthor ">Gregory H  Bird</span>, <span class="hlFld-ContribAuthor ">John R  Engen</span>, <span class="hlFld-ContribAuthor ">Loren D  Walensky</span>. </span><span class="cited-content_cbyCitation_article-title">Allosteric inhibition of antiapoptotic MCL-1. </span><span class="cited-content_cbyCitation_journal-name">Nature Structural & Molecular Biology</span><span> <strong>2016,</strong> <em>23 </em>
                                    (6)
                                     , 600-607. <a href="https://doi.org/10.1038/nsmb.3223" title="DOI URL">https://doi.org/10.1038/nsmb.3223</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nsmb.3223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnsmb.3223%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Structural%2520%2526%2520Molecular%2520Biology%26atitle%3DAllosteric%252Binhibition%252Bof%252Bantiapoptotic%252BMCL-1%26aulast%3DLee%26aufirst%3DSusan%26date%3D2016%26date%3D2016%26volume%3D23%26issue%3D6%26spage%3D600%26epage%3D607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tanner J.  McDaniel</span>, <span class="hlFld-ContribAuthor ">Theresa A.  Lansdell</span>, <span class="hlFld-ContribAuthor ">Amila A.  Dissanayake</span>, <span class="hlFld-ContribAuthor ">Lauren M.  Azevedo</span>, <span class="hlFld-ContribAuthor ">Jacob  Claes</span>, <span class="hlFld-ContribAuthor ">Aaron L.  Odom</span>, <span class="hlFld-ContribAuthor ">Jetze J.  Tepe</span>. </span><span class="cited-content_cbyCitation_article-title">Substituted quinolines as noncovalent proteasome inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (11)
                                     , 2441-2450. <a href="https://doi.org/10.1016/j.bmc.2016.04.005" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.04.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.04.005%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSubstituted%252Bquinolines%252Bas%252Bnoncovalent%252Bproteasome%252Binhibitors%26aulast%3DMcDaniel%26aufirst%3DTanner%2BJ.%26date%3D2016%26volume%3D24%26issue%3D11%26spage%3D2441%26epage%3D2450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">L. V.  Myznikov</span>, <span class="hlFld-ContribAuthor ">S. V.  Vorona</span>, <span class="hlFld-ContribAuthor ">T. V.  Artamonova</span>, <span class="hlFld-ContribAuthor ">Yu. E.  Zevatskii</span>. </span><span class="cited-content_cbyCitation_article-title">Tetrazoles with oxygen-, sulfur-, and selenium-containing substituents. </span><span class="cited-content_cbyCitation_journal-name">Russian Chemical Bulletin</span><span> <strong>2016,</strong> <em>65 </em>
                                    (4)
                                     , 923-938. <a href="https://doi.org/10.1007/s11172-016-1394-z" title="DOI URL">https://doi.org/10.1007/s11172-016-1394-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11172-016-1394-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11172-016-1394-z%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Chemical%2520Bulletin%26atitle%3DTetrazoles%252Bwith%252Boxygen-%25252C%252Bsulfur-%25252C%252Band%252Bselenium-containing%252Bsubstituents%26aulast%3DMyznikov%26aufirst%3DL.%2BV.%26date%3D2016%26date%3D2017%26volume%3D65%26issue%3D4%26spage%3D923%26epage%3D938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessandra  Scotti</span>, <span class="hlFld-ContribAuthor ">Claudio  Trapella</span>, <span class="hlFld-ContribAuthor ">Valeria  Ferretti</span>, <span class="hlFld-ContribAuthor ">Eleonora  Gallerani</span>, <span class="hlFld-ContribAuthor ">Riccardo  Gavioli</span>, <span class="hlFld-ContribAuthor ">Mauro  Marastoni</span>. </span><span class="cited-content_cbyCitation_article-title">Studies of C-terminal naphthoquinone dipeptides as 20S proteasome inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2016,</strong> <em>42 </em>, 1-8. <a href="https://doi.org/10.3109/14756366.2015.1037749" title="DOI URL">https://doi.org/10.3109/14756366.2015.1037749</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3109/14756366.2015.1037749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3109%2F14756366.2015.1037749%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DStudies%252Bof%252BC-terminal%252Bnaphthoquinone%252Bdipeptides%252Bas%252B20S%252Bproteasome%252Binhibitors%26aulast%3DScotti%26aufirst%3DAlessandra%26date%3D2016%26date%3D2015%26volume%3D42%26spage%3D1%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tatyana A.  Grigoreva</span>, <span class="hlFld-ContribAuthor ">Vyacheslav G.  Tribulovich</span>, <span class="hlFld-ContribAuthor ">Alexander V.  Garabadzhiu</span>, <span class="hlFld-ContribAuthor ">Gerry  Melino</span>, <span class="hlFld-ContribAuthor ">Nickolai A.  Barlev</span>. </span><span class="cited-content_cbyCitation_article-title">The 26S proteasome is a multifaceted target for anti-cancer therapies. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2015,</strong> <em>6 </em>
                                    (28)
                                     , 24733-24749. <a href="https://doi.org/10.18632/oncotarget.4619" title="DOI URL">https://doi.org/10.18632/oncotarget.4619</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.4619&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.4619%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DThe%252B26S%252Bproteasome%252Bis%252Ba%252Bmultifaceted%252Btarget%252Bfor%252Banti-cancer%252Btherapies%26aulast%3DGrigoreva%26aufirst%3DTatyana%2BA.%26date%3D2015%26date%3D2015%26volume%3D6%26issue%3D28%26spage%3D24733%26epage%3D24749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jayme L.  Dahlin</span>, <span class="hlFld-ContribAuthor ">James  Inglese</span>, <span class="hlFld-ContribAuthor ">Michael A.  Walters</span>. </span><span class="cited-content_cbyCitation_article-title">Mitigating risk in academic preclinical drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Drug Discovery</span><span> <strong>2015,</strong> <em>14 </em>
                                    (4)
                                     , 279-294. <a href="https://doi.org/10.1038/nrd4578" title="DOI URL">https://doi.org/10.1038/nrd4578</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nrd4578&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnrd4578%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Drug%2520Discovery%26atitle%3DMitigating%252Brisk%252Bin%252Bacademic%252Bpreclinical%252Bdrug%252Bdiscovery%26aulast%3DDahlin%26aufirst%3DJayme%2BL.%26date%3D2015%26date%3D2015%26volume%3D14%26issue%3D4%26spage%3D279%26epage%3D294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jayme L  Dahlin</span>, <span class="hlFld-ContribAuthor ">Michael A  Walters</span>. </span><span class="cited-content_cbyCitation_article-title">The essential roles of chemistry in
              high-throughput screening
              triage. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2014,</strong> <em>6 </em>
                                    (11)
                                     , 1265-1290. <a href="https://doi.org/10.4155/fmc.14.60" title="DOI URL">https://doi.org/10.4155/fmc.14.60</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.14.60&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.14.60%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DThe%252Bessential%252Broles%252Bof%252Bchemistry%252Bin%252Bhigh-throughput%252Bscreening%252Btriage%26aulast%3DDahlin%26aufirst%3DJayme%2BL%26date%3D2014%26volume%3D6%26issue%3D11%26spage%3D1265%26epage%3D1290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Margiani P.  Fortes</span>, <span class="hlFld-ContribAuthor ">Mariana M.  Bassaco</span>, <span class="hlFld-ContribAuthor ">Teodoro S.  Kaufman</span>, <span class="hlFld-ContribAuthor ">Claudio C.  Silveira</span>. </span><span class="cited-content_cbyCitation_article-title">A convenient eco-friendly system for the synthesis of 5-sulfenyl tetrazole derivatives of indoles and pyrroles employing CeCl
              3
              ·7H
              2
              O in PEG-400. </span><span class="cited-content_cbyCitation_journal-name">RSC Adv.</span><span> <strong>2014,</strong> <em>4 </em>
                                    (65)
                                     , 34519-34530. <a href="https://doi.org/10.1039/C4RA05625F" title="DOI URL">https://doi.org/10.1039/C4RA05625F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4RA05625F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4RA05625F%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Adv.%26atitle%3DA%252Bconvenient%252Beco-friendly%252Bsystem%252Bfor%252Bthe%252Bsynthesis%252Bof%252B5-sulfenyl%252Btetrazole%252Bderivatives%252Bof%252Bindoles%252Band%252Bpyrroles%252Bemploying%252BCeCl%252B3%252B%2525C2%2525B77H%252B2%252BO%252Bin%252BPEG-400%26aulast%3DFortes%26aufirst%3DMargiani%2BP.%26date%3D2014%26date%3D2014%26volume%3D4%26issue%3D65%26spage%3D34519%26epage%3D34530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Megan M.  McCallum</span>, <span class="hlFld-ContribAuthor ">Premchendar  Nandhikonda</span>, <span class="hlFld-ContribAuthor ">Jonathan J.  Temmer</span>, <span class="hlFld-ContribAuthor ">Charles  Eyermann</span>, <span class="hlFld-ContribAuthor ">Anton  Simeonov</span>, <span class="hlFld-ContribAuthor ">Ajit  Jadhav</span>, <span class="hlFld-ContribAuthor ">Adam  Yasgar</span>, <span class="hlFld-ContribAuthor ">David  Maloney</span>, <span class="hlFld-ContribAuthor ">Alexander (Leggy)  Arnold</span>. </span><span class="cited-content_cbyCitation_article-title">High-Throughput Identification of Promiscuous Inhibitors from Screening Libraries with the Use of a Thiol-Containing Fluorescent Probe. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Screening</span><span> <strong>2013,</strong> <em>18 </em>
                                    (6)
                                     , 705-713. <a href="https://doi.org/10.1177/1087057113476090" title="DOI URL">https://doi.org/10.1177/1087057113476090</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/1087057113476090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F1087057113476090%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Screening%26atitle%3DHigh-Throughput%252BIdentification%252Bof%252BPromiscuous%252BInhibitors%252Bfrom%252BScreening%252BLibraries%252Bwith%252Bthe%252BUse%252Bof%252Ba%252BThiol-Containing%252BFluorescent%252BProbe%26aulast%3DMcCallum%26aufirst%3DMegan%2BM.%26date%3D2013%26date%3D2013%26volume%3D18%26issue%3D6%26spage%3D705%26epage%3D713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fuming  Xu</span>, <span class="hlFld-ContribAuthor ">Yuping  Jia</span>, <span class="hlFld-ContribAuthor ">Qingli  Wen</span>, <span class="hlFld-ContribAuthor ">Xuejian  Wang</span>, <span class="hlFld-ContribAuthor ">Lei  Zhang</span>, <span class="hlFld-ContribAuthor ">Yingjie  Zhang</span>, <span class="hlFld-ContribAuthor ">Kanghui  Yang</span>, <span class="hlFld-ContribAuthor ">Wenfang  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of N-(4-hydroxy-3-mercaptonaphthalen-1-yl)amides as inhibitors of angiogenesis and tumor growth. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>64 </em>, 377-388. <a href="https://doi.org/10.1016/j.ejmech.2013.03.043" title="DOI URL">https://doi.org/10.1016/j.ejmech.2013.03.043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2013.03.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2013.03.043%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252BN-%2525284-hydroxy-3-mercaptonaphthalen-1-yl%252529amides%252Bas%252Binhibitors%252Bof%252Bangiogenesis%252Band%252Btumor%252Bgrowth%26aulast%3DXu%26aufirst%3DFuming%26date%3D2013%26volume%3D64%26spage%3D377%26epage%3D388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuri  Pevzner</span>, <span class="hlFld-ContribAuthor ">Rainer  Metcalf</span>, <span class="hlFld-ContribAuthor ">Melanie  Kantor</span>, <span class="hlFld-ContribAuthor ">Desiree  Sagaro</span>, <span class="hlFld-ContribAuthor ">Kenyon  Daniel</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in proteasome inhibitor discovery. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2013,</strong> <em>8 </em>
                                    (5)
                                     , 537-568. <a href="https://doi.org/10.1517/17460441.2013.780020" title="DOI URL">https://doi.org/10.1517/17460441.2013.780020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/17460441.2013.780020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F17460441.2013.780020%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DRecent%252Badvances%252Bin%252Bproteasome%252Binhibitor%252Bdiscovery%26aulast%3DPevzner%26aufirst%3DYuri%26date%3D2013%26date%3D2013%26volume%3D8%26issue%3D5%26spage%3D537%26epage%3D568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/medium/jm-2011-01118h_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/large/jm-2011-01118h_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201118h&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/medium/jm-2011-01118h_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/large/jm-2011-01118h_0012.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of representative proteasome inhibitors: Bortezomib (clinically approved), Carfilzomib (in clinical trials), and the proteasome activity profile of the “hit” <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/large/jm-2011-01118h_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201118h&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/medium/jm-2011-01118h_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/large/jm-2011-01118h_0013.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. A. Proposed synthetic modifications around compound <b>1</b> (hit); B. side chain at 1-position to probe interactions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/large/jm-2011-01118h_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201118h&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/medium/jm-2011-01118h_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/large/jm-2011-01118h_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Hydronaphthoquinone Sulfonamide Scaffold<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/large/jm-2011-01118h_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201118h&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) thiophene-2-sulfonyl chloride, Et<sub>3</sub>N, dichloromethane, rt, 14 h, 90%; (b) for <b>4a</b>, (i) H<sub>2</sub>O<sub>2</sub> (35%), CH<sub>3</sub>OH, rt, 2 h, (ii) 4 M HCl/dioxane, rt, 2 h, 22%; for <b>4b</b>, Br<sub>2</sub>, Et<sub>3</sub>N, DMF, 0 °C to rt, 12–14 h, 36%, and for <b>4c</b>, I<sub>2</sub>, Et<sub>3</sub>N, DMF, 0 °C to rt, 12 h, 100%.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/medium/jm-2011-01118h_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/large/jm-2011-01118h_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Route to Compound 1 (Hit) and Derivatives of the Hit<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/large/jm-2011-01118h_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201118h&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) HS(CH<sub>2</sub>)<i><sub>n</sub></i>COOR<sup>1</sup> (R<sup>1</sup> = ethyl, <i>n</i> = 1 for <b>8a</b>, 89% and R<sup>1</sup> = methyl, <i>n</i> = 2 for <b>8b</b>, 94%), ethanol (2.5 mL/mmol), rt 0.5 h; (b) BrCH<sub>2</sub>COO<sup><i>t</i></sup>Bu, Ag<sub>2</sub>O, CHCl<sub>3</sub>, cat. KI, reflux under Ar, 36 h, 33%; (c) R<sup>2</sup>SO<sub>2</sub>NH<sub>2</sub>, TiCl<sub>4</sub>·2THF, Et<sub>3</sub>N, DCM, microwave, 60 °C, 5–20 min, 26–62%; (d) Na<sub>2</sub>S<sub>2</sub>O<sub>4</sub>, THF, 1 h, rt or EtOAc, H<sub>2</sub>O, rt 10 min, 59–93%; (e) oxone, H<sub>2</sub>O, acetone, rt, 12–14 h, 100%; (f) conc HCl/dioxane (1:1, 16 mL/mol), rt 3–36 h or microwave, 100 °C, 10 min, 54–97%.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/medium/jm-2011-01118h_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/large/jm-2011-01118h_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Optimized Synthetic Route to Hit and Final Compounds<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/large/jm-2011-01118h_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201118h&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) R<sup>1</sup>SO<sub>2</sub>NH<sub>2</sub>, TiCl<sub>4</sub>·2THF, or 1 M TiCL<sub>4</sub> in DCM, Et<sub>3</sub>N, THF, microwave, 60 °C, 15–30 min, 30–86%; (b) EtOH:DCM (1:1) for tetrazole-5-thiol, rt, 2 h, THF for 1-methyl-tetrazole-5-thiol or 3-mercapto-1,2,4-triazole, rt, 2 h, THF, 1 equiv pyridine for thioglycolic acid, rt, 10–30 min; (c) Na<sub>2</sub>S<sub>2</sub>O<sub>4</sub>, EtOAc, and H<sub>2</sub>O (mixing in a separating funnel), 54–100%; (d) NaN<sub>3</sub>, water, reflux 2 h, 67%; (e) TFA/anisole (5:1, 2 mL/mmol), microwave 100 °C, 2 h, 93%.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/medium/jm-2011-01118h_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/large/jm-2011-01118h_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of the Thioglycolic Acid Side Chain at 1-Position<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/large/jm-2011-01118h_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201118h&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 15 equiv Br(CH<sub>2</sub>)<i><sub>n</sub></i>COOR, 2 equiv DBU, DMF, microwave, 90 °C, 50–60 min, 51%; (b) conc HCl/dioxane (1:1, 20 mL/mmol), rt, 1–12 h, 50–80%; (c) Me<sub>2</sub>NCSCl, K<sub>2</sub>CO<sub>3</sub>, NMP, 50 °C, 2 h, 90%; (d) NMP, microwave, 180 °C, 20 min, 72%; (e) (i) 4 equiv KOH, CH<sub>3</sub>OH, inert conditions, rt, 12 h, (ii) BrCH<sub>2</sub>COOC(CH<sub>3</sub>)<sub>3,</sub> rt, 12 h, 86%; (f) H-Cube, H<sub>2</sub> (40 bar, 25 °C), Pd/C (10%), CH<sub>3</sub>OH, flow rate 1 mL/min, 100%; (g) (i) pyridine, THF/H<sub>2</sub>O (4:1), 0 °C, (ii) thiophene-2-sulfonyl chloride, 0 °C → rt, 4 h, 58%.</p></p></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/medium/jm-2011-01118h_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/large/jm-2011-01118h_0014.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Stability assessment of compounds <b>1</b>, <b>15k</b>, and <b>39</b> in biological medium (DMEM and RPMI-1640) up to 7 days.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/large/jm-2011-01118h_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201118h&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/medium/jm-2011-01118h_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/large/jm-2011-01118h_0015.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effects of compound <b>39</b> on proteasomal CT-L activity, ubiquitination, and tumor cell viability in human breast cancer MDA-MB-468 cells. Exponentially growing human breast cancer cells were treated with different concentrations of compound <b>39</b> for 11 h, followed by measurement of CT-L activity in whole cell extracts (A), determination of ubiquitination by Western blot analysis (B), and cell viability as measured by MTT assay (C).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/large/jm-2011-01118h_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201118h&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/medium/jm-2011-01118h_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/large/jm-2011-01118h_0001.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Recovery of CT-L activity upon dialysis of the 20S proteasome–compound complexes after preincubation with Bortezomib (▲), compound <b>39</b> (■), and compound <b>1</b> (●).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201118h/production/images/large/jm-2011-01118h_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201118h&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i103">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72736" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72736" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 36 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Pickart, C. M.</span><span> </span><span class="NLM_article-title">Back to the future with ubiquitin</span> <span class="citation_source-journal">Cell (Cambridge, MA, U.S.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">190</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm201118h&amp;key=10.1016%2FS0092-8674%2803%2901074-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm201118h&amp;key=14744430" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm201118h&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtValsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2004&pages=181-190&author=C.+M.+Pickart&title=Back+to+the+future+with+ubiquitin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Back to the future with ubiquitin</span></div><div class="casAuthors">Pickart, Cecile M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">181-190</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review and discussion.  Two papers published in 1984 by A. Varshavsky and coworkers revealed that the ubiquitin/proteasome pathway is the principal system for the degrdn. of short-lived proteins in mammalian cells, setting the stage for future demonstrations of this pathway's many regulatory roles.  This perspective discusses the impact of those papers and highlights some of the subsequent insights that have led to the current appreciation of the breadth of ubiquitin-mediated signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMf20W4nwasbVg90H21EOLACvtfcHk0ljYru6r5cpC_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtValsrg%253D&md5=ee82d114a69232e304cf3eda29b49971</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2803%2901074-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252803%252901074-2%26sid%3Dliteratum%253Aachs%26aulast%3DPickart%26aufirst%3DC.%2BM.%26atitle%3DBack%2520to%2520the%2520future%2520with%2520ubiquitin%26jtitle%3DCell%2520%2528Cambridge%252C%2520MA%252C%2520U.S.%2529%26date%3D2004%26volume%3D116%26spage%3D181%26epage%3D190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Ciechanover, A.</span><span> </span><span class="NLM_article-title">Intracellular protein degradation: from a vague idea, through the lysosome and the ubiquitin proteasome system, and onto human diseases and drug targeting (Nobel lecture)</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">5944</span><span class="NLM_x">–</span> <span class="NLM_lpage">5967</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=5944-5967&author=A.+Ciechanover&title=Intracellular+protein+degradation%3A+from+a+vague+idea%2C+through+the+lysosome+and+the+ubiquitin+proteasome+system%2C+and+onto+human+diseases+and+drug+targeting+%28Nobel+lecture%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCiechanover%26aufirst%3DA.%26atitle%3DIntracellular%2520protein%2520degradation%253A%2520from%2520a%2520vague%2520idea%252C%2520through%2520the%2520lysosome%2520and%2520the%2520ubiquitin%2520proteasome%2520system%252C%2520and%2520onto%2520human%2520diseases%2520and%2520drug%2520targeting%2520%2528Nobel%2520lecture%2529%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2005%26volume%3D44%26spage%3D5944%26epage%3D5967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Hershko, A.</span><span> </span><span class="NLM_article-title">The ubiquitin system for protein degradation and some of its roles in the control of the cell-division cycle (Nobel lecture)</span> <span class="citation_source-journal">Angew. Chem., Int. Ed. Engl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">5932</span><span class="NLM_x">–</span> <span class="NLM_lpage">5943</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=5932-5943&author=A.+Hershko&title=The+ubiquitin+system+for+protein+degradation+and+some+of+its+roles+in+the+control+of+the+cell-division+cycle+%28Nobel+lecture%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHershko%26aufirst%3DA.%26atitle%3DThe%2520ubiquitin%2520system%2520for%2520protein%2520degradation%2520and%2520some%2520of%2520its%2520roles%2520in%2520the%2520control%2520of%2520the%2520cell-division%2520cycle%2520%2528Nobel%2520lecture%2529%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%2520Engl.%26date%3D2005%26volume%3D44%26spage%3D5932%26epage%3D5943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Rose, I.</span><span> </span><span class="NLM_article-title">Ubiquitin at fox chase</span> <span class="citation_source-journal">Prix Nobel</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_fpage">218</span><span class="NLM_x">–</span> <span class="NLM_lpage">225</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm201118h&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1egur3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&pages=218-225&author=I.+Rose&title=Ubiquitin+at+fox+chase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Ubiquitin at fox chase</span></div><div class="casAuthors">Rose, Irwin</div><div class="citationInfo"><span class="NLM_cas:title">Prix Nobel</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">218-225</span>CODEN:
                <span class="NLM_cas:coden">PRIXAL</span>;
        ISSN:<span class="NLM_cas:issn">0546-8175</span>.
    
            (<span class="NLM_cas:orgname">Almqvist & Wiksell International</span>)
        </div><div class="casAbstract">A review.  A Nobel lecture by Irwin Rose, discussing primarily ubiquitin, the ubiquitin activating enzyme, the discovery and mechanism of ubiquitin-carboxy terminal hydrolase, and unresolved issues in ubiquitin, is presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVt5Oeryc5PLVg90H21EOLACvtfcHk0lib_HDw0r0UjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1egur3I&md5=ddc72993972f9f5e5889a6bd521ca8eb</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRose%26aufirst%3DI.%26atitle%3DUbiquitin%2520at%2520fox%2520chase%26jtitle%3DPrix%2520Nobel%26date%3D2005%26spage%3D218%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Verdoes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Florea, B. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Marel, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overkleeft, H. S.</span><span> </span><span class="NLM_article-title">Chemical Tools To Study the Proteasome</span> <span class="citation_source-journal">Eur. J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_fpage">3301</span><span class="NLM_x">–</span> <span class="NLM_lpage">3313</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=3301-3313&author=M.+Verdoesauthor=B.+I.+Floreaauthor=G.+A.+van+der+Marelauthor=H.+S.+Overkleeft&title=Chemical+Tools+To+Study+the+Proteasome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVerdoes%26aufirst%3DM.%26aulast%3DFlorea%26aufirst%3DB.%2BI.%26aulast%3Dvan%2Bder%2BMarel%26aufirst%3DG.%2BA.%26aulast%3DOverkleeft%26aufirst%3DH.%2BS.%26atitle%3DChemical%2520Tools%2520To%2520Study%2520the%2520Proteasome%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2009%26spage%3D3301%26epage%3D3313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_contrib-group">Ciechanover, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, A. L.</span><span> </span><span class="NLM_article-title">The ubiquitin–proteasome pathway: the complexity and myriad functions of proteins death</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">2727</span><span class="NLM_x">–</span> <span class="NLM_lpage">2730</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=2727-2730&author=A.+Ciechanoverauthor=A.+L.+Schwartz&title=The+ubiquitin%E2%80%93proteasome+pathway%3A+the+complexity+and+myriad+functions+of+proteins+death"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCiechanover%26aufirst%3DA.%26aulast%3DSchwartz%26aufirst%3DA.%2BL.%26atitle%3DThe%2520ubiquitin%25E2%2580%2593proteasome%2520pathway%253A%2520the%2520complexity%2520and%2520myriad%2520functions%2520of%2520proteins%2520death%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1998%26volume%3D95%26spage%3D2727%26epage%3D2730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_contrib-group">Ciechanover, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz Alan, L.</span><span> </span><span class="NLM_article-title">Ubiquitin-mediated degradation of cellular proteins in health and disease</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2002&pages=3-6&author=A.+Ciechanoverauthor=L.+Schwartz+Alan&title=Ubiquitin-mediated+degradation+of+cellular+proteins+in+health+and+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCiechanover%26aufirst%3DA.%26aulast%3DSchwartz%2BAlan%26aufirst%3DL.%26atitle%3DUbiquitin-mediated%2520degradation%2520of%2520cellular%2520proteins%2520in%2520health%2520and%2520disease%26jtitle%3DHepatology%26date%3D2002%26volume%3D35%26spage%3D3%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_contrib-group">King, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshaies, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirschner, M. W.</span><span> </span><span class="NLM_article-title">How proteolysis drives the cell cycle</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">1652</span><span class="NLM_x">–</span> <span class="NLM_lpage">1658</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1996&pages=1652-1658&author=R.+W.+Kingauthor=R.+J.+Deshaiesauthor=J.-M.+Petersauthor=M.+W.+Kirschner&title=How+proteolysis+drives+the+cell+cycle"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKing%26aufirst%3DR.%2BW.%26aulast%3DDeshaies%26aufirst%3DR.%2BJ.%26aulast%3DPeters%26aufirst%3DJ.-M.%26aulast%3DKirschner%26aufirst%3DM.%2BW.%26atitle%3DHow%2520proteolysis%2520drives%2520the%2520cell%2520cycle%26jtitle%3DScience%26date%3D1996%26volume%3D274%26spage%3D1652%26epage%3D1658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_contrib-group">Adams, J.</span><span> </span><span class="NLM_article-title">The development of proteasome inhibitors as anticancer drugs</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">417</span><span class="NLM_x">–</span> <span class="NLM_lpage">421</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Fjm201118h&amp;key=10.1016%2FS1535-6108%2804%2900120-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Fjm201118h&amp;key=15144949" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Fjm201118h&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksFCmt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=417-421&author=J.+Adams&title=The+development+of+proteasome+inhibitors+as+anticancer+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The development of proteasome inhibitors as anticancer drugs</span></div><div class="casAuthors">Adams, Julian</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">417-421</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The ubiquitin-proteasome pathway plays a central role in the targeted destruction of cellular proteins, including cell cycle regulatory proteins.  Because these pathways are crit. for the proliferation and survival of all cells, and in particular cancerous cells, proteasome inhibition is a potentially attractive anticancer therapy.  Based on encouraging cytotoxic activity, bortezomib was the first proteasome inhibitor to be evaluated in clin. trials.  Efficacy and safety results from a phase 2 clin. trial contributed to approval of bortezomib for use in patients with relapsed and refractory multiple myeloma who have received at least 2 prior therapies and have demonstrated disease progression on their last therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozXYZQ-zxJdbVg90H21EOLACvtfcHk0lgrYNoaeKvlwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksFCmt7s%253D&md5=9a070d342533a3b6108150c40852834e</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1016%2FS1535-6108%2804%2900120-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1535-6108%252804%252900120-5%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DJ.%26atitle%3DThe%2520development%2520of%2520proteasome%2520inhibitors%2520as%2520anticancer%2520drugs%26jtitle%3DCancer%2520Cell%26date%3D2004%26volume%3D5%26spage%3D417%26epage%3D421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Rajkumar, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hideshima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. C.</span><span> </span><span class="NLM_article-title">Proteasome inhibition as a novel therapeutic target in human cancer</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">630</span><span class="NLM_x">–</span> <span class="NLM_lpage">639</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm201118h&amp;key=10.1200%2FJCO.2005.11.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm201118h&amp;key=15659509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm201118h&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitVartb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=630-639&author=S.+V.+Rajkumarauthor=P.+G.+Richardsonauthor=T.+Hideshimaauthor=K.+C.+Anderson&title=Proteasome+inhibition+as+a+novel+therapeutic+target+in+human+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Proteasome inhibition as a novel therapeutic target in human cancer</span></div><div class="casAuthors">Rajkumar, S. Vincent; Richardson, Paul G.; Hideshima, Teru; Anderson, Kenneth C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">630-639</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">A review.  The 26S proteasome is a large intracellular ATP-dependent protease that identifies and degrades proteins tagged for destruction by the ubiquitin system.  The orderly degrdn. of cellular proteins is crit. for normal cell cycling and function, and inhibition of the proteasome pathway results in cell-cycle arrest and apoptosis.  Dysregulation of this enzymic system may also play a role in tumor progression, drug resistance, and altered immune surveillance, making the proteasome an appropriate and novel therapeutic target in cancer.  Bortezomib (formerly known as PS-341) is the first proteasome inhibitor to enter clin. practice.  It is a boronic aid dipeptide that binds directly with and inhibits the enzymic complex.  Bortezomib has recently shown significant preclin. and clin. activity in several cancers, confirming the therapeutic value of proteasome inhibition in human malignancy.  It was approved in 2003 for the treatment of advanced multiple myeloma (MM), with approx. one third of patients with relapsed and refractory MM showing significant clin. benefit in a large clin. trial.  Its mechanism of action is partly mediated through nuclear factor-kappa B inhibition, resulting in apoptosis, decreased angiogenic cytokine expression, and inhibition of tumor cell adhesion to stroma.  Addnl. mechanisms include c-Jun N-terminal kinase activation and effects on growth factor expression.  Several clin. trials are currently ongoing in MM as well as several other malignancies.  This article discusses proteasome inhibition as a novel therapeutic target in cancer and focuses on the development, mechanism of action, and current clin. experience with bortezomib.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRgZ_Crd9Ut7Vg90H21EOLACvtfcHk0lh-4qn5eUkTew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitVartb0%253D&md5=5e8050b9dbbaf3192051c21f10bf8bb4</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1200%2FJCO.2005.11.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2005.11.030%26sid%3Dliteratum%253Aachs%26aulast%3DRajkumar%26aufirst%3DS.%2BV.%26aulast%3DRichardson%26aufirst%3DP.%2BG.%26aulast%3DHideshima%26aufirst%3DT.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26atitle%3DProteasome%2520inhibition%2520as%2520a%2520novel%2520therapeutic%2520target%2520in%2520human%2520cancer%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2005%26volume%3D23%26spage%3D630%26epage%3D639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Chauhan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hideshima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. C.</span><span> </span><span class="NLM_article-title">Proteasome inhibition in multiple myeloma: therapeutic implication</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">465</span><span class="NLM_x">–</span> <span class="NLM_lpage">476</span><div class="note"><p class="first last">2 plates.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2005&pages=465-476&author=D.+Chauhanauthor=T.+Hideshimaauthor=K.+C.+Anderson&title=Proteasome+inhibition+in+multiple+myeloma%3A+therapeutic+implication"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChauhan%26aufirst%3DD.%26aulast%3DHideshima%26aufirst%3DT.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26atitle%3DProteasome%2520inhibition%2520in%2520multiple%2520myeloma%253A%2520therapeutic%2520implication%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2005%26volume%3D45%26spage%3D465%26epage%3D476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Papandreou, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daliani, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nix, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madden, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pien, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Millikan, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, S.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pagliaro, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esseltine, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrusich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dieringer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logothetis, C. J.</span><span> </span><span class="NLM_article-title">Phase I trial of the proteasome inhibitor bortezomib in patients with advanced solid tumors with observations in androgen-independent prostate cancer</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2108</span><span class="NLM_x">–</span> <span class="NLM_lpage">2121</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm201118h&amp;key=10.1200%2FJCO.2004.02.106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm201118h&amp;key=15169797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm201118h&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpsVWlsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2004&pages=2108-2121&author=C.+N.+Papandreouauthor=D.+Dalianiauthor=D.+Nixauthor=H.+Yangauthor=T.+Maddenauthor=X.+Wangauthor=C.+S.+Pienauthor=R.+E.+Millikanauthor=S.-M.+Tuauthor=L.+Pagliaroauthor=J.+Kimauthor=J.+Adamsauthor=P.+Elliottauthor=D.+Esseltineauthor=A.+Petrusichauthor=P.+Dieringerauthor=C.+Perezauthor=C.+J.+Logothetis&title=Phase+I+trial+of+the+proteasome+inhibitor+bortezomib+in+patients+with+advanced+solid+tumors+with+observations+in+androgen-independent+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I trial of the proteasome inhibitor bortezomib in patients with advanced solid tumors with observations in androgen-independent prostate cancer</span></div><div class="casAuthors">Papandreou, Christos N.; Daliani, D.; Nix, Darrell; Yang, Hong; Madden, Timothy; Wang, Xuemei; Pien, Christine S.; Millikan, Randall E.; Tu, Shi-Ming; Pagliaro, Lance; Kim, Jeri; Adams, Julian; Elliott, Peter; Esseltine, Dixie; Petrusich, Alexandria; Dieringer, Pauline; Perez, Cherie; Logothetis, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2108-2121</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">The aim was to det. the dose-limiting toxicity and max.-tolerated dose of the proteasome inhibitor bortezomib administered i.v. weekly for 4 every 5 wk; to det. the bortezomib pharmacokinetics and pharmacodynamics using plasma levels and an assay for 20S proteasome inhibition (PI) in whole blood to correlate toxicity with bortezomib dose and degree of 20S PI; and to conduct a preliminary detn. of the antitumor activity of bortezomib in patients with androgen independent prostate cancer (AlPCa).  Fifty-three patients (48 with AlPCa) received 128 cycles of bortezomib in doses ranging from 0.13 to 2.0 mg/m2/dose, utilizing a careful escalation scheme with a continuous reassessment method.  Pharmacokinetic and pharmacodynamic studies were performed in 24 patients (at 1.45 to 2.0 mg/m2).  A dose-related 20S PI was seen, with dose-limiting toxicity at 2.0 mg/m2 (diarrhea, hypotension) occurring at an av. 1-h post-dose of ≥ 75% 20S PI.  Other side effects were fatigue, hypertension, constipation, nausea, and vomiting.  No relationship was seen between body-surface area and bortezomib clearance over the narrow dose range tested.  There was evidence of biol. activity (decline in serum prostate-specific antigen and interleukin-6 levels) at ≥ 50% 20S PI.  Two patients with AlPCa had prostate-specific antigen response and two patients had partial response in lymph nodes.  The max.-tolerated dose and recommended phase II dose of bortezomib in this schedule is 1.6 mg/m2.  Biol. activity (inhibition of nuclear factor-kappa B-related markers) and antitumor activity is seen in AlPCa at tolerated doses of bortezomib.  This agent should be further explored with chemotherapy agents in advanced prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaqizw4wtYNbVg90H21EOLACvtfcHk0lh-4qn5eUkTew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpsVWlsLc%253D&md5=17d7f5c54be7e1fce7faa303c1a53036</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1200%2FJCO.2004.02.106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2004.02.106%26sid%3Dliteratum%253Aachs%26aulast%3DPapandreou%26aufirst%3DC.%2BN.%26aulast%3DDaliani%26aufirst%3DD.%26aulast%3DNix%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DMadden%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DPien%26aufirst%3DC.%2BS.%26aulast%3DMillikan%26aufirst%3DR.%2BE.%26aulast%3DTu%26aufirst%3DS.-M.%26aulast%3DPagliaro%26aufirst%3DL.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DElliott%26aufirst%3DP.%26aulast%3DEsseltine%26aufirst%3DD.%26aulast%3DPetrusich%26aufirst%3DA.%26aulast%3DDieringer%26aufirst%3DP.%26aulast%3DPerez%26aufirst%3DC.%26aulast%3DLogothetis%26aufirst%3DC.%2BJ.%26atitle%3DPhase%2520I%2520trial%2520of%2520the%2520proteasome%2520inhibitor%2520bortezomib%2520in%2520patients%2520with%2520advanced%2520solid%2520tumors%2520with%2520observations%2520in%2520androgen-independent%2520prostate%2520cancer%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2004%26volume%3D22%26spage%3D2108%26epage%3D2121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Palombella, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conner, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuseler, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Destree, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laroux, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brand, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazarus, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCormack, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parent, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grisham, M. B.</span><span> </span><span class="NLM_article-title">Role of the proteasome and NF-kB in streptococcal cell wall-induced polyarthritis</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">15671</span><span class="NLM_x">–</span> <span class="NLM_lpage">15676</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=15671-15676&author=V.+J.+Palombellaauthor=E.+M.+Connerauthor=J.+W.+Fuselerauthor=A.+Destreeauthor=J.+M.+Davisauthor=F.+S.+Larouxauthor=R.+E.+Wolfauthor=J.+Huangauthor=S.+Brandauthor=P.+J.+Elliottauthor=D.+Lazarusauthor=T.+McCormackauthor=L.+Parentauthor=R.+Steinauthor=J.+Adamsauthor=M.+B.+Grisham&title=Role+of+the+proteasome+and+NF-kB+in+streptococcal+cell+wall-induced+polyarthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPalombella%26aufirst%3DV.%2BJ.%26aulast%3DConner%26aufirst%3DE.%2BM.%26aulast%3DFuseler%26aufirst%3DJ.%2BW.%26aulast%3DDestree%26aufirst%3DA.%26aulast%3DDavis%26aufirst%3DJ.%2BM.%26aulast%3DLaroux%26aufirst%3DF.%2BS.%26aulast%3DWolf%26aufirst%3DR.%2BE.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DBrand%26aufirst%3DS.%26aulast%3DElliott%26aufirst%3DP.%2BJ.%26aulast%3DLazarus%26aufirst%3DD.%26aulast%3DMcCormack%26aufirst%3DT.%26aulast%3DParent%26aufirst%3DL.%26aulast%3DStein%26aufirst%3DR.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DGrisham%26aufirst%3DM.%2BB.%26atitle%3DRole%2520of%2520the%2520proteasome%2520and%2520NF-kB%2520in%2520streptococcal%2520cell%2520wall-induced%2520polyarthritis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1998%26volume%3D95%26spage%3D15671%26epage%3D15676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maldonado, M. A.</span><span> </span><span class="NLM_article-title">The ubiquitin–proteasome system and its role in inflammatory and autoimmune diseases</span> <span class="citation_source-journal">Cell. Mol. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">255</span><span class="NLM_x">–</span> <span class="NLM_lpage">261</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=8&amp;doi=10.1021%2Fjm201118h&amp;key=16978533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=32&amp;doi=10.1021%2Fjm201118h&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFOnurvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=255-261&author=J.+Wangauthor=M.+A.+Maldonado&title=The+ubiquitin%E2%80%93proteasome+system+and+its+role+in+inflammatory+and+autoimmune+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12aR"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The ubiquitin-proteasome system and its role in inflammatory and autoimmune diseases</span></div><div class="casAuthors">Wang, Jingsong; Maldonado, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular & Molecular Immunology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">255-261</span>CODEN:
                <span class="NLM_cas:coden">CMIEAO</span>;
        ISSN:<span class="NLM_cas:issn">1672-7681</span>.
    
            (<span class="NLM_cas:orgname">Chinese Society of Immunology</span>)
        </div><div class="casAbstract">A review.  Protein degrdn. through the ubiquitin-proteasome system is the major pathway of non-lysosomal proteolysis of intracellular proteins.  It plays important roles in a variety of fundamental cellular processes such as regulation of cell cycle progression, division, development and differentiation, apoptosis, cell trafficking, and modulation of the immune and inflammatory responses.  The central element of this system is the covalent linkage of ubiquitin to targeted proteins, which are then recognized by the 26S proteasome, an ATP-dependent, multi-catalytic protease.  Damaged, oxidized, or misfolded proteins as well as regulatory proteins that control many crit. cellular functions are among the targets of this degrdn. process.  Aberration of this system leads to the dysregulation of cellular homeostasis and the development of multiple diseases.  In this review, we described the basic biochem. and mol. biol. of the ubiquitin-proteasome system, and its complex role in the development of inflammatory and autoimmune diseases.  In addn., therapies and potential therapeutic targets related to the ubiquitin-proteasome system are discussed as well.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqDi3IlXwNXLVg90H21EOLACvtfcHk0lhqx40Jck9kyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFOnurvJ&md5=1fab2d99f7399a8909ba88aaca70b7f5</span></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DMaldonado%26aufirst%3DM.%2BA.%26atitle%3DThe%2520ubiquitin%25E2%2580%2593proteasome%2520system%2520and%2520its%2520role%2520in%2520inflammatory%2520and%2520autoimmune%2520diseases%26jtitle%3DCell.%2520Mol.%2520Immunol.%26date%3D2006%26volume%3D3%26spage%3D255%26epage%3D261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_contrib-group">Meng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwok, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crews, C. M.</span><span> </span><span class="NLM_article-title">Eponemycin exerts its antitumor effect through the inhibition of proteasome function</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">2798</span><span class="NLM_x">–</span> <span class="NLM_lpage">2801</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=8&amp;doi=10.1021%2Fjm201118h&amp;key=10383134" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=32&amp;doi=10.1021%2Fjm201118h&amp;key=1%3ACAS%3A528%3ADyaK1MXktVOkurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=2798-2801&author=L.+Mengauthor=B.+H.+Kwokauthor=N.+Sinauthor=C.+M.+Crews&title=Eponemycin+exerts+its+antitumor+effect+through+the+inhibition+of+proteasome+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12bR"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Eponemycin exerts its antitumor effect through the inhibition of proteasome function</span></div><div class="casAuthors">Meng, Lihao; Kwok, Benjamin H. B.; Sin, Ny; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2798-2801</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">AACR Subscription Office</span>)
        </div><div class="casAbstract">Cell cycle progression requires the proteasome-mediated degrdn. of key regulatory proteins such as cyclins, cyclin-dependent kinase inhibitors, and anaphase-inhibitory proteins.  Given the central role of the proteasome in the destruction of these proteins, proteasome inhibition has been proposed as a possible cancer therapy.  We report here that dihydroeponemycin, an analog of the antitumor and antiangiogenic natural; product eponemycin, selectively targets the 20S proteasome.  Dihydroeponemycin covalently modifies a subset of catalytic proteasomal subunit binding preferentially to the IFN-γ-inducible subunits LMP2 and LMP7; moreover, the three major peptidolytic activities of the proteasome are inhibited by dihydroeponemycin at different rates.  In addn., dihydroeponemycin-mediated proteasome inhibition induces a spindle-like cellular morphol. change and apoptosis.  These results validate the proteasome as a target for antitumor pharmacol. intervention and are relevant for the design of novel chemotherapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoG883WuBcePrVg90H21EOLACvtfcHk0lhqx40Jck9kyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXktVOkurw%253D&md5=6982bd97c90a3d9d3905eaa0f274133b</span></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DL.%26aulast%3DKwok%26aufirst%3DB.%2BH.%26aulast%3DSin%26aufirst%3DN.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DEponemycin%2520exerts%2520its%2520antitumor%2520effect%2520through%2520the%2520inhibition%2520of%2520proteasome%2520function%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26spage%3D2798%26epage%3D2801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Groll, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kairies, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crews, C. M.</span><span> </span><span class="NLM_article-title">Crystal structure of epoxomicin:20S proteasome reveals a molecular basis for selectivity of a′,b′-epoxyketone proteasome inhibitors</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">1237</span><span class="NLM_x">–</span> <span class="NLM_lpage">1238</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja993588m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2000&pages=1237-1238&author=M.+Grollauthor=K.+B.+Kimauthor=N.+Kairiesauthor=R.+Huberauthor=C.+M.+Crews&title=Crystal+structure+of+epoxomicin%3A20S+proteasome+reveals+a+molecular+basis+for+selectivity+of+a%E2%80%B2%2Cb%E2%80%B2-epoxyketone+proteasome+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fja993588m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja993588m%26sid%3Dliteratum%253Aachs%26aulast%3DGroll%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DK.%2BB.%26aulast%3DKairies%26aufirst%3DN.%26aulast%3DHuber%26aufirst%3DR.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DCrystal%2520structure%2520of%2520epoxomicin%253A20S%2520proteasome%2520reveals%2520a%2520molecular%2520basis%2520for%2520selectivity%2520of%2520a%25E2%2580%25B2%252Cb%25E2%2580%25B2-epoxyketone%2520proteasome%2520inhibitors%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2000%26volume%3D122%26spage%3D1237%26epage%3D1238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Groll, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McArthur Katherine, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macherla Venkat, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manam Rama, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potts Barbara, C.</span><span> </span><span class="NLM_article-title">Snapshots of the fluorosalinosporamide/20S complex offer mechanistic insights for fine tuning proteasome inhibition</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">5420</span><span class="NLM_x">–</span> <span class="NLM_lpage">5428</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900559x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5420-5428&author=M.+Grollauthor=A.+McArthur+Katherineauthor=R.+Macherla+Venkatauthor=R.+Manam+Ramaauthor=C.+Potts+Barbara&title=Snapshots+of+the+fluorosalinosporamide%2F20S+complex+offer+mechanistic+insights+for+fine+tuning+proteasome+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm900559x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900559x%26sid%3Dliteratum%253Aachs%26aulast%3DGroll%26aufirst%3DM.%26aulast%3DMcArthur%2BKatherine%26aufirst%3DA.%26aulast%3DMacherla%2BVenkat%26aufirst%3DR.%26aulast%3DManam%2BRama%26aufirst%3DR.%26aulast%3DPotts%2BBarbara%26aufirst%3DC.%26atitle%3DSnapshots%2520of%2520the%2520fluorosalinosporamide%252F20S%2520complex%2520offer%2520mechanistic%2520insights%2520for%2520fine%2520tuning%2520proteasome%2520inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5420%26epage%3D5428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Kisselev, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, A. L.</span><span> </span><span class="NLM_article-title">Proteasome inhibitors: from research tools to drug candidates</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">739</span><span class="NLM_x">–</span> <span class="NLM_lpage">758</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm201118h&amp;key=10.1016%2FS1074-5521%2801%2900056-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm201118h&amp;key=11514224" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm201118h&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmtV2ku7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2001&pages=739-758&author=A.+F.+Kisselevauthor=A.+L.+Goldberg&title=Proteasome+inhibitors%3A+from+research+tools+to+drug+candidates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Proteasome inhibitors: from research tools to drug candidates</span></div><div class="casAuthors">Kisselev, A. F.; Goldberg, A. L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">739-758</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  The 26S proteasome is a 2.4 MDa multifunctional ATP-dependent proteolytic complex, which degrades the majority of cellular polypeptides by an unusual enzyme mechanism.  Several groups of proteasome inhibitors have been developed and are now widely used as research tools to study the role of the ubiquitin-proteasome pathway in various cellular processes, and two inhibitors are now in clin. trials for treatment of multiple cancers and stroke.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTXBSmAzp9vLVg90H21EOLACvtfcHk0lhKtdR0qRVxPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmtV2ku7g%253D&md5=b729e5f56c402172aca5b139df61c09e</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2801%2900056-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252801%252900056-4%26sid%3Dliteratum%253Aachs%26aulast%3DKisselev%26aufirst%3DA.%2BF.%26aulast%3DGoldberg%26aufirst%3DA.%2BL.%26atitle%3DProteasome%2520inhibitors%253A%2520from%2520research%2520tools%2520to%2520drug%2520candidates%26jtitle%3DChem.%2520Biol.%26date%3D2001%26volume%3D8%26spage%3D739%26epage%3D758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Meiners, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludwig, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stangl, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stangl, K.</span><span> </span><span class="NLM_article-title">Proteasome inhibitors: poisons and remedies</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">309</span><span class="NLM_x">–</span> <span class="NLM_lpage">327</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm201118h&amp;key=10.1002%2Fmed.20111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm201118h&amp;key=17880010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm201118h&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjsVerurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=309-327&author=S.+Meinersauthor=A.+Ludwigauthor=V.+Stanglauthor=K.+Stangl&title=Proteasome+inhibitors%3A+poisons+and+remedies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Proteasome inhibitors: Poisons and remedies</span></div><div class="casAuthors">Meiners, Silke; Ludwig, Antje; Stangl, Verena; Stangl, Karl</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">309-327</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  The proteasome inhibitor bortezomib has been approved as a cytostatic drug for the therapy of multiple myeloma, and is currently being tested in clin. trials for a variety of other malignancies.  At the same time, a growing no. of animal studies suggest that proteasome inhibitors may also prove to be valuable remedies for the treatment of non-tumorous diseases.  In this review, we will revisit the current applications of proteasome inhibitors in clin. research according to the cellular effects of proteasome inhibitors as poisons, which induce apoptosis, or as remedies, which modulate cellular function and protect from cell death.  We postulate that the correct distinction of a poison from a remedy depends on cell type and on the degree of proteasome inhibition.  Dose-dependent and differential inhibition of the proteasome may affect specific sets of substrates, thereby conferring substrate specificity.  According to this idea, we suggest that inhibition of the proteasome to a defined degree may offer a promising tool in achieving desired therapeutic effects in various diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozQOBlMYqIb7Vg90H21EOLACvtfcHk0lgDe6vg64bl2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjsVerurY%253D&md5=29702cf59aeec6452d5b2c91bb647814</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1002%2Fmed.20111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20111%26sid%3Dliteratum%253Aachs%26aulast%3DMeiners%26aufirst%3DS.%26aulast%3DLudwig%26aufirst%3DA.%26aulast%3DStangl%26aufirst%3DV.%26aulast%3DStangl%26aufirst%3DK.%26atitle%3DProteasome%2520inhibitors%253A%2520poisons%2520and%2520remedies%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2008%26volume%3D28%26spage%3D309%26epage%3D327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Fuchs, O.</span><span> </span><span class="NLM_article-title">Proteasome inhibition as a therapeutic strategy in patients with multiple myeloma</span> <span class="citation_source-journal">Mult. Myeloma</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">125</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm201118h&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntlOmtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=101-125&author=O.+Fuchs&title=Proteasome+inhibition+as+a+therapeutic+strategy+in+patients+with+multiple+myeloma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Proteasome inhibition as a therapeutic strategy in patients with multiple myeloma</span></div><div class="casAuthors">Fuchs, Ota</div><div class="citationInfo"><span class="NLM_cas:title">Multiple Myeloma</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">101-125</span>CODEN:
                <span class="NLM_cas:coden">69MVM2</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Nova Science Publishers, Inc.</span>)
        </div><div class="casAbstract">A review.  Multiple myeloma (MM) is the second most frequent hematol. malignancy and remains fatal despite all available therapies, because of chemotherapeutic resistance.  Novel targeted drugs for the treatment of MM are therefore needed to improve outcome of MM patients.  Bortezomib (PS-341, Velcade; Millennium Pharmaceuticals, Cambridge MA), a dipeptidyl boronic acid that reversibly inhibits the chymotrypsin-like activity in the 20S core of the 26S mammalian proteasome, is the first proteasome inhibitor that was approved by the US Food and Drug Administration (FDA) and the European Agency for the Evaluation of Medicinal Products (EMEA) for patients with relapsed and refractory MM who had received at least one prior therapy and who had already undergone or are unsuitable for the transplantation of bone marrow.  Phase I-III trials based on previous preclin. studies showed very good antimyeloma activity.  Bortezomib acts by disrupting various cell signaling pathways, thereby leading to cell cycle arrest, apoptosis, and inhibition of angiogenesis.  The main action of bortezomib is the inhibition of the key transcription factor, nuclear factor-kappaB (NF-κB) activation.  Activation of NF-κB has been noted in MM cells.  Bortezomib interferes with NF-κB-mediated cell survival, tumor growth and angiogenesis.  Several studies have shown that cancer cells are more sensitive than normal cells to the proapoptotic effects of bortezomib, perhaps due to their loss of checkpoint mechanisms for DNA repair.  The accumulation of misfolded proteins in the endoplasmic reticulum (ER) leads to the induction of the unfolded protein response, provoking apoptosis.  Proteasome inhibitors induce ER-mediated apoptosis.  The increased susceptibility of MM cells to ER stress is caused by the large amts. of Igs produced by MM cells.  The clin. success of bortezomib is encouraging.  Bortezomib is relatively well tolerated, causing manageable nonhematol. and hematol. toxicity.  However, the overall response rate was 40-50% and bortezomib resistance was also obsd.  Response rates may be improved with combination therapy (bortezomib with dexamethasone, thalidomide, lenalidomide, arsenic trioxide, cisplatin, doxorubicin, cyclophosphamide, etoposide or with melphalan and prednisone).  Clin. evaluation of addnl. proteasome inhibitors of the next generation with greater efficacy is also needed.  Three such proteasome inhibitors (carfilzomib, salinosporamide A and threonine boronic acid-derived proteasome inhibitor CEP-18770) have been recently tested in preclin. models of MM.  Carfilzomib (PR-171; Proteolix), an epoxyketone related to epoxomicin inhibits the chymotrypsin-like proteasome activity as bortezomib does.  However, carfilzomib is an irreversible inhibitor of all three proteasome proteolytic sites.  Salinosporamide A (NPI-0052), a compd. related to lactacystin binds irreversibly to the 20S proteasome and acts predominantly through caspase-8 activation.  CEP-18770 is a reversible inhibitor of the chymotrypsin-like proteasome activity as bortezomib but it inhibits also the tryptic and peptidyl glutamyl activities of the proteasome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEgVHeWnqC_rVg90H21EOLACvtfcHk0lgDe6vg64bl2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntlOmtrc%253D&md5=cb6b1732f8d4e3adc619ecb6591e1567</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFuchs%26aufirst%3DO.%26atitle%3DProteasome%2520inhibition%2520as%2520a%2520therapeutic%2520strategy%2520in%2520patients%2520with%2520multiple%2520myeloma%26jtitle%3DMult.%2520Myeloma%26date%3D2009%26spage%3D101%26epage%3D125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Lam, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lloyd, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neuteboom, S. T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palladino, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sethna, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spear, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potts, B. C.</span><span> </span><span class="NLM_article-title">From natural products to clinical trials: NPI-0052 (salinosporamide A), a marine actinomycete-derived anticancer agent</span> <span class="citation_source-journal">Nat. Prod. Chem. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">373</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm201118h&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitlCjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=355-373&author=K.+S.+Lamauthor=G.+K.+Lloydauthor=S.+T.+C.+Neuteboomauthor=M.+A.+Palladinoauthor=K.+M.+Sethnaauthor=M.+A.+Spearauthor=B.+C.+Potts&title=From+natural+products+to+clinical+trials%3A+NPI-0052+%28salinosporamide+A%29%2C+a+marine+actinomycete-derived+anticancer+agent"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">From natural products to clinical trials: NPI-0052 (salinosporamide A), a marine actinomycete-derived anticancer agent</span></div><div class="casAuthors">Lam, Kin S.; Lloyd, G. Kenneth; Neuteboom, Saskia T. C.; Palladino, Michael A.; Sethna, Kobi M.; Spear, Matthew A.; Potts, Barbara C.</div><div class="citationInfo"><span class="NLM_cas:title">Natural Product Chemistry for Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">355-373</span>CODEN:
                <span class="NLM_cas:coden">69MGLO</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The unique aspects of developing a marine actinomycete-derived therapeutic agent, NPI-0052, are highlighted.  Salinosporamide A (designated as NPI-0052) was first isolated from the fermn. broth of Salinispora tropica strain CNB392.  This highly potent 20S proteasome inhibitor is currently undergoing Phase I clin. studies for the treatment of various hematol. and solid tumor malignancies.  An account is given of events from the early mechanism of action and preclin. studies that supported its entry into clin. trials in cancer patients, to the current strategy for its continued development as an anticancer agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFzGil7yTcC7Vg90H21EOLACvtfcHk0lh0ZUMaoy-Ndw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitlCjug%253D%253D&md5=1498e5081a2ba9e7eff273ecb2124899</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLam%26aufirst%3DK.%2BS.%26aulast%3DLloyd%26aufirst%3DG.%2BK.%26aulast%3DNeuteboom%26aufirst%3DS.%2BT.%2BC.%26aulast%3DPalladino%26aufirst%3DM.%2BA.%26aulast%3DSethna%26aufirst%3DK.%2BM.%26aulast%3DSpear%26aufirst%3DM.%2BA.%26aulast%3DPotts%26aufirst%3DB.%2BC.%26atitle%3DFrom%2520natural%2520products%2520to%2520clinical%2520trials%253A%2520NPI-0052%2520%2528salinosporamide%2520A%2529%252C%2520a%2520marine%2520actinomycete-derived%2520anticancer%2520agent%26jtitle%3DNat.%2520Prod.%2520Chem.%2520Drug%2520Discovery%26date%3D2010%26spage%3D355%26epage%3D373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Zhou, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aujay Monette, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett Mark, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dajee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demo Susan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho Mark, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirk Christopher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laidig Guy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis Evan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muchamuel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parlati, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ring, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shenk Kevin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shields, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shwonek Peter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanton, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun Congcong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sylvain, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo Tina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span> </span><span class="NLM_article-title">Design and synthesis of an orally bioavailable and selective peptide epoxyketone proteasome inhibitor (PR-047)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3028</span><span class="NLM_x">–</span> <span class="NLM_lpage">3038</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801329v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm201118h&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktFemtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=3028-3038&author=H.-J.+Zhouauthor=A.+Aujay+Monetteauthor=K.+Bennett+Markauthor=M.+Dajeeauthor=D.+Demo+Susanauthor=Y.+Fangauthor=N.+Ho+Markauthor=J.+Jiangauthor=J.+Kirk+Christopherauthor=J.+Laidig+Guyauthor=R.+Lewis+Evanauthor=Y.+Luauthor=T.+Muchamuelauthor=F.+Parlatiauthor=E.+Ringauthor=D.+Shenk+Kevinauthor=J.+Shieldsauthor=J.+Shwonek+Peterauthor=T.+Stantonauthor=M.+Sun+Congcongauthor=C.+Sylvainauthor=M.+Woo+Tinaauthor=J.+Yang&title=Design+and+synthesis+of+an+orally+bioavailable+and+selective+peptide+epoxyketone+proteasome+inhibitor+%28PR-047%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of an Orally Bioavailable and Selective Peptide Epoxyketone Proteasome Inhibitor (PR-047)</span></div><div class="casAuthors">Zhou, Han-Jie; Aujay, Monette A.; Bennett, Mark K.; Dajee, Maya; Demo, Susan D.; Fang, Ying; Ho, Mark N.; Jiang, Jing; Kirk, Christopher J.; Laidig, Guy J.; Lewis, Evan R.; Lu, Yan; Muchamuel, Tony; Parlati, Francesco; Ring, Eileen; Shenk, Kevin D.; Shields, Jamie; Shwonek, Peter J.; Stanton, Timothy; Sun, Congcong M.; Sylvain, Catherine; Woo, Tina M.; Yang, Jinfu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3028-3038</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Epoxypeptides such as I are prepd. as carfilzomib analogs and proteasome inhibitors for use as antitumor agents; the inhibition of human 20S proteasomes and of the growth of multidrug-resistant and nonresistant cancer cells by selected compds. and their stabilities in simulated gastric and intestinal fluids and in liver microsomes are detd.  I selectively inhibits chymotrypsin-like activity of both the constitutive proteasome (β5) and immunoproteasome (LMP7) and demonstrated an abs. bioavailability of up to 39% in rodents and dogs.  I is well tolerated with repeated oral administration at doses resulting in >80% proteasome inhibition in most tissues and elicited an antitumor response equiv. to i.v. administered carfilzomib in multiple human tumor xenograft and mouse syngeneic models.  I is prepd. in eight steps (longest linear sequence) from Cbz-L-phenylalanine, Boc-O-methyl-L-serine, 2-methyl-5-thiazolecarboxylic acid, and isopropenylmagnesium bromide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouNBIBwb8w47Vg90H21EOLACvtfcHk0lh0ZUMaoy-Ndw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktFemtLw%253D&md5=688c8d0942539bab2e50617d083bf89a</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm801329v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801329v%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DH.-J.%26aulast%3DAujay%2BMonette%26aufirst%3DA.%26aulast%3DBennett%2BMark%26aufirst%3DK.%26aulast%3DDajee%26aufirst%3DM.%26aulast%3DDemo%2BSusan%26aufirst%3DD.%26aulast%3DFang%26aufirst%3DY.%26aulast%3DHo%2BMark%26aufirst%3DN.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DKirk%2BChristopher%26aufirst%3DJ.%26aulast%3DLaidig%2BGuy%26aufirst%3DJ.%26aulast%3DLewis%2BEvan%26aufirst%3DR.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DMuchamuel%26aufirst%3DT.%26aulast%3DParlati%26aufirst%3DF.%26aulast%3DRing%26aufirst%3DE.%26aulast%3DShenk%2BKevin%26aufirst%3DD.%26aulast%3DShields%26aufirst%3DJ.%26aulast%3DShwonek%2BPeter%26aufirst%3DJ.%26aulast%3DStanton%26aufirst%3DT.%26aulast%3DSun%2BCongcong%26aufirst%3DM.%26aulast%3DSylvain%26aufirst%3DC.%26aulast%3DWoo%2BTina%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520an%2520orally%2520bioavailable%2520and%2520selective%2520peptide%2520epoxyketone%2520proteasome%2520inhibitor%2520%2528PR-047%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D3028%26epage%3D3038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Sterz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Metzler, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahne, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamottke, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rademacher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heider, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terpos, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sezer, O.</span><span> </span><span class="NLM_article-title">The potential of proteasome inhibitors in cancer therapy</span> <span class="citation_source-journal">Expert Opin. Invest. Drug</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">879</span><span class="NLM_x">–</span> <span class="NLM_lpage">895</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm201118h&amp;key=10.1517%2F13543784.17.6.879" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm201118h&amp;key=18491989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm201118h&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmtV2ktrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2008&pages=879-895&author=J.+Sterzauthor=I.+von+Metzlerauthor=J.-C.+Hahneauthor=B.+Lamottkeauthor=J.+Rademacherauthor=U.+Heiderauthor=E.+Terposauthor=O.+Sezer&title=The+potential+of+proteasome+inhibitors+in+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">The potential of proteasome inhibitors in cancer therapy</span></div><div class="casAuthors">Sterz, Jan; von Metzler, Ivana; Hahne, Jens-Claus; Lamottke, Britta; Rademacher, Jessica; Heider, Ulrike; Terpos, Evangelos; Sezer, Orhan</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">879-895</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Background: The ubiquitin-proteasome system has become a promising novel mol. target in cancer due to its crit. role in cellular protein degrdn., its interaction with cell cycle and apoptosis regulation and its unique mechanism of action.  Objective: This review focuses both on preclin. results and on data from clin. trials with proteasome inhibitors in cancer.  Methods: Results in hematol. malignancies and solid tumors were included, and important data presented in abstr. form were considered in this review.  Results/conclusion: Bortezomib as first-in-class proteasome inhibitor has proven to be highly effective in some hematol. malignancies, overcomes conventional chemoresistance, directly induces cell cycle arrest and apoptosis, and also targets the tumor microenvironment.  It has been granted approval by the FDA for relapsed multiple myeloma, and recently for relapsed mantle cell lymphoma.  Combination chemotherapy regimens have been developed providing high remission rates and remission quality in frontline treatment or in the relapsed setting in multiple myeloma.  The combination of proteasome inhibition with novel targeted therapies is an emerging field in oncol.  Moreover, novel proteasome inhibitors, such as NPI-0052 and carfilzomib, have been developed.  This review summarizes our knowledge of the ubiquitin-proteasome system and recent data from cancer clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_Oy8M6LysgrVg90H21EOLACvtfcHk0ljWdiwrVcBY9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmtV2ktrc%253D&md5=d757314a7af0d16a619ebc6dcb697a65</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1517%2F13543784.17.6.879&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.17.6.879%26sid%3Dliteratum%253Aachs%26aulast%3DSterz%26aufirst%3DJ.%26aulast%3Dvon%2BMetzler%26aufirst%3DI.%26aulast%3DHahne%26aufirst%3DJ.-C.%26aulast%3DLamottke%26aufirst%3DB.%26aulast%3DRademacher%26aufirst%3DJ.%26aulast%3DHeider%26aufirst%3DU.%26aulast%3DTerpos%26aufirst%3DE.%26aulast%3DSezer%26aufirst%3DO.%26atitle%3DThe%2520potential%2520of%2520proteasome%2520inhibitors%2520in%2520cancer%2520therapy%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drug%26date%3D2008%26volume%3D17%26spage%3D879%26epage%3D895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Lawrence, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kendig, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ge, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santiago, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guida, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebti, S. M.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of naphthoquinone analogs as a novel class of proteasome inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5576</span><span class="NLM_x">–</span> <span class="NLM_lpage">5592</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=5576-5592&author=H.+R.+Lawrenceauthor=A.+Kaziauthor=Y.+Luoauthor=R.+Kendigauthor=Y.+Geauthor=S.+Jainauthor=K.+Danielauthor=D.+Santiagoauthor=W.+C.+Guidaauthor=S.+M.+Sebti&title=Synthesis+and+biological+evaluation+of+naphthoquinone+analogs+as+a+novel+class+of+proteasome+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLawrence%26aufirst%3DH.%2BR.%26aulast%3DKazi%26aufirst%3DA.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DKendig%26aufirst%3DR.%26aulast%3DGe%26aufirst%3DY.%26aulast%3DJain%26aufirst%3DS.%26aulast%3DDaniel%26aufirst%3DK.%26aulast%3DSantiago%26aufirst%3DD.%26aulast%3DGuida%26aufirst%3DW.%2BC.%26aulast%3DSebti%26aufirst%3DS.%2BM.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520naphthoquinone%2520analogs%2520as%2520a%2520novel%2520class%2520of%2520proteasome%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D5576%26epage%3D5592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Kazi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guida Wayne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLaughlin Mark, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springett Gregory, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berndt, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yip Richard, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebti Said, M.</span><span> </span><span class="NLM_article-title">Discovery of a novel proteasome inhibitor selective for cancer cells over non-transformed cells</span> <span class="citation_source-journal">Cell Cycle</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1940</span><span class="NLM_x">–</span> <span class="NLM_lpage">1951</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=1940-1951&author=A.+Kaziauthor=H.+Lawrenceauthor=C.+Guida+Wayneauthor=L.+McLaughlin+Markauthor=M.+Springett+Gregoryauthor=N.+Berndtauthor=M.+L.+Yip+Richardauthor=M.+Sebti+Said&title=Discovery+of+a+novel+proteasome+inhibitor+selective+for+cancer+cells+over+non-transformed+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKazi%26aufirst%3DA.%26aulast%3DLawrence%26aufirst%3DH.%26aulast%3DGuida%2BWayne%26aufirst%3DC.%26aulast%3DMcLaughlin%2BMark%26aufirst%3DL.%26aulast%3DSpringett%2BGregory%26aufirst%3DM.%26aulast%3DBerndt%26aufirst%3DN.%26aulast%3DYip%2BRichard%26aufirst%3DM.%2BL.%26aulast%3DSebti%2BSaid%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520proteasome%2520inhibitor%2520selective%2520for%2520cancer%2520cells%2520over%2520non-transformed%2520cells%26jtitle%3DCell%2520Cycle%26date%3D2009%26volume%3D8%26spage%3D1940%26epage%3D1951" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Avdeenko, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velichko, N. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romanenko, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirozhenko, V. V.</span><span> </span><span class="NLM_article-title">Chlorination of <i>N</i>-arylsulfonyl-1,4-aminonaphthols and <i>N</i>-arylsulfonyl-1,4-naphthoquinone-1,4-imines</span> <span class="citation_source-journal">Zh. Org. Khim.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1747</span><span class="NLM_x">–</span> <span class="NLM_lpage">1757</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm201118h&amp;key=1%3ACAS%3A528%3ADyaK38XhsFWhur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1991&pages=1747-1757&author=A.+P.+Avdeenkoauthor=N.+V.+Velichkoauthor=E.+A.+Romanenkoauthor=V.+V.+Pirozhenko&title=Chlorination+of+N-arylsulfonyl-1%2C4-aminonaphthols+and+N-arylsulfonyl-1%2C4-naphthoquinone-1%2C4-imines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Chlorination of N-arylsulfonyl-1,4-aminonaphthols and N-arylsulfonyl-1,4-naphthoquinone-1,4-imines</span></div><div class="casAuthors">Avdeenko, A. P.; Velichko, N. V.; Romanenko, E. A.; Pirozhenko, V. V.</div><div class="citationInfo"><span class="NLM_cas:title">Zhurnal Organicheskoi Khimii</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1747-57</span>CODEN:
                <span class="NLM_cas:coden">ZORKAE</span>;
        ISSN:<span class="NLM_cas:issn">0514-7492</span>.
    </div><div class="casAbstract">The final products of chlorination of the title compds. I ( R = H, Cl; Ar = substituted Ph) and II are the tetrachloro derivs. III.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox9DADKeOmvbVg90H21EOLACvtfcHk0lgjPaDkYzem7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XhsFWhur8%253D&md5=39d894edc3d6184bf53870061d4fb917</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAvdeenko%26aufirst%3DA.%2BP.%26aulast%3DVelichko%26aufirst%3DN.%2BV.%26aulast%3DRomanenko%26aufirst%3DE.%2BA.%26aulast%3DPirozhenko%26aufirst%3DV.%2BV.%26atitle%3DChlorination%2520of%2520N-arylsulfonyl-1%252C4-aminonaphthols%2520and%2520N-arylsulfonyl-1%252C4-naphthoquinone-1%252C4-imines%26jtitle%3DZh.%2520Org.%2520Khim.%26date%3D1991%26volume%3D27%26spage%3D1747%26epage%3D1757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Altland, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briffa, B. F.,  Jr.</span><span> </span><span class="NLM_article-title">1,4-Addition of triazolium thiolates to quinones</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">433</span><span class="NLM_x">–</span> <span class="NLM_lpage">437</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00204a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1985&pages=433-437&author=H.+W.+Altlandauthor=B.+F.+Briffa&title=1%2C4-Addition+of+triazolium+thiolates+to+quinones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjo00204a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00204a002%26sid%3Dliteratum%253Aachs%26aulast%3DAltland%26aufirst%3DH.%2BW.%26aulast%3DBriffa%26aufirst%3DB.%2BF.%26atitle%3D1%252C4-Addition%2520of%2520triazolium%2520thiolates%2520to%2520quinones%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1985%26volume%3D50%26spage%3D433%26epage%3D437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Avdeenko, A. P.; Evgrafova, N. I.; Ryazantsev, V. P.; Luk’yanenko, L. V.; Titov, E. V.; Velichko, N. V.</span><span> </span><span class="NLM_article-title">Preparation of <i>N</i>-arylsulfonyl-2-chloro-1,4-naphthoquinone imines</span>. USSR Patent 1558901, 86–4156772, 1558901, 19861204, ,<span class="NLM_x"> </span><span class="NLM_year">1990</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1990&author=A.+P.+Avdeenko&author=N.+I.+Evgrafova&author=V.+P.+Ryazantsev&author=L.+V.+Luk%E2%80%99yanenko&author=E.+V.+Titov&author=N.+V.+Velichko&title=Preparation+of+N-arylsulfonyl-2-chloro-1%2C4-naphthoquinone+imines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAvdeenko%26aufirst%3DA.%2BP.%26atitle%3DPreparation%2520of%2520N-arylsulfonyl-2-chloro-1%252C4-naphthoquinone%2520imines%26date%3D1990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Avdeenko, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evgrafova, N. I.</span><span> </span><span class="NLM_article-title">Reaction of <i>N</i>-(arylsulfonyl)-<i>p</i>-naphthoquinonimines with acylhydrazines</span> <span class="citation_source-journal">Zh. Org. Khim.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1060</span><span class="NLM_x">–</span> <span class="NLM_lpage">1063</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm201118h&amp;key=1%3ACAS%3A528%3ADyaL1cXhtlWhsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1987&pages=1060-1063&author=A.+P.+Avdeenkoauthor=N.+I.+Evgrafova&title=Reaction+of+N-%28arylsulfonyl%29-p-naphthoquinonimines+with+acylhydrazines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Reaction of N-(arylsulfonyl)-p-naphthoquinonimines with acylhydrazines</span></div><div class="casAuthors">Avdeenko, A. P.; Evgrafova, N. I.</div><div class="citationInfo"><span class="NLM_cas:title">Zhurnal Organicheskoi Khimii</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1060-3</span>CODEN:
                <span class="NLM_cas:coden">ZORKAE</span>;
        ISSN:<span class="NLM_cas:issn">0514-7492</span>.
    </div><div class="casAbstract">Title quinonimines I (R = PhSO2, 4-MeC6H4SO2; R1 = Cl, SO2Ph) reacted with R2C6H4CONHNH2 (II; R2 = H, 3-Cl, 4-MeO) in refluxing EtOH to give ∼1-2:1 mixts. of 9 corresponding I [same R, R1 = NHNHCOC6H4R2 (III); R = R2C6H4CONH, same R1] in ≤97% combined yield.  Analogous reaction of I (same R, R1 = H) with II (R2 = H, 3-Cl, 2-HO, 4-O2N, 4-MeO) gave the corresponding III in 52.6-64.7% yield as the sole product.  Reducing III (R = PhSO2, R2 = 3-Cl) with Na2S2O4 in aq. NH3 gave the corresponding (acylhydrazino)sulfonamidonaphthol, which was reoxidized rapidly in air.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAfiTd40z8o7Vg90H21EOLACvtfcHk0liO-shuzBp5rQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXhtlWhsbo%253D&md5=9680737d9bbb7825f44bcc66150047ab</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAvdeenko%26aufirst%3DA.%2BP.%26aulast%3DEvgrafova%26aufirst%3DN.%2BI.%26atitle%3DReaction%2520of%2520N-%2528arylsulfonyl%2529-p-naphthoquinonimines%2520with%2520acylhydrazines%26jtitle%3DZh.%2520Org.%2520Khim.%26date%3D1987%26volume%3D23%26spage%3D1060%26epage%3D1063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Thiols</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coj, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Afanas’eva, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chupakhin, O. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sidorov, E. O.</span><span> </span><span class="NLM_article-title">Reactions of benzo analogs of <i>N</i>-phenyl-1,4-benzoquinone monoimine with thiols</span> <span class="citation_source-journal">Zh. Org. Khim.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">2409</span><span class="NLM_x">–</span> <span class="NLM_lpage">2416</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1989&pages=2409-2416&author=+Thiolsauthor=E.+Cojauthor=G.+B.+Afanas%E2%80%99evaauthor=O.+N.+Chupakhinauthor=E.+O.+Sidorov&title=Reactions+of+benzo+analogs+of+N-phenyl-1%2C4-benzoquinone+monoimine+with+thiols"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThiols%26aulast%3DCoj%26aufirst%3DE.%26aulast%3DAfanas%25E2%2580%2599eva%26aufirst%3DG.%2BB.%26aulast%3DChupakhin%26aufirst%3DO.%2BN.%26aulast%3DSidorov%26aufirst%3DE.%2BO.%26atitle%3DReactions%2520of%2520benzo%2520analogs%2520of%2520N-phenyl-1%252C4-benzoquinone%2520monoimine%2520with%2520thiols%26jtitle%3DZh.%2520Org.%2520Khim.%26date%3D1989%26volume%3D25%26spage%3D2409%26epage%3D2416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Fujita, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sano, K.</span><span> </span><span class="NLM_article-title">Reduction of quinones and quinonemonosulfonimides with <i>N</i>,<i>N</i>-diethylhydroxylamine</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">2647</span><span class="NLM_x">–</span> <span class="NLM_lpage">2651</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo01329a012" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm201118h&amp;key=1%3ACAS%3A528%3ADyaE1MXkslCgsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1979&pages=2647-2651&author=S.+Fujitaauthor=K.+Sano&title=Reduction+of+quinones+and+quinonemonosulfonimides+with+N%2CN-diethylhydroxylamine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Reduction of quinones and quinonemonosulfonimides with N,N-diethylhydroxylamine</span></div><div class="casAuthors">Fujita, Shinsaku; Sano, Kazuya</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2647-51</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">p-Quinones and quinonemonosulfonimides were reduced by Et2NOH (I) to give the corresponding hydroquinones and sulfonylaminophenols, resp.  The I redn. is a key step in an improved synthetic route to dye developers II (R = CHMe2, CH2CH2OMe, CH2CH2OEt; R1 = H or Ac).  Nitrone-hydroquinone 1:1 complexes III (R = Ph, 4-MeC6H4, 4-BrC6H4, 4-ClC6H4, R1-R3 = H; R = R2 = Me3C, R1 = R3 = H; R-R3 = Cl) were isolated as intermediates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6BLeGBRB7ULVg90H21EOLACvtfcHk0li2UOYplILs0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1MXkslCgsr4%253D&md5=f125fa6d0f6ed6dc67d12b600a8a7502</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjo01329a012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01329a012%26sid%3Dliteratum%253Aachs%26aulast%3DFujita%26aufirst%3DS.%26aulast%3DSano%26aufirst%3DK.%26atitle%3DReduction%2520of%2520quinones%2520and%2520quinonemonosulfonimides%2520with%2520N%252CN-diethylhydroxylamine%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1979%26volume%3D44%26spage%3D2647%26epage%3D2651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Lien, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, L.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teng, C.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, S.-C.</span><span> </span><span class="NLM_article-title">Synthesis of 2-alkoxy 1,4-naphthoquinone derivatives as antiplatelet, antiinflammatory, and antiallergic agents</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">672</span><span class="NLM_x">–</span> <span class="NLM_lpage">674</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2002&pages=672-674&author=J.-C.+Lienauthor=L.-J.+Huangauthor=C.-M.+Tengauthor=J.-P.+Wangauthor=S.-C.+Kuo&title=Synthesis+of+2-alkoxy+1%2C4-naphthoquinone+derivatives+as+antiplatelet%2C+antiinflammatory%2C+and+antiallergic+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLien%26aufirst%3DJ.-C.%26aulast%3DHuang%26aufirst%3DL.-J.%26aulast%3DTeng%26aufirst%3DC.-M.%26aulast%3DWang%26aufirst%3DJ.-P.%26aulast%3DKuo%26aufirst%3DS.-C.%26atitle%3DSynthesis%2520of%25202-alkoxy%25201%252C4-naphthoquinone%2520derivatives%2520as%2520antiplatelet%252C%2520antiinflammatory%252C%2520and%2520antiallergic%2520agents%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D2002%26volume%3D50%26spage%3D672%26epage%3D674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Obafemi, C. A.</span><span> </span><span class="NLM_article-title">Studies in the heterocyclic compounds. II. The mass spectra of some thiophene-sulfonyl derivatives</span> <span class="citation_source-journal">Phosphorus Sulfur</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">201</span><span class="NLM_x">–</span> <span class="NLM_lpage">204</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm201118h&amp;key=10.1080%2F03086648008078189" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm201118h&amp;key=1%3ACAS%3A528%3ADyaL3cXlvVGhtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1980&pages=201-204&author=C.+A.+Obafemi&title=Studies+in+the+heterocyclic+compounds.+II.+The+mass+spectra+of+some+thiophene-sulfonyl+derivatives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Studies in the heterocyclic compounds.  II.  The mass spectra of some thiophene-sulfonyl derivatives</span></div><div class="casAuthors">Obafemi, Craig A.</div><div class="citationInfo"><span class="NLM_cas:title">Phosphorus and Sulfur and the Related Elements</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">201-4</span>CODEN:
                <span class="NLM_cas:coden">PREEDF</span>;
        ISSN:<span class="NLM_cas:issn">0308-664X</span>.
    </div><div class="casAbstract">The mass spectra of I (R = Cl, NH2, N3, C6H11NH, PhNMe) showed that the main fragmentation in the 1st 3 compds. is S-R cleavage.  In the cyclohexylamino deriv. this cleavage occurs in 2 steps and in I (R = PhNMe) it is unimportant.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJHFLEOETV4rVg90H21EOLACvtfcHk0liBluRR1J0K5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXlvVGhtLw%253D&md5=e6b2a23df96fd3f59221c2ce719d86b0</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1080%2F03086648008078189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F03086648008078189%26sid%3Dliteratum%253Aachs%26aulast%3DObafemi%26aufirst%3DC.%2BA.%26atitle%3DStudies%2520in%2520the%2520heterocyclic%2520compounds.%2520II.%2520The%2520mass%2520spectra%2520of%2520some%2520thiophene-sulfonyl%2520derivatives%26jtitle%3DPhosphorus%2520Sulfur%26date%3D1980%26volume%3D8%26spage%3D201%26epage%3D204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Matsubara, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doko, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uetake, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, S.</span><span> </span><span class="NLM_article-title">Enesulfonamides as nucleophiles in catalytic asymmetric reactions</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3047</span><span class="NLM_x">–</span> <span class="NLM_lpage">3050</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=3047-3050&author=R.+Matsubaraauthor=T.+Dokoauthor=R.+Uetakeauthor=S.+Kobayashi&title=Enesulfonamides+as+nucleophiles+in+catalytic+asymmetric+reactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMatsubara%26aufirst%3DR.%26aulast%3DDoko%26aufirst%3DT.%26aulast%3DUetake%26aufirst%3DR.%26aulast%3DKobayashi%26aufirst%3DS.%26atitle%3DEnesulfonamides%2520as%2520nucleophiles%2520in%2520catalytic%2520asymmetric%2520reactions%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2007%26volume%3D46%26spage%3D3047%26epage%3D3050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Adams, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitaker, L.</span><span> </span><span class="NLM_article-title">Quinone imides. XXXIX. Adducts of quinone monoimides and conversion of active methylene adducts to benzofurans</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1956</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">658</span><span class="NLM_x">–</span> <span class="NLM_lpage">663</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja01584a037" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm201118h&amp;key=1%3ACAS%3A528%3ADyaG28XmvFegug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=1956&pages=658-663&author=R.+Adamsauthor=L.+Whitaker&title=Quinone+imides.+XXXIX.+Adducts+of+quinone+monoimides+and+conversion+of+active+methylene+adducts+to+benzofurans"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Quinone imides. XXXIX. Adducts of quinone monoimides and conversion of active methylene adducts to benzofurans</span></div><div class="casAuthors">Adams, Roger; Whitaker, Leroy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1956</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">658-63</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">cf. C.A. 50, 8509f.  4,1-PhSO2NHC10H6OH (8.4 g.) and 12.6 g. Pb(OAc)4 in 42 cc. glacial AcOH stirred 1 h. at room temp, treated with 1 cc. (CH2OH)2, stirred 15 min., cooled, and filtered gave 5.31 g. 1,4-naphthoquinone monobenzenesulfonimide (I), yellow needles, m. 152-4° (from CHCl3-cyclohexane).  The appropriate quinone imide (0.01 mol) and 0.011 mol of a suitable active methylene compd. in 50 cc. dry dioxane kept with 40 mg. NaOMe at room temp. gave the corresponding adduct; the reaction mixt. was worked up by one of 4 different procedures: (A) the mixt. was filtered, the filtrate concd. to about 25 cc. in vacuo on the steam bath and dild. with ligroine (b.p. 80-100°), and the pptd. oil cooled; (B) the mixt. was poured into H2O; (C) the dioxane was evapd. in a stream of air, the residue dild. with ligroine, the dark oily ppt. dissolved in Me2CO, and the soln. evapd. slowly; (D) the dioxane was evapd. in a stream of air, the residue dild. with H2O, the pptd. oil dissolved in AcOH, and the soln. poured with stirring into H2O.  In this manner were prepd. a no. of adducts (reaction time in min., % crude yield, m.p. of pure adduct given, and method of isolation) from the following components: p-quinone monobenzenesulfonimide (II), Ac2CH2, 15, 94, 171-3.5° (decompn.) (from EtOAc-ligroine), (A) II, AcCH2CO2Et-0.5, 94, 171° (decompn.) (from EtOH), A; II, BzCH2CO2, Et, 5, 98, 197-8° (from EtOH), B; II, AcCH2CONHPh, 120, 87, 181.5-82° (from EtOAc), B; II, CH2(CO2Et)2, 3 days, 18, 160-2° (from EtOH), C; II, Et cyclohexanone-2-carboxylate, 60, 95, 175-7° (from EtOH), B; II, CH2(CO2Et)2, 1200, - , oil, A; p-quinone monomethanesulfonimide, Ac2CH2, 30, - , oil, A; I, Ac2CH2, 7 days, 184-6° (from EtOAc), 70, D.  The conversion of the active methylene adducts to benzofurans was accomplished by 4 methods: A, 1.00 g. adduct in 50 cc. const. boiling HCl was refluxed and cooled; B, 1.00 g. adduct in 50 cc. 70% H2SO4 was kept at room temp. and poured onto crushed ice; C, 25 cc. concd. HCl was added to 1.00 g. adduct in 40 cc. dioxane or Me2CO, and the mixt. refluxed and evapd.; D, 0.0067 mol quinonemonoimide and 0.07 mol active methylene compd. in 50 cc. dry CHCl3 was kept at room temp. with 3 drops Et3N, the CHCl3 evapd. in an air stream, the oily residue dissolved in Me2CO, and the soln. poured into HCl and ice.  In this manner were prepd. the following furans (m.p., % crude yield, reaction time in hrs., method, and adduct employed given): 3-acetyl-5-benzenesulfonamido-2-methylbenzofuran, 191.5-3.5° (from C6H6-ligroine), 77, 5.5, A, 3-(5-benzene-sulfonamido-2-hydroxyphenyl)-2,4-pentanedione; Et 5-benzenesulfonamido-2-methylbenzofuran-3-carboxylate, 143-4° (from Me2CO-ligroine), 96, 3, A (96%, 48 h., B), Et α-(5-benzenesulfonamido-2-hydroxyphenyl)acetoacetate;  Et 5-benzenesulfonamido-2-phenylbenzofuran-3-carboxylate, 134.5-5.5° (from EtOH), 92, 17, C, Et α-(5-benzenesulfonamido-2-hydroxyphenyl)benzoylacetate; 5-benzenesulfonamido-2-methylbenzofuran-3-carboxylic acid, 254.5° (decompn.) (from EtOH), 67, 18, C, α-(5-benzenesulfonamido-2-hydroxyphenyl)acetoacetanilide; 3-acetyl-5-methylsulfonamido-2-methylbenzofuran, 171-2° (from dioxane), 35, 12, C, 3-(5-methylsulfonamido-1-hydroxyphenyl)-2,4-pentanedione, 246-7° (from EtOH), 65, 14 days (75%, 24, hrs., A), D, 3-(4-benzenesulfonamido-1-hydroxynaphthalene-2)-2,4-pentanedione; 5-benzenesulfonamido-2-methylbenzofuran-3-acetic acid, 200-1.5° (decompn.) (from EtOH), 17, 24, C, di-Et 1-acetyl-1-(5-benzenesulfonamido-2-hydroxyphenyl)succinate; Et 2-benzenesulfonamido-7,8,9,9a-tetrahydrodibenzofuran-9a-carboxylate, 186-8° (from EtOH), 71, 6, A, Et 1-(5-benzenesulfonamido-2-hydroxyphenyl)-2-oxocyclohexanecarboxylate (III); 2-benzenesulfonamido-7,8,9,9a-tetrahydrodibenzofuran, 191-2.5° (from EtOH), 33, 18, C, III.  Et α-(5-benzenesulfonamido-2-hydroxyphenyl)-acetoacetate (1.89 g.) and 2.30 g. Pb(OAc)4 in 50 cc. glacial AcOH stirred 18 h. at room temp., treated with 0.50 cc. (CH2OH)2, stirred 5 min., and cooled gave 1.00 g. Et α-(3-acetoxy-5-benzenesulfonamido-2-hydroxyphenyl)acetoacetate, small white crystals, m. 193-5° (decompn.) (from EtOH).  II (2.47 g.) and 2.56 g. di-Et succinosuccinate (IV) in 25 cc. dry CHCl3 treated 1 h. with 40 mg. MeONa yielded 3.15 g. di-Et 3,6-dihydro-2,5-bis(5-benzenesulfonamido-2-hydroxyphenoxy)terephthalate, white crystals, m. 269-70° (decompn.); the original CHCl3 soln. evapd. gave 1.25 g. unchanged IV, m. 125.5-8.5°.  I (1.99 g.) and 0.60 g. piperidine in 30 cc. CHCl3 kept 21 h. at room temp. gave 0.66 g. unidentified pink solid, m. 161-6°; the CHCl3 soln. evapd. in an air stream and the oily residue treated with EtOH gave 1.77 g. 2-piperidino-1,4-naphthoquinone 4-benzenesulfonimide (V), m. 174.5-76° (from CHCl3-cyclohexane).  V (0.50 g.) in 10 cc. EtOH refluxed 10 min. with 0.75 g. Na2S2O4 in 5 cc. H2O, dild. with 10 cc. EtOH, and filtered, and the filtrate cooled gave 4-benzenesulfonamido-2-piperidino-1-naphthol, white solid which formed a black tar at 161°.  Morpholine (0.61 g.) and 1.99 g. I in 30 cc. CHCl3 kept 48 h. at room temp. and filtered gave 0.32 g. pink solid which could not be purified; the filtrate evapd. and the oily residue extd. with hot EtOH left 0.75 g. 4-benzenesulfonamido-2-morpholino-1-naphthol, white crystals, m. 201-2° (from CHCl3), which slowly turned pink in air; the EtOH ext. evapd. gave 1.40 g. 2-morpholino-1,4-naphthoquinone 4-benzenesulfonamide, red crystals, m. 193-4.5° (from EtOH).  I (1.99 g.) and 0.65 g. PhNH2 in 30 cc. CHCl3 kept 60 h. at room temp. and the cryst. deposit washed with CHCl3 gave 0.79 g. 4-benzenesulfonamido-1-naphthol, white crystals, m. 202-4° (from AcOH); the combined CHCl3 washings and original filtrate concd. and dild. with cyclohexane yielded 1.57 g. 2-anilino-1,4-naphthoquinone 4-benzenesulfonimide (VI), bright red needles, m. 175-6° (from EtOH).  VI (0.50 g.) in 50 cc. EtOH and 10 cc. H2O heated 10 min. with 1.00 g. Na2S2O4, filtered hot, and dild. with H2O yielded 0.48 g. 2-anilino-4-benzenesulfonamido-1-naphthol, white crystals, m. 184-5° (from EtOH under N); it turned slowly pink in air.  II (1.00 g.) in 30 cc. boiling glacial AcOH treated with 1.31 g. PhSO2Na, dild. with 80 cc. H2O, and cooled yielded 1.49 g. 4-benzenesulfonamido-2-phenylsulfonylphenol (VII), white flakes, m. 170-1° (from EtOH).  VII (0.50 g.) in 20 cc. glacial AcOH treated with stirring with 0.68 g. Pb(OAc)4 and after 0.5 h. with 5 drops (CH2OH)2, stirred 10 min., and cooled gave 0.41 g. 2-benzenesulfonamido-1,4-quinone 4-benzenesulfonimide (VIII), orange needles, m. 162.5-3.5° (from AcOH).  PhSO2Na (0.15 g.) in 2 cc. H2O added to 0.20 g. VIII in 10 cc. glacial AcOH, dild. with 10 cc. H2O, and cooled yielded 0.26 g. 4-benzenesulfonamido-2,6-bis(phenylsulfonyl)phenol, white crystals, m. 200° (from EtOH).  I (1.00 g.) in 30 cc. boiling glacial AcOH treated with 1.00 g. PhSO2Na and cooled gave 1.32 g. 1-naphthol analog of VII, white needles, m. 204.5° (from AcOH).  NaN3 (1.00 g.) in 4 cc. H2O added to 1.50 g. II in 30 cc. glacial AcOH, poured after 5 min. into 80 cc. H2O (protected from light) and cooled gave 1.67 g. 2-azido-4-benzenesulfonamidophenol (IX), white needles, m. 121-2.5° (decompn.) (pptd. from EtOH with H2O).  Na2S2O4 (6.0 g.) in 30 cc. H2O added to 1.00 g. IX in 30 cc. 5% aq. NaOH, boiled 10 min., dild. with H2O, and acidified slightly with dil. HCl yielded 0.76 g. 2-amino-4-benzenesulfonamidophenol (X), m. 165-8°.  Crude X (1.00 g.) in 100 cc. 5% aq. HCl treated slowly with 5% aq. NaOH until the mixt. became slightly turbid, the mixt. treated with a few cc. HCl, a few chips of ice, and then 10 cc. Ac2O, treated with shaking with 10 g. NaOAc in 100 cc. H2O, and cooled yielded 1.03 g. 2-AcNH analog of X, small white crystals, m. 242-2.5° (decompn.) (from Me2CO-CHCl3).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNhaz3x8PuU7Vg90H21EOLACvtfcHk0liBluRR1J0K5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG28XmvFegug%253D%253D&md5=dcab3611845a85205923a388a1f17186</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fja01584a037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01584a037%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DR.%26aulast%3DWhitaker%26aufirst%3DL.%26atitle%3DQuinone%2520imides.%2520XXXIX.%2520Adducts%2520of%2520quinone%2520monoimides%2520and%2520conversion%2520of%2520active%2520methylene%2520adducts%2520to%2520benzofurans%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1956%26volume%3D78%26spage%3D658%26epage%3D663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Travis, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciaramitaro, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borhan, B.</span><span> </span><span class="NLM_article-title">Preparation of purified KHSO<sub>5</sub>·H<sub>2</sub>O and nBu<sub>4</sub>NHSO<sub>5</sub> from oxone by simple and efficient methods</span> <span class="citation_source-journal">Eur. J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_fpage">3429</span><span class="NLM_x">–</span> <span class="NLM_lpage">3434</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&pages=3429-3434&author=B.+R.+Travisauthor=B.+P.+Ciaramitaroauthor=B.+Borhan&title=Preparation+of+purified+KHSO5%C2%B7H2O+and+nBu4NHSO5+from+oxone+by+simple+and+efficient+methods"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTravis%26aufirst%3DB.%2BR.%26aulast%3DCiaramitaro%26aufirst%3DB.%2BP.%26aulast%3DBorhan%26aufirst%3DB.%26atitle%3DPreparation%2520of%2520purified%2520KHSO5%25C2%25B7H2O%2520and%2520nBu4NHSO5%2520from%2520oxone%2520by%2520simple%2520and%2520efficient%2520methods%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2002%26spage%3D3429%26epage%3D3434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Altland, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briffa, B. F.,  Jr.</span><span> </span><span class="NLM_article-title">1,4-Addition of triazolium thiolates to quinones</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">433</span><span class="NLM_x">–</span> <span class="NLM_lpage">437</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00204a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1985&pages=433-437&author=H.+W.+Altlandauthor=B.+F.+Briffa&title=1%2C4-Addition+of+triazolium+thiolates+to+quinones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjo00204a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00204a002%26sid%3Dliteratum%253Aachs%26aulast%3DAltland%26aufirst%3DH.%2BW.%26aulast%3DBriffa%26aufirst%3DB.%2BF.%26atitle%3D1%252C4-Addition%2520of%2520triazolium%2520thiolates%2520to%2520quinones%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1985%26volume%3D50%26spage%3D433%26epage%3D437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Johnston, C. I.</span><span> </span><span class="NLM_article-title">Angiotensin receptor antagonists: focus on losartan</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">346</span><span class="NLM_x">, </span> <span class="NLM_fpage">1403</span><span class="NLM_x">–</span> <span class="NLM_lpage">1407</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=346&publication_year=1995&pages=1403-1407&author=C.+I.+Johnston&title=Angiotensin+receptor+antagonists%3A+focus+on+losartan"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohnston%26aufirst%3DC.%2BI.%26atitle%3DAngiotensin%2520receptor%2520antagonists%253A%2520focus%2520on%2520losartan%26jtitle%3DLancet%26date%3D1995%26volume%3D346%26spage%3D1403%26epage%3D1407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Patani, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaVoie, E. J.</span><span> </span><span class="NLM_article-title">Bioisosterism: A rational approach in drug design</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">3147</span><span class="NLM_x">–</span> <span class="NLM_lpage">3176</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr950066q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm201118h&amp;key=1%3ACAS%3A528%3ADyaK28XntFSitLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1996&pages=3147-3176&author=G.+A.+Pataniauthor=E.+J.+LaVoie&title=Bioisosterism%3A+A+rational+approach+in+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Bioisosterism: A rational approach in drug design</span></div><div class="casAuthors">Patani, George A.; LaVoie, Edmond J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3147-3176</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review, with 191 refs., on bioisosteres that incorporates sufficient detail to enable the reader to understand the concepts being delineated.  Classical bioisosteres, such as monovalent atoms and groups, divalent isosteres, trivalent atoms and groups, tetra substituted atoms, and ring equiv., and non-classical bioisosteres, such as cyclic vs. non-cyclic non-classical bioisosteric replacements and non-classical bioisosteric replacements of functional groups, are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrADeNoRGbU9LVg90H21EOLACvtfcHk0lii-n06BZ8h7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XntFSitLg%253D&md5=4b3ec55087feabc53e0490ebd5a3ddcd</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fcr950066q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr950066q%26sid%3Dliteratum%253Aachs%26aulast%3DPatani%26aufirst%3DG.%2BA.%26aulast%3DLaVoie%26aufirst%3DE.%2BJ.%26atitle%3DBioisosterism%253A%2520A%2520rational%2520approach%2520in%2520drug%2520design%26jtitle%3DChem.%2520Rev.%26date%3D1996%26volume%3D96%26spage%3D3147%26epage%3D3176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i99"><a href="/doi/suppl/10.1021/jm201118h">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_34432"></div></div></div></div></div><hr /></hr><p class="last">Supporting analytical data; <sup>1</sup>H NMR, <sup>13</sup>C NMR, LCMS, and HPLC for key compounds.  This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm201118h/suppl_file/jm201118h_si_001.pdf">jm201118h_si_001.pdf (9.26 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm201118h&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm201118h%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-5" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm201118h" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67999c6ea981d94a","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
